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SUMMARY
A hereditary form of lymphosarcoma in Large White
pigs, associated with an autosomal recessive gene, is
diagnosed usually before 3 months of age and is fatal
by 15 months. The suitability of this condition for
testing anticancer chemotherapeutic agents has been in¬
vestigated using four agents representing each of the
four major modes of action. Prednisolone, adriamycin
(doxorubicin), cyclophosphamide and cytarabine as single
agents were administered to normal pigs to determine
appropriate dose levels and then to lymphosarcoma cases,
and the results compared with previously reported effects
in man and other species.
Prednisolone produced a reduction in numbers of cir¬
culating lymphocytes and in size of lymph nodes, which
was striking in the lymphosarcomatous pigs, an increase
in serum albumin and decrease in serum globulins and in¬
volution of the thymus with "overshoot" on recovery.
The lymphosarcoma cases showed improvements in appetite
and vigour and in neutrophil, thrombocyte and red cell
counts.
Adriamycin was cumulatively toxic at high
dose levels, producing bone marrow depression, involving
all types of white blood cells, red cells and thrombo¬
cytes, gastro-intestinal damage, stunting of growth, alo¬
pecia, stomatitis, sclerosis of blood vessels and pos¬
sibly cardiotoxicity . Lymphosarcoma cases did not
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survive a dose level of 2mg/kg. One of these
died of liver failure. A dose-level of lmg/kg pro¬
duced a general improvement in fitness, body condition
and weight gain with temporary suppression of the tumour
after each dose.
Cyclophosphamide produced few effects, other than
a consistent reversible, neutropenia during the 1st week
after dosing, even at high dose-levels. Alopecia and
haemorrhagic cystitis were not seen. Depression of
skin delayed hypersensitivity response and thymus in¬
volution were unexpected results. Lymphosarcoma
cases showed evidence of temporary suppression of the
tumour after each dose.
Normal pigs given cytarabine showed slight weight
loss and progressive bone marrow depression. Anti-
tumour effect was disappointing, only one lymphosarcoma-
tous animal showing evidence of response, despite the
fact that levels of deoxycytidine kinase, which acti¬
vates cytarabine, were shown to be four times higher
in lymphoid tissue from the lymphosarcoma cases compared
with the normal pigs.
Further studies were an investigation of the chemo-
tactic response to casein of blood monocytes and neutro¬
phils from normal pigs and lymphosarcoma cases, both
untreated and treated with prednisolone.
1.
INTRODUCTION
Tumours of the Haematopoietic System
Lymphocytes are formed chiefly in the lymph nodes,
spleen, Peyer's patches, and to a lesser extent in other
sites, such as the bone marrow. The other types of
leukocyte, the neutrophils _ eosinophils , basophils f
(granulocytes)and monocytes, and the red blood cells, are
formed in the bone marrow. Precursors of any of these
cells may be affected by neoplastic transformation, and the
result is a tumour, the abnormal cells of which resemble
the cell which originally became neoplastic. This may
occur at any stage of differentiation from the primitive
stem cell to the mature cell.
When abnormal white cells appear in the peripheral
blood, the condition is called "leukaemia". This term is
used to classify the range of diseases which originate from
the haematopoietic cell precursors of the bone marrow
and in which tumour cells circulate in the
blood early in the disease. If the disease develops
rapidly, i.e. if it is acute, the tumour cells tend to be
immature and are often called "blast" cells e.g. acute
lymphoblastic leukaemia. If the disease develops slowly
i.e. if it is chronic, the cells tend to be more mature.
The type of disease is diagnosed by examination of
peripheral blood smears and bone marrow samples, stained to
demonstrate features of the different kinds of cell.
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Solid tumours of the lymphoid system also occur.
These are called "lymphomas". They are initially
localised, usually in haematopoietic, but sometimes in
non-haematopoietic, areas of the body. From the initial
site, they spread by the lymphatics and by the bloodstream,
to involve other lymph nodes, bone marrow and organs such
as the liver, gastro-intestinal tract, and brain. At
this stage, abnormal lymphocytes may appear in the peri¬
pheral blood, and the disease will resemble, and in some
cases will be almost indistinguishable from leukaemia.
Lymphomas are usually diagnosed by histopathologic exam¬
ination of lymph node or other tissue.
The terms "lymphocytic leukaemia" and "lymphoma" in
the past have been used indiscriminately. However,
studies of these two types of disease in man have
indicated that they may be very different. Lingeman
(1969) discussed the differences between the leukaemias
and the lymphomas and the epidemiological patterns of
these diseases in different parts of the world. She
stated that, although a wide range of cell types of
leukaemias and lymphomas is seen, the most frequent types
fit into fairly well-defined clinical and pathological
syndromes, and the epidemiology of each of these has been
investigated. For example, in the United States,
leukaemias occur in definite age-associated distributions.
Acute lymphocytic or lymphoblastic leukaemias are seen
mainly in children and young adults, whereas acute myelo¬
cytic leukaemias most commonly occur in adults. Chronic
granulocytic leukaemia is commoner in young and middle-
aged adults, whereas chronic lymphocytic leukaemia is
rarely seen in people under the age of 40 years.
Because of the desire to treat these diseases in
man, much attention has been devoted to classification,
so that the epidemiology and natural progression of each
type could be identified, and results of treatment
assessed. However, there is still no general agree¬
ment on the classification of either the leukaemias or
the lymphomas. Recent proposals for classification of
the acute leukaemias were made by Bennett, Catovsky,
Daniel, Flandrin, Galton, Gralnick and Sultan (1976).
Lymphomas in man
1. Hodgkin's disease Named after Thos. Hodgkin,
an English physician (1798 - 1866).
The classical feature of this disease is the presence
of Reed-Sternberg giant cells in histological sections of
lymph nodes. The distinctive histology of the disease
was first recognised by Greenfield (1878) but Sternberg
(1898) and Dorothey Reed (1902) have been credited with
the discovery and the typical giant cells have been
named after them. The tumour is usually restricted
initially to one group of lymph nodes and spreads con¬
tiguously from one node to another, becoming widespread
in the body late in the disease. The age groups in
which the disease is more common are 20 to 30 years and
60 to 70 years. The tumour is very radiosensitive and
is usually treated with x-rays, unless fairly advanced,
but most cases are also given drugs.
2. Non-Hodgkin's lymphoma.
Following the recognition of Hodgkin's disease, the
non-Hodgkin lymphomas were identified, and a great deal
of literature on the subject has been published over the
years. In many reports the term "lymphosarcoma" has
been used to describe cases which were probably of this
type. Non-Hodgkin's lymphomas can involve bone
marrow and other organs, mainly spleen, liver and groups
of lymph nodes, very early in the course of the disease.
The incidence increases with age.
There are two important methods commonly used to
describe the varieties of the disease - the histopatho-
logical type and the extent of the disease at diagnosis.
1. Histopathological features of the disease;
Most authors now classify the non-Hodgkins lymphomas in
accordance with Rappaport, Winter and Hicks (1956). Con¬
fusion over terminology makes many pre-1956 reports of
doubtful relevance, but two large surveys which cannot be
ignored are those of Gall and Mallory (1942) who compiled
results from 618 cases of malignant lymphoma, 389 of
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which had non-Hodgkin's type and Rosenberg, Diamond and
Craven (1960), who reviewed 1269 patients with lympho¬
sarcoma. Rappaport, et al. , (1956) used the following
criteria in their classification:-
a) Cell type - lymphocytic or histiocytic.
b) State of cell differentiation.
i. Well differentiated i.e. small cells
with the typical appearance of lympho¬
cytes .
ii. Poorly differentiated i.e. large cells
which look immature (sometimes called
lymphoblastic).
iii. Undifferentiated.
c) Presence or absence of distinguishable normal
lymph node architecture i.e. presence or
absence of lymph nodules or follicles. If
present, the disease is termed "nodular".
If absent the term "diffuse" is used.
This classification has greatly helped to standardise
nomenclature, but it is not universally accepted (Lukes
and Collins, 1975).
Recent immunological techniques have made it possible
to define the origin of the tumour cell in many cases, and
a new classification based on the function of the cells
is now being widely used. Nevertheless, the prognostic
value of the Rappaport classification has been confirmed
in several other large series. Jones, Fuks, Bull, Kadin,
Dorfman, Kaplan, Rosenberg and Kim (1973) studied 405
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cases, Patchefsky, Brodsky, Menduke, Southard, Brooks,
Nicklas and Hoch, (1974) 293 cases, Brown, Peters,
Bergsagel and Reid (1975) 460 cases, and Dumont,
Duffillot, Flandrin, Chelloul, Tristant and Bernard
(1975) 244 cases.
II. Staging; Another major factor determining
the prognosis in the non-Hodgkin's lymphomas is the extent
of the disease when diagnosed. Staging is usually de¬
termined according to the Ann Arbor Classification, which
was proposed for Hodgkin's disease (Carbone, Kaplan,
Musshoff, Smithers and Tubiana 1971). With this classi¬
fication, patients are given a) a clinical stage, based
on history, physical examination, initial biopsy evidence
of lymphoma and radiography, and b) a pathologic stage
which is derived from histological findings after special
surgical procedures such as exploratory laparotomy, and
biopsies of various organs and bone marrow.
Table I shows the Ann Arbor Staging Classification
for non-Hodgkin's lymphomas (as modified by Jones et al.,
1973). Accurate determination of the stage of disease
is important when deciding on treatment. In the
series of Jones et. al., (1973) the final pathologic stage
based on the biopsy specimens (e.g. bone marrow) was more
advanced than was. indicated by the clinical assessment
in 46% of their patients.
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TABLE I.
Ann Arbor Staging Classification - non-Hodgkin's lymphoma.
Clinical Staging (CS)
Stage I: Involvement of a single lymph node region (I) or
of a single extralymphatic organ or site (IE).
Stage II: Involvement of two or more lymph node regions
on the same side of the diaphragm (II), or localised in¬
volvement of an extralymphatic organ or site and of one
or more lymph node regions on the same side of the diaph¬
ragm (HE).
Stage III: Involvement of lymph node regions on both
sides of the diaphragm (III) , which may also be accompanied
by localised involvement of the spleen (Ills), extra¬
lymphatic site (IIIE) or both (IIISE).
Stage IV: Diffuse or disseminated involvement of one or
more extralymphatic organs or tissues, with or without
associated lymph node enlargement.
Pathological Staging (PS)
Based on the state of involvement found at laparotomy
or by any further removal of tissue for histologic exam¬
ination, other than that taken for original diagnosis.
Includes annotations for specific sites biopsied:-
N+ or N- for other lymph node positive or negative
by biopsy.
H+ or H- for liver positive or negative by biopsy.




L+ or L- for lung positive or negative by
biopsy.
M+ or M- for bone marrow positive or negative
by biopsy.
P+ or P- for pleura or pleural fluid positive
or negative by biopsy or by cytologic
examination.
0+ or 0- for bone positive or negative by
biopsy.
D+ or D- for skin positive or negative by
biopsy.
If the reports of the four large series mentioned
earlier (Jones et al., 1973, Patchefsky et al., 1974,
Brown et a^. , 1975, and Dumont et al.., 1975) are con¬
sidered together, it is possible to determine some of the
typical features of the non-Hodgkin's lymphomas.
In all the series, diffuse lymphomas were more
common than nodular, and the latter type were very rarely
seen in patients under the age of 20. Jones et al.,
(1973) stated that older patients (over 60 years) also
tended to have diffuse lymphomas, but the other series
found no correlation in adults between age distribution
and histological type. Dumont et al., (1975) found
that the sex ratio of their patients was two males to one
female, but this male predominance was not seen in the
other series. Neither was there significant relationship
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between sex and histological type, though Jones et al.,
(1973) stated that a greater percentage of women had
nodular lymphomas and diffuse lymphomas were commoner
in men. The occurrence of systemic symptoms was de¬
scribed in three out of the four series. Weight loss,
fevers and night sweats were the commonest symptoms and
were seen much more frequently in patients with Stage IV
disease than in those with localised disease.
When the survival data from these series are consid¬
ered, it is clear that patients with lymphocytic, well-
differentiated and nodular tumours have a better prognosis
for long survival than those with histiocytic, poorly-
differentiated and diffuse lymphomas. Cases with
widespread disease at diagnosis had a worse prognosis
than cases with localised disease. The presence of
systemic symptoms appeared to give an unfavourable prog¬
nosis but this was probably because they were much com¬
moner in patients with Stage IV disease. Age at diagnosis
and sex did not appear to affect the prognosis to any
great extent.
Two types of initial extralymphatic involvement
were frequently observed - gastro-intestinal tract and
bone marrow. Once again, the prognostic significance
of involvement of these sites depended on whether the
tumour had a nodular or diffuse pattern, the latter giving
the poorer prognosis, but according to Jones et al., (1973),
gastro-intestinal tumour was commoner in patients with ad¬
vanced diffuse lymphomas, and localised gastro-intestinal
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involvement was rare.
Progression to a leukaemic form of the disease may
occur, especially in the poorly differentiated diffuse
type. Out of 323 patients studied by Stenfert Kroese,
Cleton and Somers (1975), 5.5% developed leukaemia. They
stated that this was not seen in patients aged between 30
and 50.
Childhood non-Hodgkin1s lymphoma
The natural history of the disease in children is
different from that in adults. Lingeman (1969) gave a
detailed review of the literature to that date and dis¬
cussed the patterns of the disease in different parts of
the world. In children it is a comparatively rare tumour.
Jones and Klingberg (1963) gave an incidence of 3.5 to 7.7%
of childhood neoplasms. It is a fulminating disease and
about 30% of cases undergo "leukaemic transformation" i.e.
the disease spreads rapidly throughout the body, involving
the bone marrow and occasionally the central nervous system,
and leukaemia appears. They tend to have a poor response
to treatment, and 50% of cases are dead within 6 months,
compared with 27 months in adults. In another article by
13 co-authors
Jones and / (1967) she stated that lymphosarcoma in children
is very difficult to differentiate from acute lympho¬
blastic leukaemia (ALL), and recommended that the disease
should have the same intensive chemotherapeutic approach
as ALL. Watanabe, Sullivan, Sutow and Wilbur (1973)
stated that bone marrow involvement was present in 70%
of their cases, but, surprisingly, that bone marrow and
meningeal disease were not necessarily an indication of
short survival. Glatstein, Kim, Donaldson, Dorfman,
Gribble, Wilbur, Rosenberg and Kaplan (1974) stated that
in their series of cases 97% were of diffuse lymphocytic
type, and that the nodular type was rare in children.
This contrasts with the figure given by Jones et al.,
(1973), for adults of 56% diffuse. In the study by
Murphy, Frizzera and Evans (1975), 93.5% of their cases
had diffuse histology. Only 7.7% of those with Stage
III and IV disease survived for 3 years, whereas 50% of
those with Stage I and II disease survived for that time.
The gastrointestinal tract was the most common site of
origin of the tumour. Central nervous system involve¬
ment occurred in 32% and leukaemia developed in 19%. In
another study reported by Hutter,Favara, Nelson and
Holton (1975), all cases had diffuse histology and 16
of 22 cases were diffuse poorly-differentiated lympho¬
cytic. Males were more commonly affected than females,
and this was also stated by Pinkel, Johnson and Aur (1975).
Of their patients, 41 out of 64 had diffuse, undifferen¬
tiated (lymphoblastic) lymphoma. They tended to be
boys under 10 years old and their median survival was 1
year. The next most common type was diffuse, poorly-
differentiated histiocytic lymphoma, also commonest in
boys.
The Ann Arbor staging classification has been applied
and accepted as being useful in the management of the
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disease. However, Lemerle, Gerard-Marchant,
Sarrazin, Sancho, Tchernia, Flamant, Lernerle and
Schweisguth (1973) suggested that the Ann Arbor classi¬
fication was far from adequate for staging lymphosarcoma
in children. Recently, the problem was discussed by
Murphy (1977). She quoted an alternative staging
scheme for children.
Pinkel e_t al. , (1975) and Murphy (1977) questioned
the value of the Rappaport classification in children,
since most cases are of the diffuse type, and they
stressed the difficulty of distinguishing between non-
Hodgkin's lymphoma with bone marrow involvement and
tumour cells in the blood, and acute leukaemia with extra
medullary disease at diagnosis. Pinkel et al.. , (1975)
recommended that, unless they had localised Stage I
disease, patients should all be treated with anti-leukaemic
therapy including multiple drug therapy, and central nervous
system irradiation to prevent meningeal involvement.
However, Murphy (1977), though advocating anti-leukaemic
drug therapy, did not agree that all patients should have
prophylactic treatment of the central nervous system.
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In general, survival time in patients of all ages
with non-Hodgkin's lymphoma may vary from a few months
to several years depending on the factors mentioned
previously, but apart from histological type, the most
important prognostic sign in cases of non-Hodgkin's
lymphoma is their response to treatment. The disease
may be treated by surgery and/or radiotherapy if
localised, but most cases, especially if widespread in
the body are treated with drugs.
The best prognosis is indicated when there is a rapid
response to treatment, with no signs of tumour at post-
therapy staging (Skarin, Pinkus, PYyerowitz, Bishop and
Moloney 1974 and Lister, Cullen, Beard, Brearley,
Whitehouse, Wrigley, Stansfield, Sutcliffe, Malpas and
Crowther, 1978) and it is now possible that many cases
may actually be cured (McKelvey and Moon, 1977). How¬
ever, for those cases not achieving complete remission,
for those who relapse early, and for children with ful¬
minating disease, hope for the future must be in con¬
tinuing research into new drugs and more effective com¬
binations of existing drugs.
Aetiology
There have been several theories advanced as to the
aetiology of haematopoietic neoplasms.
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Lymphomas and leukaemias are known to result from
exposure to ionising radiation - for example there is a
high incidence of lymphomas as well as leukaemias among
the survivors of the atomic bomb which devastated
Hiroshima (Anderson and Ishida 1964). Apart from
such obvious causes however, the theories are difficult
to prove.
One theory is that lymphomas result from prolonged
lymphocyte stimulation, possibly due to a failure of the
feedback mechanism which "switches off" lymphocyte re¬
sponse to an antigen (Isliker, Leuchtenberger, and Kliem
1973). This could certainly be the reason why renal
transplant recipients have a high incidence of cancers,
which are often poorly differentiated lymphocytic lym¬
phomas. However, these patients are also immuno-
suppressed by drugs. Untreated cancer patients
especially those with advanced disease, frequently show
immunosuppression and these facts lend support to
another theory, the "immunologic surveillance" theory,
which suggests that the tumour is due to a failure of
the immune system to recognise and destroy defective
cells, which are being produced all the time due to
genetic errors. These theories were discussed by
Schwartz (1975). Both these explanations are possible
in the case of tumours induced by oncogenic viruses.
Many viruses are known to cause immunosuppression. It
is possible also for the virus to become incorporated
into the genome of the host cell and thus alter the
growth control of the cell. Viruses are known to
cause lymphomas in several species but there is little
evidence as yet incriminating viruses in human lymphomas,
apart from Burkitt's lymphoma in Africa, a disease mainly
associated with
of children. This has been shown to bef a DNA
herpes virus called Epstein Barr Virus, spread by
mosquitoes (Epstein, 1970). Evidence for the pre¬
sence of tumour viruses in human lymphoid tumours has
been discussed by Spiegelman, Kufe, Hehlmann and Peters
(1973) and Chezzi, Dettori, Manzari, Agliano and Sanna
(1976) .
Genetic causes or predisposition cannot be discounted
when considering the aetiology of tumours. Although
evidence for this is scarce in humans, there are reports
in the literature of lymphomas in families e.g. Johnson
and Peters (1957). Freeman, Sinks and Cohen (1970)
described lymphosarcomas in siblings, associated with
cytogenetic abnormalities, immune deficiency and abnormal
erythropoiesis, and Maurer, Gotoff, Allen and Bolan (1976)
reported malignant lymphomas of the small intestine in
multiple family members, associated with an immunological
deficiency. Familial Hodgkin's disease (Grufferman,
Cole, Smith and Lukes, 1977) and leukaemias (Heath and
Moloney, 1965, Miller 1968, Rigby, Pratt, Rosenhof and




Haematopoietic neoplasms also occur commonly in
animals. Lymphomas are seen much more frequently
than leukaemias and have been reported in all the dom¬
esticated species, in wild animals and in fish. Disease
in animals unlike that in humans, has usually been
identified at post mortem examination rather than in
life. Probably this is the reason why there has been
a different approach to the classification of lymphoid
tumours in animals. The recognised types are based





4) Other forms, such as liver, kidney and
cutaneous
Confusion over terminology has led to the use of
many different names for the condition in the veterinary
literature, "leucosis", "lymphomatosis", "malignant
lymphoma", "malignant reticulosis", "pseudo-Hodgkin's
disease", "a-leukaemic leukaemia" and other terms have
all been used in the past, but the term which is now most
widely used is lymphosarcoma.
Multicentric lymphosarcoma in animals has been de¬
fined by Jarrett and Mackay (1974) as follows, "A dis¬
seminated neoplasm of the lymphoid organs in which there
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is usually bilateral and more or less symmetrical in¬
volvement of the lymph nodes; some regional groups
may be more obviously affected than others. Involve¬
ment of the spleen is usual but may range from a mere
prominence of Malpighian bodies to a marked and diffuse
splenomegaly. The other organs most commonly affected
are the liver, kidneys, lungs, heart, gastro-intestinal
>»
tract and bone marrow.
Alimentary, thymic and other forms are much less
common.
The alimentary type involves the Peyer's patches
of the gastro-intestinal tract and associated nodes.
Occasionally other organs are infiltrated.
The thymic type may involve the thymus only, or
it may spread to the mediastinal lymph nodes and some¬
times other organs.
The disease may involve the kidneys more than other
organs - this occurs occasionally in the cat. The
cutaneous form is rare, occurring chiefly in cattle
and dogs.
Lymphosarcoma in Cattle
The disease in cattle may be sporadic or infectious.
The latter is due to an oncogenic virus, Bovine Leukaemia
Virus, (BLV), and is usually called the enzootic form.
The Sporadic Form
There is usually only a single case in a herd.
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This form of the disease occurs in all ages, but most
cases are calves and yearlings, and it may even be found
in the newborn.
Calves less than 6 months old tend to develop the
multicentric type. There is sudden enlargement of all
the lymph nodes, and the superficial nodes are usually
visible as well as palpable, as painless hard swellings.
Yearlings and young cattle up to the age of 30
months commonly show the thymic type, which is recog¬
nisable by a large swelling in the posterior ventral part of
the neck.
In adults, there may be enlargement of the peri¬
pheral lymph nodes, but it is in older animals that the
cutaneous type may be found. Plaques appear in the
skin, covered with white scales, and the hair in these
areas is lost. The plaques then shrink and the hair
regrows. The peripheral nodes also shrink at this time,
but relapse occurs 1 to 2 years later, with involvement
of the internal nodes and organs.
Progressive loss of condition, depression, weakness
and anaemia are clinical signs which are typical with all
forms of the disease. In addition, pressure from en¬
larged nodes or thymus, or infiltration of organs such
as the heart, liver, abomasum or central nervous system
may produce a variety of other clinical signs. The
temperature is usually normal unless the tumour is




The virus form of the disease occurs in most parts
of the world and has been studied mainly in Scandinavia,
Germany and North America where it is a serious problem,
particularly in dairy herds. Until recently, there
was no evidence that the virus form occurred in Great
Britain, though the sporadic form is seen quite fre¬
quently. The essential features of the enzootic form
were summarised by Anderson and Jarrett (1968) as
follows:-
(a) Several cases occur within one herd.
(b) Most affected animals are over 4 years
old.
(c) The anatomical type is nearly always
multicentric.
(d) Apparently normal cattle in the same herd
may show a lymphocytosis on haematological
examination.
Anderson and Jarrett (1968) used these criteria
when considering the results of their British abattoir
of bovine neoplasms,
survey/ The abattoirs studied killed 1.3 x 10 cattle
in 1 year. From these animals, 302 specimens of
bovine neoplasms were recovered and 75 (25%) of these
were lymphosarcoma, the incidence being 58 per million
animals slaughtered. The percentage of animals under
4 years of age was 61, and the disease was found in
neonatal calves on several occasions. The thymic type
was more common than multicentric. Follow-up investi¬
gations among live animals did not reveal any cases,
and blood samples showed no evidence of lymphocytosis.
They therefore concluded that the virus type was unlikely
to occur in Great Britain. They made the point, how¬
ever, that many cases would be diagnosed in life, never
reaching an abattoir and estimated a true morbidity
rate of 200 per million based on experience at Glasgow
Veterinary Hospital.
The infectious form of the disease, known as
(EBL)
enzootic bovine leucosis,/has been known to be common in
Germany for many years, since lymphosarcoma was first
reported in cattle by Bollinger (1874). Two decades
ago in certain areas of Sweden, the condition was found
in 1% of slaughtered cattle (Olson, 1961) . At around
the same time, parts of Denmark had 10 times more cases
than other areas and the disease was increasing. This
situation led to the identification of multiple incidence
herds, and there was evidence of horizontal transmission
(Bendixen, 1960). The disease had previously been
shown to be transmissible in detailed studies by Go'tze
Rosenberger and Ziegenhagen (1956).
Investigations into the situation in the United
States as well as detailed descriptions of clinical,
pathological and haematological findings were published
by Marshak, Coriell, Lawrence, Groshaw, Schryver, Attera
and Nichols (1962) and Theilen, Dungworth, Lengyel and
Rosenblatt (1964).
Measures for the control of the disease were intro¬
duced in countries where the disease was a problem.
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Bendixen (1963 and 1965) described the system instituted
in Denmark, which consisted of compulsory reporting of
cases, haematological examinations and slaughtering out.
A large scale control programme was also undertaken in
Germany, and control measures, with recording of cattle
introduced, are now applied in some other countries,
but not U.S.A. or Canada.
Although it had long been suspected that a virus
was involved, it was not proven until Miller, Miller,
Olson and Gillette (1969) demonstrated Bovine Leucosis
Virus in stimulated lymphocyte cultures. This was shown
to be capable of producing lymphosarcoma when inoculated
into calves (Miller, Miller and Olson, 1972).
Bendixen (1965) summarised reports by authors who
had carried out pedigree studies in herds with the en¬
zootic form and established a higher incidence in some
cow families. The disease is known to be transmitted
from cow to calf, through the placenta. However,
the viral genetic material is not incorporated into the
chromosomes of the reproductive cells of the host,
therefore hereditory transmission does not occur,
(Callahan, Heber, Todaro, Graves and Ferrer, 1976).
The main problem in the control of the disease, however,
is the very long incubation period, because by the time
clinical disease has appeared, widespread infection is
inevitable. The exact mode of horizontal transmission
has not yet been elucidated, although spread by biting
insects is a possibility, and veterinary surgeons may
also unwittingly spread the disease by blood-sampling or
vaccination.
A range of serological tests is now being developed,
the most widely used of which is an agar gel immuno¬
diffusion test. These tests have been reviewed by
Mussgay and Kaaden (1978). The immunodiffusion test
has been adopted by the EEC for control of the disease,
and removal of reactor animals is now practised in some
countries, as it is preferable to total herd slaughter
where there is a high incidence of infection. Tyler
(1978) reviewed the literature concerning the disease
and the problems associated with its control.
On December 1st 1977, bovine lymphosarcoma became
a notifiable disease in Great Britain. Recently,
antibodies to BLV were detected in imported Canadian
Holstein cattle and in in-contact animals, therefore it
must be assumed that EBL is now established in the cattle
population of this country (Tyler, 1978).
Lymphosarcoma in Sheep
The incidence of lymphosarcoma in sheep slaughtered
in abattoirs in different countries was summarised by
Bostock and Owen (1973). In most countries, the in¬
cidence of lymphosarcoma is less than 25 cases per million,
and in Britain, according to Anderson and Jarrett (1968),
it is only 10 cases per million, these cases being
isolated and sporadic. Multiple incidence flocks were
reported from Germany by Enke, Jungnitz and Rossger (1961)
and Fritzshe (1970)
Ulbrich, Best, Paulsen, Nitzschke / and in Rhodesia by Boyt,
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Mackenzie and Emslie (1976). Lymphosarcoma is one
of the commonest tumours of sheep in most countries
but is a relatively uncommon tumour in New Zealand
according to Cordes and Shortridge (1971). These
authors' survey also gave different results from those
of other authors about the age of animals affected.
Fourteen of their 20 cases were less than 1 year old
whereas Webster (1967), also in New Zealand, Anderson
and Jarrett (1968) and Migaki (1969) agreed that it
occurs mostly in older animals.
Clinical reports in the literature are rare since
most cases are diagnosed at autopsy. Nobel, Neumann
and Klopfer (1967) described one animal with jaundice
as the presenting sign, and another with subcutaneous
nodules. The clinical and haematological findings in
one of the multiple incidence flocks were described by
Ulbrich et al., (1970). Enlarged submaxillary nodes
and pneumonia were the most obvious signs.
Multicentric lymphosarcoma is the most common
anatomical type but thymic and skin types are seen.
Bovine Leucosis Virus has been shown to be capable
of causing lymphosarcoma in sheep (Olson, Miller, Miller
and Hoss, 1972 and Van der Maaten and Miller 1976).
Lymphosarcoma in Horses
Many authors have credited Leisering with the first
published report of lymphosarcoma in an animal in 1853.
This was a description of the disease in a horse. The
literature has been reviewed by Jarmai (1934), Cotchin
(19561)) Dekkerand Kroneman (1958) Squire (1964) Misdorp
(1966) and Lamberg (1968). Neufeld (1973a) cited 91
cases reported in the literature during a period of
120 years. He subsequently (1973b) reported another
case.
Lymphosarcoma in the horse apparently occurs in all
parts of the world. Four to nine years old is the age
group with most cases although the disease has been re¬
ported at all ages except in horses over 23 years. All
anatomical types are seen. However, single circumscribed
tumour masses seem to be commonly mentioned in post¬
mortem findings particularly in males. The mare appears
to be more likely to have widespread tumour involvement
of lymph nodes and other organs. Clinical signs vary
considerably, and differential diagnosis is not always
easy when the animal is presented with signs such as
loss of condition, cough, abdominal enlargement, attacks
of colic or shifting lameness.
Haematological findings also vary, though relatively
few authors have studied this aspect in detail. Neufeld
summarised findings in twenty six cases in which 15% were
leukopenic, 58.3% were leukaemic and 36% were anaemic.
It is likely that many cases of equine lymphosarcoma
may not be diagnosed. Nevertheless it is quite a rare
condition. Cotchin (1960) saw 90 horse tumours - only
two were lymphosarcoma and were classified as alimentary.
Smith (1962) quoted an incidence in slaughtered horses
of 1.55 per 100,000. Migaki (1969) quoted figures
taken from the records of the Federal Meat Inspection
service (1957 - 1967) which show wide variation from
year to year (because of irregular culling practices)
but the figures are still low when one considers that
the horses slaughtered are usually adults (0 - 18.75/
100,000).
Genetic susceptibility has not been investigated,
and there is only one report which suggests possible viral
aetiology (McKercher, Wada, Straub and Theilen 1963).
Lymphosarcoma in Cats
Haematopoietic. tumours are among the commonest malig¬
nancies of the cat. (Cotchin, 1952 and 1956§.f and
Holzworth, 1960). In 1964, the study of lymphosarcoma
in the cat was dramatically directed along new lines by
Jarrett's investigation of a cluster of cases in unrelated
cats in one household in Glasgow. This led to suc¬
cessful transmission of the disease to susceptible
kittens and to the isolation of Feline Leukaemia Virus.
(Jarrett, Crawford, Martin and Davie 1964a and b) .
Feline Leukaemia Virus (FeLV) is an RNA virus of
the retro-virus group. The epidemiology of the con-
and Cotton
dition has been investigated (Hardy, 01dyHess ,Essex^l973)
and it has been shown that the virus can be spread hori¬
zontally, probably shed by infected cats in urine and
saliva, and from dam to offspring in utero and via the
milk. It is much commoner in cities than in country
areas. It may be a serious problem in breeding colonies
if infected cats are introduced.
The fate of an individual cat which becomes infected
depends on the type and dose of virus and the ability of
the cat to mount an immune response against the three
classes of antigen associated with the virus. Two
types of antibody have been identified - virus neutralising
antibody and antibody against feline oncornavirus -
associated cell membrane antigen (FOCMA).
The conditions produced by FeLV have been described
by Mackey (1975). The virus affects rapidly dividing
cells and produces both degenerative and proliferative
diseases. It is associated with 90% of cases of lymph¬
osarcoma in cats (Hardy and McClelland, 1977). It also
causes leukaemias, both lymphoid and myeloid, and it may
cause malignancies of red cell, monocyte or thrombocyte
precursors.
Anaemia is often see n in FeLV infected cats. This
may be associated with lymphosarcoma or leukaemia, or it
may not. If not it may be haemolytic or aplastic.
FeLV also causes immunosuppression and thymus atrophy in
Jarrett
kittens (Anderson, Jarrett^and Laird 1971) and has been
implicated in cases of abortion, foetal resorption and neo¬
natal deaths (Cotter, Hardy and Essex, 1975).
There is an association between FeLV infection and
feline infectious peritonitis, also glomerulonephritis
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and a panleucopenia-like syndrome.
A simple immunofluorescence test has been developed
by Hardy, Hurshaut and Hess (1973) in the United States
for the detection of FeLV antigens and this is being
used in the control of the disease.
Useful descriptions of feline leukaemia and the ef¬




Lymphomas are common neoplasms in dogs. According
to Cohen, Booth and Sussman (1959) based on reports by
several authors, these neoplasms have an incidence of
0.1% to 0.2% in all dogs, account for 1 to 4% of canine
tumours. MacEwen, Patnaik and Wilkins (1977) reported
a figure of 5-7% of canine tumours. Jarrett, Crighton
and Dalton (1966) found that lymphosarcoma constituted 22%
of fatal malignant neoplasms in the dog which is much
higher than the 8-9% given by Dorn, Taylor and H ibbard
(1967) .
There is still no real evidence of viral aetiology,
though the disease can be transplanted experimentally.
This was achieved by Moldovanu, Moore, Friedman and Miller
(1966), by Owen and Neilsen (1968) and Kakuk, Hinz,
Langham and Conner (1968), using Beagle puppies as re¬
cipients of transplanted cells.
The sporadic disease is usually multicentric or ali¬
mentary, though the other types are seen, and is more
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common in older dogs. Some breeds of dog seem to be
more susceptible than others. Breeds commonly mentioned
are the Boxer (Dorn et al., 1967, Priester, 1967, Squire
1969) the Scottish Terrier (Bloom and Meyer 1945,
Jennings 1953, and Cotchin 1956b)and the Cocker Spaniel
(Squire 1969, MacEwen et al., 1977).
The literature on lymphosarcoma in the dog is very
extensive but was reviewed by Jarmai (1934), Bloom and
Meyer (1945) and Cotchin (1956^^. The clinical, haema-
tological and diagnostic aspects of the disease were dis¬
cussed by Bloom and Meyer (1945) , Jennings (1953) , Squire
(1964 and 1969), Jarrett et al., (1966), Van Pelt and
Conner (1968) and MacEwen et al., (1977).
Clinical signs vary, depending on the extent and
location of the disease. Sometimes the dog is presented
with non-specific signs such as fever, weight loss and
anorexia. Most dogs with multicentric lymphosarcoma
have painless enlargement of the superficial lymph nodes,
and the tonsils may also be enlarged. Dogs with the
alimentary form usually have vomiting and diarrhoea.
Leukaemia is usually absent except in the very late
stages. A neutrophilia is often discovered and the dog
may be anaemic.
Lymphoid Tumours in Laboratory Animals
Mice
Leukaemias and lymphomas are rare in wild mice
(Gardner, Henderson, Rongey, Estes and Huebner 1973)
but are very common in laboratory mice. Strains of mice
with a high incidence of
spontaneous leukaemia have appeared during inbreeding,
sometimes with selection for this character, sometimes in
the course of selection for other characters. There are
also strains with low or intermediate incidence of leukaemia.
The inheritance of a liability to develop leukaemia is
probably multifactorial and its investigation by standard
Mendelian methods has not been very successful. The
genetic factors may include rate of cellular differentiation,
hormone balance and cellular susceptibility to infection and
malignant transformation by viruses (Salaman, 1967).
A murine leukaemia virus was first discovered by
Gross (1951). He reported that leukaemia could be in¬
duced in certain inbred strains of mice by the inoculation
of cell-free extracts of liver, spleen and mesenteric
tumours from mice with spontaneous or transplanted leukaemia.
Following this, some 14 different leukaemogenic RNA
murine viruses have been isolated (Friend 1957, Moloney,
1960, Rauscher, 1962). Viruses from high leukaemic strains,
when injected into suckling mice, induce leukaemia in sig¬
nificant incidence in low-leukaemic strains and accelerate
its appearance in the parent strain. The infant mouse
is much more susceptible to injected leukaemogenic viruses
than the adult, probably because there is a scarcity of
mature lymphocytes and an abundance of relatively undif¬
ferentiated lymphoid cells in the cortex of the thymus.
Leukaemogenic viruses are remarkable for the variety
of effects they produce, and yet different viruses may pro¬
duce diseases which are pathologically indistinguishable.
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Many laboratory strains of murine leukaemia viruses
probably do not bear any aetiological relationship to
the tumour from which they were derived e.g. Moloney
strain, which causes lymphocytic leukaemia, was derived
from sarcoma 37, and Friend's leukaemia virus originated
from an adult mouse inoculated shortly after birth with
a cell-free extract of Erlich ascites tumour (Buxton
and Fraser, 1977).
Transplantable tumours are important for research
purposes because they provide predictable systems. Two
well-known examples are L1210 and P388 leukaemias, and
these are routinely used for screening of new anti-cancer
agents.
It is very difficult to find a strain of laboratory
mice entirely free from leukaemia, and even in mice of
strains known to have a low incidence of spontaneous
tumours, it is possible that lymphosarcoma or leukaemia
can be induced by total body irradiation or by admini¬
stration of hormones or chemical carcinogens.
The murine leukaemias have been repeatedly reviewed,
e.g. by Furth (1951), Kirchbaum (1951), Law (1954), Miller
(1961) and Moloney (1964).
Rats
Most murine leukaemia viruses produce leukaemia in
rats. Spontaneous lymphosarcoma and leukaemia, however,
are quite rare in rats (Bullock and Curtis, 1930, McEuen
1939, Kim, Clifton and Furth, 1960).
In 1957, Dunning and Curtis reported a transplantable
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acute leukaemia in in-bred rats, and this is still used
for experimental purposes at the National Cancer Insti¬
tute. (Goldin, Venditti and Carter, 1977).
Guinea-Pigs
Leukaemia is rare in guinea-pigs, but there is a
virus-induced type (Opler, 1969).
Hamsters
Mouse Moloney virus produces leukaemia in hamsters
(Buxton and Fraser, 1977).
Rabbits
Lymphosarcoma is uncommon in the rabbit and a virus
has not yet been implicated. Kampen (1968) reviewed
the literature, as well as describing a case.
A hereditary form of lymphosarcoma in WH strain
rabbits was reported by Fox, Meier, Crary, Myers, Norberg
and Laird (1970). The condition is apparently inherited
in association with an autosomal recessive gene.
Affected rabbits were usually less than 1 year old
when the disease was diagnosed. Clinical signs were
weight loss, lethargy and anaemic mucous membranes. High
white blood cell counts were infrequent but there was a
predominance of lymphoid cells in smears and many appeared
to be blast cells.
At autopsy, visceral lymph nodes were enlarged and
spleen, liver and kidneys were usually involved. The
thymus and adrenals were enlarged in some rabbits.
A few of the cases had produced progeny, but it
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appears that an affected rabbit was never mated to
another affected rabbit to produce 100% affected progeny.
Nevertheless, the ratios of affected to normal rabbits
obtained from other types of mating suggested a Mendelian
type of inheritance.
Lymphoid Tumours in Poultry
The Avian Leukosis Complex (Helmboldt and Fredrickson,
1969) .
The avian leukosis complex is a group of viral dis¬
eases which results in major economic losses in the
poultry industry. Most diseases of the complex are
disseminated proliferative processes involving cells of
the haematopoietic system or their precursors. The
most prevalent are those involving lymphoid cells.
The causative viruses of most avian solid tumours
are related to those causing disseminated haematopoietic
diseases. Both RNA and DNA viruses have been implicated.
The two most important diseases are lymphoid leukosis,
also called lymphomatosis, and Marek's disease. Unlike
other
in man and/mammals, spontaneous occurrence of these di¬
seases reaches epizootic proportions and in some areas
are considered to be enzootic.
Lymphoid leukosis
Ellermann and Bang (1908) first reported trans¬
mission of lymphoid leukosis by cell-free filtrates. It
is a disease of mature birds. The liver and spleen
are most often involved, though any organ may be affected.
Bone marrow is commonly involved but tumour in the brain
is rare. The lymphomas are usually multiple and the
affected organs are usually enlarged.
The virus first attacks the cells of the follicles
of the Bursa of Fabricius. If the bursa is removed at
the time of hatching, the disease fails to develop,
(Peterson, Burmester, Fred rickson and Good 1963). A
tumour is formed in the bursa, which metastasizes primari
to the liver and spleen. Leukaemia has been reported
but is rare. Both vertical transmission of virus
through the egg and horizontal transmission among chicks
occur, but the carrier hen is the chief vehicle. Elimi¬
nation of carrier hens can prevent transmission of the
disease.
Marek's Disease
This disease is also called neurolymphomatosis or
fowl paralysis. It was first described by Marek (1907)
as a polyneuritis, but it has many features of a neo¬
plastic process. The disease is seen in growing birds
and is characterised by multiple neoplasms of lymphoid
cells that are difficult to differentiate from those of
lymphoid leukosis. The central nervous system is the
site of a diffuse non-purulent encephalomyeloradiculitis.
This rarely progresses to become neoplastic. In peri¬
pheral nerves, an inflammatory lesion with oedema and a
diffuse infiltration of lymphocytes, histiocytes and
plasma cells is believed to precede the formation of
diffuse lymphomas. The sciatic nerve and dorsal root
ganglia are common sites. Gross visible enlargement of
the nerves may be seen and there may be clinical paralysis
Lymphomas may be present in viscera and muscles, but neo¬
plastic proliferations are not seen in all birds. Some
birds apparently recover from the disease.
In the acute form of the disease, the ovaries, lungs
and haematopoietic tissue, predominantly the bone marrow,
are overrun by lymphoblastic cells, resulting in lympho¬
sarcoma. The bird usually dies before obvious anaemia
or leukaemia develops.
In 1967, electron microscopic examination of blood
lymphocytes and cell cultures infected with cells from
birds with Marek's disease showed particles resembling
DNA virus of the Herpes group (Biggs, 1967, Wight, Wilson,
Campbell and Fraser, 1967, Nazerian, Solomon, Witter and
Burmester, 1968).
It was shown by Churchill, Payne and Chubb (1969)
that immunization of birds against Marek's disease was
possible, using a live attenuated strain of virus, and
because of the major commercial importance of the disease,
vaccination in poultry flocks is now carried out.
Other viral neoplastic diseases are erythroblastosis,
myeloblastosis, myelocytomatosis and various solid tumours
The classification of diseases induced by the avian
tumour viruses has been frequently revised, (Campbell




As in some other species already considered, lympho¬
sarcoma is not rare in swine. It is the most common
pig tumour according to Plummer (1956), Cotchin (1960)
Jarrett et al., (1966) and Fisher and Olander (1978).
Many cases have been reported in the literature and, as
in cattle, records of the incidence of the disease are
available from abattoir surveys. Bostock and Owen (1973)
have summarised the incidence in slaughtered pigs in re¬
ports from Belgium, France, Germany, Great Britain,
Netherlands, United States and Norway. In all these
countries, except France, the incidence is under 25 cases
per million animals slaughtered, though probably many never
reach slaughter weight. In Brittany however, the in¬
cidence is given by Renier, Friedmann, Chevrel, Gacquiere
and Guelfi (1966) as 65 per million overall, the incidence
in the eastern area of the province being six times that
seen in the west. A wider survey in France by Lombard
(1968) showed a very low incidence in many areas but a
very high incidence in a few regions, particularly Gers
in the south-west, with over 2000 cases per million. There
is no suggested explanation of this extraordinarily high
figure by Lombard, but Renier et al., (1966) suspected
that a virus might be involved in Brittany. Anderson
and Jarrett (1968) followed up every one of 92 cases diag¬
nosed at the abattoirs in their survey in Great Britain,
and in no case was there any evidence that the disease was
present in other animals, or that it had occurred before on
any of the farms. The literature from other parts of the
world also indicates that the disease is sporadic -
isolated cases only are reported. The extensive liter¬
ature has been reviewed by Jarmai (1934), Englert (1955),
Cotchin (1956^ Squire (1964), Lombard (1968) and Bostock
and Owen (1973).
Most authors seem to agree that the disease is com¬
monest in young animals. The majority of Englert's
(1955) cases were under one year old. Of Anderson and
Jarrett's 92 cases, 59% were immature animals. In the
series of 200 cases described by Migaki (1969) 60% were
between 6 and 8 months of age. Of the cases seen by
Renier et al., (1966) 80% were around 6 months. However,
the actual prevalence of cases was proportionately lower
in this age group than in the older age group (mean age
21 months) when they consider the number of animals of
each age group slaughtered. In 15 cases recorded by
Cotchin (1960) the age range was newborn to 16 months.
The pathological types of lymphosarcoma seen in the
pig are multicentric or thymic. Of the cases recorded
by Jarrett et al., (1966), 30% were thymic. Despite
the large volume of literature on the subject, the vast
majority of reports are essentially pathological descriptions
and clinical and haematological findings are rare. As in
other species gross enlargement of superficial lymph
nodes may be a prominent feature of some cases of multi¬
centric lymphosarcoma. On the whole, however, cases are
not usually diagnosed in life, and young pigs with
lymphosarcoma are probably disposed of by the farmer
without investigation.
Englert (1955) discussed in detail the clinical
findings both as reported in the literature to that date,
which consisted of only nine references, and his own ex¬
perience of 30 cases, the majority of which were sent
for emergency slaughter. Clinical signs were noted by
him in 22 cases. Reduced appetite and loss of con¬
dition were the main signs but constipation, an impression
of exhaustion, laboured respiration, fever, recumbency,
hind-leg lameness, difficulty in swallowing and haemorr¬
hages of the skin were also seen.
Reichel (1962) described two cases in detail. Clinical
findings, results of blood serum and bone-marrow examinations
were recorded, and the terminal course of the disease was
monitored. Both pigs were leukaemic especially Pig II
9
which had a white blood cell count of 91 x 10 /litre.
Photographs showed that the superficial lymph nodes were
very large. Pig I was treated with prednisolone for
three days, but it died despite the fact that the blood
lymphocyte and blast counts fell. Adamesteanu and
Adamesteanu (1969) reported three cases of lymphosarcoma,
one of which was diagnosed in life. The clinical course
9
was acute with a white-blood cell count of 200x10 /litre.
The pathology was described in detail.
Where figures are quoted from references, they have been
altered to S.I. units.
Chevrel, Renier, Richier, Raraee and Treguer (1969)
reported their findings in 38 cases. The most common
clinical signs were unthriftineas, anaemia (with jaundice
in one case) respiratory trouble in five cases and in
four cases, the presence of localised tumour in the neck
region.
Stevenson and DeWitt (1973) described an unusual
case in a 13 month-old boar with only loss of appetite
and mild fever for three days before death occurred. The
main gross pathological lesions were haemorrhages through¬
out the body. Invasion of most organs by immature
lymphocytes was seen on histological section.
Transmission of the disease to one-day-old piglets
was attempted by Case and Simon (1968). Although some
lymphoid hyperplasia was seen in lymph nodes of inoculated
pigs they did not develop the disease, and the lympho¬
cytosis reported, which regressed, was probably physio¬
logical. A lymphocytosis often occurs in normal pigs at
from 9 to 16 weeks of age (McTaggart, 1975).
The production of C-type virus particles by a per¬
manent cell line obtained from tissues from a pig with
lymphosarcoma was reported by Strandstrom, Veijalainen,
Moennig, Hunsmann, Schwarz and Schafer (1974). These
particles were shown to be capable of infecting normal
pig kidney cells. In general, however, there is as yet
convincing
no/evidence implicating viruses in the aetiology of lympho¬
sarcoma in the pig.
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Hereditary Pig Lymphosarcoma
In 1963, at the Royal (Dick) School of Veterinary
Studies Field Station near Edinburgh, a new piggery was
set up to investigate the possible beneficial effects
on productivity of a minimal disease environment.
The foundation stock were hysterectomy derived Large
White pigs, which were hand-reared. The piggery has
since remained closed, and although new blood-lines have
been introduced occasionally by means of artificial in¬
semination, inevitably a degree of in-breeding has been
necessary.
In order to check on minimal disease status in the
piggery any animal which died was sent for autopsy. In
1966, lymphosarcoma was diagnosed at autopsy in a three-
month-old pig which had been culled because of failure to
thrive. The significance of this fact might have gone
unappreciated, were it not for an observation by the
pathologist that it was one of a litter resulting from a
brother/sister mating, and that possibly a genetic factor
might be involved. The rest of the litter were examined
and blood samples revealed in one of them a lymphatic
leukaemia. Unfortunately, the mating could not be re¬
peated because the boar had been disposed of, and although
another boar was obtained, a full brother of the sire of
the piglets, no more cases were produced.
In 1969 several cases of lymphosarcoma appeared in
different litters and when the pedigrees of these animals
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were examined, it became obvious that they were ex¬
clusively inbred descendents of the same boar which had
been the sire of the first two cases. By the end of
1974, 64 cases had been identified. These had 211
normal litter mates which survived to bacon weight at
5 to 6 months of age. These cases represented 23.27%
of the litters in which they occurred. This is not
. . 2
significantly different from the 25% to be expected (X_=
0.44) if transmission of the disease is associated with
a recessive gene. The condition was reported by
McTaggart, Head and Laing (1970).
Further studies have defined the characteristic
features of the disease. The clinical signs, haemato-
logy and pathology have been described by Head, Campbell,
Imlah, Laing, Linklater and McTaggart (1974). The
ultrastrueture of lymphosarcomatous tissues from these
pigs has been reported by Campbell (1977). The main
characteristics of the disease are as follows:
(a) The disease occurs in young pigs and can usually
be diagnosed between 6 and 8 weeks of age. The
longest surviving untreated case was 17 months old.
(b) It is not sex-linked, occurring fairly equally
in males and females.
(c) No untreated case has ever reached functional
sexual maturity therefore it has never been
possible to confirm the genetic theory by
mating two affected animals to produce 100%
affected piglets.
(d) All cases are clinically and pathologically similar
except for the rate at which the disease develops
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and the effects of intercurrent disease.
(e) Carrier parents so far appear to be identical
in every way to normal non-carrier animals. No
genetic marker has yet been found, therefore
mating with a known carrier is the only method
of testing a potential carrier, at present.
(f) The disease is not transmissible by any means
yet tried, between pigs.
Clinical Features
The cardinal clinical features of the disease are:
(a) Stunting of growth.
(b) Moderate enlargement of superficial lymph nodes
particularly inguinal and precrural nodes since
these are most readily visible and palpable.
Gross enlargement as sometimes seen in the
sporadic form never occurs.
(c) Pot-bellied appearance see Plate (1).
(d) Upward arching of the spine.
Fever is unusual, except as a result of intercurrent in¬
fection. In advanced disease bodyweight levels off,
rarely reaching bacon weight (90kg) , and then fluctuates
from week to week, probably due largely to variations in
gut-fill, as the appetite becomes capricious. During
spells of "natural remission" (see haematology) the
appetite is good and the pigs are quite lively, but be¬
tween these spells they are listless, reluctant to rise
and have poor appetites. Eventually, usually during one
of these periods of decline, death occurs, if the animal
has not succumbed previously as a result of intercurrent
disease such as colibacillosis or necrotic enteritis.
Actual causes of death are very varied but the tumour
itself is rarely the direct cause unless death results
from severe haemorrhage.
All the characteristic features may be seen in a
variety of other conditions, and therefore haematol-
ogical examination is necessary.
Haematology
The blood picture in lymphosarcoma varies consid¬
erably and often leukaemia does not appear until the
later stages of the disease. Renier et al., (1966)
considered that haematology was not very useful in the
diagnosis of sporadic lymphosarcoma in pigs, as 10 of
the 25 cases that they sampled had a normal blood picture.
In hereditary porcine lymphosarcoma the following
haematological features are usually seen from about 6 to
8 weeks of age onwards:-
(a) Total white cell counts within the normal range
9
(10 - 20 x 10 /litre) or moderately elevated.
9
Counts rarely exceed 30 x 10 cells/litre,
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though occasionally counts of up to 100 x 10 /
litre are found for a short time in an in¬
dividual animal. The highest white cell
count observed was in a treated animal in re¬
lapse - 160 x 10^/litre.
(b) Over 70% mononuclear cells on differential
count.
(c) Abnormal mononuclear cell morphology i.e.
large cells with pale often vacuolated cyto¬
plasm and irregular lightly staining nuclei,
frequently with nuclear protrusions. Occ¬
asionally mitotic figures are seen.
(d) A progressive macrocytic, sometimes hypo¬
chromic anaemia with very few normoblasts.
(e) A progressive thrombocytopenia.
When diagnosis is attempted between 9 weeks
and 16 weeks, difficulties are occasionally encountered
because normal pigs of this age tend to have a lympho¬
cytosis (McTaggart, 1975). High white cell counts
and percentages of lymphocytes of 70 to 80 may be en¬
countered. The morphology of the cells is quite dif¬
ferent however, consisting of a high proportion of darkly
staining, typical small lymphocytes.
If the course of the disease is followed in any one
animal it is found that there are sometimes periods of
natural remission when the total white cell count falls
and the anaemia improves. In between, there are spells
of decline as mentioned previously, when the opposite
occurs and the thrombocyte count may fall to such an ex¬
tent that haemorrhage may readily occur. In the
terminal stages of the disease, the total white cell
count and percentage of abnormal cells usually fall.
At autopsy, all cases are grossly and histologically
essentially alike though the degree of abnormality seen
depends on the age at death. In the earlier years
before the start of therapeutic studies, many lympho¬
sarcoma pigs died at a fairly early age mainly due to
post weaning colibacillosis. In life some showed
advanced disease at this time, others appeared relati¬
vely normal apart from enlarged nodes and white blood
cell picture typical of the disease. Age at death
showed a bimodal distribution. If the pigs did not
die before 120 days old, they tended to live much
longer, to a mean of 180 days and sometimes as long as
15 months.
Pathology
The most obvious gross pathological feature is the
enlargement of the lymph nodes but the gastric, mesenteric
and bronchial nodes show a much greater degree of abnor¬
mality than the other visceral and carcase nodes. The
gastrosplenic and mesenteric nodes in the more advanced
cases may be 30 times (and the bronchial nodes up to eight
times) the weight of those of normal pigs of comparable
age. On cut surface, a flat field of pale fawn or
white tumour tissue is seen, except for the gastro-
splenics which may be dark red in patches, due to haemo¬
rrhage and fibrin. The cut surface of the superficial
nodes, which enlarge to approximately 1.5 times normal
weight, may show the remains of normal lymph node archi¬
tecture, especially in the less advanced cases. Corti¬
cal nodules are seen as well as tumour tissue and these
may be surrounded by a darker coloured area of medulla.
The thymus is never involved in the tumour and in
fact it is usually involuted. The spleen is enlarged -
in the advanced cases it may be very large indeed - and
it may have nodules on the visceral surface which on
section are deeper red than the remainder of the spleen
which is soft with a mottled bulging lobular pattern.
Splenic infarcts are occasionally seen,also torsion of
the ventral end of the organ in a few cases.
The tonsils are not enlarged. The glandular
mucosa of the stomach may have numerous white nodules.
The Peyer's patches of the small intestine are pro¬
minent and nodules are seen in the wall of the caecum and
colon. The liver enlarges progressively with the
stage of the disease and becomes paler in colour. Oc¬
casionally, focal areas of tumour infiltration are seen
or even white nodules of tumour tissue. Gross tumour
involvement of the epididymis often occurs but the ovary
and uterus are never affected. Occasionally tumour
nodules may be seen in the kidneys.
The marrow of the diaphysis of long bones (the
femur is usually examined) may contain white foci of
tumour tissue. It is usually red, and active with de¬
pletion of fat in most cases.
Histopathology
On histological examination, the white tissue seen
macroscopically appears as large numbers of lymphocytes,
many of them typical large tumour cells with mitotic
figures. They are found in the perilobular connective
tissue of the liver, peribronchiolar tissue in the lungs,
in the red pulp of the spleen, in perivascular cuffs at
the cortico medullary junction in the kidney, in the
interstitial tissue of the testis and peritubular con¬
nective tissue of the epididymis, in the submucosa of
the intestine and in the bone marrow.
Other common pathological findings in lymphosarcoma
pigs are gastric ulcers. These are usually in the
oesophageal region but may also be found in the fundus.
Haemorrhage from these ulcers is fairly common and
occasionally they perforate, causing escape of stomach
contents into the peritoneal cavity and death from acute
peritonitis.
Hydrothorax, hydropericardium and ascites may also
be found especially in those which have died. (It is
not usually present in animals which are deliberately
destroyed, but has been found in fairly advanced cases
at laparotomy - see later. )
Widespread petechial haemorrhages may be observed
and animals which have been bullied by their normal
litter mates often have severe subcutaneous and in¬
ternal haemorrhages.
The possibility of viral aetiology has been in¬
vestigated, and reverse transcriptase has been detected.
This enzyme is necessary for the incorporation of viral
RNA into the DNA of the host cell. C-type virus
particles have been seen occasionally in ultrastructural
photographs of tumour cells. However, if a virus is
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involved it is undoubtedly completely incorporated into
the DNA of the host, even within the reproductive cells,
and is unlikely to be released as free virus. The
fact that the disease cannot be transmitted would appear
to support this theory.
Chemotherapy
Cancer chemotherapy means treatment of cancer
with drugs. The rationale of anticancer drug usage
is to selectively destroy or control the growth of mali¬
gnant cells. Malignant tissue is made up of dividing
cells and nondividing cells, the relative proportions of
each depending on the type of tumour. Generally the
larger the tumour, the slower is the rate of cell div¬
ision. Dividing cells go through a series of events
which has become known as "the cell cycle". Most anti¬
neoplastic drugs interfere with nucleic acid production
and function.
The phases of the life cycle of the dividing cell
are: -
(1) Mitosis (usually given the letter
(2) Gap one (G^ a relatively quiescent phase
during which RNA and protein synthesis occurs.
(3) DNA synthesis (S-phase).
(4) Gap two (G2) another apparently resting phase
during which there is more RNA and protein




The S, G2 and D phases in most dividing cells are
fairly constant. The variation in length of the cell
cycle occurs during phase. When proliferative
activity is high, G^ may be very short. When it is
low, G^ may be so long that the cell seems to become
dormant, ceasing to divide. It is then described as
being in Gq phase.
After a variable time, these cells may resume
division and return to the cell cycle.
Different drugs act at different phases of the cell
cycle. Some drugs may kill cells at any stage in the
cycle. These are classed as phase non-specific.
Most drugs, however, act at one stage in the cycle and
are classed as phase specific.
Replicating cells are most sensitive to attack
usually during S phase. Those in GQ are very re¬
sistant, making the task of destroying every tumour cell
in the body a very difficult one.
Although drugs may be classified as phase specific
or non-specific, the most usual classification is based
on their mechanisms of action. These are as follows:-
1) Hormones - Steroids a) Androgens, b) Oestrogens
c) Progesterone d) Adrenal cortical.
The first three groups are useful because cancers
from hormone - sensitive tissues may retain some of their
hormonal responsiveness and their effects are exagger¬
ations of their physiological effects. The mechanism
of action of the corticosteroids in cancer is not known
but may be related to the presence of corticosteroid
receptor proteins within sensitive cells leading to
direct nuclear damage (See Chapter I).
2) Alkylating agents.
These are agents which can substitute an alkyl
(R - CH2 - CH2+) group for the hydrogen ions of many
organic compounds. Their cytotoxic effects are
thought to be due to the formation of a covalent bond
between a side limb of the drug molecule and the 7 -
nitrogen group of guanosine, and other sites may also be
attacked. Since most alkylating agents have more than
one side chain, "cross-linking" of DNA occurs and breaks
are produced in the molecule, preventing division of the
helix in mitosis or if it does divide, causing it to re¬
unite in an imperfect form. These effects result in
cell death. As similar effects are produced by certain
kinds of ionising radiation, these drugs may be de¬
scribed as "radiomimetic".
3) Antimetabolites
These are structural analogues of naturally-
occurring compounds, capable of entering into the series
of metabolic reactions leading to the synthesis of
nucleic acids. They react with a specific enzyme,
causing inhibition of the enzyme, or synthesis of a mole¬
cule which is incapable of functioning normally.
4) Anti tumour antibiotics
Like the antibacterials, these are natural products
of fungi and particularly the genus Streptomyces. Their
mechanism of action is to form a stable complex with DNA,
therebye inhibiting synthesis of DNA or RNA or both.
5) Unclassified agents e.g. the Vinca Alkaloids.
These drugs have large and complex molecules, and are
extracted from the periwinkle plant (Vinca rosea). They
bind to the essential contractile proteins of the
mitotic spindle of dividing cells and this leads to
mitotic arrest.
Cancer chemotherapy is one of the most rapidly de¬
veloping fields in medical science, most advances having
been made since the 1950s.
However, according to Haddow (1970) the chemo-
therapeutic approach to cancer is very old indeed - at
least 1500 years. In Renaissance times, there was
much interest in it and most of the drugs used contained
inorganic elements such as arsenic. In more recent
times, potassium arsenite was used by Lissauer (1865) to
treat leukaemia. Coley (1893) attempted to treat
cultural material of human
malignant disease by repeated injections of^erysipelas.
Lead salts were also used in the early 1900s.
After this, it seems there were no real developments
until the 1940s when the chemotherapy of bacterial
disease was advancing rapidly. The steroid hormones
were found to have anti tumour effects. Oestrogens
were used in carcinoma of the prostate and oestrogens or
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androgens in breast carcinoma.
Ileilman and Kendall (1944) demonstrated the effect
of cortisone in mouse lymphosarcoma and by 1949 ACTH
and cortisone were shown to be effective in lymphoid
tumours in man. (Pearson, Eliel, Rawson, Dobriner and
Rhoads 1949). The first alkylating agent was also in¬
troduced in the 1940s. This was nitrogen mustard,
which had been developed as a clinical weapon in World
War I. Krumbhaar and Krumbhaar (1919) studied
soldiers dying of bone marrow aplasia as a result of
being exposed to mustard gas, and during World War II it
was shown to cause damage to lymphoid organs as well as
bone marrow. This led to trials first in mouse lym¬
phosarcoma, and then in patients with lymphoid tumours
(Gilman, 1963) . Since then, many improved deriva¬
tives of nitrogen mustard have been developed, such as
cyclophosphamide, chlorambucil and melphalan.
By the 1930s the sulphonamides had been shown to
be active against various bacteria because of a metabolite
- antimetabolite relationship with para-amino benzoic
acid. This theory of antimetabolites led to the syn¬
thesis by Seeger, Smith and Hultquist (1947) of the
folic acid antagonists aminopterin and amethopterin (meth¬
otrexate) . Farber, Diamond, Mercer, Sylvester and
Wolff (1948) showed that aminopterin could regularly
produce remissions in acute leukaemia in childhood.
By 1955 a range of antagonists of purines^and pyri-
madinesfsuch as mercaptopurine and thioguanine) had
been synthesised, based on the studies by Hitchings,
Elion, Falco, Russell and Vander Werff (1950). In
1957, Heidelberger, Chanduri, Danneberg, Mooren, Gries-
bach, Duschinsky, Schnitzer, Pleven and Scheiner, re¬
ported the synthesis of 5-fluorouracil, an antimetabolite
of uracil which has proved extremely useful in adeno¬
carcinoma of the colon, stomach, pancreas and breast.
A different type of pyrimidine antimetabolite was syn¬
thesised in 1959, namely cytosine arabinoside (ara-C).
This was shown to be active in mouse leukaemias by Evans,
Musser, Bostwick and Mengel (1964). This compound has
now become important in treatment of leukaemias in man,
particularly acute myeloid leukaemia (Ellison, and 20
co-authors 1968).
The first cytotoxic antibiotics were the actinomycins
which were discovered by Waksman and Woodruff (1940).
Because of the severe toxicity of these compounds there
was little interest in them until 1952 when they were
shown to be active in mouse tumours by Hackman (1952),
and also in Hodgkin's disease by Schulte (1952). This
led to the development of many more antibiotics with
anticancer activity, the most effective of which are
mitomycin, bleomycin, which is unusual because it has
no bone marrow suppressant effect, and daunorubicin and
its now widely used derivative doxorubicin (adriamycin).
This last drug was introduced in 1969 (DiMarco, Gaetani
and Scarpinato 1969).
In the late 1950s, Johnson, Armstrong, Gorman and
Burnett (1963), and others, demonstrated that an extract of
the periwinkle Vinca rosea was active against leukaemia in
the mouse. The compounds vinblastine and vincristine
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were isolated and were shown to be effective in the treat¬
ment of Hodgkin's disease, acute lymphoblastic leukaemia
and other tumours (Warwick, Darte and Brown 1960,
Armstrong, Dyke and Fouts 1962, Karon, Freirich and
Frei 1962).
The greatest advances in cancer chemotherapy have
occurred mainly since 1968 with the development of com¬
binations of drugs which act in different ways so that
the problem of additive toxicity is avoided. Initial
studies reviewed by Goldin and Mantel (1957) laid the
foundations for the protocols which are now so successful
in the treatment of Hodgkin's disease and some of the
other leukaemias and lymphomas. The principles of




The major problem in cancer chemotherapyyyis drug
toxicity. As cytotoxic drugs mainly attack cells in
division, normal tissues with a naturally high turnover
of cells such as bone marrow, gut, hair follicles,
and testis may be damaged almost to the same degree as
the tumour cells.
The most serious toxicity is bone marrow depression,
and this occurs with most of the drugs in common use.
Marrow depression may result in neutropenia, leading to
infection, or thrombocytopenia, leading to bleeding or
anaemia. The immune response is generally depressed,
but the effects on specific immune responses depend on
the drug and how it is administered - occasionally there
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is an increase in a specific immune response. This
has been noted in animals as well as humans (Schwartz
1969), but there is at present no clear explanation for
this. Increased susceptibility to infection is a
great problem, as many of the infectious agents are
opportunists which would not normally cause disease in
a healthy individual.
Gastro-intestinal toxicity may result in ulcerative
stomatitis, pharyngitis, vomiting and diarrhoea. Nausea
is very common in man. Alopecia is a frequent side-
effect of many drugs in man and some animals.
Effects on the ovary and testis usually result in
sterility but if conception does occur, cytotoxic drugs
are then liable to be teratogenic.
In addition to these common toxicities, antineo¬
plastic drugs often have side effects on organs and
systems which are independent of their action on rapidly
dividing cells. Examples are:-
a) Neurotoxicity - this occurs most commonly with
vincristine.
b) Cardiotoxicity - this is a severe side-effect of
daunorubicin and doxorubicin.
c) Pulmonary toxicity - this constitutes the therapy-
limiting toxicity of bleomycin.
d) Hepatotoxicity - this occurs with several agents.
e) Renal toxicity - this is common with high doses
of methotrexate.
Additive toxicity in combination therapy may be
avoided by using drugs which have side effects on di-
ferent types of tissues. Malignant cells are usually
not as efficient at repairing the damage caused by the
drugs as normal cells. This is the reason why a rest
period is often included in anticancer protocols, so
that the normal tissue can recover. The tumour has
less potential to recover, therefore the effect is
theoretically as shown in Figure I. (Note that the
cell kill is graphed as a line with a negative slope,
expressed in logarithmic terms). In man with severe
malignant disease, the number of tumour cells in the
12
body may be greater than 10 . The number of tumour
cells killed by one course of a drug is likely to be
between 10 and 105, therefore it may take many
courses of treatment to eradicate all the tumour cells,
if that is even possible (Schabel, 1975, DeVita et al., 1975).
Drug Resistance
Another problem of cancer chemotherapy is drug re¬
sistance. It is often the case that the first course
of treatment with a given drug is successful, but that
if the patient relapses, a second course of the same
treatment is much less successful. There are several
possible reasons for this, such as selective survival
of more resistant cell lines, decreased permeability of
the tumour cell to the drug, improvement in the ability
of the tumour cell to repair itself, use of alternative
biochemical pathways, an alteration in the specificity of
FIGURE I
Theoretical effects of five three-weekly doses of an anti¬
cancer agent on tumour cell numbers.
an inhibited enzyme or changes in the metabolism of the
drugs. The end result is very similar to the develop¬
ment of resistant strains of bacteria. Combinations
of drugs are often more successful than single agents
as there is less chance of resistant strains of tumour
cells developing.
Changes in the effects of the drugs may be seen
when a different route of administration is employed,
or when the dose or the schedule is altered or when a
different formulation of the drug is given. The effects
of the drug on the tumour depends on the degree of con¬
tact between the drug and the tumour cell. If the
drug is carried in the blood-stream, it will have little
Note: Poor blood supply is
should be a preferred tumour
histologically. (Innes, p
not the reason why the testis
site, as drug damage is seen
ersonal communication).
Three methods of measuring a patient's response to
cancer therapy are as follows.
1) No response (NR) partial remission (PR) and
complete remission (CR). With this widely-
used simple system, patients are considered to
be in complete remission if all post-therapy
staging studies, including bone marrow biopsy,
are normal. A partial remission is defined as
a 50% (or by some authors a 75%) decrease in
the product of two diameters of all palpable
57.
tumour. Most authors do not consider that
a subjective improvement, or relief of pain,
can be considered a response.
The method of Hewlett, Battle, Bishop, Fowler,
Schwartz, Hagen and Louis (1964) for assessing
response in the leukaemias. Patients are
given a number on examination of bone marrow
(M), haemogram (H), physical condition (P)
and performance status (S) e.g. a complete
remission would be Ml, HI, Pi, and SI. A
good partial response would be Ml or 2, Hi or 2,
Pi or 2 and SI or 2.
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Category I - A Distinct subjective benefit
with favourable objective
changes in all measurable
criteria for one month or more
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Category I - B Objective regression of all
palpable or measurable neo¬
plastic disease (all lesions be
reduced at least 50% in bulk)
for 1 month or more in a relat¬
ively asymptomatic patient.
I - C Complete relief of symptoms
if any, and regression of all
manifestations of disease for
one year or more.
Category II Interruption or slowing in the
progression of the disease with¬
out definite evidence of subjective
or objective improvement.
Veterinary Chemotherapy
Veterinary medicine has lagged far behind human
medicine in the investigation into therapy of tumours in
the domesticated species. The most important reasons
are the high cost of treatment in relation to the
economic value of a farm animal, an unwillingness on the
part of a pet animal's owner to consider treatment which
will probably result only in a temporary improvement
in the animal's condition and the frequent development
of side-effects caused by cytotoxic drugs. Neverthe¬
less, in recent years the specialty of Veterinary On¬
cology has begun to develop especially in the United
States of America. As domestic pets now tend to live
longer because of better control of infectious diseases,
it seems likely that the treatment of cancer, parti¬
cularly in the dog and cat, will become more sophisti¬
cated .
Most of the early attempts at chemotherapy of
tumours were in dogs. In 1946, Innes, Parry and
Berger treated a Golden Retriever with lymphosarcoma,
using urethane. They kept it alive and reasonably
well for 58 days, which is remarkable because they con¬
sidered the dog to be near death when treatment was
started. Bloom (1952) showed that corticosteroids
could produce transitory regression of inoperable canine
mast cell tumours.
In 1953, Jennings treated two dogs with urethane,
one of which survived 20 days, and one with urethane plus
nitrogen mustard, which was destroyed at the owner's
request after 31 days. All three had lymphosarcoma.
McCoy, Allison, Crossley and Wannemacher (1956)
used N (3- Oxapentamethylene) -N^ N - diethylene-
phosphoramide (MEPA) in 25 cases of neoplasia in dogs,
including seven cases of lymphosarcoma. All except
one of these seven showed regression of the tumour, but
severe drug toxicity was responsible for death in most
of the cases.
Clover (1958) successfully treated a Scottish
Terrier with lymphatic leukaemia using prednisolone,
and Agresti (1959) reported clinical and haematological
improvement in a dog with lymphatic leukaemia treated
with triethylenemelamine, prednisolone and adreno-
corticotrophic hormone (ACTH).
Jacquier (1963) recorded his attempts to treat six
dogs with various types of leukaemia with corticosteroids
cyclophosphamide and multivitamins, and McClelland (1963)
described results with cyclophosphamide in four cases
of canine lymphosarcoma. One of these achieved com¬
plete remission, but died, presumably from drug toxicity.
Lymphosarcoma appears to be the tumour most commonly
treated by chemotherapy, and since 1963, there have been
many references in the literature. As in humans,
combination chemotherapy has been found to be more
successful than single agent therapy in canine lympho¬
sarcoma. A variety of drugs have been used by various
workers and no one regime has emerged as superior to
the others, though corticosteroids, cyclophosphamide
and vincristine have been favoured in more than one trial
See Table 2.
Cohen, Schmidt, Lucas and Palmer (1975) used these
three drugs to treat beagles with transplanted canine
lymphoma, and this produced long term remissions.
Chemotherapy of lymphosarcoma in cats has not often been
attempted because of the probability that the disease
is caused by Feline Leukaemia Virus infection. Affected
cats are therefore a danger to others and are usually
and Norsworthy
destroyed. Freitag/(1976) treated two Siamese cats
successfully with vincristine and prednisone. These
were considered suitable cases for therapy because they
TABLE 2.
VETERINARY CHEMOTHERAPY
AUTHORS No. of cases treated Drugs Used (MST or MRT)
Doqs Cats
Moldovanu, 14 0 C MST-110 days
Friedman and Miller
(1966)
Old, Boyse, Campbell, 3 0 L-A MST-33 days
Brodey, Fidler and + one still
Teller (1967) alive at 50 days
Brick, Roenigk and 4 1 C MST- 4.5months
Wilson (1968) 6 2 P 2.5months
9 2 Chi. 3.5months
7 1 P+Chl. 2.3months
Squire and Bush 100 15 P MST-Dogs -156
(1973) C days
V Cats-not stated
0 but all dead
6-M within 3 months
Ara-C
Squire, Bush, Melby, 49 0 P MRT- 53 days
Neely and Yarborough 34 0 P 62 "
(1973) +C
19 0 COP 184 days
23 0 COP 136 days
6-M
Madewell (1973) 20 0 Induction MST-211.5 days
COP (1 case ex¬
cluded )
Maintenance MRT of respond-







MST - 138 days
Single drugs:-
































MRT - 13 weeks
Abbreviations - P - Prednisolone, C- Cyclophosphamide, V-Vinblastine,
0- Vincristine, L-A - L-asparaginase, M- Methotrexate, 6-M - 6-mer-
captopurine, Ara-C - cytarabine, Chi- Chlorambucil^ A- Adriamycin.
MST - Mean survival time
MRT - Mean remission time.
were negative to the commonly used serological test for
FeLV. He concedes, however, that they may have had
FeLV in their tissues even though it was not detected.
As the mean survival times in Table 2 indicate,
none of the authors could report outstanding success.
Survival times of untreated cases vary greatly, partly
because of delays in diagnosis or delay by the owner in
taking the animal for examination. Madewell (1975)
has summarised survival times of untreated cases in dogs
as reported in the literature. The mean survival
times quoted vary from as short as 9.8 days to 99.5 days
therefore it would seem that in most chemotherapy trials
there is a definite prolongation of life.
Cancer chemotherapy in domesticated species other
than the dog and cat has only been attempted very rarely
In the larger species, the size of the animal means
using large volumes of drugs which makes the cost pro¬
hibitive. Ward and Whitlock (1967) tried chemotherapy
in a case of equine leukaemia with amethopterin.
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Hereditary Lymphosarcoma - Its Value as a Model of
Human Disease
New anticancer drugs are continually being produced
by research chemists, but because of the probability of
severe side-effects, the use cf these agents must be re¬
stricted until they have been extensively tested in
vitro and in laboratory animals.
There are two major aims in drug tests i) to pre¬
dict toxicity and ii) to predict efficacy.
(1) The animals most commonly used are rodents such as rats
and mice, rabbits, guinea-pigs, and the dog. Monkeys
are also frequently used. There are three principle
reasons for the initial toxicity trials. Firstly, com¬
pounds whose toxicity is likely to be unacceptable, i.e.
those which produce lifethreatening toxic effects in all
species, can be eliminated. Secondly, essential phar¬
macological information must be gained so that a trial
dose may be calculated. Thirdly, details of the toxic
effects in different species, are ascertained, how variable
they are and whether or not they can be reversed. In
this way, toxic effects in man can supposedly be pre¬
dicted, though there have been cases of drugs which pro¬
duced unexpected adverse reactions in man after being
tested in laboratory animals. Reasons for this may be,
a) that the experiments performed were inadequate,
b) that there are marked species differences in response
to the drug,
c) that human cancer patients are often in poor general
have
condition, possibly/impairment of function of organs
such as liver and kidneys, and may have been given pre¬
vious toxic therapy, whereas only healthy animals are
used for toxicity tests.
In many laboratories, the procedure of finding
the dose of a drug which is lethal to 50% of the animals
tested is carried out. This is known as the LD 50 for
that drug, in that species of animal and it is used as
a basis for calculating an initial clinical dose. In
other centres, four dose levels are determined. These
are a) the highest nontoxic dose, b) the lowest dose
which produces pathological effects of any kind, c) the
dose which produces toxic signs and when doubled causes
death, and d) the lowest dose which causes drug-induced
death in any animal during treatment (Creaven and Mihich,
1977) .
(2) The procedures for testing the efficacy of an
anticancer drug are not quite so well defined. As
mentioned previously, the effects of a drug are modified
greatly depending on the mode of administration, the for¬
mulation and alterations in metabolism, and its effects
on the tumour depend on whether or not the drug has ade¬
quate contact with the target cell. The host immune
response, the functions of lymphocytes and macrophages
against the tumour must not be forgotten - these functions
may be altered by the drugs, as most are immunosuppressive.
When these problems are considered, it would seem that in
vitro tests, such as the effects of drugs on tumour cell
lines in tissue culture, are fairly limited in their use¬
fulness for predicting the effectiveness of drugs in
cancer therapy, though they may provide important data
about the actions of various drugs in the different
stages of the cell cycle.
The obvious requirement, therefore, is a suitable
animal model of the tumour against which the drug is
intended to be used. Scientists have been searching
for many years for animal models of human tumours, and
relatively little progress has been made in the treatment
of human cancers which do not have common animal equiva¬
lents. The neoplasms of the laboratory rodents, to
which I have already referred, have been very useful in
the advancement of knowledge about leukaemias and lymph¬
omas and their treatment, but they are too different from
man to provide anything other than basic information.
Many scientists, doctors and veterinary surgeons now be¬
lieve that tumours in the larger domesticated species
should be studied, not only because they are interesting
curiosities, but because they could be important as
models of human cancer. Professor Cotchin in his
presidential address to the Royal Society of Medicine in
1976, gave some of the reasons why he thought that tumours
in animals are still not being investigated from the com¬
parative aspect with the attention that they deserve.
One of these was that there is a popular belief that
successful laboratory work on cancer demands the use of
highly inbred strains of experimental animals. He
pointed out however that it is questionable how im¬
mediately relevant work on experimentally induced or
even spontaneous tumours occurring in these animals is
to the spontaneous cancers occurring in largely out-
bred human populations. Another reason was that the
practical problems of studying tumours in domesticated
animals are difficult to overcome: the animals are much
more expensive to keep because they are larger than mice,
and trained investigators are few. However against
the problem of size and expense must be weighed the ad¬
vantages - more tissue, blood and other material is pro¬
vided for analysis, the tumour may be accessible at all
stages of its development, and the animal is much more
suitable for therapeutic studies because of its larger
life-span.
The dog is considered by many to be the best species
for use as a model, e.g. Engstrom, Shumway, Jones,
Bertino (1965), Owen, Bostock, Betton, Onions, Holmes,
Yoxall and Gorman (1975) but the major problem is that,
as mentioned previously, most canine tumours are sporadic,
of unknown aetiology and tend to occur in old age. Cases
for study are usually obtained by cooperation with
veterinary surgeons in general practice who may refer
them to a centre with the expertise and facilities for
therapy. However owners are often unwilling to have
their animals used for experimental work, therefore the
number of cases is bound to be limited. The work which
is being done on transmitting canine lymphoma, as already
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discussed, may solve this particular problem. However
as with other induced tumours, an artificial situation
is created which may not be identical with the naturally-
occurring disease.
Neoplasms of many kinds, and haematopoietic ones in
particular, are very common in the cat, but its useful¬
ness as a model may be limited because of the tendency
of this species to have unusual reactions to many drugs.
Although cases of feline lymphosarcoma are readily ob¬
tained in the laboratory, the presence of Feline
Leukaemia Virus means that the pathogenesis of the
disease may well be different from that in species such
as man in which a virus has not so far been implicated.
The other main problem which will always exist,
in Great Britain at any rate, is that the use of cats
and dogs for experimental purposes, whatever the bene¬
fits to be gained from it, is a very emotive subject.
The pig is a domestic species which resembles
man in several ways. It is comparable in body weight,
monogastric, omnivorous, and relatively hairless.
On the other hand the gestation time is quite short
(114 days), litter size is large with a survival mean
of about 10, and with good management two litters
can be produced in a year. Hereditary lymphosarcoma
is a naturally occurring pathologically homogeneous
condition which resembles closely poorly-
differentiated lymphocytic lymphoma of man. Being
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associated with an autosomal recessive gene it can be
produced simply by the mating together of two known
carrier animals, when, on average, 25% of the progeny
are affected.
Because of these facts, it was considered that
affected pigs might be suitable for use as a model for
testing the antitumour effects of new drugs before they
were introduced for clinical trials in man. They
could also be used to increase the present knowledge of
the pharmacokinetics and scheduling of drugs which are
already in use in man. However it was necessary first
of all to show that the pig, and in particular the lym-
phosarcomaitous pig would respond in the same way as
man to the different types of cytotoxic drugs already
in common use.
Reichel (1962) appears to be the only author to
have reported the effects of chemotherapy on lympho¬
sarcoma of the pig. Published work on the effects
of cytotoxic drugs in the normal pig appears to be scarce.
The use of corticosteroids, adriamycin and cyclophos¬
phamide has been reported (See Chapter I, II and III).
The purpose of the project documented by this thesis
was to investigate:
1) The clinical, haematological, biochemical and
pathological effects of some cancer chemotherapeutic
agents in the normal pigs. It was not to determine an
LD^q, which would have required large numbers of animals
and much more extensive studies, but merely to establish,
if possible, a dose which would be effective but relatively
non-toxic.
2) To discover whether or not these agents would
produce remission in the lymphosarcomatous pigs.
3) To determine how closely the effects of various
agents on pigs were comparable to their effects on man.
4) To demonstrate whether or not hereditary porcine
lymphosarcoma is a suitable model for research into the
effects of new antitumour agents intended for use in the
therapy of lymphoma in man and companion animals.
Choice of Drugs
A wide variety of drugs could have been used in
this study, and the ones which are recognised to be most
useful in the treatment of cancer in man are shown in
Table 3. Those marked with an asterisk (*) were
chosen because they have been shown to be particularly
effective in cases of human lymphoma and leukaemia,
and there is a great deal of information about them in
the literature (Cline and Haskell, 1975 ) .
Cytarabine was chosen from the antimetabolite
group because lymphoid tissue from the lymphosarcomatous
pigs had been shown to contain high levels of deoxy-
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69.
MATERIALS AND METHODS
The materials and methods used were basically the
same throughout the whole series of experiments, though
not all the measurements and techniques were necessarily
carried out in every experiment. Techniques which
were only used for experiments using one drug are des¬
cribed in detail in that chapter.
For each drug used as a single agent, there was a
trial using normal pigs and a therapy trial using lym-
phosarcomatous pigs.
Trials in normal pigs
Animals
The first trial used eight pigs divided into four
groups of two - one pair for a high dose level, one pair
for a medium dose level, one pair for a low dose level
and two saline - treated controls. After the results
of this first experiment were analysed, it was considered
that two control pigs were not sufficient, and in all
the subsequent trials using normal pigs, ten were used,
four of which were saline-treated controls. Initially,
it was thought desirable that all the pigs used in these
trials should be from the same litter, so as to eliminate
as much as possible, genetic variation in response to the
drugs. However, this created a problem because in a
large litter there was, usually, a "runt" pig, i.e. one
which was smaller and less vigorous than the others, for
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a variety of reasons. The results from a "runt"
animal tended to differ from the results obtained from
the other pigs, and so it was decided that only the
healthiest and fastest-growing pigs from two closely
related litters, born at approximately the same time,
should be used if possible. All normal pigs were from
the lymphosarcoma strain, but were from non-carrier dams
and, if possible, sired by non-carrier boars.
All the pigs used were bred in a piggery which was
modernised for the purpose, using breeding stock trans¬
ferred from the older minimal disease piggery referred
to in the Introduction. The disease precautions
practised in both piggeries were the same. Only auth¬
orised personnel wearing protective clothing were allowed
access.
The normal experimental pigs were weaned at 6 weeks
of age, provided they were well grown and consuming an
adequate quantity of creep feed. Before the experiments
started, they were introduced to a diet of pig nuts
(Breeder's Cubes, SAI Ltd., Edinburgh) with the following
analysis:-
Vit. A 11,000 iu/kg
Vit.D^ 2,000 iu/kg











All pigs used in one experiment were housed together
in the same pen. Free access to water was provided by
an automatic water bowl.
Male pigs were castrated before weaning, usually
at about 3 weeks of age.
Delayed hypersensitivity skin tests
Since Aisenberg's studies (1962) in Hodgkin's
disease patients, dinitrochlorobenzene, and the related
compound dinitrofluorobenzene (DNFB), have been used as
skin contact antigens for the study of cell-mediated im¬
munity in lymphoid malignant disease.
At about 7 or 8 weeks of age, all the young pigs
were sensitised to DNFB and tested in an identical manner
2 weeks later.
The method was as follows. The pig was restrained
and a patch of hair was removed from the skin of the
back using surgical scissors (the most usual areas were
in the mid-line between the tops of the shoulder blades,
or the sacral region.) The skin was thoroughly cleaned
with a cotton-wool swab soaked in methylated spirit, to
remove dirt, skin scales and grease, and the area was
dried with another piece of cotton wool. A small round
area of 14mm diameter was defined using a short piece
of glass tube, and 5 pi of 10% DNFB in equal volumes of
dimethylsulphoxide (DMSO) and acetone was dropped inside
the tube using an automatic micropipette with disposable
tips. The DNFB solution was spread using the flattened
end of a glass rod within the area, and allowed to dry
before releasing the pig. Rubber gloves were worn by
the operators to prevent self-sensitisation.
Observations on the state of the skin, to which the
DNFB had been applied, were made at 24 hours and 48 hours
and were recorded using the following arbitrary scale:-
0 12 3 4
no change slight erythema erythema+ marked ery- severe ulcer-




Skin tests were repeated at intervals during the ex¬
periments, always at the end of treatment and after recovery
from the effects of the drug. The response to these tests
gave a measure of cell-mediated immunity.
Body weight
At about the same time as skin sensitisation, weekly
weighing was started, the weight being recorded to the
nearest 0.5kg using a pig weighing-crate (Kwikway Products
& Co. Ltd., Birmingham). This was continued to the end
of the experiment.
Collection of blood samples
Shortly after this, blood-sampling was started. Before
treatment in all experiments, this was carried out
weekly, at the same time of day, usually at 9.30 a.m.
During treatment samples were taken weekly, or more
frequently, depending on the drug.
The pigs were restrained by blood sampling either
in dorsal recumbency, or held on their feet by means
of a rope noose round the upper jaw, depending on their
size.
Up to approximately 40 kilograms body weight, the
young pigs were placed in dorsal recumbency on a V-
shaped trestle of wooden boards held by a metal frame¬
work on metal legs 3 feet high. With one hand pressing
the head down and the neck stretched, a blood sample was
obtained from the anterior vena cava using a 10ml dis¬
posable syringe and a 19 or 20 gauge 1% or 2 inch needle,
or occasionally using "Vacutainers" (Beeton-Dickinson).
The skin was cleaned with cotton wool soaked in a 1 in
1000 dilution of "Hibitane" in surgical spirit. The point
of entry of the needle was in the right supraclavicular
fossa about h to 1 inch cranial to the manubrium of the
sternum, the needle being directed caudally, dorsally
and towards the mid-line. Part of the sample was put
into a plastic EDTA sample bottle (Searle) for haemat-
ological examination, and the remainder put into a dry
10ml glass test-tube with a rubber stopper for serum.
Haemorrhage after sampling was usually easily controlled
by pressure using a pad of dry cotton wool, but if a
haematoma developed at the site, the next sample was
taken from the left side in the same manner. While
drawing the sample into the syringe, excessive suction
had to be avoided so that the red cell haemolysis did
not occur. Over 40kg body weight the pigs were
tipped on to their backs and restrained in a modified
ground level V-shaped cradle (McTaggart, 1977).
Most of the pigs were not allowed to reach body
weights greater than 60kg but occasionally it was nec¬
essary to restrain a pig by means of the rope noose,
tied to a suitable firm object or in a handling crate.
In these cases, blood samples were taken using EDTA and
plain vacutainers from an ear vein, raised by means of
a rubber band round the base of the ear. Even less
frequently a small blood sample was obtained by puncturing
a vein with a 16 gauge needle near the edge of the ear
after clipping the hair, cleaning the skin with cotton
and
wool soaked in surgical spirit,/applying petroleum jelly
to the skin surface. Blood was then allowed to flow
into the tube . The methods used in handling of blood
samples in the laboratory will be dealt with later.
Clinical examinations
In addition weekly clinical examinations were carried
out before the start of drug treatment. Rectal temper¬
atures were taken using a lubricated mercury clinical
thermometer or an Ivac 821 (Loxley-Luxan) electronic
thermometer in heavier pigs which were more difficult to
restrain. This was done at the same time of day each
time, but there was still a variation in temperature
readings obtained. It was possible however to as¬
certain an approximate "normal" range for each pig, so
any
that the relevance of/ marked alteration in rectal
temperature during drug treatment was appreciated. Re¬
spiratory and pulse rates were not accurately measured
as they were considered to be too variable, due to ex¬
citement, to be of much relevance. However, each pig's
thorax was auscultated to detect any abnormalities in
lung sounds or cardiac sounds, before treatment was
started. The body condition of each pig as well as the
state of its appetite was noted, also the appearance of
its faeces and urine. Any injuries or other abnormal¬
ities were noted and treated if possible before the start
of the experiment. Occasionally, a pig was found to
have developed a condition which made it unsuitable for
inclusion in the experiment. It was rejected and
another pig substituted.
During drug treatment, the pigs were observed every
day for signs of ill health, particularly loss of ap¬
petite and soft faeces, and they had a similar complete
clinical examination to that carried out before treat¬
ment once every week.
All the trials using normal pigs followed the same
basic pattern with half of the pigs being destroyed and
autopsied at the end of the prescribed period of treat¬
ment, which varied according to the drug, i.e. one high
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dose pig, one medium dose pig, one low dose pig and
one (of two) or two (of four) controls were killed.
The remaining pigs were left untreated until it was
felt that all the effects of the drug had disappeared,
when they too were destroyed and autopsied.
Therapy Trials
Animals
Each litter resulting from the mating of a carrier
boar and a carrier sow was ■ checked for enlargement of
the superficial inguinal and precrural lymph nodes at 6
or 7 weeks of age. Any animals showing suspicious
signs were blood sampled at this stage for haematology.
Sometimes, there was no evidence of disease at this
stage. The litters were checked at 8 or 9 weeks by
which time most cases were showing signs. One more
check at 10 or 11 weeks was usually carried out to be
sure that no cases had been missed. In general, diag¬
nosis presented few difficulties except where there had
been a problem with intercurrent disease in the litter.
Once cases were definitely identified, they were
separated from their normal littermates. Males trans¬
ferred from the older piggery were castrated. Those
bred in our own piggery were left entire.
On 16th November, 1977 the lymphosarcoma animal
house was opened, and cases were moved to this building.
Prior to this date, lymphosarcomatous pigs were all kept
together in one pen in the breeding piggery. Introducing
animals of different sizes never caused problems as these
pigs did not fight as normal pigs tend to do when mixed
with other strange pigs. However, there were disad¬
vantages. Individual feed intakes could not be ass¬
essed or controlled, and it was difficult to make ob¬
servations on the state of faeces and urine for indivi¬
dual pigs. There were no facilities for surgery, other
than very minor operations. No heat source could be
provided in the pen, and the pigman had no time to nurse
sick animals.
Accommodation for pigs in the new house comprised
five loose boxes, which were each subdivided into three
individual pens with walls 5 feet high between them, and
solid metal gates with sliding diagonal bolts. The
floors of the pens had raised bedding areas at the back
and dunging areas at the front, each of the three pens
draining to the centre of the entrance area of each
loose box. The floors were insulated but straw was
also given and heat lamps provided for use when pigs were
sick, or after surgery when recovering from anaesthesia.
Nipple drinkers were situated on the walls near the doors
to encourage defaecation and urination in the correct
area by keeping the floor wet. No built-in mangers
were provided. Metal moveable mangers were found to be
unsatisfactory and so the pigs* food was placed on the
floor in the bedding area.
Handling was carried out in the central passageway
between the loose boxes. Trestles used were similar
to those described for the trials using normal pigs, but
no crate was available for handling larger animals.
Two metal rings were inserted in the wall of the pass¬
ageway and these were used to tie up larger pigs using
a rope noose. Problems were encountered when the canine
teeth were not large enough to keep the noose from sliding
off and to overcome this, a harness was designed. This was
made of heavy nylon strapping and was fully adjustable.
It consisted of a strap around the body of the pig behind
the fore-legs, attached to a strap over the shoulders,
neck and between the ears with a ring on the end through
which the rope noose was passed before tying up.
The pig food used was similar to that used in the
breeding piggery, but when pigs' appetites were poor, a
variety of other foods were offered including milk and
fruit and vegetables. Careful nursing was found to
be essential and undoubtedly saved pigs which would other¬
wise have died.
Disease staging
When cases were moved to the animal house, they were
kept in a separate "quarantine" loose box as far from the
inmates as possible for 3 weeks until their condition
could be properly assessed. Once the pigs had become
accustomed to the new accommodation, they were prepared
for laparotomy. This procedure confirmed the diagnosis.
Disease staging in man is an essential procedure before
commencing therapy, and is usually defined according to
the Ann Arbor Staging Classification, (See Introduction,
Table 1).
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In man, staging laparatomy is usually carried
out after biopsies of bone marrow and liver, radiogr¬
aphy of chest and abdomen. Radiography was not
possible with the pigs as X-ray apparatus could not
be brought into the piggery and the pigs could not
be moved. However, although it was important to as¬
certain the degree of involvement of various organs in
individual pigs before therapy started, it was known
that they were all likely to be in Stage IV by the time
of diagnosis, and so the omission of these procedures
was considered unimportant. The main reasons for
laparotomy were to obtain mesenteric lymph node biopsy
material, to demonstrate by photography the effects of
the drugs, if any, on mesenteric nodes and spleen by
repeating the procedure immediately after therapy was




The pig was starved the day before surgery. On
the morning of the operation, the animal was given
azaperone ('Suicalm', Janssen) intramuscularly at a dose
rate of 4mg/kg body weight. Twenty minutes was allowed
to elapse so that this tranquilliser would produce its
maximum effect. The pig was then gently restrained in
ventral recumbency on the high bleeding trestle, one ear
was cleaned with methylated spirit-soaked cotton wool
and a 2.5% solution of thiopentone sodium ('Intraval',
May and Baker) was injected intravenously to effect
using an approximate dose of 20mg/kg, through a 23 gauge
'butterfly' Miniven set' (Portex Ltd., Hythe). When
sufficient jaw relaxation had been achieved and the
'gag' reflex had been abolished, the mouth was held open
by an assistant, using two pieces of bandage, one piece
round the lower jaw, under the tongue and the other round
the nose and upper jaw. A rubber or plastic cuffed
endotracheal tube (various makes, 6.0 to 11.5 millimetre,
depending on the size of the pig) was inserted, with the
aid of a laryngoscope. Once it was satisfactorily in
place, which was confirmed by feeling air rushing down
the tube as the animal breathed, the cuff was inflated
and the tube tied in place with the piece of bandage
round the upper jaw.
The pig was then moved to the operating theatre
and placed on the table in dorsal recumbency but tilted
slightly to the left. It was held in position with
sand bags. The endotracheal tube was attached to a
anaesthetic machine with vaporiser. A halothane
('Fluothane', I.C.I. Ltd.) and oxygen mixture was used
to maintain and deepen anaesthesia slightly so that
surgery could begin. Nevertheless, the plane of an¬
aesthesia was kept as light as possible, since respir¬
ation was often poor, and the heart rate was monitored
frequently in case of cardiac arrest. During the first
*
series of operations, one pig died due to shock and
failure of venous return. Pressure on the diaphragm
caused by the huge volume of abdominal organs and tumour
tissue, in addition to the poor general condition of the
animal, was thought to be responsible, and in subsequent
operations the table was tilted about 20 degrees so that
the pig's head was higher than its tail. This was very
successful. Respiration improved and there were no more
anaesthetic deaths. The air temperature in the operating
theatre was kept as high as possible, and hot water bottles
were arranged round the pigs during and after the operation
in case of hypothermia. An area of skin around the in¬
tended site of the incision was shaved using shaving foam
and a safety razor and the skin was disinfected with a 1
in 10 solution of "Hibitane" 5% concentrate in 70%
alcohol.
Operating Procedure
The surgeons wore sterile gowns and disposable sur¬
gical gloves. Four sterile green calico drapes were
held in place with towel clips around the site of the
incision, which was longitudinal, parallel to the midline,
from about 5 centimetres caudal to the costal arch to
a similar distance cranial to the fold of the flank.
This site was chosen in males to avoid the prepuce. When
operating on the first female, a mid-line incision was
tried, but the approach to the small intestine was more
difficult and the internal sutures broke down resulting
in a large hernia, and so in all subsequent operations
the paramedian incision was used. The incision was
made with a scalpel and the aponeurotic sheets of the ex¬
ternal oblique, internal oblique and transverse abdominis
muscles were cut through one by one with straight scissors
Bleeding points were swabbed and then crushed with artery
forceps, and, if necessary, tied off with catgut. The
peritoneum was exposed, lifted with rat-tooth forceps and
nicked with scissors. Peritoneal forceps were attached
on each side, and then the peritoneum was also cut along
the incision line with straight scissors, taking care not
to cut any organs underneath. Tissue forceps were then
applied to the peritoneal and muscle layers on each side,
for better grip. The loops of the small intestine were
exteriorised. If possible, the terminal part of the
ileum with the characteristic hook-shaped lymph node, were
brought to the incision, and laid on the drapes for photo¬
graphy. If, however, the incision was fairly far forward
this part was difficult to find and, to save excessive
handling of the intestine, a more accessible part was
photographed. A piece of lymph node was then removed,
for histological examination. The peritoneum covering
it was slit and a piece was removed by blunt dissection,
controlling any haemorrhage, which was usually slight, by
pressure, and then the peritoneum was closed again by a
continuous suture with catgut (straight needle attached).
The loop of intestine was then returned to the abdominal
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cavity. The next stage was to exteriorise as much of
the spleen as possible without pulling too much on it,
as in most cases it was very enlarged and rather friable.
The spleen was also photographed. For all photographs,
a metal rule marked in centimetres and millimetres was
placed beside the lymph nodes and spleen. By this
method, it was hoped to be able to demonstrate the
effect of the drugs on the nodes and spleen. However,
in many photographs, the metal rule reflected the flash
light and the numbers were unreadable.
Finally the abdomen was closed. The peritoneum and
muscle layers were closed with a continuous suture of
catgut using a curved round-bodied needle. The skin
incision was closed with interrupted mattress sutures
of nylon with or without a cutting needle attached
using a pair of Gillie's needle holding forceps.
An injection of long-acting benzathine penicillin
('Penidural', Wyeth) was given intramuscularly after
the operation. The anaesthetic machine was switched
off and the pig disconnected from it. The animal was
then returned to its pen with the heat lamp switched on,
to recover from the anaesthetic. By this time most
animals were beginning to show signs of recovery, there¬
fore the cuff was deflated and the endotracheal tube was
removed. The pig was made to lie on its sternum using
sand bags to support it. Cases which had undergone
surgery were usually drinking by the same evening, and
eating a little by the next day. Healing of the wound
was usually uneventful but one or two post-operative
complications arose, which will be described in the
appropriate chapters later on.
Pre-treatment routine
Clinical observations were recorded daily and de¬
tailed clinical examinations were carried out weekly.
These examinations included taking the rectal temperature,
auscultation of heart and lungs and careful examination
of eyes, mouth, skin and feet. Measurement of the
lengths and breadths of the superficial inguinal and pre-
crural lymph nodes were carried out, using a pair of
tuberculin-testing calipers, without lifting the nodes
into a fold of skin. When pigs were in remission, it
was frequently impossible to measure the nodes. Even
when they were quite large, it was often difficult to
measure the precrurals with accuracy, but since the pro¬
cedure was carried out in exactly the same way each time
it is to be hoped that the error was fairly constant.
The circumference of the abdomen was measured at the level
of the umbilicus using a measuring tape at the end of
expiration. Initially the reason for taking this meas¬
urement was that with certain drugs the pigs' abdomens
seemed to become more pendulous than they were before
the start of therapy. However, with these measurements
which were taken with the pig in dorsal recumbency, it
was possible to estimate whether this apparent enlargement
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was real or not. In fact they proved to be useful as
an indication of the state of the tumour. (See Results).
Before therapy was started, the pigs were photo¬
graphed standing in front of a black board, marked off
in squares with white tape, or in front of the grey-
painted door of the animal house, which was marked off
in identical squares with black tape. They were also
photographed in dorsal recumbency with the hind legs
frogged and held well apart to display the inguinal lymph
nodes.
Skin sensitisation and testing were performed and
blood sampling and weighing were carried out, as descri¬
bed for the trials in normal pigs.
Procedure during therapy trials
Four pigs were used in each experiment, except for
the trials using corticosteroids in which an extra two
pigs were used, for reasons which will be explained later.
The dose rates used, methods of dosing and duration of
experiments were different for each trial and will be
described in detail in the appropriate chapter.
Weekly weighing, bleeding and detailed clinical ex¬
aminations were continued during therapy. In some
experiments, it was necessary to blood sample more
frequently, usually to monitor white blood cell
counts. Clinical observations were made daily on
fitness, appetite, whether faeces were soft, hard or
diarrhoeic and any other details that were noticed.
The most frequent problem encountered was diarrhoea.
This was often severe enough to cause rapid loss of
condition and dehydration especially in small pigs,
and even death on one or two occasions, therefore
treatment was usually given without delay. If the
pigs were afebrile and small enough to be easily dosed
by mouth, the usual mixture administered was 'Streptaquaine
(Elanco Products Ltd.) 15 to 20ml/day. This contains
1.76g dihydrostreptomycin sulphate, 1.76g sulphadimidine
and 21.lg light kaolin per 100ml. The dosing appara¬
tus was a 20ml. syringe attached to a piece of polythene
tubing about 25cm long, with rubber tubing inside it
and turned out over the sharp end to protect the pig's
pharynx.
In stubborn cases, or those in which the diarrhoea
recurred, sulphadiazine powder with trimethoprim
(Tribrissen, Burroughs Wellcome & Co. Dispersible powder)
or neomycin sulphate powder ('Neobiotic' Upjohn Ltd.)
or framycetin sulphate (Framomycin Feed Additive C-Vet.
Ltd.) were given mixed with the feed. The dose rates
were o.25g/kg, 0.2g/kg and lOmg/kg respectively. 'Strep-
Sulpha*
taquaine/ was given once or twice daily for 3 days and
in-feed powder for 5 days or longer. Framycetin
sulphate was used mainly when the pigs were in the
breeding piggery and was administered daily at prophy¬
lactic dose level (5mg/kg) for the duration of the
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experiment, because it was considered that challenge
from infection was much greater in that situation. If
the pigs were febrile and off food, antibiotics were
given by intramuscular injection. A variety of pre¬
parations were used. These were:-
(1) Ampicillin (150mg/ml) ('Penbritin', injectable
suspension, Beecham Animal Health) dose rate 5mg/kg
bodyweight, for 3 days.
(2) Oxytetracycline, 50mg/ml ('Terramycin Q-50', in¬
jectable solution, Pfizer Ltd.). Dose rate 2 to 9mg/
kg for 3 days.
(3) Chloramphenicol (150mg/ml) ('Ertilen', Ciba-Geigy
(U.K.) Ltd.). Dose rate 30mg/kg body weight for 5
days. This was only used in very severe cases.
Occasionally, faeces samples were submitted for
bacteriological examination but it was already known
that the likeliest infectious causes of intestinal prob¬
lems were pathogenic strains of Escherichia coli, and
Campylobacter sputorum var. mucosalis, the latter also
allowing opportunist pathogens including spirochaetes
and the protozoan parasite Balantidium coli, to gain a
hold. Campylobacter sputorum has been implicated in
a variety of conditions of the intestine of the pig
(Rowland and Lawson, 1975).
If cases were severely dehydrated they were given
fluid replacement therapy intravenously and subcutane-
ously with sterile glucose saline solution.
Other disease problems occurred much less commonly
and will be described, along with treatment given, else¬
where.
At the end of therapy, skin tests and photographs
were repeated. Half of the pigs were then destroyed,
as in the normal pig trials, by an intravenous injection,
into an ear vein, with 20% pentobarbitone sodium ('Expiral',
Ceva Ltd.). These pigs were autopsied. If the remain¬
ing pigs had had laparotomies before therapy, this was re¬
peated. Thus it was possible to confirm whether all
the pigs in the experiment responded in the same way.
The two remaining animals were left untreated until
all the effects of the drugs had apparently disappeared.
By this time, the tumour had in most cases returned to
the same stage of development, as before therapy started.
Methods of handling blood samples in the laboratory
Every week, lOml. of blood was taken from each
animal, 2ml for haematology and 8ml for serum, as pre¬
viously explained. The haematology sample bottles
were agitated gently by hand for about 1 minute after
taking the sample, to ensure that the anticoagulant was
mixed well with the blood. In the laboratory, the
sample bottles were placed on a rotating apparatus to mix
them thoroughly before processing. The blood for serum was
left to clot in the test-tubes on the bench at room tem¬
perature until the clot was well-formed and sufficiently
retracted not to adhere to the glass when the tube was
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inverted. The sample was centrifuged hard for 30
minutes and the serum decanted into another tube. Re¬
sidual red cells were removed by another half an hour's
centrifugation and the serum was decanted again into
plastic conical test-tubes.
Haematological techniques
White Blood Cell Counts (WBC) -
These were carried out using a Coulter electronic
counter, (Coulter Electronics Ltd., Harpenden) Model ZF,
using threshold setting 8 and sensitivity settings 0.707
and 16. Samples were diluted using the Coulter Dual
Diluter III, and 6 drops of 0.3% potassium cyanide ("Zap-
oglobin") were added to the 20ml of diluted blood, to
haemolyse the red blood cells. A mean of two successive
counts at opposite polarities were taken and the figure
obtained multiplied by 10^ gave the number of WBCs per
litre.
Differential Counts
A drop of well-mixed blood was placed at one end of
a clean glass microscope slide, using a platinum loop.
Another slide, with a corner cut off, was used as a
spreader. A blood smear was prepared by allowing the
drop of blood to run along the edge of the spreader, and
then moving the edge of the spreader along the slide at
an angle of about 45 degrees.
Blood smears were stained, using concentrated
Leishman's stain for 2% minutes and then diluting it with
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double the volume of buffered distilled water, pH 6.8,
leaving this on the slide after mixing for 15 minutes.
Slides were then washed with a stream of distilled water
and left to dry at room temperature. Differential
counts were based on 200 cells counted using a 54 times
magnification oil immersion objective on a light field
microscope (Leitz) with a blue filter. In blood smears
from lymphosarcoma cases it was not easy to differentiate
between the various types of mononuclear cells, therefore
"total mononuclear cells" were counted.
Red Blood Cell Counts (RBC)
These were also carried out on the Coulter electronic
counter, with the same settings for threshold and sens¬
itivity as for WBC counts. A mean of two counts was
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taken and multiplied by 10 to give the count per litre.
Packed Cell Volume (PCV)
PCV was measured using microhaematocrit tubes,
centrifuge and reader (Gelman Hawksley, London), the
samples being centrifuged for 5 minutes.
Haemoglobin (Hb)
Hb was estimated by the cyanmethaemoglobin method,
using a Coulter Haemoglobinometer.
Thrombocytes
The platelet diluting fluid recommended by Baar
(1948) was used. This was made up as follows:-
Saponin (BDH) - 0.25g
Sodium citrate - 3.5g
Formalin (40% Formaldehyde) - 1.0ml
Distilled water to 100.0ml
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Baar included O.lg brilliant cresyl blue but this
was found to be unnecessary.
Dilutions were made into white cell diluting pip¬
ettes. Blood was drawn up to the 0.5 mark on the
pipette and the excess wiped off. Diluting fluid was
then drawn up into the pipette until it reached the 11
mark. Pipettes were shaken for several minutes on a
mechanical shaker. Counts were carried out in an
Improved Neubauer haemocytometer (Hawksley). The
first half of the fluid in the pipette was discarded and
the chambers filled. The chambers were then placed in
a closed box, with moist tissues on the bottom, for 20
minutes before counting.
The red cell counting area was used for counting.
Five groups of 16 small squares were counted at 400 times
magnification, using a green filter. The count obtained
9
multiplied by 10 gave the number of thronbocytes per litre.
Derived red cell indices
These were calculated from the haematology results,
using the following formulae:-
Mean corpuscular haemoglobin (MCH) - this is the
average haemoglobin content of a single red cell expressed
-12
as pico-grams (10 g)
MCH = Haemoglobin in g/dl x 10
Red blood cells per litre
Mean corpuscular volume (MCV) - this is the average
red cell volume expressed in femtolitres (fl)
MCV = PCV in 1/1 x 103
RBCs/litre
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Mean corpuscular haemoglobin concentration (MCHC) -
this is the concentration of haemoglobin as g/dl of red
blood cells.
MCHC = Haemoglobin in g/dl
Packed cell volume in 1/1
Serum Biochemistry and Enzyme Estimations
The methods used for these measurements were those
in current use in the clinical laboratory at the Royal
(Dick) School of Veterinary Studies, Edinburgh.
In order to reduce costs, the only parameters meas¬
ured were those considered most likely to reveal changes
which would be of clinical relevance in each experiment.
This varied with the drug used.
In assessing the results, comparisons were made with
figures obtained from normal pigs, performed in the same
laboratory if available. Most of these animals were
from the same piggery as the experimental pigs. These
figures were thought to be more reliable than results
quoted by other authors in different parts of the world
and from different breeds of pig under different man-
agemental conditions. If control results were not
available from this source, other references were con¬
sulted .
Total serum protein, determined by the Biuret reaction
Protein forms a coloured complex with cupric ions
in alkaline solution. The protein-biuret complex is
read against a reagent blank, and the amount of protein
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is calculated against a known protein standard carried
through the same procedure (Henry, Sobel and Berkman,
1957).
Reagents used were:-
(1) Biuret reagent (Benedict's Qualitative glucose
reagent). This was made up as follows:-
(a) Copper sulphate (CuSO^ 5H2O), 17.3g, dissolved
in 100ml hot distilled water.
(b) Sodium citrate, 173g, and anhydrous sodium
carbonate, lOOg, dissolved in 800ml water by heating.
When cool (a) was poured into (b) while stirring and
diluted to 1 litre at room temperature.
(2) NaOH solution 3% (w/v)
Test-tubes were set up as follows:-
Blank Standard Control Test
3% NaOH 5.0ml 4.9 ml 4.9 ml 4.9 ml









The tubes were mixed without delay, left at room
temperature for at least 15 minutes and then examined for
turbidity. If clear, or only a trace was present, the
absorbance of standard, control and unknown were read
against a reagent blank in a spectrophotometer at 545nm.
Turbidity due to lipaemia was cleared by adding 3ml
of ether, shaking vigorously for 30 seconds and centri-
fuging.
Haemolysis was important because O.OOlg Hb/dl is
equivalent to 1.9mg serum protein. However Hb concen¬
tration of less than O.lg/dl can be ignored, and haemo¬
lysis was seldom as severe as this.
The formula for calculation of total protein in g/
litre is test absorbance x 1000 x g protein in standa
standard absorbance 0.1
Albumin determination in serum
The method used was similar to that of Doumas, Watson
and Biggs (1971). The addition of albumin to a solution
of bromocresol green in a 0.075M succinate buffer at pH
4.2 results in an increase in absorbance at 628nm.
Reagents used were:-
(1) Working bromocresol green solution, made by diluting
one volume of 0.6mM bromocresol green solution (419mg of
bromocresol green in 10ml 0.1N NaOH made up to 1 litre
with distilled water) with three volumes of 0.1M succin¬
ate buffer (11.9g succinic acid in distilled water, pH
adjusted to 4.0 with NaOH and made up to 1 litre with
distilled water). A non-ionic surfactant (30% Brij.
35, Fisher Scientific Co.), 4ml/litre, was added to re¬
duce the absorbance of the blank, prevent turbidity and
ensure a linear absorbance-concentration relationship,
and the pH was adjusted to 4.2.
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(2) A standard pig albumin solution, made up in
0.05% aqueous sodium azide. The concentration was de¬
termined several times by the total protein method and
the average value used as the constant in the calculation.
Concentration of Serum albumin in g/litre test absorbance x constant
standard absorbance
Test-tubes were set up as follows:-
Blank Standard Control Test
BCG working 5.0ml 5.0 ml 5.0 ml 5.0 ml
solution
Albumin standard - 0.025ml - -
Control serum - - 0.025ml -
Test serum - - - 0.025ml
These were allowed to stand at room temperature for
10 minutes and were then read in the spectrophotometer at
628nm against the blank.
Blood Urea Determination
The Urease-Nesslerisation method involves digestion
of a sample of blood or serum with urease (obtained from
soya beans), converting the urea into ammonium salts.
The proteins are precipitated, the supernatant removed and
Nessler's reagent added. The colour produced by the
ammonium salt and Nessler's reagent is compared colori-
metrically with the colour produced under the same con¬
ditions by a standard urea solution. Nessler's reagent
is an alkaline solution of potassium mercuric iodide. With
ammonia this forms dimercuric iodide which gives a yellow
colour.
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The calculation is:- Test x 16 m mol/1
Standard
NH4C1 + 2K2 (Hg I4) + KOH - Hg2 NI, N20 + 7KI + 3H20 +
KC1
Reagents used were:-
1. 10% Zinc sulphate
2. 0.5N Sodium hydroxide
3. Urea standard - 96mg Urea dissolved in
100ml distilled water (16 mmol/1)
4. Urease suspension - 1 tablet crushed
finely and suspended in 5ml of 30% ethanol
5. Nessler's reagent
Test-tubes were set up as follows:-
Blank Standard Control Test
Distilled water 3.2ml 3.0ml 3.0ml 3ml
Urea standard - 0.2ml - -
Control serum - - 0.2ml -
Blood specimen - - - 0.2ml
Urease suspension 0.2ml 0.2ml 0.2ml 0.2ml
The tubes were incubated in a water bath at 50°C for 15
minutes and then 0.3ml of zinc sulphate and 0.3ml of
sodium hydroxide were added to each tube. Each was
mixed thoroughly and centrifuged for 10 minutes. During
the incubation period the appropriate number of boiling
tubes were set up with 5ml distilled water in each and
these were cooled in the refrigerator.
After centrifugation, 2ml supernatant was removed
from each tube and added to the water in the boiling
tubes. Finally 1ml of Nessler's reagent was added
and the yellowish-brown colour produced read immediately
against the blank in an EEL (Evans Electroselenium Ltd.)
"Spectra" at 460nm.
Serum bilirubin estimation
Methods of detecting and estimating bilirubin in
serum are based on the fact that sulphanilic acid dia-
zotised with sodium nitrite and hydrochloric acid, com¬
bines with bilirubin in alcoholic solution to form a
red-violet azo dye,azo-bilirubin.
In cases of obstructive jaundice, in which mainly
conjugated serum bilirubin is increased, the azo-bili¬
rubin colour develops quickly in the absence of alcohol.
This is the basis for the direct Van den Bergh reaction,
named after the man who demonstrated it. In haemolytic
jaundice most of the total bilirubin is in the free state
and requires to be brought into solution by the addition
of alcohol. This is called the indirect Van den Bergh
reaction.
In Van den Bergh's original method, serum proteins
were precipitated by ethyl alcohol. Several methods
are now available without precipitation of protein. The
method of Powell (1944) uses an aqueous solution of
sodium benzoate and urea which gives an almost immediate
colour development from the whole of the bilirubin pre¬
sent in "*~/10 dilution and is more accurate with low con¬
centrations of bilirubin. Both total and direct
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reacting bilirubin can be estimated without precipitation
of protein.
Reagents used were:-
(1) Diazo reagent - this was prepared freshly before
use by adding 0.3ml of soln B to 10ml of Soln A.
Solution A - lg of sulphanilic acid dissolved in 15ml
concentrated HC1 and made up to 1 litre with distilled
water.
Solution B - 0.5g sodium nitrite dissolved in distilled
water and made up to 100ml.
(2) Diazo blank - 1.5% HC1.
(3) Sodium benzoate - urea solution - lOg sodium
benzoate was dissolved in 60ml distilled water, lOg of
urea was added and dissolved. The solution was then
made up to 100ml. and filtered.
(4) Standard solution of bilirubin: lOmg bilirubin
in 100ml chloroform.
Working standard - 4ml stock solution was diluted to 50ml
with 95% ethanol.
This equals 0.8mg/100ml bilirubin.
5ml. of standard given above plus 1ml diazo reagent
and 4ml of 95% ethanol, gives a colour equivalent to 4mg/
100ml if read after 30 minutes. Methyl red artificial
standard - 0.29g methyl red was dissolved in glacial
acetic acid and made up to 100ml with acetic acid,, 1ml
of this solution v*as transferred to a litre flask and 5ml
acetic acid plus a little water was added and 14.4g sodium
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acetate was washed in and dissolved. Thiswas then made
up to 1 litre with distilled water.
1 in 10 dilution = 4mg/100ml bilirubin.
Both total and direct reacting bilirubin can be
estimated without precipitation of protein.
Serum and reagents were mixed in four test-tubes as
follows:-
Total Direct
bilirubin Blank bilirubin Blank
Serum 0.4ml 0.4ml 0.4ml 0.4ml
Diazo reagent 0.2ml - 0.2ml -
Diazo blank - 0.2ml - 0.2ml
Benzoate-Urea 3.4ml 3.4ml - -
Distilled water - - 3.4ml 3.4ml
The tubes were allowed to stand at room temperature for
10 minutes and read against appropriate blanks, at 520nm.
The standard solution was read against a water blank.
(624 green for EEL colorimeter).
Calculation:- Reading of Test x 68.4 = pmol of total
Reading of standard or direct bili-
rubin/litre
Serum glutamic oxaloacetate transaminase estimation (SGOT)
This was performed using a kit (Calbiochem, California,
U.S.A.) using a modification of the method of Karmen,
Wroblewski and La Due (1955).
The test principle is
GOT
o<- ketoglutarate+L-aspartate —i L-Glutamate+oxaloacetic
acid (GOT - glutamic-oxaloacetate transaminase)
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malate dehydrogenase
oxaloacetic acid + NADH > NAD + L - malate
(NAD - Nicotinamide - adenine dinucleotide
NADH -Nicotinamide - adenine dinucleotide reduced)
i.e.0*1 - ketoglutarate and L - aspartate react in the
presence of GOT to yield L - glutamate and oxaloacetate.
The latter is subsequently reduced by malate dehydro¬
genase to L - malate and simultaneously, a molar equiv¬
alent of NADH is oxidised. The rate of change in ab-
sorbance is proportional to the activity of GOT in the
sample. Lactate dehydrogenase is present to eliminate
endogenous pyruvate, the major source of non-specific
side reactions.
The reagents were supplied in "A" and "B" vials,
to be reconstituted with distilled water, and mixed
before use.
The contents of an "A" vial yields a solution of
pH 7.4 containing Phosphate buffer - 0.05 mol/1.
_2
L - aspartic acid - 3.6xlO mol/1
L - ketoglutarate - 7.6x10 3 mol/1
Malate dehydrogenase - 333 iu/1
Lactate dehydrogenase - 333 iu/1
The "B" vial contains the cofactor NADH (2.0 x 10 ^
mol/1) and non-reactive stabiliser.
The GOT assay was performed on serum, separated
from the clot as soon after collection as possible. It
was desirable that the specimens were free from haemoly¬
sis. GOT is stable for 3 days at room temperature, for
1 week at 4°C and for 1 month frozen at - 25 C. Acti¬
vity could still be detected however in samples frozen
O
for 2 years at - 60 C.
Sera of known activity were used as controls.
Using a suitable pipette, 3.0ml of the reagent
solution from vial A was dispensed into a clean dry
cuvet, with a 1cm light path. The cuvet was placed
in a constant temperature waterbath for 3 minutes, at
30°C. The test sample was preincubated for the same
length of time in the same bath. To the cuvet was
added 0.2ml of the test sample. This was mixed
quickly by gentle inversion, avoiding shaking. The
cuvet was wiped dry and immediately inserted into the
temperature controlled cell compartment of the photo¬
meter. Water was used as a blank. The initial
absorbance was measured approximately 3 minutes after
placing the cuvet in the instrument. Exactly five
minutes after the initial reading, the final absorbance
was determined. All measurements were made at 340nm.
If the absorbance change of a sample was more than
0.25 in 5 minutes (GOT activity greater than 130iu/l),
or if the sample was icteric or lipaemic, the test was
repeated using less sample.
The GOT activity in i u/1 = the observed change in
absorbance in the 5-minute period x 514.
If less sample was used, the result was multiplied
by a dilution factor, depending on the volume of sample.
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This was 1.94 when O.lml of sample was used and 3.81
when 0.05ml was used.
An International Unit is defined as the activity
of enzyme which converts 1 micromole of substrate in 1
minute under standard conditions.
Serum glutamic pyruvate transaminase estimation (SGPT)
This was also performed using a kit (Calbiochem)
using a modification of the method of Wroblewski and La
Due (1956).
The test principle is
GPT
tJL - ketoglutarate + L-alanine A L-glutamate+pyruvate
pyruvate + NADH + L - lactate
In this reaction, - ketoglutarate and L-alanine
react in the presence of GPT to yield L-glutamate and
pyruvate. The latter is subsequently reduced by lactate
dehydrogenase into L-lactate; simultaneously a molar
equivalent of NADH is oxidised. The rate of change in
absorbance at 340 nm is proportional to the activity of
GPT in the sample.
As with the SG0T kit, the reagents were supplied in
"A" and "B" vials to be reconstituted with distilled
water and mixed.
The contents of an "A" vial yields a solution of
pH 7.4 containing
Phosphate buffer - 0.05 mol/1
L - Alanine - 0.17 mol/1
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cJ-- ketoglutarate - 7.0 x 10 ^ mol/1
Lactate dehydrogenase - 333 iu/1
The "B" vial again contains the cofactor NADH (2.0
-4
x 10 mol/1) and non-reactive stabiliser.
The GPT assay was performed on serum as with the
GOT assay. Sera of known activity were used as con¬
trols .
The method and calculation of results were exactly
the same as for the SG0T assay.
The result is also expressed in iu/1.
Serum alkaline phosphatase estimation
This was carried out by the colorimetric method
of Bessey, Lowry and Brock (1946).
The principle of the test is as follows:-
alkaline phosphate
p - nitrophenyl phosphate > phosphate+
p-nitrophenol.
Reagents used were:-
(1) Buffer - glycine buffer - 50 mmol/1 pH 10.5
MgCl2 - 0.5 mmol/1
(2) Substrate - sodium p - nitrophenyl phosphate - 5.5
mmol/1
One tablet of the substrate was dissolved in 10ml of
buffer solution.
(3) NaOH solution - 0.02N
Tubes were set up as follows:-
Control blank - 1ml substrate solution Test blank -
lml substrate solution.
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Control test - Test -




The samples were added at 30 second intervals exactly.
The tubes were incubated at 37°C in a waterbath for 30
minutes.
After this, at 30 second intervals, 10ml NaOH was ad¬
ded and 0.1ml of sera were added to the blanks.
The tubes were mixed well and the liquid poured into
cuvets . The absorbance of each test was read against
the blanks at 405 nm in the spectrophotometer.
Alkaline phosphatase (iu/litre) - 200 x absorbance.
Inorganic phosphate determination in serum
This was carried out by the method of Fiske and
Subbarow (1925). The principle is as follows:-
The proteins of blood, serum or plasma, are precipi¬
tated with trichloracetic acid. The protein-free fil¬
trate is treated with acid molybdate solution which forms
phosphomolybdic acid from any phosphate present. The
phosphomolybdic acid is reduced by the addition of 1, 2,
4 - amino-naphthal-sulphonic acid reagent to produce a
blue colour whose intensity is proportional to the amount
of phosphate present. The molybdenum blue colour is
a mixture of the lower oxides of molybdenum.
Reagents used were as follows:-
(1) 10% trichloroacetic acid.
(2) ION sulphuric acid - 450ml concentrated sulphuric
acid was added to 1,300ml distilled water, taking the
necessary precautions to avoid excessive heat being gen¬
erated. To check, 10ml of this volume was diluted to
100ml with distilled water and a 10ml volume titrated
with standard N/1 NaOH. Any necessary adjustment was
then made.
(3) Molybdate solution - 25g ammonium molybdate was
dissolved in 200ml of distilled water, 300ml of ION
sulphuric acid was placed in a litre volumetric flask,
the molybdate solution was added and the whole was dilu¬
ted with distilled water to 1 litre and mixed.
(4) Amino-naphthal sulphonic acid solution ( ANSA)
0.2g of 1, 2, 4 -amino naphthal-sulphonic acid, 12g
sodium metabisulphite and 2.4g sodium sulphite (Na2S02
7H2O) were dissolved in 100ml of distilled water.
(5) Standard phosphate solution.
Exactly 0.351g of pure dry monopotassium phosphate
(K I^PO^) was dissolved in 500ml distilled water in a
1 litre volumetric flask, 10ml of ION sulphuric acid was
added and the solution was diluted to the mark with di¬
stilled water. This solution contained 0.00064 milli-
moles phosphorus in 0.25ml.
Technique -
lml of serum was added to 4ml of 10% trichloroacetic
acid and mixed. This was centrifuged at 3,000rpm for
five minutes, 2.5ml of the filtrate was transferred to
another tube and test, blank and standard tubes were set
up as follows:-
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Blank Standard Test Gbntrol
Control serum - 2.5ml
Protein-free filtrate - - 2.5ml
10% trichloroacetic acid 2.5ml 2.5ml
Molybdate solution 0.5ml 0.5ml 0.5ml 0.5ml
Standard solution - 0.25ml
A.N.S.A. reagent 0.2ml 0.2ml 0.2ml 0.2ml
Distilled water 1.8ml 1.8ml 1.8ml 1.8ml
The tubes were allowed to stand for 10 minutes for
full colour development and the blue colour is read using
at nm
a red filter / 608 /in an EEL colorimeter.
Calculation - Reading of test x 0.00064(a) x 1000 = T x 1.292
Reading of standard 1 0.5(b) S~
= mmol inorganic phosphate/litre
N.B. a) = amount of standard used
b) = amount of test used.
Serum Calcium and Magnesium
Calcium and magnesium were measured by atomic ab¬
sorption spectrophotometry. This is an analytical
technique based on the absorption of photons by an atomic
vapour. The wavelength at which absorption occurs is
characteristic of the element and the degree of absorption
is a function of the concentration of atoms in the vapour.
To prepare the samples, 0.2ml of serum was diluted
to 10ml (i.e, ^/50) with 0.1% lanthanium chloride in a
volumetric flask.
Standard calibration solutions were prepared as
follows. The low standard for calcium was 0.625
mmol/litre, made by diluting 1.25ml of stock 2.5mmol/
litre calcium chloride solution with 0.1% lanthanium
chloride to 250ml. The high standard was 3.125mmol/
litre, made by diluting 6.25ml of stock solution as
above. The low standard for magnesium was 0.4mmol/
litre made by diluting 4.8ml of 0.416mmol/litre mag¬
nesium chloride solution to 250ml as above. The high
standard was 1.6mmol/litre made by diluting 19.23ml
of stock solution as above.
The wave lengths were 422.7 mm for calcium and
285mm for magnesium. The instrument used was Model
A3400 (Shandon Southern). This consists of a light
source, which is a hollow cathode lamp, a nebulizer
and air/acetylene burner for sample atomization, a
wavelength selector, a photomultiplier detector and
an amplifier and read-out system.
Serum sodium and potassium
These were measured by flame emission spectro¬
photometry. This technique measures the light emitted
when an element, which has been heated and atomised in
a flame and has absorbed energy, returns to a lower
energy level. This emitted light has a wavelength
characteristic of the element.
The same instrument was used as for atomic absor¬
ption spectrophotometry, the Shandon Southern A3400
108.
but using the emission mode.
Serum samples were prepared by diluting with dis¬
tilled water to ^/100 for potassium estimation and
I/500 f°r sodium estimation.
Calibration solutions were made by dissolving 7.46g
of pure potassium chloride and 58.5g of pure sodium
chloride in distilled water and making up to 1 litre
(1000mmol/l) respectively.
The wavelength for potassium was 766.5nm and for
sodium 589nm.
Serum Chloride
This was measured using an EEL chloride meter
(Evans Electroselenium Ltd.). The principle of the
method is as follows.
A known current flow between two silver electrodes
is by definition the transfer of a known number of
silver ions. When such a transfer takes place through
an aqueous solution of chloride, the two substances com¬
bine, ion for ion, until all chloride has been precip¬
itated as silver chloride. This stage is marked by
a change in the conductivity of the solution and the
appearance of free silver ions. In the chloride Meter
this change is registered by two sensing electrodes and
applied to stop a timer calibrated to give a direct
measurement.
The sample used was 0.2ml serum.
A standard sodium chloride solution was made by
109.
dissolving 3.946g in de-ionised water and making up
to 500ml.
The acid buffer solution was made by adding 46ml
glacial acetic acid and 3ml concentrated nitric acid
to de-ionised water and making up to 1 litre.
Gelatine solution was made by adding 2.5g gela¬
tine to 250ml de-ionised water, bringing to the boil
and adding slowly 0.5g thymol blue in 100ml methanol.
When cold 0.5g thymol was added as a preservative.
The test sample was added to 13ml acid buffer and
five drops of gelatine solution, and was read against
a blank of buffer and gelatine solution only.
The serum biochemistry estimations, with the ex¬
ception of blood urea, were carried out by Mr. R. Brown
and the technical staff of the Department of Medicine,
Royal (Dick) School of Veterinary Studies, Field
Station, Easter Bush, Roslin.
Pathology
Autopsy examinations were carried out as soon as
possible after death, usually within 20 minutes after
euthanasia, by Mr. K.W. Head, Department of Veterinary
Pathology, Royal(Dick) School of Veterinary Studies,
Edinburgh. I was present at all autopsies and
assisted where possible. The autopsy results docu¬
mented in this thesis were compiled from Mr. Head's de¬
tailed records, and are included because it would have
been difficult to interpret the clinical and haematolo-
gical findings without also considering the post-mortem
findings.
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The lymph nodes, thymus, spleen, liver, kidneys
and adrenal glands were dissected out and weighed.
Mean values were obtained for kidneys and adrenals but
only one of a pair of lymph nodes, always from the
same side, was weighed.
The anatomy of the lymph node in the pig is unus¬
ual. The tissues which correspond functionally with
the medulla and paracortical zone in other mammalian
species surround and are interspersed with the lymphoid
nodules. The terms "cortex" and "medulla" are used
in the autopsy reports to describe the regions of the
node whose functions correspond with the cortex and
medulla of other species. They do not refer to





In 1937, Selye described a syndrome, which occurred
following exposure of an organism to various harmful or
potentially harmful agents, and which was characterised
by adrenocortical hypertrophy and increased secretion
of adrenal corticosteroid hormones. This became
known as the "stress syndrome", and Selye1s observations
led to widespread interest in, and study of, the adrenal
cortex and the role of the hormones which it produces.
In the same year, Moon (1937) showed that growth in
castrated rats could be inhibited with pituitary extract.
Several years later, Dougherty and White (1943a and
b and 1944) showed that injection of adrenocorticotrophic
hormone (ACTH) into normal mice was associated with loss
of weight of axillary, inguinal and mesenteric lymph
nodes and of the thymus, a decrease in total white blood
cell count, a lymphocytopenia and a polymorphonuclear 1euco-
cytosis. Similar findings were obtained when mice
were injected with adrenal cortical hormone. Soon after
this, Murphy and Sturm (1944) showed that ACTH adminis¬
tration was followed by rapid regression of transplanted
murine lymphoid tumours, and Heilman and Kendall (1944)
achieved similar results with ll-dehydro-17-hydroxy-
corticosterone, which they called "Compound E". They
found that the tumour recurred after the treatment was
discontinued and that it was then much less responsive
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to the hormone than it had been originally. Law and
Speirs (1947) found that when adrenocortical extract
was injected into mice in the terminal stages of
spontaneous lymphoid leukaemia, there was a decrease in
circulating lymphocytes, extensive degeneration of im¬
mature lymphocytes, and a decrease in the size of lymph
nodes and the thymus.
The first report of the effects of ACTH and corti¬
sone on lymphoid tumours in man was that of Pearson,
Eliel, Rawson, Dobriner and Rhoads (1949). They found
that there was a dramatic decrease in size of the liver,
spleen and lymph nodes, though remissions were usually
incomplete and the disease recurred when treatment was
discontinued. They described problems with side ef¬
fects such as fluid retention. In another early
trial, Rosenthal, Saunders, Schwartz, Zannos, Santiago
and Dameshek (1951) observed excellent tumour responses,
but also stated that they were of short duration.
In 1954, it was discovered that it was possible to
increase the therapeutic efficacy of cortisone by in¬
ducing modifications in the steroid molecule. By a
synthetic process, 9®4-fluorocortisol was produced and
was found to have increased anti-inflammatory effect
compared with cortisone (Myles and Daly, 1974). Research
was therefore directed to the production of new cortico¬
steroids .
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Good responses in malignant lymphomas and lymphoid
leukaemias, using massive doses of the closely related
synthetic corticosteroids prednisone and prednisolone,
were reported by Hill, Marshall and Falco (1956) and
Ranney and Gellhorn (1957). Further trials using
corticosteroids in the treatment of lymphomas were re¬
viewed by Kyle, McParland and Dameshek (1962), Hall,
Choi, Abadi and Krant (1967) and Ezdinli, Stutzman,
Aungst and Firat (1969), in addition to describing their
own observations. As a result of these trials, it was
generally accepted that corticosteroids, especially pre¬
dnisolone and prednisone, were of value in the treatment
of lymphoid tumours in man.
The effects that the corticosteroids have in these
diseases are mainly due to their action on lymphoid cells,
though they also have important effects on other tissues
(See Page US')
All steroid hormones have the same basic structure.
The nucleus consists of three joined six-carbon rings
linked to a five-carbon ring. Each carbon atom has
been given a number so that the position of substituted
groups can be identified and the rings are identified
XI
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The naturally-occurring corticosteroid Cortisol,
or hydrocortisone, corticosterone and certain of their
synthetic analogues, are referred to as glucocortico-
steroids because of their action of increasing hepatic
glucose output. They stimulate hepatic gluconeo-
genesis, while depressing protein synthesis in muscle.
Dougherty, Berliner, Schneebeli and Berliner (1964)
summarized the characteristics of glucocorticosteroids
which are active on lymphoid tissue. They have an
unsaturated A ring, a ketone at position 3, an 0 or OH
group at position 11 and a COC^OH group filling
positions 20 and 21.




Two main types of lymphocyte populations are re¬
cognised, those which mature in the thymus known as "T"
cells, and those which mature in other sites, known as
"B" cells. T cells are involved with cell-mediated
immune responses, and graft rejection. B cells are
precursors of plasma cells which produce immunoglobulins.
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There are two very important factors which de¬
termine the effects of corticosteroids on lymphoid
tissue (Claman, 1972) .
Firstly, there are species differences in suscep¬
tibility to corticosteroids. The basis of these
differences is still not understood, but certain species
have been defined as steroid-sensitive and others as
steroid-resistant, depending on the ease with which
lymphoid depletion is produced after a given regimen of
systemic glucocorticosteroids.
Secondly, there are differences in sensitivity be¬
tween different populations of lymphoid cells within the
same species, and in addition, corticosteroid effects
on malignant lymphoid cells differ from their effects
on normal cells. This was demonstrated by Schrek
(1961) using human and rat lymphocytes.
In steroid-sensitive species such as the mouse,
rat, hamster and rabbit (Claman 1972) , administration
of corticosteroids produces rapid involution of the
thymus, shrinkage of spleen and lymph nodes, lymphopenia,
inhibition of antibody production and graft rejection
inhibition. Normal lymphocytes from these species are
killed by culturing them with low concentrations of
corticosteroids.
On the other hand, lymphocytes from steroid-resistant
species such as the ferret, guinea-pig, monkey and man
are much more difficult to lyse in vitro even with much
116.
higher concentrations of corticosteroid. Malignant
lymphocytes are much more easily destroyed, however.
In vivo, some involution of the thymus occurs but only
after several days of high dosage. In man, a de¬
crease in blood lymphocyte counts may occur, soon
after dosing, but it is probable that this is due to
redistribution of lymphocytes, to spleen and bone-
marrow, rather than destruction. In leukaemia, how¬
ever, a rapid fall in blood lymphocytes may be accom¬
panied by a rise in serum uric acid, which strongly
suggests that malignant lymphocytes are killed in vivo
by corticosteroids, as well as in vitro. (Claman, 1972).
Other haematological effects in man have been
widely reported. A neutrophil leucocytosis usually
occurs, especially pronounced in children and mono¬
cytosis may also occur (John, 1966). The neutro¬
philia appears to be due to both an influx of neutro¬
phils from the bone marrow and retention within the blood
as a result of decreased capillary permeability (Myles.,
1974) .
and Daly/ The effect occurs imediately after corti¬
costeroid administration is started and persists
throughout treatment. Depletion of circulating mono¬
cytes also occurs (Fauci and Dale, 1974) . The eosino¬
phil count falls rapidly (Thorn, Forsham, Prunty and
Hills, 1948) and later there is a less marked fall in
circulating basophils (Juhlin, 1963). The effect
of corticosteroids on thrombocyte counts appears to be


















in early studies with ACTH reported no change in throm¬
bocyte counts. Cohen and Gardner (1961) reported
depression of bone marrow thrombocyte production during
corticosteroid therapy of patients with ideopathic thro¬
mbocytopenic purpura, and Hall et al., (1967) reported
the development of thrombocytopenia in two patients
with lymphomas treated with corticosteroids.
However, Rosenthal et al., (1951), Kyle et al.,
(1962) and Burningham, Restrepo, Pugh, Brown, Schlossman,
Khuri, Lessner and Harrington (1964) reported striking
improvements in thrombocyte counts in patients with mali¬
gnant lymphoproliferative diseases.
According to Myles and Daly (1974), corticosteroids
do not produce any effects on erythropoiesis or circul¬
ating red cells in normal humans. However, Fisher
(1958) showed that red cell parameters in normal rats
were significantly increased by administration of corti¬
costeroid, and reviewed the reported evidence supporting
the theory that adrenocortical hormones do influence red
cell production. Agarwal (1964) reported that haemo¬
globin and total red cell volume were increased in asth¬
matic children treated with corticosteroids. Beneficial
effects on the red cell picture have been reported by
many authors in collagen diseases, anaemias and lymphoid
malignant diseases during corticosteroid therapy.
The mechanisms of action of the glucocorticosteroids
t the cellular level are still not fully understood.
They affect the metabolism of most tissues and frequently,
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they influence a number of functions in the same tissue,
which together produce a pattern of metabolic changes.
Corticosteroids, whether produced naturally by the
adrenal cortex, or administered, are soluble in plasma
to a certain extent, but also tend to bind with protein,
mostly with a specific alpha globulin, known as "trans-
cortin" or "corticosteroid-binding-globulin", or, to
a much lesser extent, with other serum proteins such
as albumin. The resulting protein-bound complex acts
as a circulating reservoir. Only free corticosteroid,
which is in equilibrium with the bound corticosteroid,
is active and capable of entering cells. The synthetic
corticosteroids have less affinity for transcortin than
naturally occurring Cortisol, and this accounts for
their increased potency.
After diffusion through the cell membrane, corti¬
costeroids bind to specific protein receptors in the
cytoplasm. Then the steroid-receptor complex enters
the nucleus and is thought to bind to specific sites
on the chromatin, possibly to DNA itself, where it may
modify transcription of DNA into RNA, influencing
either the amount or activity of messenger RNA. The
effects on cell metabolism may be either catabolic or
anabolic depending on the tissue. The catabolic effects
on lymphoid tissue may lead to cell death or to growth
inhibition. The mechanisms of action of the gluco¬
corticoids were discussed in detail by Baxter and
Forsham (1972).
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Until recently, it was widely believed that the
steroid-specific cytoplasmic receptor interaction was
necessary for a response, and therefore the sensiti¬
vity of tissues, in particular malignant lymphoid
tissues, could be predicted by estimating the steroid
binding capacity (Lippman, Halterman, Leventhal, Perry
and Thompson, 1973). However, Crabtree, Smith and
Munck (1978) and Duval and Homo (1978) stated that it
was not possible to correlate cytoplasmic receptor levels
with glucocorticoid response.
Apart from their effects on lymphoid tissue,
corticosteroids have many other actions, some of which
are clinically desirable and others which make their
use hazardous.
These actions were discussed in detail and the ex¬
tensive literature reviewed by David, Grieco and Cushman
(1970) and Myles and Daly (1974), the most important
being as follows:-
a) Anti-inflammatory action. Corticosteroids are
widely used clinically for this effect, particularly in
cases of arthritis and skin disease. Vascular perme¬
ability is decreased, and neutrophil and macrophage
migration towards areas of inflammation are inhibited.
Fibroblast proliferation is also inhibited and collagen
deposition decreased. It is also likely that inter¬
feron synthesis may be impaired. When these effects
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are combined with the previously discussed actions on
lymphoid tissue, it is not surprising that there is
increased susceptibility to virus, bacterial and
fungal infections. Infections are particularly common
in patients with neoplastic diseases when high doses of
corticosteroids are used and immunosuppression is a
feature of the condition.
Another result of the anti-inflammatory action may
be a delay in wound-healing.
(b) Corticosteroid therapy in man is associated with
an increased incidence of gastric ulcers, particularly
in children, in whom gastric ulcers are normally very
uncommon. Possible mechanisms are increased acid se¬
cretion in response to histamine stimulation, reduction
in quantity of gastric mucus and changes in its quality,
and reduction in turnover of gastric epithelial cells.
The evidence suggests that the action on the stomach is
systemic rather than local.
(c) The glucocorticosteroids cause increased hepatic
gluconeogenesis and glycogen deposition and tend to
produce hyperglycaemia, with the possibility of pre¬
cipitating, or aggravating existing diabetes mellitus.
(d) There is inhibition of protein synthesis and a
catabolic effect on muscle protein. Myopathy, resulting
in muscular weakness, is a common side-effect of cortico¬
steroid therapy but histological changes in muscles are
slight and the condition is reversible when therapy is
reduced or withdrawn.
(e) There are alterations in fat distribution with
corticosteroid therapy. In man, total body fat in¬
creases, though this may be partly due to an increase
in dietary intake, because there is also an improvement
in appetite.
(f) Electrolyte metabolism is commonly affected, al¬
though the extent of this varies with the type of corti¬
costeroid used. Sodium retention and potassium loss
may occur, though the synthetic glucocorticosteroids have
less salt-retaining effect than Cortisol. Calcium
transport across the gut wall is decreased, possibly as
a result of antagonism of the calcium absorption effect
of Vitamin D, and there may be a decrease in renal pro¬
ximal tubular reabsorption of calcium and magnesium.
Hypophosphataemia and phosphaturia may occur.
(g) Polydipsia and polyuria are fairly common side-
effects in man. However, large doses of corticosteroids
cause water retention which may result in problems with
oedema, hypertension or even cardiac failure.
(h) Osteoporosis often occurs during corticosteroid
therapy, producing vertebral collapse and an increased
tendency for other bones to fracture. Both increased
bone resorption and reduced new bone formation have been
reported. Osteoporosis may take years to develop, and
x-ray changes are not apparent until the condition is
advanced.
(i) Long-term corticosteroid therapy in children is








administered daily. Intermittent therapy is less
likely to cause the problem. When the drug is with¬
drawn a spurt of growth often occurs.
( j) Suppression of the hypothalamic-pituitary-
adrenal system (HPA). This is the negative feed¬
back system which controls the release of ACTH from
the pituitary and in turn the conversion of cholesterol
to Cortisol in the adrenal cortex. If doses of corti¬
costeroids are administered which are higher than the
physiological range, the inhibitory feedback pathway is
activated. Adrenal atrophy is apparent in many species
after 10 days of high-dose corticosteroid therapy
(Melby, 1974).
Sudden withdrawal of corticosteroid therapy is
dangerous, because, especially in stressful situations,
normal HPA function and production of natural corti¬
costeroid hormones cannot recover rapidly enough to
replace the administered corticosteroid, and adrenal
failure may result. Alternate day or intermittent
therapy does not suppress the HPA system to the same
extent, and daily therapy is now avoided if at all
possible. The reasons for this were discussed by
Melby (1974). Burningham et al., (1964) reported
successful results in leukaemias and lymphomas with high-
dose weekly corticosteroid therapy and stated that side-
effects with this protocol were minimal.
Many other side-effects of corticosteroid treatment
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have been reported but those mentioned above are the
commonest in man.
Bearing in mind the information gained from the
literature, trials were designed to investigate the
effects of the commonly used corticosteroid predniso¬
lone in normal and lymphosarcomatous pigs.
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EFFECTS OF PREDNISOLONE ON NORMAL PIGS
MATERIALS AND METHODS
For the first trial, eight normal pigs were used.
They were all littermates and there were five females and
three castrated males. The sire and dam were of the
lymphosarcoma strain but were both non-carriers. The
piglets were weaned at 8 weeks, and housing, management
and feeding were as described in the General Methods
section.
They were randomly allotted to four groups, of two
pigs in each - low-dose, medium-dose, high-dose and
controls.
Pre-treatment procedures (See General Methods)
At weekly intervals, from 3 weeks before treatment
commenced, all the pigs were weighed and blood-sampled.
EDTA samples were taken for WBC and RBC counts, PCV, Hb,
differential and platelet counts.
Sensitisation with DNFB was performed 11 days before
treatment started. The pigs were observed in their pens
daily for appetite and general fitness and state of urine
and faeces.
Treatment procedure
The prednisolone preparation used was prednisolone
sodium phosphate, 16 mg/ml (Codelsol, MSD ) .
The pigs were 12 weeks old at the start of treatment.




















The drug, or saline, was administered by intra¬
muscular injection after swabbing the site with spirit-
moistened cotton wool. Four injection sites were
used in rotation i.e. the right and left hind legs and
the right and left sides of the neck. The first in¬
jections were administered immediately after the last
pre-treatment blood sample, and the pigs were injected
once daily for 5 days per week. Doses were adjusted
for weight gain.
Treatment was continued for 5.5 weeks. During
this time, the pigs were examined clinically and rectal
temperatures recorded daily, at the time of each in¬
jection. Injections and temperature recording were
always carried out at the same time each day. Weekly
weighing and blood sampling were continued. In ad¬
dition, sera from clotted samples were taken to measure
serum sodium, potassium, chloride, calcium, magnesium,
inorganic phosphate, total protein and albumin.
DNFB skin test were carried out at 2 weeks, 3
weeks, 4 weeks and 5 weeks after treatment started.
The first test was unsatisfactory because 1% DNFB was
tried and found to be too weak. The concentration
used at 3 and 4 weeks was 10%, and at 5 weeks was 5%.
After 5h weeks of treatment, one pig from each
pair was killed by intravenous pentobarbitone overdose,
and autopsies were carried out as soon as possible.
Treatment of the remaining animals continued until
the end of that week, being reduced to half, quarter and
one-eighth during the last three days before being finally
discontinued. Detailed clinical examinations were
stopped but the pigs were observed daily in the pen.
Skin tests were carried out again 2 weeks and 5
weeks after treatment was stopped with 10% DNFB.
After five weeks, when it was considered that the
visible effects of the drug had disappeared, the animals
were slaughtered and autopsied.
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RESULTS
Clinical Examinations (For Clinical records, see Tables 1 to 8
Appendix I)
Throughout the experiment, all the pigs were bright
and active. Appetites were excellent, but since the
pigs were not allowed ad lib feeding, and individual
intakes could not be measured, it was not possible to
detect any change in appetite. However, it did appear
that the pigs drank more frequently from their automatic
water bowls during the treatment period and also that they
passed more urine, as the floor of the pen became very
wet. These observations were subjective, because
facilities were not available for measuring volume of
water intake and urine output. Pigs on the higher
dose levels acquired a markedly "pot-bellied" appearance
after the first two or three weeks of treatment, and
pigs 3, 5 and 8 tended to show rectal eversion occasion¬
ally from the 3rd week of treatment onwards. This
corrected itself spontaneously.
Only one animal had diarrhoea during the experiment.
This was pig 2, a control, in the week before the start
of dosing. This animal was the "runt" of the litter,
in poorest condition from the beginning. The diarrhoea
cleared up without treatment and did not recur.
Rectal temperatures varied widely during the experi¬
ment, even though recorded at the same time each day in
animals which showed no evidence of fever (See Table 4).
TABLE4










































































































































































































From Table 5 , the following conclusions can be
drawn:-
a) All pigs not destroyed at the end of treatment
gained more weight during the post-treatment period
than during the treatment period, even the control
animal. This could have been due to recovery from
the stress of weaning and the infections to which young
pigs are susceptible at this time, and also reduced
handling stress.
b) Both high-dose pigs, 3 and 7, had lower weight
gains during the treatment period than any of the other
pigs, despite the fact that their commencing weights
were average for the litter.
c) Pig 3 also had the lowest weight gain during the
post-treatment period.
d) Control pig 4 had the best total weight gain
(33kg). Control pig 2 was in poor condition, as pre¬
viously mentioned, therefore it would be unlikely to
show a similar weight gain. However its weight gain
was still greater than those of the high-dose pigs.
It would appear, therefore, that treatment with
prednisolone at the 6mg/kg dose level resulted in de¬
pression of growth.
DNFB Skin Test Results
The reaction scores in Table 6 suggest that by
Week 5 of the treatment both high-dose group pigs (3
and 7), one medium-dose pig (5) and one low-dose pig
TABLE6
PREDNISOLONEINORMALPIGS

















































































(1) showed an anergy to DNFB, compared with the controls.
This could not have been due to using a weaker solution
of DNFB because the controls had the same scores during
Week 4, when the stronger solution was used, as they
did in Week 5. After withdrawal of the drug, control
pig 4 had an unexpectedly poor response in Week 8 and
a negative response was also recorded at this time in
medium-dose pig 8. However, by Week 11, the remaining
control and treated pigs all had similar strong reactions.
It would appear, therefore, that treatment with pre¬
dnisolone depressed cell-mediated response, particularly
in those pigs given the highest dose.
Haematology
See Tables 9 to 24 Appendix I.
White blood cell counts were high in all groups
during the pretreatment and treatment periods. This
was due mainly to the neutrophil counts which were ele¬
vated compared with figures from other normal pigs in
this piggery, particularly in the Group A pigs 1 and 6,
Group C pig 7 and control pig 2. Mean - 1 S.D. of WBC
and absolute neutrophil, lymphocyte and monocyte counts
are shown in Table 7. Lymphocyte counts were also
high as is to be expected at from 9 to 16 weeks of age
(McTaggart, 1975) .
During the treatment period, WBC counts in the
treated groups fell slightly compared with the control

















































































































































































































































neutrophil counts fell in all groups, as did the
lymphocyte counts, but the fall in lymphocyte counts
was greater in the treated groups than in the control
group. If the differences between absolute lympho¬
cyte counts at the beginning and end of treatment are
considered for each pig, it appears that the effect
is dose-related. See Table 8.
TABLE 8
EFFECT OF PREDNISOLONE ON ABSOLUTE LYMPHOCYTE COUNTS
x 10^/L
Dose Level Control 2 mgAg 4 mgAg 6 mgAg
Pig No. 2 4 1 6 5 8 3 7
Pre-treatment 11.4 12.5 12.3 12.1 12.5 16.6 12.8 10.2
End of treatment 10.2 10.3 9.3 9.2 9.0 10.9 6.2 7.0
Difference 1.2 2.2 3.0 2.9 3.5 5.7 6.6 3.2
Monocyte <counts varied considerably throughout the
experiment and there were no differences between groups
which could be attributed to the treatment.
After the treatment was stopped, absolute neutro¬
phil counts in the remaining animals continued to fall
to more normal levels, and there were no differences be¬
tween the pigs from each treatment group. Absolute
lymphocyte counts remained lower in the previously
treated pigs than in the control animal, especially in
the pig which had received the highest dose.
TABLE 9
PREDNISOLONE IN NORMAL PIGS - ABSOLUTE EOSINOPHIL COUNTS X 1Q9/L
DAYS FROM
START OF CONTROLS 2 mg/kg 4 mg/kg 6 mg/kg
DOSING 2 4 1 6 5 8 3 7
- 12 0.29 0 0 0 1.20 0 0 0.45
- 5 0 0.22 0 0 0.26 0 0.24 0.46
0 0.38 0.24 0.36 0 0 0.31 0.24 0.73
Start of
Dosing
7 0.19 0.12 0.16 0.15 0 0 0 0.18
14 0 0.40 0.30 0.26 0.37 0.44 0.39 0.17
21 0.21 0.31 0.52 0.56 0.35 0.12 0.57 0.80
28 0 0.20 0.60 0.43 0.93 0.11 0.25 1.06
35 0 0.41 0.59 0.11 0.94 0.09 0.27 1.36
End of
Dosing
42 Dead 0.19 Dead 0.09 Dead 0.30 0.13 Dead
49 0.65 0.38 0.10 0.32
56 0.20 0.29 0.18 0.06
63 0.46 0.29 0.53 0.29
70 0.47 0.45 0.38 0.17
Eosinophil counts and basophil counts remained
at low levels throughout the experiment and therefore
any effects are difficult to assess. However, ab¬
solute eosinophil counts, calculated from differential
counts, are shown in Table 9 • In all the treated
animals, there was an increase in eosinophil counts
during the treatment period, compared with the last
pretreatment counts, and at the end of treatment,
three out of the six treated animals, one from each
dose group, had higher eosinophil counts than either
of the control pigs. Therefore it appears that pre¬
dnisolone treatment did not depress eosinophil counts
in these animals.
Table 10 shows mean - 1 S.D. of RBC counts, PCV
and Hb Eor figures from individual pigs, see Appendix
I. Table 10 shows that from day 0 to day 35,
the red cell counts of the control pigs changed little
and their PCV and Hb levels increased only slightly.
Although standard deviations are wide it appears that
there was a greater increase in mean RBC counts, PCV
and Hb in the treated groups, especially in Groups A
and C during the treatment period. However, during
the post-treatment period, the remaining control pig's
figures increased to match those of the remaining
treated pigs, therefore it is possible that this ob¬
servation was not an effect of prednisolone.
TABLE10

















































































































































































The derived red cell indices showed no changes
which could be attributed to the treatment.
Table 11 shows mean thrombocyte counts - 1 S.D.
Counts in the treated groups on day 28 were much lower
than those of the control group, but there was a rise
in these mean counts by day 35, and none of the
treated pigs had a dangerously low count at any time
during the experiment.
Serum Electrolytes
The results are shown in Tables 25 to 32 in Appendix
I. Levels fluctuated but there were no differences
between groups which could be attributed to the treat¬
ment, and in particular, there was no evidence of
sodium retention or of potassium or calcium depletion
in the treated groups.
Serum Proteins
Although no pretreatment serum samples were taken,
it appears from Table 12 that mean serum albumin levels
increased in all groups during treatment but that the
increase was greater in Groups A, B and C than in the
control group. Serum globulins were obtained by
subtraction of serum albumin from total protein values
(See Appendix I Tables 33, 34). In Group D, mean serum
globulins increased during treatment, whereas in all
treated groups there was a marked decrease. The
lowest levels were recorded on day 28, before the end
of treatment.
TABLE 11
PREDNISOLONE IN NORMAL PIGS - MEAN THROMBOCYTE COUNTS +1 S.D. x 109
DAYS FROM
START OF GROUP D GROUP A GROUP B GROUP C
DOSING (CONTROLS) (LOW DOSE) (MEDIUM DOSE) (HIGH DOSE)
- 12 300 + 245 348 + 37 284 + 13 261 + 13
- 5 610 + 181 512 + 3 566 + 217 538 + 5
0 638 + 382 530 + 22 555 + 9 520 + 56
Start of
Dosing
7 580 + 243 683 + 182 637 + 32 553 + 54
14 438 + 100 536 + 192 531 + 18 477 + 16
21 517 + 235 590 + 52 491 + 53 478 + 110
28 419 + 137 244 + 28 196 + 54 263 + 47
35 502 + 94 346 + 48 468 + 28 387 + 40
End of
Dosing
42 + 297 391 470 364
49 + 315 479 365 309
56 + 321 450 459 380
63 + 261 388 405 312
70 + 252 390 383 251
+




















































































































Post-Mortem Findings - Gross Pathology
Control Pigs
2 - killed at end of treatment.
This was a rather small, thin pig, but normal
apart from about 50 ml clear fluid in the abdominal
cavity.
4 - killed 5 weeks later.
This was a normal pig, except for the caecum in
which the mucosa was slightly thickened and nodular.
Low-dose pigs
1 - killed at end of treatment.
This was an anatomically normal carcase, with no
fluid in chest or abdomen, and only a slight excess of
fluid in the pericardial sac.
The thymus was composed of rather small, brown,
firm nodules.
The liver was slightly pale.
The bone marrow of the femur was red in the can¬
cellous tissue at either end with white soft fat in the
shaft.
(5 - killed 5 weeks later.
This was also a normal pig, showing slight fluid
in the pericardial sac and abdominal cavity only.
Medium-dose pigs
5^ - killed at end of treatment.
This was a normal carcase. The thymus was quite
large with pale buff-coloured lobules.
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£ - killed 5 weeks later.
This was also a normal pig. There was a slight
amount of clear fluid in the pericardial sac.
Peyer's patches in the ileum were very distinct.
High-dose pigs
1_ - killed at the end of treatment.
This was a small, thin pig, having similar amounts
of fat compared with the others, but not as muscular.
The carcase showed no abnormalities.
There was no fluid in chest or abdomen.
The thymus was small with brown, firm nodules.
The bone marrow of the shaft of the femur was dull
pink throughout its length, but it floated in formalin.
3 - killed 5 weeks later.
This was a normal carcase, showing a slight amount
of clear fluid in pericardium, chest and abdomen.
Histological Examination
Microscopic examination of the tissues from these
pigs, and from the lymphosarcoma pigs in the following
experiment, was carried out by Mr. K.W. Head, Department
of Veterinary Pathology, Royal (Dick) School of
Veterinary Studies. The results described in this
chapter are summarised from his reports.
Tissues from pigs killed at the end of treatment
The thymus in each of the four pigs, including the
control, was involuted. Of the treated pigs, the in¬
volution was most marked in the high-dose animal, and
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showed as a reduction in lobule size, the lobules
being separated by fat and connective tissue. Both
cortex and medulla were reduced, cortex more than
medulla. However the density of the cell population
of both cortex and medulla was normal.
In the spleens, there was some variation in size
and number of nodules and degree of activity of the
white pulp but it did not correlate with dose regime,
time of death or weight of spleen.
There were no differences in the total width of the
adrenal cortex between animals.
In all the pigs, the Peyer's patches showed reaction
centres with mitotic figures, except in the high-dose
pig in which the nodules were smallest and the cells
in the centre were inactive.
The lymph-nodes in the high-dose pig, 7, were
distinctive in several respects. In contrast to the
control and other treated pigs, a) the submandibular node
showed many "blast" cells with numerous mitotic figures,
both in the reaction centres and in some of the para-
cortical regions where there was a reduction in small
lymphocytes, b) the prescapular node had almost no
lymphocytes in the cortex, c) the medulla of the mesen¬
teric node was reduced in size and the paracortical zone
was more extensive than usual, and d) the external iliac
node showed more foci of megakaryocytes and normoblasts
in the medulla.
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Lung, liver, kidney and stomach were normal and
similar in all the pigs. There was no evidence of
osteoporosis.
The bone marrow samples varied in cellularity but
they showed only differences that could be attributed
to age and growth rate.
Tissues from pigs killed 5 weeks after stopping treatment
Cryostat sections of the caecum of control pig 4
showed that the mucosal thickening was not due to adeno¬
matosis. Smears showed numerous spirochaetes.
The thymus in each of the four pigs was histologi¬
cally normal.
The external iliac lymph nodes of all the pigs
showed more extramedullary haemopoiesis than in any of
those killed earlier. In addition, the ratio of cortex
to medulla was reversed from 1:3 to 3:1, this being due
to an increase in size of both the reaction centres and
the paracortical zone.
Lymph node and Organ Weights
See Appendix I for absolute weights in grams.
Table 13 shows the effects of prednisolone by calcul¬
ation of the relative weights in centigrams/kilogram
body weight of lymph nodes and organs. In this way,
results from pigs of differing body weights may be com¬
pared. At the end of the treatment period, there was
a dose-related reduction in relative weight of the
TABLE 13
RELATIVE WEIGHTS OF LYMPH NODES AND ORGANS (cg/kg body weight)
Prednislone - Normal Pigs
KILLED AT END OF TREATMENT KILLED AT END OF EXPERIMENT
DOSE CONTROL 2mg/kg 4mg/kg 6mg/kg CONTROL 2mg/kg 4mg/kg 6mg/kg




be Colonic 523 341 324 374 408 325 250 275
Gastric
& Splenic 33 28 25 24 31 34 32 32
Bronchial
Group 11 13 9 8 10 8 7 11
Total
Splanchnic 567 382 358 406 449 367 239 318
Head Group 30 27 30 24 24 28 21 21
Iliac Group 8 10 6 7 8 10 8 6
Prescapular 3 2 7 4 3 5 3 5
Precrural 4 3 3 2 2 3 2 3
Inguinal 15 12 13 9 12 10 10 10
Popliteal 2 2 1 0.4 NF 1 1 1
Total
Superficial 62 56 60 46 49 57 45 46
Thymus 91 69 38 26 133 203 185 210
Spleen 227 185 121 212 122 125 87 138
Liver 3500 3741 3862 3234 3306 3325 2731 3075
Kidney 250 259 241 200 167 175 183 188
Adrenal 5 7 6 6 4 6 4 6
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thymuses of the treated pigs. When compared with
the control, in which the thymus was also more involuted
than would be expected in a normal pig of this age,
the reduction amounted to 24, 58 and 71% in the low,
medium and high dose pigs respectively.
In the pigs killed 5 weeks after treatment was
discontinued, the relative thymus weights represented
156, 142 and 165% respectively of the corresponding
control value.
There was also a reduction in relative weights of
the lymph nodes of the treated pigs killed at the end
of treatment. This was not dose-related, but averaged
23% in the splanchnic nodes and 13% in the superficial
nodes.
In the pigs killed at the end of the experiment,
the relative weights of the superficial nodes were
similar to those of the control, but the splanchnic
nodes still averaged only 72% of the relative weights
of the control's splanchnic nodes.
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DISCUSSION
The effects of corticosteroids in man have already
been described (see Introduction to Chapter I).
Before discussing the results of this experiment,
it was necessary to consider the effects of cortico¬
steroid administration in the other domestic species.
There are many reports in the veterinary literature
concerning the,uses of corticosteroids in animals.
These uses were reviewed by Uvarov (1959), Sodikoff
(1966) and Austin (1971).
Despite the many reports of therapeutic effects of
corticosteroids in a wide variety of animal diseases,
there are very few reports which consider their pharma¬
cological and toxicological effects in any of the
domestic species, and those that do are often descriptions
of the immediate effects of a single dose or short-term
treatment.
As early as 1944, Reinhardt, Aron and Li showed
that injection of ACTH produced a lymphopenia and neut¬
rophilia in normal rats and dogs. Demanet, de Meutter
and Gepts (1958) investigated the metabolic effects of
long-term cortisone treatment in dogs. Treated dogs
became obese on an ad lib diet rich in carbohydrate,
showed increases in «^2 globulin component of serum protein,
alterations in carbohydrate and fat metabolism, and ad¬
renal atrophy but no change in serum electrolytes.
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Fielder, Hoff, Thomas, Tolksdorf, Perlman and Cronin
(1959) studied the toxicity of prednisolone, methyl-
prednisolone and triamcinolone in dogs fed a standard
ration. They were treated orally for 6 weeks with
2.5 and 5 mg/kg daily. Triamcinolone caused death
with emaciation, gastro-intestinal haemorrhage,
pneumonia and pleural effusion, pyogenic infection,
and possibly bone marrow toxicity. Weight loss was
pronounced with triamcinolone, and occurred with meth-
ylprednisolone at the higher dose rate, but not with
prednisolone. Diuresis, and falls in PCV and Hb
also occurred with triamcinolone.
All treated dogs showed increased urinary ex¬
cretion of sodium.
The effects of ACTH, flumethasone and dexametha-
sone in horses were studied by Osbaldiston and Johns on
(1972). Leucocytosis, lymphopenia and neutrophilia
were recorded for 17 hours after one injection. There
was apparently an eosinophilia but no effect on plate¬
lets, RBC counts or monocyte counts. Targowski
(1975) described similar effects in ponies given a
single intravenous dose of prednisolone, except that
he found depression of eosinophil counts. He also
tested dermal response to an antigen to which the
ponies were sensitive, and found that the delayed
hypersensitivity reaction was suppressed by predniso¬
lone .
Goetsch, McDonald and Odell (1959) investigated
the effects of one injection of each of four synthetic
corticosteroids in the cow. All the preparations
caused neutrophilia and mild eosinopenia, and raised
blood glucose levels, but lymphocytes and plasma
sodium and potassium were unaffected.
The immediate effects of ACTH and adrenal cortical
extract on the blood picture of the pig were investi¬
gated by Luke (1953). He found that they produced
an increase in absolute neutrophil counts, with a peak
between 4 and 8 hours after injection, and a lympho¬
penia 2 hours after injection. Patt and Eberhart
(1977) used ACTH in newborn piglets and found no stati¬
stically significant effects on the WBC picture. Wulf
(1969) investigated the immediate effects of predniso¬
lone and dexamethasone in pigs. The dose of pred¬
nisolone used was 1.5 mg/kg, given intramuscularly
and the pigs were blood-sampled at 30 minutes, and at
1, 2, 3, 4, 7 and 9 hours. A slight fall in mean
lymphocyte counts and a marked neutrophilia were re¬
corded, particularly between 3 hours and 7 hours after
dosing. Seidel, Mhller, Kolb and Pohle (1967) admini¬
stered prednisolone to pigs for 14 days and showed
that similar effects occurred, and were maintained
throughout the treatment period. There was a fall
in eosinophil counts after administration of ACTH,
which was administered twice during prednisolone
treatment and once after it was stopped. There was a
rise in blood glucose, but no effects on serum
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electrolytes.
Attempts to find other literature reports of long
term administration of corticosteroids in normal pigs
have been unsuccessful.
The mild clinical effects of prednisolone treat¬
ment, in the experiment described here, particularly
in the high-dose group which were given 6 mg/kg, are
fairly typical of the effects recorded in man. The
marked "pot-bellied" appearance was not due to ascites
or any disease of the abdominal organs, and disappeared
when the animals were laid on their backs, therefore
it must be assumed that it was due to abdominal muscle
weakness. Depression of weight gain in pigs, given
the same and higher dose-levels of prednisolone for 19
days, was noted by Zamora, Kowalczyk, Hoekstra, Grummer
and Will (1975).
The neutrophilia, expected from the many reports
of this in the literature in man and animals was not
observed in any of the treated pigs, even in three
pigs which had normal neutrophil counts at the start
of the experiment. Videbaek (1969) stated that the
neutrophilic response to corticosteroid administration
has several components. Firstly there is a transi¬
tory release of neutrophils from the "marginal pool"
i.e. those which "stick" to blood vessel walls and are
not normally counted in WBC counts. These are
thought to be the first to go to sites of tissue in¬
flammation. Secondly, there is a reduction in the
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migration of granulocytes from the blood stream.
Thirdly, if corticosteroid administration is continued
there is thought to be an overproduction of neutro¬
phils, with premature release, through an apparently
direct influence on the bone marrow.
In man, (Myles and Daly, 1974) and in pigs
(Seidel et: al., 1967) it has been shown that the neutro¬
philia persists while treatment last^ though in neither
case was the route of administration specified, therefore
timing of the weekly blood-sampling was unlikely to be
the reason why it was not detected. The pigs were
not ill and there was no shift to the rightf therefore
there was no question cf the bone-marrow being unable
to respond. Two of the pigs used by Wulf (1969) had
neutrophilia prior to intramuscular prednisolone treatment,
which became even more pronounced after treatment.
The dose-related fall in lymphocyte counts did
correspond with corticosteroid effects recorded in man
and other animals. However, the eosinopenia and
monocytopenia expected from the literature reports did
not occur. It is possible that different results
might have been obtained if a special staining and
counting method for eosinophils has been used.
The observed depression of serum globulin and in¬
crease in serum albumin levels associated with treat¬
ment are similar to the effects described in arthritic
swine treated with cortisone by Shetlar, Shetlar,
Payne, Neher and Swenson (1958). These effects have
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also been described in man in relation to cortico¬
steroid therapy of chronic diseases. Mistilis and
Lam (1972) reported a decrease in serum globulins
and an increase in serum albumin in patients with
chronic active hepatitis treated with prednisolone.
They suggested that the relationship between serum
albumin and globulin levels may be reciprocal.
The extent and rate of development of the effects
on the thymus, lymphnodes and blood lymphocytes of
the treated animals suggests that the pig belongs to
the corticosteroid-resistant group of species, which
includes man, the ferret and the guinea-pig (Claman,
1972). In the corticosteroid-sensitive mouse, rat,
hamster and rabbit, the lytic effects are much more
severe and rapid at comparable dosage. The reduction
in size of the thymus during treatment, and its re¬
covery with "overshoot" after withdrawal of treatment,
is a phenomenon which has been described in non-lympho-
matous children treated with prednisone and triam¬
cinolone, (Caffey and Silbey 1960).
The corticosteroid suppression of cell-mediated
immunity recorded above also places the pig within the
steroid-resistant group of species, since it required
large doses and prolonged treatment. In man, for
example, prednisone given orally in 40 mg/day doses
had to be administered on average for 13.6 days to
negate the effects of the tuberculin test (Bovornkitti,
Kangsadai, Sathirapat and Oonsombatti, 1960).
Zamora et al., (1975) carried out a similar type of
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experiment in pigs to investigate the effects of intra¬
muscular prednisone administration on gastric secretion
and development of stomach lesions. All their treated
animals showed pathological changes in the glandular
region of the stomach, such as interstitial haemorrhage,
catarrhal and haemorrhagic gastritis and erosions.
Since prednisone is converted to prednisolone in the
body, and similar dose levels were given to pigs of com¬
parable age, the absence of gastric lesions in our
treated pigs is difficult to explain. It should be
noted, however, that two of the five control animals
used by Zamora et al., (1975) also showed gastric lesions,
therefore other factors may have been operating. Gastric
ulceration is common in pigs, although it usually in¬
volves the non-glandular oesophageal region of the stomach,
(Kowalczyk, 1975). Many factors are suspected to be invol¬
ved, the most important of which is food particle size.
However, Zamora et al., (1975) did show that 10 mg/kg
for 8 days temporarily increased the volume and acidity
of gastric secretion. They also discussed reported
evidence in pigs and other species which suggests that
fasting may encourage the development of gastric lesions.
Their pigs were fed only once daily whereas our pigs were
fed twice daily, and this may have helped to protect the
gastric mucosa of our pigs in some way.
From this experiment, it is evident that the re¬
actions of normal pigs to prednisolone show some promising
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similarities to the effects recorded in man. The
results were of use in planning the therapy trial, and
since a dose level of 6 mg/kg was apparently capable
of producing a degree of toxicity, 4 mg/kg was chosen





Animals and Pre-treatment Procedures
Four female pigs were used for the therapy trial.
Two were 6 months old and two were 5 months old at the
start of the experiment, the latter pair being litter-
mates. Lymphosarcoma had been diagnosed when they
were between 8 and 10 weeks of age. The four pigs vvere
housed together in the same pen. In addition to the
normal feed (see General Methods), a vitamin-mineral
supplement ("Nutrequin", Berk) was given throughout, as
the pigs were in poor condition before the experiment
started and supportive therapy was considered necessary.
Weekly weighing and blood-sampling commenced 4
weeks before the start of treatment. As in the trial
using normal pigs, EDTA samples were taken for haemato-
logy, and clotted samples for measurement of serum sodium,
potassium, chloride, calcium, magnesium, phosphate, total
protein and albumin. A detailed clinical examination
was carried out weekly from 2 weeks before treatment
started. Rectal temperatures were recorded daily and
lymph node and abdominal measurements were taken weekly
as described in "General Methods". Sensitisation




As in the trial using the normal pigs, the drug
used was prednisolone sodium phosphate, 16 mg/ml
f'Codelsol", MSD) . However, during the 3rd week of
treatment, "Codelsol" was unavailable and it was nece¬
ssary to use other preparations ("Vecortenol" - pre¬
dnisolone pivalate 10 mg/ml, Ciba-Geigy, and "Nisolone",
10 mg/ml prednisolone, Bimeda).
The prednisolone dose level used for all four pigs
was 4 mg/kg, administered intramuscularly at the same
time each day for 5 days/week, using injection sites
in rotation, as in the normal pig trial. As before,
doses were adjusted for weight gain.
Prophylactic oral antibacterial therapy was given
during the period of prednisolone dosing. The pre¬
paration used was framycetin sulphate f'Framomycin
Feed Additive" C. Vet.).
During treatment the pigs were examined and rectal
temperatures recorded daily at the time of each in¬
jection. Weighing, blood-sampling and lymph node
measurements were carried out weekly as before. Skin-
testing was performed after 4.5 weeks of therapy.
After 5.5 weeks, two pigs, one of each age pair, were
killed by pentobarbitone overdose, and autopsied.
Treatment of the survivors was tailed off during the
following three days. These animals were examined
and blood-sampled weekly thereafter, but no further
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treatment was administered and temperature recording
was stopped. Skin-tests were carried out 4 weeks
after stopping prednisolone. After 5 weeks, the
remaining pigs were also destroyed and autopsied.
At the time when this experiment was in progress,
tous
a non-lymphosarcoma/female littermate of the younger
pair of pigs developed a right deviation of the nasal
bones. It had been used as a control for the meas¬
urements of skin hypersensitivity to DNFB and two days
after one of its siblings had been destroyed at the
end of treatment, this animal was also killed. The
deformity did not have an infectious cause and was con¬
sidered to be congenital. This was the only abnor¬
mality in the carcase, and so it provided a useful age
and sex-matched normal control for the autopsy lymph-
node and organ weights. Data from 17 untreated lym¬
phosarcoma cases which had died or been killed at com¬
parable ages to the treated pigs, were also used in
the assessment of the autopsy results.
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RESULTS
Clinical Examinations (see Clinical Records, Appendix I ).
Before treatment, all four pigs ate fairly well but
were less active and easier to handle than normal pigs
of similar age. Weight gains were poor, and one pig
had previously had persistent diarrhoea. Within a
few days of starting prednisolone therapy, there was a
marked improvement in appetite and vigour. The pigs
became more interested, active and more difficult to
handle. As in the previous experiment, the pigs
drank more frequently and appeared to pass more urine,
though this could not be measured. The "pot-bellied"
appearance, typical of the lymphosarcomatous pig, did not
Plates 2 and 3.
disappear, and in fact became more marked./ However
abdominal measurements taken with the pigs lying on
their backs remained fairly steady in three animals,
and actually decreased progressively from 88 cm to 80 cm
in the fourth (3637) during treatment. There was no
clinical evidence of ascites, and little or no fluid
could be withdrawn by paracentesis abdominis. All
pigs had normal faeces throughout the experiment.
Two pigs developed cellulitis from abrasions and
bite wounds during treatment. Procaine penicillin
('Mylipen', Glaxo Vet) was administered intramuscularly
for 3 days and recovery was rapid. The rectal tem¬
peratures of these pigs were fairly high when the in¬
fection was noticed, but temperatures as high were
TABLE14 PrednisoloneTherapy
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recorded at other times with no evidence of other signs
of fever. (See Clinical Records, Appendix I).
During the 4th week of treatment, pig 3630 was
noticed to be trembling. It was depressed, though
not anorexic. Its rectal temperature was rather low at
38.0°C. Prednisolone treatment was continued, but
it was separated from the other animals, to prevent
bullying, and given a heat lamp. The trembling lasted
for 2 days. When blood sampled the previous week,
its serum potassium level had been low (see serum elec¬
trolyte results p. 155 ). Since the trembling may
have been due to potassium loss, lg potassium chloride
was administered by mouth, mixed with treacle, once
daily for 2 days until the trembling stopped.
After prednisolone therapy was withdrawn, the two
surviving animals remained active with good appetites,
but after 5 weeks, they were again pale and anaemic-
looking. There was no sign during the post-treatment
period, of adrenal insufficiency.
During prednisolone treatment, there was a dra¬
matic shrinkage of superficial lymph nodes (see Table
14 ). By the 3rd week of treatment, all four pigs
showed a reduction in the mean products of lengths and
breadths of inguinal nodes of at least 45%, and pre-
crural nodes of at least 58%. By the 5th week of
treatment, the superficial nodes were so small and soft
that they could not be measured. During the post-
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treatment period, the nodes in the remaining pigs
gradually increased in size again, until they were as
large as they had been before treatment started.
See plates 4 and 5.
TABLE 15







3630 - 0.5 2 Dead
3656 4 6 Dead
3637 3 0.5 9
3652 2.5 2.5 6
Weight Gains
During the observation period before the start of
the experiment, weight gains were poor and one pig
actually lost weight (See Table 15 ). During treat¬
ment, all four pigs gained weight but there was little
difference from the weight gain during the pretreatment
period. After the prednisolone was withdrawn, however,
both the remaining animals increased their weight gain,
producing similar results to those obtained in the
previous experiment (See Page 129) with normal pigs.
DNFB Skin-Test Results
The reaction scores in Table 16 show that skin
hypersensitivity to 10% DNFB was minimal or absent in all
four lymphosarcomatous pigs before therapy began.
TABLE16 PrednisoloneTherapy
























During and after therapy, a response of score 2
(erythema and swelling) was apparent. The untreated
sarcomatous
littermate of two of the lympho/ pigs was only tested
on one occasion after sensitisation. However, it
was useful to compare its much more severe reaction
(large ulcerations) with the pretreatment scores of the
treated pigs. It would appear therefore that
treatment with prednisolone improved the cell-mediated
sarcomatous
response of the lympho/ pigs, the opposite effect to
that observed in the previous experiment (see page 129)
but that the response was still poorer than that which
would be expected in normal untreated pigs.
Haematology
Before the start of prednisolone therapy, all
sarcomatous
four lympho/ pigs had high WBC counts and variable
numbers of abnormal mononuclear cells were present in
blood smears. In pigs 3630 and 3637 these cells
were particularly numerous, and, in the latter animal,
accounted for around 90% of the WBCs in differential
counts (See Appendix I).
The effects of prednisolone therapy on mean ab¬
solute mononuclear and neutrophil counts are shown in
Figures 2 and 3. There was a dramatic fall in
the absolute mononuclear cell counts. The lowest
+ 9
mean value obtained was 4.1 - 0.5 x 10 /I during the
5th week of treatment when no recognisable tumour cells
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FIGURE 2 (above)
Absolute mononuclear cell counts (means - 1 S.D.) and
FIGURE 3 (below)
Absolute neutrophil counts (means - 1 S.D.) of lympho¬
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after treatment was withdrawn the mononuclear counts
of the two surviving pigs rose progressively to approx¬
imately pretreatment levels, and abnormal cells re¬
appeared in blood smears in large numbers.
Absolute neutrophil counts fluctuated widely in
individual pigs, but the mean counts fell slightly
during the 2nd week of treatment, rising to a peak of
+ 9
15.6 - 2.5 x 10 /I during the 5th week and then falling
again at the end of treatment.
Eosinophil counts remained at a low level through¬
out the experiment and so any effect is difficult to
assess. However, they were observed in blood smears
as frequently during prednisolone therapy as before or
after. This was also true of basophils.
Mean RBC counts, Hb and PCV tended to fall during
the pretreatment period, but rose rapidly from the
commencement of treatment until about the 3rd week
when they had almost reached normal levels. This
improvement was maintained in the surviving pigs until
the 2nd week after treatment ceased, after which there
was a rapid fall in the red cell parameter values. By
the end of the experiment, both pigs were once more
anaemic. These changes are shown in Figures 4, 5 and 6.
The only discernible treatment-related effects on
the derived red cell indices were in the surviving pigs
during the post-treatment period, when the MCV fell
immediately after the end of treatment and then rose
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FIGURE 4 (above)
RBC counts (means + 1 S.D.) and
FIGURE 5 (below)
PCV (means - 1 S.D.) of lymphosarcoma cases. Arrows
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Hb (means - 1 S.D.) and
FIGURE 7 (below)
Thrombocytes (means - 1 S.D.) of lymphosarcoma cases.
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Two weeks before treatment started, all four pigs
+ 9
had low thrombocyte counts (mean 99 - 20 x 10 /I) .
(See Figure 7 and Appendix I.) By the 5th week of
+ 9 r
treatment, the mean had risen to 359 - 19 x 10 /l.(.See
Figure 7 .) By the end of the experiment, the mean
count had fallen again in the two remaining animals but
neither were thrombocytopenic at this stage.
Serum Electrolytes (See Table 17 and Appendix I).
The mean serum magnesium concentration, which had
remained fairly steady before treatment started, showed
upward fluctuations during treatment (See Figure 8)
but was still within the normal range for the pigs in
this piggery (0.8 to 1.25 mmol/1). After treatment
ceased, in the two surviving pigs it fell immediately.
The mean serum potassium concentration changed
little throughout the experiment and was within the
normal range (4.0 to 5.4 mmol/1). However, pig 3630
had a potassium level of 3.5 mmol/1 during the 3rd week
of treatment, just before showing clinical signs which
could have been due to potassium deficiency. The
following week, after potassium had been administered
by mouth, its serum potassium level had risen to 5.2
mmol/1.
Mean serum sodium, chloride, calcium and inorganic
phosphate showed fluctuations but revealed no changes
which could be attributed to the treatment. The range



























































































































































































































































































































































Serummagnesiuml v ls(means+1S.D.)oflymphosarcoma cases.Arrowindicatebeginningde fpred isolone trpatmpnf.
was rather wider than our figures for the normal range
(142 to 148 mmol/1) but Baetz and Mengeling (1971) gave
a figure of 131 mmol/1 as normal for adult animals.
This is closer to the results obtained during the pre-
treatment period. Serum chloride levels also tended
to be lower than normal (92 to 110), again particularly
during the pretreatment period, but serum calcium and
inorganic phosphate were mostly within the normal range
(2.3 to 2.8 and 1.71 to 3.10 mmol/1 respectively).
Serum Proteins
Previous experience has shown that serum protein
sarcomatous
levels in untreated lympho/„ pigs vary considerably be¬
tween animals, and within animals from time to time, but
there is usually a marked increase in globulins, due to
an increase in immunoglobulin factor IgG (Imlah and
McTaggart, 1977), whereas serum albumin tends to be low.
Total serum globulin values were obtained by sub¬
traction of serum albumin from total protein. Measured
results are shown in Appendix I and mean figures -IS.
in Table 18 Figure 9A shows mean values only of
serum albumin and total serum globulin. During treat¬
ment, mean serum globulin fell sharply, reaching a nadir
of 21.0 - 5.2 g/1 during the fourth week. At the same
time, mean serum albumin rose, reaching a peak during
the fourth week, of 46.0 ^ 3.9 g/1. Total protein
levels were not much affected.
These effects were exaggerated when the albumin/
globulin ratios were calculated. See Figure 9B.
TABLE 18
SERUM PROTEINS OFP REDNI S0L0NE-TREATED LYMPHOSARCOMA. PIGS.
MEANS + 1 S.D. FROM 4 PIGS UP TO DAY 37 AND 2 PIGS THEREAFTER (g/1)
DAYS FROM
START OF
DOSING TOTAL PROTEIN SERUM ALBUMIN SERUM GLOBULIN
(BY DIFFERENCE)
- 25 60.5 + 4.4 23.0 + 4.3 37.5 + 3.4
- 19 74.0 + 2.8 23.0 + 5.2 50.75 + 7.2
- 12 70.0 + 3.3 24.0 + 4.6 45.5 + 7-0
- 5 62.5 + 2.6 24.0 + 3.6 38.8 + 7.0
Start of
Dosing
2 69.0 + 4.3 26.5 + 1.7 42.8 + 5.1
9 64.0 + 8.5 33.0 + 1.6 31.6 + 6.2
16 67.5 + 3.0 37.0 + 3.7 30.5 + 4.1
23 67.0 + 8.9 46.0 + 3.9 21.0 + 5.2
30 68.3 + 4.5 38.5 + 2.1 29.8 + 4.7
37 62.0 + 8.0 37.5 + 6.1 24.5 + 6.8
End of
Dosing
44 66.5 + 7.8 37.5 + 0.7 29.0 + 8.5
51 67.0 + 7.1 37.0 + 1.4 30.0 + 5.7
58 58.0 + 1.4 32.5 + 0.7 25.5 + 0.7
65 63.0 + 4.2 30.0 + 2.8 33.0 + 1.4
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Figure 9 A (above)
Mean serum albumin ( • • ") and globulins (
Figure 9B (below)
) and
Albumin/globulin ratios (means + 1 S.D.) of lymphosarcoma
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Post-Mortem Findings - Gross Pathology
Pig 3630 - killed at end of treatment.
This was a well-developed, well-nourished carcase.
The thymus consisted of a sheet 1cm wide by 0.2cm
thick throughout the whole length of the neck and in
the anterior mediastinum.
There was about 50 ml of clear fluid in the peri¬
cardial sac but none in chest or abdominal cavity.
There were a few petechiae on the lungs.
The heart showed a wedge-shaped dry red area 2.5cm
across, with several 0.2cm yellow dry foci centrally, on
cut surface of a papillary muscle. The valves were
normal.
The spleen was red and engorged. White pulp foci
of 1mm diameter could be seen when the blood ran out.
The stomach was normal and full of food.
Small and large intestine, liver and kidneys showed
no abnormalities.
The semimembranosus and semitendinosus muscles of
the hind legs showed 3 to 4cm diameter irregular areas
of fibrosis with some yellowish firm streaky areas with
congested borders.
All lymph nodes showed a very firm, fawn cut sur¬
face with no distinguishable cortex and medulla but di¬
stinct fibrous trabeculae. The cervical, popliteal,
gastric and splenic nodes showed haemorrhage in the
medulla region.
The bone marrow of the femoral shaft was red and
158.
cellular. Both ends of the long bone, the bodies
of the lumbar vertebrae and wing of the ilium were also
active.
Pig 3656 - killed at end of treatment.
This was a moderately developed, moderately nour¬
ished carcase, with fat present.
The thymus was a thin white sheet of 1 to 2 mm
soft nodules, mostly fat.
There was no fluid in chest or abdominal cavity
but about 30 ml of clear fluid was present in the peri¬
cardial sac.
The liver was slightly pale. Lobulation was not
distinct.
Lungs, heart and kidneys showed no abnormalities.
The spleen was contracted. White pulp nodules of
1 mm or less were just visible on cut surface.
The stomach was full of food. The oesophageal
region showed a 5 mm by 2 mm green raised necrotic ul-
f
cerated area and a 5mm wide, 12mm long depressed white
scar. The remainder of the stomach was slightly
flushed but normal.
The small intestine showed distinct corrugations
in the duodenum, slightly nodular but without necrosis.
Peyer's patches were not easily seen and the rest was
normal. The mucosa of the caecum was finely nodular
but the wall was not thickened. The colon was normal.
In the muscles on each side of the neck and in the
semitendinosus and semimembranosus muscles there were
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ill-defined areas of consolidation due to white fibrosis
between and replacing muscle fibres. There were small
groups of red and yellow dry 2mm foci in these areas.
The lymph nodes showed firm, fawn lobulated tissue
with a hint of medulla. The iliac and popliteal nodes
showed wider areas of congested medulla. The mesen¬
teric and gastric nodes were mottled and greenish on cut
surface, firm with no cortex and medulla distinguishable
but some clear fluid cysts. The splenic lymph node
was mainly red, and on cut surface was mottled deep red
in a grey background.
The bone marrow of the shaft and epiphyses of the
femur, vertebral bodies and ilial wing was red and active-
Pig 3637
This was a well-developed, moderately nourished
carcase.
The thymus was relatively large compared with un¬
treated cases of comparable age with pale, fawn-coloured
lobules.
There was no fluid in chest or abdominal cavity,
but there was about 20ml of clear fluid in the pericardial
sac.
The liver was of moderate size with slightly pro¬
minent perilobular pallor, either fibrosis or tumour.
Lungs, heart, kidneys and stomach showed no ab¬
normalities .
The spleen was enlarged. Along the hilus, there
was a series of 2cm nodules. The borders were curled
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over to the non-hilar surface in some regions. The cut
surface was red and cellular with 2 to 3mm pale pink
foci scattered throughout. The nodules extended into
the substance. They measured 1.5 to 2cm and were com¬
posed of pink tissue with some ill-defined white areas.
They had a sharp border but no capsule.
The duodenum showed marked corrugation along its
long axis, 5 cm wide, raised 3 to 4 mm, closely resembling
adenomatosis, but on fixation clearly due to white tissue
under the mucosa. The corrugation was present for the
first 35 cm, then the intestine was normal until the
ileum, where Peyer's patches were slightly thickened.
The large intestine was normal.
There was no evidence of muscle lesions.
All lymph nodes were enlarged, and on cut surface
showed a flat field of fawn cellular tissue with a faint
nodularity but no medulla, except in the internal and
external iliacs and popliteal which showed a 1mm wide
brown medulla and white cortical nodules.
The splenic lymph node showed a red patchy haemorr¬
hage in the medulla region.
The bone marrow of the midshaft of the femur was
yellow/red mottled and translucent. It floated in for¬
malin.
Pig 3652
This was a moderately developed, pot-bellied animal,
with little fat present.
The thymus was very small, composed of pale fawn
lobules.
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There was no fluid in chest or abdominal cavity
but about 20ml of clear fluid was present in the peri¬
cardial sac.
Lungs, heart, liver, kidney and stomach showed ho
abnormalities.
The spleen was enlarged but there were no nodules
along the hilus. The edges curled over onto the non-
hilar surface and were attached by adhesions in some
regions. There were two infarcts near the dorsal ex¬
tremity approximately 3cm by 5cm extending from the
border as far as the hilus. They were yellowish red
in colour. Nodules of white pulp were present but
less distinct than in 3637. After fixation the in¬
farcts were more distinct as yellow, dry necrosis with
a reddish border in some areas.
The duodenum and remainder of the alimentary tract
were similar to 3637 but the corrugation was less marked.
All carcase lymph nodes were enlarged and showed a
flat field of fawn cellular tissue with no evidence of
medulla except the external and internal iliac nodes
which showed a slight pink medullary pattern. The
medullary region of the splenic node showed very marked
haemorrhage.
Histological Examination
Tissues from pigs killed at the end of treatment
In the pigs killed at the end of treatment, the
lymph nodes showed a depletion of cells in the para-
cortical region, and the few nodules found had reverted
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to primary cell structures. There were a few probable
tumour cells in the paracortical tissue but none was in
mitosis. The inguinal nodes were unique, in that one
pole showed lymphoid depletion but the other pole was
replaced by tumour.
The thymuses were reduced to lobules of adipose
tissue with occasional epithelial cells and groups of up
to 50 lymphocytes.
The white pulp of the spleen showed no nodules and
the red pulp was depleted of cells.
In bone marrow samples from these pigs no tumour cell
masses were found. There were more haemopoietic cells
and less adipose tissue than normal. The femoral shaft
marrow contained haemopoietic tissue. It is normally
a fat store in this age of pig.
In contrast to other lymphoid sites, the lymphoid
tissue in the stomach, Peyer's patches and caecum showed
large centres of proliferating cells, particularly in
pig 3656.
Tissues from pigs killed at the end of the experiment
As in typical, advanced, untreated cases of lympho¬
sarcoma, the lymph nodes of these animals showed replace¬
ment of normal structure almost completely by tumour cells,
except for a few small nodules.
The thymuses showed recovery of normal cortical and
medullary structure, resembling that seen in the pred-
nisolone-treated normal pigs, but the more rapidly re-
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growing tumour had caused some thymus suppression in
pig 3652.
The spleens resembled those of typical late-
stage untreated lymphosarcoma. The tumour had regrown,
nodules had reformed and extramedullary haemopoiesis had
developed.
Bone marrow samples showed an increase in normo¬
blast foci, a reduction in megakaryocytes and large
islands of tumour cells. The marrow of the femoral
shaft was haemopoietic and neoplastic in both pigs.
Tumour lymphocyte infiltration was present in some
organs e.g., in the kidney and in the ovarian stroma,
and there were proliferating tumour masses in the peri¬
portal areas of the liver and peribronchial areas in
the lung.
Lymph node and organ weights
See Appendix I for absolute weights in grams. Table
19 shows the relative weights of lymph nodes and organs,
compared with those of a normal litter-mate, and 17 un¬
treated cases (mean and range).
From the results of the pigs killed at the end of
treatment it can be seen that prednisolone dramatically
reduced the relative weights of the splanchnic nodes
(mesenteric and colonic, gastric and splenic and
bronchial nodes) to below the minimum value of the 17
untreated cases, but they were still about three times
larger than those of the untreated normal pig. The
TABLE19.



























































































































































































weights from the pigs which were allowed to relapse
approximated to the mean values of the untreated cases.
Similar, but less spectacular effects were observed in
the superficial nodes, individually and as a group.
The relative weights of the thymuses in the re¬
lapsed pigs were about twice as great as those of the
pigs killed at the end of treatment. All were above
average for untreated cases, in which the thymus is
usually suppressed, but none was as large as that of
the untreated normal pig.
The effects on the splenic relative weights were
similar to those on the lymph node weights. Liver re¬
lative weights were similar to untreated cases and





Two uncastrated male pigs were used. Lymphosar¬
coma had been diagnosed when they were 6 weeks old. One
(141) was 5 months old and the other (67) 7 months
old at the start of the experiment.
The pigs were housed in separate pens. No suppor¬
tive therapy was given, since the pigs were in reasonably
good body condition.
Methods were as in Experiment A except that pre-
treatment blood-sampling was only carried out for 2
weeks. Serum electrolytes were not measured, because
of the expense involved, but the same haematological
parameters plus serum total protein and albumin, and
blood urea were recorded.
Prednisolone tablets (Evans Medical), 5mg, were
crushed and added to food once daily, 5 days per week for
6.5 weeks, at the same dose rate of 4mg/kg. As before,
weighing, blood-sampling and detailed clinical examin¬
ations with lymph node measurements were carried out
once weekly.
Sensitisation to DNFB was carried out at -4 weeks,
and testing at -2 weeks and 6 weeks. One pig (67) was
destroyed at the end of treatment, by pentobarbitone over¬
dose and autopsy was carried out. The remaining pig
•I
(141) was given a h. dose, h dose and g. dose over 3
166.
days and then treatment was discontinued. It was
examined and blood-sampled weekly for a further 6 weeks,
after which it was skin-tested, destroyed and autopsied.
167.
RESULTS
Clinical Examinations (See Clinical Records, Appendix I)
Before treatment, both pigs were lethargic but had
reasonably good appetites. No difficulties were en¬
countered with dosing.
Within the first two weeks of treatment, both
animals had an attack of severe diarrhoea. Although
appetite was depressed both pigs could still be persuaded
to eat. They were treated with neomycin sulphate
("Neobiotic", Upjohn), lg each per day mixed with food
for 5 days, during which time both recovered. Two days
after neomycin was stopped, 141 again developed severe
diarrhoea. This time, it refused to eat. A sample
was submitted for bacteriology, and chloramphenicol
("Ertilen", Ciba-Geigy 150mg/ml), lml/lOkg, was admini¬
stered intramuscularly for 5 days. By the following
day, a marked improvement was noticed. Four days
after the injections were stopped 141 again developed
severe diarrhoea. Laboratory tests failed to demon¬
strate the presence of accepted bacterial pathogens,
but very large numbers of Balantidium coli were seen in
faecal smears. Though this is not normally pathogenic
in pigs, treatment with 20ml of a mixture containing
sulphadimidine, dihydrostreptomycin sulphate and kaolin
("Streptaquaine sulpha", Elanco) was administered by mouth
for 5 days. Once again improvement was rapid. No
further trouble with this animal was encountered until
just before it was destroyed at the end of the experiment,
TABLE20 PREDNISOLONEORALTH R PY
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when it again developed diarrhoea. Pig 67 also had
two further attacks of diarrhoea during treatment. It
was also treated with "Streptaquaine" and recovered.
Rectal temperatures were within the normal range
throughout the experiment.
As in Experiment A, there was a shrinkage of
superficial lymph nodes during prednisolone treatment
(See Table 20). In pig 141, this was very rapid -
45% in the inguinal nodes and 46% in the precrural nodes
by the end of the 1st week of treatment. By the 3rd
week on prednisolone, the decrease in the mean product
of lengths and breadths of the inguinals was 55% and
50% in the precrurals. In pig 67, the decrease in
size of the nodes was not quite so rapid and by the 3rd
week, the inguinal nodes only showed a decrease of 24%.
However the precrurals were decreased by 43%. By the
5th week, the inguinals were reduced by 52%.
As before, when treatment was stopped, the lymph
nodes rapidly increased again, until by 6 weeks after the
end of treatment, they were as large as they had been at
the beginning of the experiment.
TABLE 21.
Body Weight Gains - Oral Prednisolone Therapy
Pig Wt. at start Wt. at end of Wt. at end
No. of trea tment(kg) treatment (kg) Gain of expt.(kg) Gain
67 27 36.5 9.5 Dead -
141 28 40 12 57 17
169.
Weight Gains (See Table 21) .
Compared with the results in Experiment A (see
Table 5 pagel28 ) weight gains during treatment were
better, despite the attacks of diarrhoea, than with
intramuscular therapy. As in Experiment A, weight
gain increased after treatment was stopped in pig 141.
TABLE 2 2
Pig At Pre- Last week of 6 weeks post-
No. sensitisation treatment treatment treatment
67 1 0 0 Dead
141 2 0 0 0
DNFB Skin Test Results
Before treatment started both pigs were anergic to
DNFB, and this situation did not change during the ex¬
periment. (See Table 22 above).
Haematology
(See Appendix I, Tables 46, 47, 52 and 53).
Total WBC counts fell in both pigs during treatment.
If the absolute mononuclear cell and neutrophil counts
are examined, the results are spectacular (See Figure 10) .
Before treatment started, both animals had low neutro-
9
phil counts (3.5 and 1.6 x 10 /I) and high mononuclear
cell counts (23.1 and 25.7 x 109/:1) with a very high
percentage of these being morphologically abnormal.
Within 1 week of starting oral prednisolone therapy,
weeks
FIGURE 10
Absolute mononuclear and neutrophil counts of two lymphosarcoma
cases treated orally with prednisolone. Arrows indicate beginning





neutrophil counts rose and mononuclear counts fell,
and abnormal cells almost disappeared from blood smears.
Within 1 week of stopping treatment in 141, the neutro¬
phil count fell to pretreatment level, and the mono¬
nuclear cell count started to rise, as abnormal cells
reappeared.
As in Experiment A, thrombocyte counts rose during
9 9
therapy, from 154 x 10 /I to a peak of 404 x 10 /I by week
Q
2 in pig 67, and from 65 x 10/1 to a peak of 562 x
9
10 /I in week 4 in pig 141. After treatment was with-
9
drawn, the count in 141 fell again to 119 x 10 /I (See
Appendix I
At the beginning of the experiment, both pigs were
anaemic. Pretreatment RBC counts, PCV and Hb were
3.45 x 10^/1, 0.20L/1 and 7.1g/dl in pig 67 and 3.72 x
lO^/l, 0.215 1/1 and 7.5g/dl in pig 141. As in
Experiment A, red cell parameters increased during the
treatment period. In pig 67, the RBC count rose only
to 4.85 x 10^^/1, and Hb to 9.9 g/dl, in the last week
of treatment, but PCV improved markedly, reaching 0.32
1/1 in the 5th week. In pig 141, there was a rapid
rise in all red cell parameters, and as in Experiment A,
the improvement lasted for a short time after treatment
was stopped. At this time, its red cell picture was
almost normal (RBC - 6.24 x lO^/l, PCV - 0.38 1/1,
Hb - 12.6 g/dl). After this, however, it became pro¬
gressively more anaemic again (See Appendix I).
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MCV increased slightly during treatment in both
animals.
Serum Proteins (See Appendix I)
Once again, the results were very similar to those
obtained with parenteral prednisolone therapy, namely
a fall in total serum globulin and a rise in serum
albumin, which was reversed in pig 141 when treatment
was withdrawn .
The albumin/globulin ratios increased, from pre-
treatment values of 0.69 and 0.61 to peak values of
2.09 in the 3rd week in pig 67, and 1.97 by the end of
the 1st week in pig 141. As 141 relapsed, the al¬
bumin/globulin ratio fell again to 0.59.
Blood Urea
Blood urea levels stayed within the normal range
in both animals throughout the experiment.
Post Mortem Findings - Gross Pathology
Pig 67 - killed at end of treatment.
This was an anatomically normal carcase, though
rather small for its age and slightly pot-bellied.
There was plenty of fat at all normal body sites.
At the site of the thoracic and cervical thymus
there was a structure which was lobulated and white,
but which was probably all fat as it was soft and greasy
and floated in formalin.
Head and neck and lungs showed no abnormality.
There was a trace of serosanguinous fluid in the
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chest cavity and about 20ml in the pericardial sac.
The thoracic surface of the rib muscles and ribs showed
a white nodular thickening, especially ventrally and
towards the diaphragm, which mostly appeared to be due
to deposition of fat but in one area there was distinct
fibrosis with adhesion to the adjacent part of the
diaphragm. The epicardium of the right ventricle
showed numerous small organising fibrin tags, also pre¬
sent on the left ventricular side but only towards the
tip. The muscle and valves were normal.
There was no evidence of fluid in the abdominal
cavity and none of the organs was excessively large,
therefore the pot-bellied appearance was due to slack¬
ness of the abdominal muscles.
The spleen was slightly enlarged but with no curving
over of the borders. The cut surface was red and cell¬
ular and no blood exuded from it. The white pulp was
visible.
The liver was slightly pale but of normal consis¬
tency and the lobulation was not distinct.
The kidneys, bladder and adrenals showed no ab¬
normality.
The oesophageal region of the stomach showed slight
yellow thickening especially near the mucous membrane
junction but no true ulceration. The cardiac region
showed a coating of mucus in which tags of black altered
blood were visible. These arose from irregular small
cracks in the mucous membrane, which, on cut surface,
extended 1mm into the underlying mucosa, never more than
halfway through it. The fundic region showed four
nodules 5mm in diameter slightly raised above the sur¬
face, probably due to lymphoid aggregates under the
mucosa. The pylorus was normal.
The duodenum, small intestine, large intestine and
pancreas were normal. The small intestine contained
two adult ascarid worms.
The testes were of normal size, and smears made from
them showed numerous adult and nearly adult sperm.
On opening the skull, haemorrhage could be seen
under the meninges, and on cut surface this was up to 5mm
thick over the cerebrum and extending round ventrally
under the base of the brain, but it did not appear to in¬
volve the cerebellum. On seeing this the attendant .
remarked that the animal had been behaving peculiarly
the day before it was destroyed, but there had been no
obvious trauma and there was no subcutaneous bruising.
The bones of the skull appeared normal.
All the lymph nodes showed half and half white no¬
dular cortex and buff medulla. Some of the gastric
nodes, the iliacs and splenics showed areas of haemorr¬
hage in the medulla. There were chalky white foci in
the inguinal and cervical nodes. The mesenteric nodes
were smaller than the colonic nodes.
The bone marrow of the femur appeared to show half
and half white fat and red active marrow.
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Pig 141 - killed 6 weeks after end of treatment.
This was a well-developed, well-nourished car¬
case with plenty of normal fat.
The thymus was large with soft, white lobules,
both in the neck and in the chest.
There was about 50ml of clear fluid in the peri¬
cardial sac but none in the chest or abdomen.
Head, neck and heart showed no abnormality. The
lungs were partially collapsed, probably due to post¬
mortem change but there were no focal lesions.
The spleen was grossly enlarged. The cut surface
showed ill-defined 2 to 3mm nodules, probably enlarged
white pulp. Only a little blood flowed out. No
tumour nodules were visible along the hilus.
The liver lobulations were more distinct than
normal, but colour and consistency were normal.
The kidneys, bladder and adrenals showed no ab¬
normality.
The fundus of the stomach was slightly thickened
and flushed. The duodenum showed prominent corrugation
due to thickening of the wall by up to 1cm of white
cellular tissue. Cryostat sections showed lymphocytes
causing most of the infiltration and there was no evi¬
dence of adenomatosis. Peyer's patches showed up as
thickening of the mucosa by white tissue.
The mucosa of the caecum and colon showed small
nodules.
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The right testis was descended and was of normal
shape and size with a normal cut surface. The
epididymal tubules were large and filled with a milky
fluid. This contained large numbers of very active
sperm under phase contrast and when stained eosin
nigrosin only a few stained pink i.e. were dead.
Many however showed cytoplasmic remnant part way down
the tail.
The left testis was in the abdominal cavity at
the internal inguinal ring. It was much smaller in
size (weight 48g compared with 232g for the right).
The epididymal tubules were small and empty.
The seminal vesicles were moderately enlarged,
though not the size of a fully-developed boar, and on
cut surface they were more congested.
All the lymph nodes were enlarged and on cut
surface were lobulated, with an almost flat field of
white or buff tissue with no visible medulla. Only
the splenic lymph node showed the medulla outlined by
haemorrhage.
The last mesenteric and left bronchial node
showed several cystic structures containing straw-
coloured fluid.
The bone marrow of the femur was red mottled with
white and floated heavily in formalin - probably a
mixture of congestion and activity, throughout the
length of the shaft.
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Relative weights of lymph nodes and organs
Table 23 shows the relative weights calculated
from the absolute weights shown in Table 60, Appendix I.
These are compared with those of the normal untreated
pig from Experiment A and 17 untreated cases. It can
be seen that the results are similar to those in
Experiment A, showing a marked reduction in the weights
of the lymph nodes to below the minimum value for un¬
treated cases in 67. The superficial nodes in the re¬
lapsed pig 141 were heavier than the mean value for un¬
treated cases but the splanchnic nodes were lighter.
The thymus weight in 141 was greater even than that of
the normal pig.
TABLE23








































































































































Soon after the first reports of the successful
use of corticosteroids in human cancer, Bloom (1952)
used corticosteroids in cases of mast cell tumour,
and Clover (1958), Agresti (1959) and Jacquier (1963)
described good results in the therapy of lymphosarcoma
in dogs. In one small experiment, successful steroid
treatment of chickens paralysed with Marek's disease
was reported (Foster and Moll, 1968). Reichel (1962)
treated two pigs in the terminal stages of lympho¬
sarcoma with prednisolone, and showed that the white
blood cell counts fell although the pigs subsequently died.
Prednisolone was a logical choice therefore, for
the first therapy trial of hereditary porcine lympho¬
sarcoma. The dose level of 4mg/kg had produced no
serious adverse effects in the normal pigs, and was
considered likely to be safe in these pigs, which were
in poor condition as a result of the advanced stage of
the disease.
The results of the treatment were dramatic in
several respects. It became obvious very soon after
the start of the treatment, that the tumour was being
destroyed as shown by the rapid shrinkage of the super¬
ficial lymph nodes and the decreasing numbers of abnormal
mononuclear cells seen when performing differential WBC
counts. The percentage reduction in circulating mono¬
nuclear cells was twice as great as that observed even
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at the highest dose level (6mg/kg) in the normal pigs.
This was in keeping with the observation by Schrek (1961)
that leukaemic lymphocytes were more sensitive to
corticosteroids than were normal lymphocytes. The
suppression of the tumour was accompanied by an improve-
vigour
ment in the fitness/and appetite of the pigs, even though
their growth rate did not improve. The poor body
weight gains during treatment and increases after pre¬
dnisolone withdrawal were in keeping with the known
growth-depressive effects of prednisolone (Myles and
Daly, 1974). However, the weights recorded may have
been affected to some extent by changes in tumour mass.
Although the average skin hypersensitivity reaction
score of two in the pigs given prednisolone intramuscul¬
arly was not as high as would be expected in a normal un¬
treated pig, it was higher than that observed in untreated
tous
lymphosarcoma/pigs (unpublished data). These reactions
suggest that prednisolone had a slightly beneficial effect
on the cell-mediated response, unlike that observed in
the normal pigs, where the effect was to suppress the
hypersensitivity reaction. However this beneficial
effect was not apparent in the pigs given prednisolone
orally.
A major difference between the intramuscular and
oral therapy was the effect on neutrophil counts. In
the pigs given prednisolone intramuscularly, there was a
slight rise in the neutrophil counts, especially during
the 5th week, but the counts fell again at the end of
treatment. As in the experiment using normal pigs,
this did not correspond with the marked neutrophilia
reported in the literature. In the pigs given oral
prednisolone, however, there was a much more pronounced
rise in the neutrophil counts which lasted until the
end of treatment. These two animals suffered from
severe diarrhoea during the treatment period, whereas
the four pigs given intramuscular prednisolone did not.
Although no bacterial pathogens were isolated, it is
possible that the prednisolone, or the immunosuppression
produced by the lymphosarcoma, reduced the pigs' re¬
sistance to a normally harmless protozoan inhabitant of
the large intestine, Balantidium coli, and that the
neutrophilia was a response to the diarrhoea.
Red cell pictures and thrombocyte counts improved
greatly during prednisolone treatment and the improve¬
ment in the red cell pictures continued into the second
week after treatment was discontinued. This might
have been due to a stimulating effect of prednisolone
on early red cell precursors in the marrow, so that the
resulting increased population of maturing cells in the
"pipeline" continued to appear in the blood. The
destruction of tumour in the marrow would also contri¬
bute to an improvement in the red cell and thrombocyte
pictures by allowing previously suppressed precursor
cells to regenerate.
It was shown in the experiment using normal pigs
that prednisolone produced no effects on serum electro¬
lyte levels. However, the upward fluctuations of
serum magnesium observed in Experiment A, may have been
due to release of the element from damaged malignant
cells, and this has been recorded during treatment of
human leukaemia patients by Ilicin (1971). The re¬
duction to subnormal levels after the end of treatment
in Experiment A might have been associated with in¬
creased uptake of the element from the blood stream by
the rapidly regrowing tumour. It might be expected
that serum potassium levels would alter in the same
way as magnesium, but these remained unchanged, apart
from the low level recorded in pig 3630 during the 3rd
week. The clinical signs shown by this pig may have
been due to low serum potassium levels, but at autopsy,
it was discovered that it had a cardiac infarct and
this would appear to be a more likely cause of the
problem.
In the experiment using normal pigs there was a
rise in serum albumin and a fall in serum globulins.
This observation was confirmed in both therapy experi¬
ments and the effects were even more pronounced in the
tous
lymphosarcoma/pigs. The reduction in globulins may
have resulted from corticosteroid lympholysis, prim¬
arily of tumour cells which were producing an excess
of gamma globulin. However it has not yet been
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demonstrated that the high level of gamma globulin
found in pigs with hereditary lymphosarcoma is produced
by the tumour cells. Indeed, these appear to be
neither T nor B cells (unpublished data). It may be
that the gamma globulin came from normal B lymphocytes
in response to the presence of the tumour. These
cells were then lysed by the corticosteroid, or reduced
their production of globulin as the tumour disappeared,
or both.
Increased serum albumin production would be helped
by prednisolone-induced improvement in appetite, resulting
in increased protein uptake, and improved utilisation
following reduced interference with organ function by
the tumour or its products.
The suspicion that prednisolone produced a nadir
in total serum globulins before the end of treatment
in the normal pigs was confirmed in the lymphosarcomatcus
pigs, in which it was accompanied by a peak in serum
albumin. A similar nadir in the mononuclear cell
counts and peaks in neutrophil and thrombocyte counts,
in Experiment A during the 5th weeks of treatment,
suggest that after this time the effects of predniso¬
lone began to decline. Rosenthal et al., (1951) stated
that remissions in lymphoid neoplasia with ACTH or corti¬
sone were of short duration. This waning of effect
may occur because of suppression of the hypothalamic-
pituitary-adrenal axis. The mean relative weight of
the adrenal glands of pigs killed at the end of treat¬
ment in Experiment A was only two-thirds that of the
pigs which were allowed to relapse. The relative
weights of the adrenal glands of all the treated pigs
were much less than the mean weight for untreated lym¬
phosarcoma pigs.
In the experiment using normal pigs no stomach
lesions were found. In the therapy experiments, two
out of the six treated pigs had gastric ulceration.
In 3656 the lesion was in the usual site, but 67 showed
cracks in the mucosa of the cardiac region, which may
have been caused by prednisolone administration.
The histology results revealed that tumour growth
was suppressed to different degrees in different sites
in the body, and even in a single organ, e.g. in the
inguinal node only localised suppression was achieved.
It is impossible to identify isolated non-dividing
tumour cells by conventional histology, therefore it
was difficult to state whether treatment completely
destroyed all the tumour cellsin an area or just
reduced their number and mitotic rate, so that they
were no longer detectable.
The finding of tumour infiltration in the ovaries
of the pigs which were allowed to relapse was intere¬
sting, because this has never been observed in untreated
cases Head et al., (1974).
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The results of these experiments show clearly
that prednisolone treatment of hereditary lymphosarcoma
produced at least a good partial remission, which
corresponds well with the results obtained from the






Adriamycin, which is also known by its synonym
doxorubicin is an anthracycline antibiotic, a ferment¬
ation product of the fungus Streptomyces peucetius
var caesius. Like the closely related drug dauno-
rubicin, the adriamycin molecule has an aminoglucoside
ring attached, and this sugar enables the drug to inter¬
calate between adjacent base pairs in the double helical
structure of DNA, inducing template disordering, thereby
inhibiting the enzymes involved in DNA synthesis and
RNA synthesis.
Formula of adriamycin and daunorubicin:-
and binds to nuclear structures, causing an immediate
disturbance of mitosis. It inhibits prophase at low
concentrations and at higher levels causes complete
mitotic block.
Adriamycin and daunorubicin are most effective,
therefore, during S-phase of the cell cycle, leading to
accumulation of cells in late S or phase, but at
higher concentrations, all stages of the cell cycle
are affected (Chabner, Myers and Oliverio, 1977).
Adriamycin hydrochloride is the compound used in
chemotherapy. It is a stable, bright red powder,
readily soluble in water or physiological saline. It
is manufactured by Pharmitalia (Farmitalia in Italy)
who discovered it.
The in vitro antitumour activity of adriamycin was
first assessed in various mouse tumours, such as Erlich
ascites carcinoma, sarcoma/80, Oberling Guerin-Guerin
carcinoma, a nitrosomethylurea-induced lymphosarcoma in
C^Hf mice and L1210 and P388 leukaemias. It produces
an increase in survival time in all these tumours, fre¬
quently greater than that produced by daunorubicin.
(DiMarco, 1972, Goldin, 1972). DiMarco also de¬
scribed the effects of therapy with adriamycin and
daunorubicin in murine sarcoma virus (Moloney)-induced
tumours in 16-day-old Swiss CD-I mice. Normally un¬
treated mice infected at this age developed the tumour
but then showed a complete and permanent tumour regression.
If treated with daunorubicin the tumour regressed but
then recurred and killed the mouse.
This also happened to a lesser extent with adria¬
mycin. When the drugs were administered before the in¬
fection, daunorubicin inhibited the natural tumour re¬
gression whereas adriamycin did not. These effects
were attributed to differences in action of these com¬
pounds on the immune system, as well as to their action
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against the tumour, disturbing the complex relationship
between host, tumour and virus.
It is interesting that two such similar compounds
can have quite different effects and this has been con¬
firmed when these drugs have been used in human medicine.
Daunorubicin is mainly used in the treatment of leukae¬
mias, but adriamycin has been shown to be active against
a wide range of tumours, either on its own or in combin¬
ation with other drugs. (Bonnadonna, Monfardini, DeLena
and Fossati-Bellani 1969, Bonnadonna, Monfardini, DeLena,
Fossati-Bellani and Beretta, 1972, Middleman, Luce and
Luce, Talley, Gottlieb, Baker and Bonnadonna
Frei, 1971, 0'Bryan,^1973, Tan, Etcubanas, Wollner, Rosen,
Gilladoga, Showel, Murphy and Krakoff 1973, Blum and
Carter, 1974 and Carter 1975). Examples of tumours
against which adriamycin has been effective are malig¬
nant lymphomas, acute leukaemias, sarcomas and carcino¬
mas of the breast, lung, thyroid, testis and urinary
bladder, and Wilm's tumour in children.
Like most anticancer drugs however, its toxicity
to the patient has been a major cause for concern.
The fate of adriamycin in the body after adminis¬
tration seems to vary considerably in different species.
In mice, after intravenous dosaqe the druq was rapidly
transferred to the tissues and reached high concentra¬
tions in all organs except the brain. Measurable con¬
centrations in spleen, liver and kidneys were still
present at 72 hours. High concentrations were found in
the heart up to 24 hours after dosing (Arena, D'Allessandro,
Dusonchet, Gebbia, Gerbasi, Sanguedolce and Rausa, 1972).
The same authors investigated the pharmacokinetics
in the rabbit. The major route of excretion was via
the bile, with practically none of the drug being ex¬
creted in the urine. They found that the drug was not
absorbed by the gastro-intestinal tract. Yesair, Asbell,
Bruni, Bullock and Schwartzbach (1972) stated that the drug
was metabolised in hamsters but not in mice, rats or dogs.
Rats excreted six percent of an intravenous dose in urine
and eight percent in bile in 24 hours, and there were
measurable concentrations of the drug in kidney, heart,
liver and small intestine for 48 hours, higher than con¬
centrations of daunorubicin at 48 hours. Arena et al., (1972)
also investigated the immediate effects of adriamycin
on the heart in rabbits and dogs. Rabbits developed
tachycardia and T-wave inversion, shown by electrocardio¬
graphic examination. Dogs developed a temporary increase
in coronary and aortic flow and arterial blood pressure,
followed by a decrease in coronary flow to well below
normal. Tachycardia also occurred. Pretreatment
with strophanthin apparently inhibited the appearance of
toxic cardiac effects.
Benjamin, Riggs and Bachur (1973) described the
disappearance of adriamycin and its metabolites from the
plasma in man. An initial half-life of 1.1 hours
suggested widespread and rapid uptake of adriamycin by
the tissues. This was followed by a prolonged second
phase of 16.7 hours. Metabolites were present in the
plasma for 31.7 hours. The drug appears to undergo
extensive metabolism in the liver (Creasey, Mcintosh
Odujinrin, Aspnes, Murray and Marsh
Brescia/L976). Metabolites produced in the liver
account for 50% of the compounds excreted in urine, the
remainder being the parent drug. However, only a re¬
latively small percentage of the administered drug can
be accounted for in the urine and the remainder is pre¬
sumed to undergo biliary excretion. When the drug is
being administered to human patients, pre-existing abnor¬
malities of renal function seem to be of little importance
but impaired liver function is known to delay metabolism
of the drug and may result in severe toxicity. The
long plasma half-life of adriamycin means that there is a
prolonged effective drug level after a single injection.
When this was discovered, medical opinion changed about
dosage schedules - early work in mice had suggested that
frequent dosage was more effective, but experience with
the drug in clinical practice showed that toxicity was
decreased and antitumour activity unaffected if an inter¬
mittent single high dosage schedule was adopted once every
3 weeks (Benjamin, Wiernick and Bachur 1974).
The main toxicity problems with adriamycin are alo¬
pecia, severe stomatitis with ulceration, myelosuppression,
gastroenteritis, cardiotoxicity and chemical cellulitis if
extravasation occurs during intravenous administration. It
also causes sclerosis of smaller blood vessels if injected
directly into them. Stomatitis appears to be much less
of a problem with three-weekly dosing than with more
frequent dosing, though why this is so is not clearly
understood. This was first reported by Kenis, Michel
Rimoldi, Israel and Levy (1972).
Myelosuppression is the acute dose-limiting toxic
effect of adriamycin, but it is rapidly reversible and
is said to be platelet-sparing in humans. The nadir
of leukopenia occurs about 12 days after administration
and the white cell counts have returned to normal within
a further 7 days. Benjamin (1975) discusses this and
other complications of adriamycin therapy and how they
can be dealt with.
Perhaps the most serious side effect of adriamycin
is its effect on the heart. A large amount of litera¬
ture exists on the subject of adriamycin cardiotoxicity.
Many theories have been advanced regarding the way in
which the drug damages the heart, what can be done to
prevent it happening during adriamycin therapy, and
methods of early detection of the damage before it is
fatal.
The cardiac abnormalities produced by adriamycin in
man are either (a) electrocardiograph (ECG) alterations
or (b) congestive heart failure (CHF) (Cortes, Lutman,
Wanka, Wang, Pickren, Wallace and Holland 1975).
(a) ECG alterations are not specific, they may occur
at any time during adriamycin therapy and at any dose
level. Abnormalities of rhythm, premature atrial or
ventricular contractions, atrial flutter and fibrillation,
decreased QRS voltage, a variety of ST-T wave abnormali¬
ties, and prolongation of QT interval have all been re¬
ported. Decreased QRS voltage is perhaps the only
abnormality which is consistently seen and this may
reflect the diffuse nature of the cardiac damage.
(b) CHF occurs after prolonged dosage with adria-
mycin, usually occurring in patients who have received
2
more than 550-600 mg/m . The damage to the heart ap¬
pears to be cumulative and irreversible. Minow,
Benjamin and Gottlieb (1975) cited two human cases whose
therapy with adriamycin was discontinued and then started
6 months and 13 months later. There was no evidence
of cardiac damage at the end of the initial course but
fatal cardiotoxicity developed soon after starting adria¬
mycin again. They also described a case in whom severe
CHF developed three and a half months after stopping
adriamycin therapy, cardiac examinations having been
normal at the end of treatment. The occurrence of CHF
is apparently not necessarily related to ECG changes,
and it is usually sudden in onset. It responds poorly to
treatment, unless mild, when forced rest, and administration of
digitalis and diuretics may keep the patient alive.
Pathological examination of the heart in a case
of adriamycin cardiomyopathy shows that the organ is en¬
larged, flabby and pale in colour. The coronary
arteries and the valves are normal but the ventricles are
usually dilated and may be hypertrophied.
The histopathological appearance of the myocardium
reveals a decreased number of myocardial cells with
degeneration of the remaining cells, interstitial oedema
and, if the patient has survived the acute phase, inter¬
stitial fibrosis. There are no indications of an in¬
flammatory response, either acute or chronic. Examin¬
ation of the tissue with the electron microscope shows
in more detail, cellular loss and degeneration - in
particular the mitochondria are severely damaged
(Minow, et al., 1975).
Certain risk factors have been identified in human
patients. Most authors are agreed that the cardiotoxic
2
threshold is approximately 550 mg/m total dose. The
risk of cardiotoxicity is increased in patients who have
had prior radiation therapy to the heart, who have had
cyclophosphamide therapy, or who have had a history of
heart disease. In these patients the maximum recommended
2
total dose is 450 mg/m body surface area.
In children, cardiotoxicity may occur even before
this dose is reached. Prout, Richards, Chung, Joo
and Davis (1977) cite two cases of children who developed
2 2
CHF at 350 mg/m and 400 mg/m . Both had received
prior thoracic irradiation, however.
The efficacy of adriamycin as a single agent in cases
of lymphoma was considered by Carter (1975). Quoting a
number of authors, he stated that the objective response
rate was 37%. These were cases which were refractory
to standard treatments. A reference not quoted by
Carter was that of Cimo, Rudders and Hensleigh (1974).
Out of 14 patients, they had an objective response in five
(36%), three with Hodgkin's and two with non-Hodgkin's
lymphomas. All these responders had had previous re¬
missions but had relapsed on conventional therapy.
The median duration of response was 7 weeks. Short
response duration has been reported by most authors
when adriamycin is used alone in lymphoma cases. More
recently, adriamycin has been used in combination with
other drugs, for example cyclophosphamide, bleomycin,
vincristine and prednisolone (McKelvey 12 co-authors
(1976), Rodriguez, Cabanillas, Burgess, McKelvey,
Valdivieso, Bodey and Freireich (1977) , Skarin, Rosenthal,
Moloney and Frei (1977), O'Connell, Silverstein, Kiely
and White (1977).
Using the information gained from the literature,
trials were designed to investigate the effects of adria¬
mycin in normal and lymphos arcomatous pigs.
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THE EFFECTS OF ADRIAMYCIN IN NORMAL PIGS
MATERIALS AND METHODS
Ten pigs were used, eight females and two castrated
males. These were litter-mates, bred from proven non-
carrier parents of the lymphosarcoma strain. They were
divided into three groups of two pigs in each, low-dose,
medium-dose and high dose, and one group of four control
pigs.
The pretreatment procedure for this experiment was
as described in the general methods section. All the
pigs were sensitised to DNFB at 6 weeks of age, and
tested 16 days later. Weekly blood sampling was
started when they were 9 weeks old. White blood cell
counts, differential counts, red blood cell counts,
haemoglobin concentrations, PCV, thrombocyte counts and
blood urea levels were measured from the haematology
sample, and serum samples were examined for levels of
serum alkaline phosphatase, and serum glutamic-oxalo-
acetate transaminase (SGOT), although the tests on serum
were not carried out every week because of the expense
involved. If there was a rise in the SGOT level,
total bilirubin was also measured from the serum sample.
By using these measurements along with clinical obser¬
vations, it was hoped to detect evidence of bone marrow,
liver or cardiac toxicity. Clinical examination was
started at the same time as the blood sampling and con-
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sisted of daily observations on general fitness and ap¬
petite, and weekly detailed clinical examination, in¬
cluding recording of rectal temperature, examination of
mucous membranes of the eyes and mouth, condition of
skin and feet and auscultation of the thorax, with
particular attention to heart sounds. Weekly weight
recording was also started at 9 weeks of age.
On the day following the fourth pre-treatment blood
sample, the first dose of adriamycin was given. The
pigs were 12% weeks old at this stage. The adria¬














GROUP B - 2mg/kg
Pig No. 41
Pig No. 48
GROUP C - 4mg/kg
Pig No. 39
Pig No. 42 GROUP D - Saline equivalent in
Pig No. 43 volume to the medium
Pig No. 46 dose.
All the pigs were given intramuscular injection
of 4% azaperone ('Suicalm', Janssen) at a rate of 4mg/kg,
and were left alone for 20 minutes to allow the tranqui-
liser to act. This not only made the pigs easier to
handle, but also dilated the superficial veins, facilitating
intravenous injection. The drug was prepared for in¬
jection by dissolving 50 mg Adriamycin powder (Phar-
mitalia) in 10 mis of "Water for Injection" and the
calculated dose was drawn into a syringe, making sure
that all air bubbles were expelled. This dilution
made the preparation more concentrated than recommended
on the instruction leaflet, but it was decided that
there was more chance of the pig moving and causing
perivascular extravasation if the volume to be injected
was very large. With the pig suitably restrained, the
ear was swabbed with spirit on cotton wool and injection
made into an ear vein, using a 23 gauge "Miniven" set
(Portex). After all the drug had been injected, 5 to
10 mis of normal saline was injected to flush out the
vein, otherwise phlebosclerosis would have occurred.
Saline only was injected intravenously in the controls.
When the Miniven needle was removed from the vein» a
piece of cotton wool was pressed on to the ear over the
injection site until any bleeding stopped. The pigs
were then returned to their pen and left to recover
from the effects of the tranquiliser. This took
several hours.
This procedure was repeated every 3 weeks for six
courses. Actual doses of adriamycin in mg were as
in Table 24 with total doses for each pig.
During the 18 weeks of the treatment period,
























































before, except that if an animal was noticed to be
off colour, it was given a detailed examination
immediately. After the second dose of adriamycin,
it was thought necessary to bleed the pigs at 9 days
after dosing, as well as at 6, 13 and 20 days.
DNFB skin tests were repeated 1 week before the
last dose of adriamycin.
After the fifth and sixth doses of adriamycin,
it was decided that clinical examination and auscul¬
tation of the heart might be insufficient to indicate
the presence and nature of any cardiac abnormalities,
and therefore attempts were made to obtain electro¬
cardiographic (ECG) recordings. In order to do this,
the pigs either had to be heavily sedated or anaesthe¬
tised, because any movements made the traces unreadable.
This was achieved using azaperone as before, followed
by a small intravenous dose of pentobarbitone, ("Sagatal",
May and Baker) to effect. The ECG leads were
attached to the left fore-leg, right fore-leg and hind-
leg, by means of metal needles introduced under the skin,
to ensure the best possible electrical contact. Despite
every precaution, there were great technical difficulties
with the machine being used (Videograph 1A with ECG
writer, Medical and Industrial Equipment Ltd., London)
and some of the traces were completely useless. Un¬
fortunately the pig with the most obviously abnormal
heart beat died before a trace could be obtained.
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Nine days after the last dose of adriamycin, two
of the four control pigs and one of the group A pair
were killed by intravenous injection of 20% pento¬
barbitone sodium. All pigs in Groups B and C had
already died (See Results).
All dead pigs, whether they had been destroyed or
had died suddenly, were autopsied as soon as possible.
The three pigs left alive were given no further
treatment and detailed clinical examinations and weighi
were stopped. Weekly blood sampling was continued
for 5 weeks more, to allow any effects of the drug to
disappear. These pigs were then killed and autopsied




Clinical Examinations (For clinical records see Appendix II
Throughout the experiment, all the control pigs re¬
mained well, except that control pig number 42 was injured
by the others 2 days before being destroyed at the end of
the treatment period. Control pig number 39 was the runt
of the litter and therefore was much smaller than the rest.
It had a slight navel infection before the start of the
treatment period but recovered from this rapidly.
The toxic effects of adriamycin became obvious most
rapidly in the Group C pigs (4mg/kg). Pig number 41
died suddenly overnight 9 days after its first dose of
adriamycin. Before it died, it was noted to have purpura,
and subcutaneous haematomata, mainly on the abdomen (See
Plate 6 ), but also on its limbs and ears. It also
developed mouth ulcers.
The other Group C pig, number 48, survived three
doses of adriamycin, but during the 2nd week after its
third dose had to be destroyed on humane grounds. During
the treatment period, its body weight remained almost un¬
changed (fluctuating between 20 and 22kg) but it lost con¬
dition rapidly. It had slight diarrhoea for much of the
time. This became moderate in the 3rd week after the
second dose, improved again and then became very severe
after the third dose. It was then separated from its
litter mates to prevent bullying. The pig became list¬
less with no interest in its surroundings, its appetite
decreased and it had large mouth ulcers. Its mucous
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membranes were pale. With the diarrhoea, it became
dehydrated though it tended to drink a great deal of
water. Its skin was dry, wrinkled and scurfy, with
definite hair loss, especially on the flanks, all its
hooves became dark in colour and began to separate at
the coronary bands. These hoof lesions were obviously
infected, as there was exudation of pus when pressed
gently. It shivered and its rectal temperature rose
to 40.7°C. It had tachycardia (over 200/minute) and
its superficial lymph nodes were enlarged. The animal
could hardly stand when it was decided to destroy it
and it would undoubtedly have died very shortly anyway
see Plates 7 and 8. The pigs in Group B (2mg/kg)
took longer to show signs of toxicity. Both remained
in good health for the first two courses of adriamycin,
despite having been a little thin to start with, but
during the 3rd week after the second dose, both were
noted to be rather listless. Neither were off their
food, however. In the 1st week after their third
dose, one pig, number 49, developed a cardiac arrythmia,
which did not occur at regular intervals. The heart
sounds themselves were normal. The following week the
heart sounds were normal and regular. In the 2nd week
after the fourth dose, this abnormality was noted again
on auscultation and it became very pronounced. Both
pigs were by this time noticeably thinner than the control
and Group A pigs and had patchy alopecia, again particularly
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on the flanks. During the 1st week after the fifth
dose of adriamycin, the heart rates of both pigs were
irregular, and in 49 extra heart sounds were heard.
Attempts were made to obtain ECG tracings from
these pigs but due to technical difficulties with the
machine, only one rather poor trace was obtained from
Lead III on pig number 47. The intervals between
QRS complexes, measured in millimetres on the trace, were
found to vary from 14 to 20, in contrast to the intervals
in traces from the control pigs which varied a little
between pigs but were reasonably constant for any one
animal. In order to ascertain whether or not
there were other abnormalities present, it would have
been necessary to compare the traces with a pretreatment
trace from the same animal. It was possible to
obtain another trace from pig 47, although it was very
ill by this time with a definitely abnormal rhythm to the
heart sounds, after the sixth dose of adriamycin, there
was a marked difference between the traces. The heart rate
was very rapid and on the same lead, Lead III, the appear¬
ance and heights of the T-waves had changed, also the
heights of the QRS complexes were 10 to 12mm, compared
with 13 to 16mm in the previous trace. Heights of QRS
complexes in the control animals on Lead III were vari¬
able, but constant for each animal. Pig number 49
died before the ECG machine was repaired and no traces
were obtained. Since its heart sounds were much more
irregular than those of 47, this was unfortunate. Before
47 died, it developed severe haemorrhagic diarrhoea. 49
had buccal ulceration, mainly inside the lower lips and on
the gums round the base of the incisor teeth. Body weight
gains were obviously affected in this group (See Table25)
Both pigs in Group A (lmg/kg) remained fit with ex¬
cellent appetites. One pig, 45, developed a large ulcer
between the gum and lower lip below the incisor teeth in
the third week after the fourth dose. This healed
rapidly, but another ulcer developed in the same position
after the sixth dose. ECG tracings were taken the day
before half of the pigs were destroyed at the end of
treatment. These did not reveal any abnormality or
alteration in rhythm in either Group A pig, although a
slight irregularity in rhythm had been noted in pig 45
after the fifth dose of adriamycin. Body weight gains
in this group varied (See Table 25 ).
In no pig, other than in the highest dose group, was
there any evidence of fever. Rectal temperatures stayed
below 40°C, usually between 38 and 39°C. This seemed
to be the normal range for pigs of post-weaning age in
the piggery.
DNFB Skin-Test Results
It can be seen from Table 26 , that all the treated
pigs which survived to be tested, showed a decrease in














































































































































the results are confused by the poor second test scores
of control pigs 39 and 43.
Haematology
The effects of adriamycin on white blood cells
were shown most obviously by the counts obtained from
the two pigs given the highest dose, (4mg/kg). Because
these animals died fairly early in the experiment, their
counts are not included in the table of group means but
are to be found with the figures for individual pigs
(Appendix II). There was a marked fall in total
white blood cell counts by 6 days after dosing in both
9
pigs. No. 41 was leucopenic (5.5 x 10 /litre) just
before it died 9 days after the first dose. In pig
no. 48, the counts improved following the nadir after
the first two doses, but 6 days after the third dose,
9
the count fell to a nadir of 3.9 x 10 /litre and was
still low at 13 days (6.7 x 10^/litre). It was destroyed
3 days later in extremis.
Figure 11 illustrates the absolute lymphocyte and
neutrophil counts of these pigs compared with the mean
lymphocyte and neutrophil counts of the four saline-
treated controls. From these graphs, it can be seen
that there were effects on both lymphocytes and neutro¬
phils, but the effect on the lymphocyte counts was more
dramatic and prolonged, recovery taking place between
13 and 20 days after each treatment in pig no.
48. It is interesting that neutrophil counts were
beginning to recover in both pigs before death but
FIGURE 11
Absolute neutrophil counts (above) and lymphocyte counts
(below) of two normal pigs treated with 4mg/kg adriamycin
compared with mean counts of four saline-treated controls.
2U3.
lymphocytes were not. Monocyte counts
also appeared to be depressed in the treated pigs,
but since monocyte counts are usually low and very
variable, it is difficult to draw definite conclusions.
The total white cell counts and absolute neutro¬
phil, lymphocyte and monocyte counts (means - S.D.) of
Groups A, B and D are shown in Table 27 . There was
a marked effect on mean total white cell counts from
6 to 9 days after dosing in Group B when compared
with Group D as illustrated in Figure 12 . Mean
counts in Group A were also lower than Group D, though
this was less marked and only from the third dose on¬
wards. Standard deviations were larger in Group A
than in Group B, and neither pig in Group A was ever
leucopenic.
When the mean neutrophil counts at 6 days after
dosing are examined (Table 28A ) the standard deviations
are wide. There were no consistent or dose-related
effects, though the counts of the treated pigs di^d
tend to be lower than those of the controls.
However at 6 days after each dose, the mean
lymphocyte counts of Group B were consistently lower
than those of Group A, which in turn were consistently
lower than the controls, indicating a clear-cut dose-
related effect. (Table 28B)
There were no differences in mean monocyte counts
between Groups A, B and D, which could be attributed
to the treatment.
Eosinophils and basophils were noted when seen
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not possible to say whether they were affected by the
treatment or not.
As with the white cells, effects on the red blood
cell picture were most readily seen in the results from
pig 48 which survived three doses of 4 mg/kg adriamycin.
(See Appendix II ) Figure 13 shows the depression in
Hb, PCV and red cell counts which occurred in this
animal at 13 days after each dose, compared with mean
values from the four control pigs (one standard deviation
shown at 13, 34 and 55 days, for others see Table 29).
Red blood cell (RBC) counts remained slightly below those
of the controls all through the treatment period, but
were beginning to recover from the nadir by 20 days
after the first and second doses. The highest values
were obtained 6 days after the following dose, before its
effect became apparent. This also happened with Hb
concentration and PCV. In fact, the "rebound" values
for Hb and PCV after the second dose were even higher
than the mean values for the controls.
The mean corpuscular volume (MCV) began to increase
after 34 days of the treatment period and the mean
corpuscular haemoglobin (MCH) also showed a slight in¬
crease after this time (See Appendix II ) . Mean cor¬
puscular haemoglobin concentration (MCHC) values were
similar to those of the controls.
Pig 41 which died after one dose of 4 mg/kg showed
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FIGURE 13
3 (above), PCV (centre) and RBC counts (below) of one
Drmal pig treated with 4mg/kg adriamycin, compared
ith mean values of four saline-treated controls,
ertical lines indicate times of dosing.
as with 48. The Hb concentration was 10.9 g/dl.
At 9 days, only the Hb concentration was measured, the
low figure of 6.1 g/dl being obtained. This was not
unexpected considering the multiple haemorrhages which
had occurred in this animal.
The mean RBC counts, Hb and PCV values for the
pigs in Group B showed a milder effect, in that they
were lower than those of the controls throughout the
treatment period, and especially at 9 and 13 days after
the third, fourth and fifth doses. The lowest figures
for this group were obtained on day 55, after which there
was a rise in the mean values. RBC counts in the con¬
trol groups were also low at this time (See Table 29).
Mean values for RBC counts of pigs in Group A also
tended to be lower than those of the controls during
treatment, but taking into account the standard deviations
which overlap, it is unlikely that there was any real
effect. Mean PCV and Hb levels were actually higher
than those of the controls on many occasions.
There was no consistent effect on MCV, MCHC or MCH
in either Group A or B, the mean values being similar to
those of the controls.
The effects of adriamycin on thrombocyte counts were
again shown, quite dramatically, by the results from the
See Figure 14.
two high-dose pigs 41 and 48./ After each dose, there
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figures being obtained at 9 and 13 days after dosing.
Pig 48 recovered remarkably well from the throm¬
bocytopenia on two occasions, the counts at 20 days
being similar to those of the controls. However,
9
after the third dose, the count fell to 22 x 10 /litre.
The pigs in Group B showed a milder depression in
mean thrombocyte counts compared with the controls, es¬
pecially after the third, fourth and fifth doses (See
Figure 15 and Table 30. Standard deviations are
shown on the graph only where there is likely to be an
important difference). The nadir was around the 9th
day. Neither of the Group B pigs was ever dangerously
thrombocytopenic.
There was no effect on thrombocyte counts in Group
A which could be attributed to the treatment.
Serum Enzymes
Alkaline Phosphatase
At 9 weeks of age, when blood sampling started, the
serum alkaline phosphatase levels in all ten pigs ranged
from 93 to 204 IU/litre. These were within the normal
range for 9 week old pigs (Imlah, 1968). During the
following 3 weeks of the pretreatment period, there
was considerable fluctuation in the levels of alkaline
phosphatase, and mean levels for the low and medium dose
group pigs were lower than those for the control and
high dose pigs. During the treatment period, for the
11 weeks during which alkaline phosphatase levels were
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TABLE 30
ADRIAMYCIN : NORMAL PIGS - MEAN THROMBOCYTE COUNTS + I S.D.




DOSING GROUP D (Controls) GROUP A (1 mg/kg) GROUP B (2 IT
- 22 410 + 17 473 + 44 465 + 10
- 15 418 + 73 403 + 7 473 + 13
- 8 448 + 37 512 + 118 325 + 163
- 1 408 + 49 371 + 14 417 + 85
Dose 1 - 0
+ 6 546 + 204 314 + 22 221 + 5
13 592 + 89 711 + 56 528 + 78
20 572 + 177 477 + 33 478 + 33
Dose 2 - 21
27 449 + 64 554 + 46 362 + 71
30 412 + 81 433 277 + 83
34 419 + 44 468 + 88 402 + 64
41 680 + 263 578 + 263 257 + 196
Dose 3 - 42
48 494 + 54 431 + 40 281 + 12
51 487 + 66 427 + 15 169 + 57
55 552 + 143 541 + 18 267 + 7
62 448 + 71 440 + 55 409 + 51
Dose 4 - 63
69 343 + 65 304 + 16 227 + 33
72 372 + 45 268 + 34 193 + 43
76 312 + 40 331 + 41 201 + 0
84 262 + 36 294 + 12 266 + 103
Dose 5 - 84
90 309 + 36 293 + 18 181 + 2
93 262 + 45 264 + 36 109 + 4
97 290 + 84 269 + 33 241 + 60
104 307 + 78 276 + 1 213 + 15
Dose 6 - 105
111 267 + 41 214 + 23 _
TABLE 31
ADRIAMYCIN : NORMAL PIGS
MEAN LEVELS OF SERUM ALKALINE PHOSPHATES +ISD (i.u/litre)
DAYS FROM
START OF
DOSING GROUP D - CONTROLS GROUP A - 1 mg/kg GROUP B
- 22 146 + 48 148 + 12 120 + 0
- 15 132 + 20 111 + 13 77 + 50
- 8 96 + 36 77 + 16 88 + 14
- 1 132 + 23 100 + 16 109 + 3
Dose 1 - 0
6 104 + 20 85 + 4 67 + 3
13 138 + 20 70 + 33 82 + 29
20 108 + 27 87 ± 8 96 + 13
Dose 2 - 21
27 123 + 24 104 + 16 106 + 35
30 134 + 25 93 + 38 98 + 15
34 134 + 12 88 + 14 99 + 15
41 117 + 23 89 + 16 101 + 44
Dose 3 - 42
48 137 + 16 99 + 16 71 + 16
51 112 + 31 112 + 6 53 + 11
55 138 + 34 115 + 18 80 + 11
62 132 + 23 107 + 6 125 + 7
Dose 4 - 63
69 93 + 20 62 + 1 88 + 11
72 114 + 22 66 + 9 114 + 34
76 Discontinued
be lower than those of the controls, particularly at
6 and 9 days after the first and third doses of adria-
mycin. However, the effect was not consistent or
dose-related, and since the fluctuations seemed to
occur in a similar pattern to those recorded in the
control animals, it is unlikely that this was due to
the action of the drug.
If the serum alkaline phosphatase levels of the
high-dose animals are individually compared with the
mean - S.D. of the control animals, it can be seen that,
at 6 days after the first dose of adriamycin, the pig
which died at 9 days had an alkaline phosphatase concen¬
tration which was higher than those of the controls,
but which was almost exactly the same as that recorded
in the same animal before it was dosed. However, the
surviving high-dose pig showed a decrease from 136 IU/
litre before dosing, to 34 lU/litre 6 days after dosing,
and the concentration remained low thereafter, until its
death.
See Table 31 and Table 33 (Appendix II)
SGOT
Levels of SGOT in all ten pigs were low at the
start of blood sampling, ranging from 16.5 to 25.2 1U/
litre. From time to time during the experiment small
rises occurred in every animal, even the controls. As
this enzyme indicates cell damage in liver, heart and
muscle, the importance of these changes is very doubtful.
2G8.
(See Table 34 in Appendix II). However, on one
particular day 6 days after the first dose of adriamycin,
all pigs, except one control and one high-dose animal,
had elevated SGOT levels. One of the pigs given the
lowest dose, number 40, had a moderately high concen¬
tration of 238 lU/litre. Total bilirubin was measured
in those pigs which had SGOT levels greater than 50 IU/









None of these values for total bilirubin is greatly
different from the figure of 5.8 ;umol/litre given by
Baetz and Mengeling (1971) for normal swine. Since the
elevation of SGOT was present in the control pigs as well
as the treated animals it is unlikely that this effect
was connected with adriamycin dosage.
Blood Urea (See Tables 21 to 30 Appendix II).
Blood urea measurements in the treated pigs showed
no differences from those in the control pigs which could
be attributed to the effects of the drug. All measure¬









normal range, apart from that obtained in the control
pig, number 42, in the last week of treatment (11.11)
which could have been associated with the injuries it




This small, moderately well nourished pig
had extensive fibrous adhesions of the lungs to the ribs
and diaphragm, though the lungs themselves were normally
aerated. Adhesions were also present in the pericardial
sac but the heart appeared normal in thickness and the
valves were normal.
There were extensive fibrous adhesions between the
liver and diaphragm. There was fibrosis on the visceral
surface of the liver but no adhesions to any of the other
viscera.
42
This was a normal carcase but showing extensive red
graze marks all over the skin, especially on the head
and shoulders.
43 and 46
Neither of these carcases showed any abnormality.
Low-Dose Pigs
40
This pig showed no abnormalities. Most
lymph nodes had 3 to 4 mm of white nodular cortex but
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no cortex was visible in the bronchial nodes and little
in the gastric nodes.
45
This was a small, moderately nourished carcase.
The only abnormality seen was approximately 20 ml of fluid
in the pericardial sac. All lymph nodes had about 3 mm
of white cortex visible.
Medium-Dose Pigs
47
This was a moderately developed carcase but
with less fat than normal at all sites.
There was marked oedema of the eye-lids and the skin
showed red blotchy mottling.
The meninges of the brain were slightly congested
with some fibrin.
The thymus lobules were very small and thin.
The chest showed extensive fibrous adhesions between
the lungs and the ribs, especially anteriorly, and between
the diaphragmatic lobes and the diaphragm. The lungs were
moderately congested and oedematous and not fully expanded.
The heart showed marked fibrous adhesions obliterating
the pericardial space. The right ventricle was dilated
and 4 mm thick. The left ventricle was 20 mm thick.
The endocardium and cut surface showed pink/red mottling
(as 49). All valves were normal except the left A-V
valve which was slightly thickened, nodular and oedematous.
The abdominal cavity contained about 200 ml of cloudy
brown fluid but with no fibrin or thickening of the peri¬
toneum.
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The liver was rather small with extensive fibrous
adhesions between the diaphragm and the liver.
The spleen was contracted.
The cardiac region of the stomach showed blurred
1mm petechiae. There was haemorrhage in the submucosa
of the fundus. The pylorus was slightly blood stained.
There was marked oedema of the mesentery and between
the coils of the colon. The caecum and colon were dis¬
tended with dark brown mealy fluid and the mucosa was
bright red with a few small yellow foci.
The bone marrow of the femur was red and active.
All the carcase lymph nodes showed a white network
in which there were small areas of red cellular tissue and
no typical normal cortex.
49
This was a well-developed moderately nourished carcase.
The skin over the lower limbs showed a few red ulcers and
brown scabs.
There was no fluid in the pericardial sac, thorax or
abdomen.
The thymus was thin. All lobes of the lungs showed
slight partial collapse.
The heart showed fibrous adhesions over a 1cm area
near the apex of the left ventricle. Epi-and endocardial
surfaces showed "thrush-breast mottling" and also the cut
surface, probably due to fatty change. The right ventricle was
4mm thick, the left 20mm, with rather flabby muscle, the
valves were normal.
212 „
The liver was rather small, sharp bordered, with
some fibrous adhesions to the membranous portion of
the diaphragm.
The spleen was contracted.
The cardiac region of the stomach showed multiple
2mm petechiae.
There was haemorrhagic material in the submucosa
of the fundus.
The serosa of the small intestine was red to dark
red. Peyer's patches were visible but without obvious
lymphoid nodules. The wall was not thickened.
The ileocaecal valve showed a very congested mucosa
with a thin grey necrotic surface. The caecum was full
of thin, fibrous, fluid food and the mucosa showed some
petechiae. The coils of the colon showed multiple
2 mm yellow raised nodules surrounded by 1-2 mm wide
congested zones.
The feet showed cracks between the sole and the
of the heel.
wall at the junction between sole and bulb/ Some
cracks extended down into the underlying connective
tissue.
The cut surface of all lymph nodes showed little
evidence of white lymphoid tissue. All showed con¬
gestion and sometimes haemorrhage.
High-dose pigs
41
This was an anatomically normal carcase with
blue slightly raised haemorrhages 2-3cm diameter on the
213.
belly and l-2cm (not raised) on the ears and lower
limbs.
On cut surface there were subcutaneous haemorr¬
hages on the ventral abdomen and chest up to 1cm
thick. The animal was not dehydrated. There was a
moderate amount of blood in cut vessels.
There were multiple l-2mm petechiae in the sub¬
cutaneous fat, especially on the sides of chest and
belly.
The upper gum of the mouth showed a 2mm red ulcer
opposite the lower canines.
All lymph nodes showed up prominently because they
were dark red. On cut surface they were mainly com¬
posed of red haemorrhage with a l-2mm white nodular
cortex centrally. The prescapular was all red, the
mesenteries showed a brown, quite extensive medulla.
The cervical thymus was very thin with small
brown nodules.
The thoracic thymus was only 3mm thick, surrounded
by yellow oedema.
The lungs, on the right side, showed congestion
and oedema and petechiation. The left side was
emphysematous with no petechia and little oedema.
Serosanguinous fluid was present in the pericardial
sac, thoracic and abdominal cavities but no fibrin was
present.
The heart showed many sub-epicardial petechiae and
a few sub-endocardial ones. The muscle was normal.
The liver was slightly pale, lobulation not dis¬
tinct. The spleen was contracted.
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There were petechiae in the bladder and serosa
of the stomach.
The large intestinal wall was slightly thickened
with oedema between the coils of the colon. Just
below the caeco-colic junction for lh coils were areas
of yellow/green necrosis doubling the thickness of the
gut and giving it a corrugated appearance.
Cultural examination of large intestinal contents
proved negative for the presence of accepted bacterial
pathogens.
48
The pig was not markedly thin'. The skin surface
showed many 5-10mm black/brown scabs - largest on the
ears and lower limbs and over the carpal region. If
pulled off these left a white scab.
The blood was thin and watery.
There were a few l-2mm depressed shallow brown
ulcers on the inside of the lips and sides of the tongue.
There was no subcutaneous lesions on skinning.
The thymus was thin.
Both ventricles of the heart were rather thin walled
otherwise N.A.D.
The spleen was contracted.
The caecum and colon were much dilated with thin
brown-grey porridge-like fluid. The wall was not
thickened. The mucosa was slightly congested and finely
nodular, grey in colour - possibly necrotic.
The meninges of the brain were congested and some fibrin
215.
was present.
Limb joints showed a slight excess of clear fluid
but synovial membranes and joint surfaces were normal.
Most lymph nodes showed an ill-defined cortex
forming white nodules more than three quarters of the
node with a pale brown medulla.
The feet showed fluctuating swellings on the
lateral aspect of the bulbs of the heels. On sawing
through the digits, small irregular penetrating wounds
were found with variable-sized abscess cavities con¬
taining yellow pus and necrotic material, mainly under-
running the sole but sometimes arising from the coronary
band. Neither the joints nor the bones of the foot
were involved.
The bone marrow of the femur was red and cellular.
Lymph Node and Organ,Weights
Relative organ and lymph node weights in cg/kg are
shown, for all treated and control pigs, in Table 32.
The weights from both animals in the low-dose group are
similar to those of the control group.
However the medium and high-dose animals had re¬
lative lymph node weights which were markedly greater
than those of the controls. This was true for all
the nodes, in both splanchnic and superficial groups.
Liver, kidneys and adrenals were also enlarged, especially
in the high-dose animals. In contrast, thymus and spleen
TABLE32
























































































































































































































relative weights were markedly reduced in the medium
and high dose groups.
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DISCUSSION
It is clear from the results of this experiment that
adriamycin, when administered at a dose level of 2 mg/kg
or greater, produces severe toxic effects, and that these
effects are cumulative.
The effects noted clinically were dullness, loss of
condition, enlargement of superficial lymph nodes, buccal
ulceration, patchy alopecia, diarrhoea, haemorrhage, lame¬
ness, pale mucous membranes, tachycardia and cardiac
arrythmia, fever in one animal probably as a result of in¬
fection of the feet, and possibly depression of the skin
hypersensitivity response.
The haematology results indicated bone marrow de¬
pression with temporary decreases in lymphocyte, neutrophil,
red blood cell and thrombocyte counts, PCV and Hb, and
increases in MCV and MCH.
These effects were similar to those described in
humans (Benjamin, 1975), apart from the time of the nadir
in the WBC count, which was at 6 days after dosing com¬
pared with 12 days in man, and the depression of thrombo¬
cyte counts, which is not a frequent side-effect in man.
Benjamin stated that tumour infiltration of the bone
marrow was one of the risk factors associated with in¬
creased adriamycin toxicity, especially with regard to
thrombocytopenia, therefore this was an important consid¬
eration when deciding on a dose level to be used in
treating the lymphosarcomatous pigs.
Though the fall in serum alkaline phosphatase level
in high-dose pig 48 is striking, it would appear to be
unrelated to the adriamycin administration, unless in
some way it reduced the formation of alkaline phos¬
phatase. This enzyme is mainly produced extrahepati-
cally, e.g. in bone, and according to Bodansky (1961),
elevation of serum alkaline phosphatase in obstruction
of the bile ducts and hepatitis is due to failure of
the liver to metabolise and excrete the enzyme.
In the veterinary literature only four reports
have been found which described trials using adriamycin
in normal animals of the domestic species.
Smith and Kirk (1976) injected adriamycin intra¬
venously at weekly intervals into seven dogs, six of
which were clinically normal, and one of which had a
mammary tumour. Varying dose levels were used.
Generalised alopecia and stomatitis did not occur.
Effects on lymphoid tissue, bone marrow and blood counts
were reported. A dose level of 0.5 mg/kg produced only
slight bone marrow depression, whereas the highest dose
level, 2.5 mg/kg produced complete depression of haemato¬
poietic activity. WBC counts decreased in all but one
dog, both lymphoid and myeloid cells being affected.
RBC counts were not measured and Hb and PCV values did
not change appreciably during treatment. Total protein
did not alter either. There was no mention of thrombo¬
cyte counts. All the dogs were destroyed without
allowing them to recover from the effects of treatment.
Histological changes in spleens, lymph nodes, lungs, livers,
bone marrow, testes and ovaries were investigated, but
weights of organs or lymph nodes were not recorded.
Henness, Theilen and Lewis (1977) administered
adriamycin intravenously to normal cats, in three groups
of two. Antihistamine and glucocorticoid injections
were also given to minimise toxic effects. Another dose
of adriamycin was given 3 weeks later. Decreases in
WBC counts and diffuse alopecia with delayed hair growth
were reported.
Van Vleet, Greenwood and Ferrans (1979) administered
adriamycin intravenously to normal pigs at varying dose
levels from 0.64 mg/kg/week to 6.4 mg/kg/week. In three
out of the five dose groups, the drug was continued until
all the pigs were dead, and the pigs left alive in the
other groups were destroyed at the end of treatment. Sur¬
vival time varied from 10 days in the highest dose group
to 134 days in a low dose group, and was prolonged in
younger pigs i.e. those that were 4 weeks old, and in
those given smaller, more frequent doses.
The detailed results described in this paper were
almost entirely pathological, though it did mention that
alimentary tract lesions were manifested clinically by
inappetence associated with painful oral ulcers and
diarrhoea, and also mentioned marked cellulitis and nec¬
rosis of skin, muscle and ear cartilage caused by peri¬
venous extravasation. It stated in the "Methods"
220.
section that the pigs were weighed and blood samples
collected each week but no results of the measurements
were included, other than the statement that leucopenia,
anaemia and thrombocytopenia occurred. At autopsy,
the alimentary tract lesions were very similar to those
seen in our experiment, being concentrated in the mouth,
caecum and colon. Bacteriology results were not re¬
ported, though clumps of bacteria and Balantidia were
seen histologically in the gut lesions and evidence of
widespread bacterial embolism was found in many tissues.
In those of our pigs which had these gut lesions, very few
bacteria were seen in frozen sections and cultural
examination showed that the lesions were not associated
with any bacterial pathogens.
Those pigs which died with haemorrhagic diathesis
showed autopsy results similar to pig 41.
Skin lesions were described which were similar to
those seen in pig 48, but alopecia apparently did not
occur and there was no mention of foot lesions such as
those seen in 48 or 49.
Lymphoreticular tissues were described as atrophied
and congested, and lymph nodes in many of their pigs
showed extensive haemorrhage. In our high- and medium-
dose pigs, there was a marked decrease in relative weights
of spleens and thymuses compared with those of the control
pigs. Grossly, haemorrhage was suspected in the lymph
nodes of 47, 49 and particularly 41 because of the red
appearance of the nodes, but all lymph nodes in all four
animals were much heavier than those of the controls,
which was surprising in the case of pig 48, whose nodes
showed an ill-defined cortex and no gross evidence of
haemorrhage.
The toxic effects of adriamycin already discussed
are not unexpected in tissues such as bone marrow,
lymphoid tissue, alimentary epithelium, skin and coronary
band of the hoof, where there is a high turnover of cells.
Van Vleet et al., (1979) were interested in the fact
that intestinal lesions were most common in the colon and
caecum. They suggested three reasons for this, firstly
that the turnover time of porcine large intestinal
mucosal cells is more rapid than that of small intestinal
cells, secondly that the bacterial and protozoal flora
of the large intestine makes the mucosa more vulnerable
to invasion, and thirdly that the small intestinal
epithelium has a greater ability to regenerate in the
face of continual drug-induced injury.
Van Vleet et al., (1979) had many problems with in¬
travenous injections and the tissue necrosis which oc¬
curred after perivascular extravasations. Although it
is possible that the metabolism of the tranquiliser in
some way might have affected the actions of adriamycin,
it was considered that the advantages of relative im¬
mobility and vasodilatation that the tranquiliser pro¬
duced far outweighed any theoretical disadvantages. As
a result, no extravasation occurred, despite repeated
injections, and sclerosis of the ear veins was avoided
by flushing out the veins with saline.
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Other toxic effects were reported by Van Vleet
et al., (1979), the most important of which was cardio-
toxicity, which occurred only in pigs which were given
the lower dose levels and those which had prolonged sur¬
vival .
Several of their pigs showed acute fibrinous peri¬
carditis or hydropericardium. Fibrous adhesions were pre¬
sent in the pericardial sacs in treated pigs 47 and 49.
However extensive similar adhesions were seen in the little
control pig 39, and this post-mortem finding was fairly
common in stunted young pigs in the piggery at this time.
Since the lesions were old, isolation of microorganisms
was never attempted, but a mycoplasma infection occurring
in early life was suspected. It was unlikely therefore
that these findings in 47 and 49 were related to adria-
mycin dosage. Low dose pig 45 had an excess of fluid
in the pericardial sac and an irregularity of cardiac
rhythm was detected in this animal, though the ECG tracing
did not reveal any abnormality.
Kehoe, Singer, Trapani, Billingham, Levandowski and
Elson (1978) administered adriamycin to 10 normal dogs.
2
Four were given a high dose (80mg/m ) on 3 consecutive
days and were then destroyed. Six were given a lower
dose (25mg/m /week) for up to 20 weeks. Cardiac moni¬
toring revealed an increase in sinus rate which lasted
several hours after infusion, ectopic dysrhythmias consis¬
ting of premature atrial and ventricular contractions,
ventricular tachycardia and atrial fibrillatio^and atrio-
ventricular block, but no constant alterations in QRS
contour or amplitude or QT interval. High-dose dogs
also exhibited a pronounced fall in arterial blood pres¬
sure within 5 minutes of the start of administration.
They concluded that if their findings were also applicable
to man, they could provide an explanation of sudden deaths
of human patients treated with adriamycin. There was no
consistent correlation between onset of dysrhythmia and
either drug dosage or duration of therapy in the dogs and
the more severe changes could well be life-threatening,
particularly in patients with pre-existing conduction de¬
lays or coronary disease.
Alterations in ECG such as those observed by Kehoe
et al., (1978) were not present in the traces from pig
47 and the low-dose pigs, and there was no clinical or
autopsy indication of congestive heart failure in any of
the treated pigs. The cause of death in pig 49 may
have been the necrotising colitis seen at autopsy but the
lesions were not particularly severe. Heart action in
this animal must have been restricted by the fibrous ad¬
hesion between the pericardium and the left ventricle.
However much more severe adhesions were present in pig
47 and caused surprisingly little inconvenience to the
animal, though they may have been responsible for the
irregularity of rhythm showed by the first ECG trace.
It is tempting to speculate that the cardiotoxic action
of adriamycin may have contributed to the sudden death of
pig 49.
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The results of this experiment were considered when
planning a therapy trial in lymphosarcomatous pigs. Al¬
though a dose level of 2mg/kg was clearly toxic, it was
decided to attempt treatment with this dose in two
animals so that maximum antitumour response could be as¬





Two pairs of pigs were used, and these were two cas¬
trated males from one litter which were 7 months old at
the start of the experiment and a male and a female from
another litter, which were 11 weeks old. All four were
cases of lymphosarcoma, which were diagnosed before 8
weeks of age, based on clinical and haematological findings.
One pair were given 2mg/kg adriamycin intravenously,
and the second pair were given 1 mg/kg. Since the
higher dose was likely to cause toxicity problems, both
pigs received 4 mg/kg prednisolone intramuscularly for
5 days, 1 week before the start of the adriamycin
schedule. This was considered necessary because both
9
had thrombocyte counts below 100 x 10 /litre as a result
of the lymphosarcoma, and the results of the toxicity ex¬
periment had indicated that adriamycin would further
depress their thrombocyte counts.
Apart from this, the pre-treatment procedure was as
described in the general methods section for therapy ex¬
periments. Staging laparotomies were not carried out at
this time. As in the experiment using normal pigs, hae¬
matological parameters measured were WBC counts and dif¬
ferential counts, RBC counts, PCV, haemoglobin, thrombo¬
cyte counts and urea levels. Serum levels of total
protein, albumin and SGOT were measured at intervals, and
total and free bilirubin if the SGOT was elevated or if
the serum looked yellow.
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Weekly weighing and blood sampling commenced 5 weeks
before the start of adriamycin dosing in the case of the
pair receiving the higher dose, and 3 weeks before in the
case of the pair receiving the lower dose. As in
previous therapy experiments clinical examinations included
weekly measurements of the inguinal and precrural lymph
nodes, and abdominal measurement at the level of the um¬
bilicus .
Sensitisation and skin tests with DNFB were carried
out at 30 days and 10 days before the first adriamycin
dose, in pigs 192 and 194 only.
The dosing procedure was identical to that already
described in the experiment using normal pigs, and as be¬
fore dosing was carried out every 3 weeks. The low-dose
pigs received eight treatments, the higher-dose pigs only
survived two and three treatments respectively.
Actual doses in mg were as in Table 33 with total
doses for each pig.
The third dose given to 3785 was reduced by 75%, in
accordance with the recommendations of the adriamycin dosage
instruction leaflet (Pharmitalia) for cases with elevated
serum bilirubin (see Results).
During the treatment period, the high-dose pigs were
bled at 6, 9, 13 and 21 days after the first injection
and at 4, 7, 11 and 18 days after dosing thereafter. Since
little toxic effect was expected in the lmg/kg group, from
the results of the experiment using normal pigs, 192 and
194 were bled at 5, 12 and 19 days after dosing. Weighing
TABLE33
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and clinical examinations were continued. Lymph node
measuring was continued until the pigs reached 60 to 70 kg
body weight, after which they were too heavy to turn over
on to their backs.
Skin tests were repeated on pigs 192 and 194 after
three and eight adriamycin treatments.
Twelve days after the last dose, one pig from the
lmg/kg group, the female 192, was destroyed by pentobarbi¬
tone overdose. Both high-dose pigs were already dead.
Autopsies were carried out as soon as possible after death.
Three weeks after the last dose of adriamycin, 194
was tranquilised as before, and then given halothane by
mask until surgical anaesthesia was achieved. An incision
was made through the scrotal skin and tunica vaginalis and
the right testis and epididymis were removed, using an
emasculator to crush and cut the spermatic cord. The
skin was sutured with nylon. The tissue was examined to
investigate the possibility of using this animal for
breeding. No further adriamycin treatment was admini¬
stered. Weekly weighing, clinical observations and
blood sampling were continued until 7 weeks after the last
dose, when it was considered that the pig had relapsed.





Both higher-dose pigs died fairly soon after starting
therapy, one, (3786) 19 days after its second dose, and
the other, (3785) 14 days after its third dose. Both
were advanced cases, which were deteriorating in condition
at the beginning of the experiment. They were in poor
body condition, with the typical "pot-bellied" appearance.
Five days of prednisolone therapy, given during the week
preceding the adriamycin therapy, produced similar effects
to those previously described in Chapter I. General
fitness and appetite improved and there was a slight shrin¬
kage of superficial inguinal and precrural nodes in both
animals (see Clinical Records, Appendix II ). There
was a decrease in abdominal measurements, which was also
noticeable looking at the animals, from 85.5 cm to 77.0
cm in pig 3786 and from 92.0 cm to 82.5 cm in pig 3785.
A slight body weight loss occurred - 2.7 kg in 3786 and
2.0 kg in 3785. Both animals had slight diarrhoea 2
weeks before starting adriamycin therapy, but this cleared
up without treatment.
Pig 3786 remained well throughout the treatment period
with a good appetite and no further deterioration in body
condition, until a few hours before its death, when it
suddenly became very listless. It was noted to be
constipated and be uninterested in food, but no other
clinical signs were apparent. Its rectal temperature
was 40°C, which was a little higher than the range of 37
to 39°C previously recorded in this animal during treat¬
ment but not as high as 40.3°C, which was recorded one
pretreatment week when there were no other clinical signs
associated with it.
As stated previously, there was a decrease in abdom¬
inal measurement when prednisolone was administered. There
was no increase in the week following the first dose of
adriamycin, but in the next 2 weeks, there was a gradual
increase. After the second dose, the abdominal measure¬
ment decreased again, this time 6 cm, increasing once more
during the 5th week. This decrease in the circumference
of the abdomen may have been simply a result of a decrease
in food consumption or other cause. However, if the
superficial lymph node measurements, taken at the same time,
are examined, it will be seen that the same pattern occurred
especially during week 4, after the second dose, when a
decrease in length occurred in all four nodes measured, of
between 3 and 5 mm.
Pig 3785 remained bright with a good appetite for the
first 4 weeks of therapy. However, during the 2nd week
after the second dose of adriamycin, it was noticed to be
rather listless and not eating quite so well. When
examined, it was found to have an ocular discharge and its
mucous membranes were slightly yellow. This was more
noticeable in the sclera of the eyes. By the next week,
the jaundice was much more obvious. The third dose of
the drug was reduced by 75% as previously mentioned, but
even so, by the next week, the 7th, the whole skin-surface
of the pig was bright yellow. It was losing condition
rapidly, was very miserable, and was hardly eating, and so
it was decided that it should be destroyed on humane
grounds.
Its rectal temperature stayed within the normal range
for these pigs throughout the experiment. Plates 9 and 10
show this pig before and at the end of treatment. It can
be seen from the latter plate, that at the end, it lost its
"pot-bellied" appearance and became very "tucked-up".
This happened fairly suddenly during the 7th week as
can be seen from the abdominal measurements in Appendix II.
There had been a gradual increase in the first 6 weeks,
after the decrease noted while on prednisolone, but during
the 7th week this measurement decreased by 20 cm from 89 cm
to 69 cm.
When the lymph nodes of 3785 were examined, it was clear
that there was a definite shrinkage of these nodes after
each dose of adriamycin. Comparing the measurements
with those obtained in week 0, this was slight after the
first dose because the nodes had already been reduced by
the prednisolone treatment. However the effects of the
prednisolone would be expected to have disappeared by the
time the second dose of adriamycin was administered. If
the measurements taken the 1st week after the second dose
are compared with those taken before prednisolone in week 1,
by multiplying the length and breadth of each node as pre¬
viously described in Chapter I the reduction was from
1710 to 1200 (510), from 1848 to 1104 (744), from 760 to
448 (312) and from 798 to 504 (294), giving an overall
mean decrease for the inguinal and precrural nodes of 37%.
After the third dose, only the inguinals could be measured
with any accuracy, but using the same method, the mean de¬
crease in size was 43.6% compared with the measurements
in week-1.
Weight Gains - Higher Dose Pigs
Pig 3786 showed no improvement in weight gain with
therapy. Its body weight increased and decreased so that
there was only 4.5 kg actual gain in weight during the
whole period of the experiment. Its weight at death was
0.5 kg lighter than at the start of treatment.
During the first 5 weeks of therapy, pig 3785 gained
5 kg in weight. However, after that, it lost weight
rapidly and when weighed before post-mortem it was found
to have lost 15 kg in 2 weeks. This was obvious from
its appearance see plates 9 -> 10.
During the pre-treatment period, both low-dose pigs
suffered from an upper respiratory infection, which de¬
veloped into pneumonia. The female made a satisfactory
recovery after treatment with ampicillin for 5 days.
However, the male continued to have difficulty in breathing
due to a chronic rhinitis, particularly when tranquilised,
and auscultation of the thorax revealed abnormal lung
sounds, particularly high-pitched rhonchi, for a considerable
time. Periodic treatment with antibacterial drugs was
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necessary, and atropine sulphate was administered with
each dose of tranquiliser. On one occasion, oxygen
was given by mask to relieve severe respiratory distress.
Both low-dose pigs survived eight doses of adriamycin,
and during this time their body condition improved greatly.
By the end of the treatment, both animals looked much like
normal pigs, though slightly small for their age, and the
male, 194, was easily fat enough to be mistaken for a
bacon pig (see plates 11 to 14).
Apart from the recurrent upper respiratory problem
previously described, male 194 remained well and there was
little to note clinically. It developed small ulcers on
the gum round the base of the lower incisor teeth during
the 11th week of treatment, but these healed rapidly and
did not recur. Vomiting occurred only once, 5 weeks
after the last dose of adriamycin. The chronic rhinitis
caused severe dyspnoea particularly during the 13th week
of treatment, when a febrile response was recorded and the
pig lost its appetite. This responded to intramuscular
chloramphenicol. Since it was considered likely that
the adriamycin treatment was reducing the pig's resistance
to infection, a trimethoprim/sulphonamide preparation
("Tribrissen", Burroughs Wellcome) was given in food for
6 days after the following two doses of adriamycin, the
sixth and seventh. Although its respiration was still
noisy, it remained fit and lively. "Tribrissen" was not
given after the eighth dose, and once again the pig became
rather listless and developed a slight cough.
At the end of treatment, one testis was removed
under halothane anaesthesia to test for sexual maturity.
The epididymis was almost replaced by hard, white cellular
tissue and no normal spermatozoa were identified in the
small amount of fluid from the epididymis.
By 4 weeks after the last dose of adriamycin, the
pig was starting to lose condition, and by 6 weeks, its
skin was pale and its abdomen was becoming more pendulous.
Its rectal temperature rose to 40.7°C and it showed little
interest in food. At this stage, the decision was made
to destroy it. The abdominal measurement of pig 194
decreased slightly from 75 cm to 71 cm the 1st week after
the first dose of adriamycin and from 84 cm to 82.5 cm
after the third dose. Apart from these occasions, its
abdominal measurements increased steadily, until after
the fifth dose it became too heavy to turn over on to its
back. It was decided that measurements made any other
way would be unreliable and so they were stopped. How¬
ever plates 13 and 14 of 194 before and during therapy
illustrate that the enlargement of the abdomen, typical
of the lymphoma pig, was no longer obvious, and increase
in abdominal measurements would certainly have been due
to growth and deposition of fat.
It was only possible to measure the inguinal lymph
nodes of 194 with reasonable accuracy and these measure¬
ments were also stopped after the fifth dose of adriamycin.
There was a slight shrinkage of the nodes the 1st week
after each dose, as had occurred with the two higher dose
pigs. The nodes increased in size again during the
2nd and 3rd weeks after each dose. However, the nodes
must have been decreasing in size relative to the size
of the animal as the measurements noted after the fifth
dose were very similar to those taken during the last
pretreatment week (56mm x 32mm compared with 56mm x 29mm,
and 57mm x 34mm compared with 53mm x 31mm) even though
the pig had increased in body weight from 26.5 kg to
63.5 kg in that time.
The female 192, which was also given 1 mg/kg adria-
mycin for eight doses, developed a high fever (41.9°C)
during the 8th week of treatment. It was anorexic and
vomited once. As several animals in the piggery were
showing similar signs, it was suspected that erysipelas
might have been introduced and all were given intramus¬
cular injections of a solution of crystalline penicillin
immediately and procaine penicillin for 3 days. No
further signs of erysipelas developed but all the pigs
which had been ill, including 192, improved rapidly and
three days later were fit and eating normally, and rectal
temperatures were within the usual range. After this,
192 remained well until after the fifth dose of adriamycin.
During dosing, the drug was accidentally injected into
the auricular artery, lying beside the central branch of
the posterior auricular vein. The error was soon
noticed as the whole pinna became red and half-an-hour
later a mottled purple. The irritant nature of the drug
became apparent over the next 3 weeks. After 2 to 3
days, the ear was very swollen though seemed to be more
pruritic than painful. The edges of the pinna started
to curl over after 7 days and the skin was blistered.
After 21 days the skin lesions had dried up and healed,
and the scabs had mostly fallen off, leaving the ear
curled and distorted. Pruritis was still evident
(see Plate 15 to 17).
During the 14th week of treatment, and again during
the 17th week, this pig suddenly collapsed and for about
an hour was unable to rise. Rectal temperature was
normal and the heart, though the rate was rapid, sounded
normal on auscultation. At these times, it was not
interested in food or in its surroundings. As there
appeared to be no clinical explanation for the collapse,
it was assumed that the animal had slipped in its pen
and fallen heavily. On both occasions, it recovered
without treatment, though it was unsteady in gait for
several hours.
192 was destroyed 10 days after the eighth dose of
adriamycin, so that the maximum effect of the drug could
be shown at autopsy.
Abdominal measurements decreased slightly after the
first dose from 68 cm to 65 cm, after the second dose
from 75 cm to 73.5 cm and after the third dose from 80.5
cm to 79 cm. After this, they increased steadily as
its body condition improved, until they were stopped after
the 15th week of treatment when it became too heavy to
turn over. Inguinal lymph node measurements shrank
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slightly after each dose of adriamycin as in the other
treated pigs and became difficult to carry out because
of subcutaneous fat. In the 2nd week after the fifth
dose, the nodes were impossible to measure. The week
before this, as with the other low-dose pig, the measure¬
ments were almost identical to those obtained just be¬
fore treatment started (46 mm x 20 mm compared with 45 mm
x 20 mm and 41 mm x 20 mm compared with 44 mm x 20 mm)
even though the pig's body weight had increased from 21.5
kg to 53.5 kg.
Electrocardiograph tracings from both low-dose pigs
and the end of treatment showed a perfectly regular
pattern. The intervals between QRS complexes were
measured in millimetres on all parts of the traces from
leads I, II and III from pig 192 and lead I from pig 194.
The intervals in pig 192 were 18.5 to 19 mm, and in pig
194 18 to 18.5 mm, without exception.
However when the height of the QRS complexes were
measured (leads II and III) from pig 192 they were
found to vary from 10 mm to 17 mm. The only satis¬
factory trace (lead 1) from pig 194 did not show
pronounced QRS complexes but if they were measured they
varied between 6 and 8 mm. This variation might have
been magnified on the other lead tracings, but the pig's
rapid jerky respiration made them impossible to follow.
To ascertain whether this variation in height of QRS compl¬
exes was caused by the drug it would have been necessary
to examine a pretreatment trace. No other abnormality was
i
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seen on traces from either low-dose pig.
Weight Gains Low-dose-pigs
During the treatment period, and for 3 weeks after
the last dose of adriamycin, pig 194's weight gain was
pig
excellent for a lymphosarcomatous /reaching 90 kg (bacon
weight) by 214 days of age. Since lymphosarcoma was
first diagnosed in the piggery, 28 untreated cases sur¬
vived 30 weeks or over. Of these 28 cases, records of
weight gain were kept for 17. Only 3 cases reached
90 kg by 30 weeks of age. The weight gain of 194 was,
however, still not as rapid as that of a normal animal.
Figure 16 illustrates the body weight gain of this
animal and of the other low-dose pig, 192, compared with
maximum and minimum weight gains of a normal, closely
related litter.
Although 192 did not gain weight quite as rapidly as
194, its weight at 30 weeks was 60 kg. Records of un-
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DNFB Skin-tests
From table 34 it can be seen that before treatment
started, 194 was anergic to DNFB and 192 showed only a
very slight response. During treatment, the reaction
scores increased to 2 in both animals. It would appear
that, as in the first prednisolone therapy experiment,
treatment with adriamycin temporarily improved the cell-
mediated response, though it was still poorer than would
be expected in normal, untreated pigs.
Haematology Results
Higher-dose pigs (2mg/kg)
Total WBC counts were low in both pigs at 6 and 9
days after the first dose of adriamycin, increased be¬
tween 13 and 21 days and decreased again after each sub¬
sequent dose (See Appendix Tables 36 and 37). When absolute
mononuclear cell and neutrophil counts are considered in¬
dependently, the results are shown in figure 17.
Absolute mononuclear cell counts fell with prednisolone
and still further with each adriamycin dose. The nadir
was at 6 days after the first dose. After the second
and third doses these pigs were bled at 4,7, 11 and 18
days and the nadir was at 4 days, with a terminal fall
at 11 days in 3785. Absolute neutrophil counts did
not show a consistent pattern in these pigs. After the
first dose, there was a fall in the counts at 9 days,
though in 3786 a similar fall had occurred spontaneously
before the start of treatment. After the second dose,





Absolute neutrophil counts (above) and mononuclear cell counts
(below) of two lymphosarcoma cases treated with 2mg/kg adriamycin.







and fell again at 18 days. After the third dose, the
absolute neutrophil count in 3785 rose sharply as the
pig's condition deteriorated.
RBC counts, PCV and Hb concentration ( Appendix
I I ) followed almost parallel courses in both higher-
dose animals, falling progressively in weeks - 4 to - 1,
rising with prednisolone treatment, and then after dosing
with adriamycin, maintaining a fairly constant level until
the 5th week of treatment. Pig 3786 died 6 days after
it was blood-sampled on day 34. After this, RBC counts,
PCV and Hb concentration of the remaining pig 3785 rose
sharply, reaching values of 7.06 x lO^litre, 0.40 and
13.7 g/dL respectively on day 51 and falling again slightly
before it was destroyed on day 56. From these figures,
it might be assumed that the drug had caused the red cell
picture to return to normal, but as the animal was severely
ill at this point, dehydration may have confused the re¬
sults .
When the derived red cell indices are considered, it
appears that there was no effect on MCH which could be
associated with adriamycin dosage, but MCV decreased after
each dose. There was little overall change in MCHC from
beginning to end of treatment in either animal, but there
was a decrease in MCV from 58.4 fl before treatment to
51.7 fl in 3785, and from 65.7 fl to 55.0 fl in 3786
Thrombocyte counts in both pigs increased rapidly
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with prednisolone therapy but were not affected by
2 mg/kg adriamycin. Counts ranged from 86 to 237 x
10^/litre in 3785 and from 160 to 239 x 10^/litre in
3786, but the fluctuations could not be attributed to
drug dosage.
Lower-dose pigs (lmg/kg)
Total WBC counts were lowest in both pigs at 7 days
after the first dose of adriamycin and at 5 days after
each subsequent dose (See Appendix II) Figure 18 clearly
shows the effect of dosing on absolute mononuclear cell
counts, particularly in pig 194. From day 40 onwards,
this animal appeared to be going through a leukaemic
phase of the disease, which was certainly controlled,
though not prevented, by three weekly dosing with adria¬
mycin. Only six doses are illustrated but the same
pattern was repeated after doses seven and eight in both
animals (See Appendix II).
Figure 18 also shows absolute neutrophil counts
of both pigs. As the results from the higher-dose
pigs showed, there was no consistent pattern which could
be attributed to dosing with adriamycin, but the counts
remained low throughout the treatment period, especially
towards the end of treatment. The lowest neutrophil
y
count was 0.8 x 10 /L, which was recorded 5 days after
the sixth dose in 194 and 6 days after the eighth dose
in 192. This depression of neutrophil counts was al¬
most certainly due to adriamycin.
After the last dose of adriamycin in 194, there was
 
a rapid increase in total white cell counts and this was
due to an increase in mononuclear cells.
The low-dose pigs were only mildly anaemic before
the start of dosing. RBC counts, PCV and Hb values
during treatment revealed no repeated effect which could
be interpreted as a result of adriamycin treatment.
Neither was there any overall worsening or improvement
in the red cell picture during the whole treatment period
in either animal (See Appendix II ). Though there were
fluctuations from week to week, these were more likely to
be manifestations of the state of activity of the disease.
They were more noticeable in 194 and the lower RBC counts,
PCV and Hb values were recorded between days 47 and 110,
a period which corresponds with the "leukaemic" phase
indicated by the white cell picture in this animal.
The same conclusions can be drawn from the calculated
values of MCV, MCHC and MCH.
After treatment was stopped, the pig which was left
alive showed a decrease in RBC counts, PCV and Hb, from
four weeks after the last dose until it was destroyed.
This corresponded with the clinical evidence of relapse
and rapid tumour growth during this period.
Thrombocyte counts were also unaffected by 1 mg/kg
adriamycin.Counts were within the range of values for
normal pigs before the start of treatment, for 15 weeks
during treatment in pig 192 and for 4 . weeks of treat-
9
ment in 194. Thereafter, low counts (< 100 x 10 /l)
were frequently obtained in both animals, but these low
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counts were almost always associated with severe clumping
of thrombocytes. Often this was due to delay in ob¬
taining the blood samples as the pigs grew larger and
more difficult to handle, but sometimes it occurred even
when there were no sampling problems. It is unlikely,
therefore, that these low counts were an indication of
thrombocytopenia (See Appendix II ).
S.G.O.T. - Higher dose pigs 3785 and 3786 only
See Table 44 , Appendix II.
Pretreatment levels of SGOT were higher than normal
particularly on days -15 and -9. However there was a
fall in both animals after prednisolone therapy. During
adriamycin therapy, SGOT levels stayed within the normal
range in 3786 until it died, but in 3785 by day 34, it
had risen to 119 iu/litre. At this time, though the
pig still looked normal, the serum was slightly yellow
and it was thought advisable to measure serum bilirubin.
It was also measured in 3786 for comparison and there was
little difference, both levels of bilirubin being on the
low side of the normal range. However, by day 41, the
SGOT level in 3785 was 210 iu/L, the pig was clinically
jaundiced and total serum bilirubin had risen to 73.9
pmol/1. Free and conjugated bilirubin were almost
equal (35.6 and 38.3 pmol/1 respectively). On day 48,
SGOT had fallen slightly to 149.3 iu/1, but total serum
bilirubin had risen to 208 pmol/1. Free bilirubin had
increased only slightly but conjugated bilirubin accounted
for 168.1 umol/1. By day 55, SGOT had risen again to
181 iu/1, and the serum was brown with a total bilirubin
level of 279 umol/1. The free bilirubin had risen to
110 umol/1 and conjugated bilirubin was unchanged at
169 umol/1.
On days 34 and 41 when SGOT was first found to be in¬
creased in pig 3785 serum glutamic pyruvic transaminase
(SGPT) was also measured, though it was too expensive to
carry out measurements of both of these enzymes routinely.
On day 34, when SGOT was 119.4 iu/1, SGPT was 83.4 iu/1.
On day 41, when SGOT was at the highest level measured,
210 iu/1, SGPT was only 42.2 iu/1, though this was still
higher than the normal range.
Blood Urea (See Tables 40 to 43 Appendix II).
Blood urea levels were within the normal range
throughout the experiment, except in pig 3785 which had
slightly elevated levels before treatment started, and at
the end of treatment, particularly on day 48, when it was
jaundiced.
Serum proteins - higher-dose pigs 3785 and 3786
See Table 45, Appendix II.
Changes in serum proteins in pig 3786 during treat¬
ment were slight. There were small increases in total
protein and albumin and a very small decrease in globulins.
In pig 3785, the most dramatic change was a progres¬
sive fall in serum albumin and in the albumin/globulin
ratio from day 34 to the end of treatment. This corres¬
ponded with the clinical loss of condition, appearance of
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jaundice, and raised SGOT and bilirubin levels. Globulins
fell at the start of treatment but rose markedly at the
end of treatment.
Serum Proteins - Low-dose pigs 192 and 194
During the course of treatment, in both 192 and 194,
serum albumin rose gradually from a fairly low level of
around 25g/L, to around 40 g/L in the week after the last
dose of adriamycin (See Appendix II). In the surviving
pig 194, it reached 49.4 g/L the following week, and then
fell again to 32.2 g/L as the animal's condition deterior¬
ated .
Total serum globulin was calculated as before by sub¬
traction of albumin from total protein measurements. There
were wide fluctuations in total globulin levels during the
treatment period, but these did not appear to be related
to adriamycin dosing. Pig 194 showed a marked rise in
serum globulin as it relapsed after the end of treatment
(See Appendix II, Table 46.)
The albumin/globulin ratio increased at the end of
the treatment period, especially in pig 194 in which it
was greater than unity from the 2nd week after the
sixth dose onwards. After the eighth dose in this
animal, it rose to a peak of 2.23, and then fell to 0.69
as it relapsed (See Appendix II.)
Post-Mortem Results
High-dose pigs - 2 mg/kg adriamycin
3786 castrated male
This was a well-developed, well nourished carcase.
The thymus was found in the neck as a narrow ribbon
of whitish-yellow small firm nodules. The thoracic
thymus was less distinct.
There was about 50 ml of clear fluid in the peri¬
cardial sac. The heart was small and the muscle flabby.
The right ventricle was 8 mm thick, the left ventricle
was 18 mm thick. The muscle and valves were normal.
The liver was uniformly slightly pale, pinkish-
brown in colour. On close inspection this was due to a
pale outlining of the lobules. There were no focal
lesions.
The edge of the spleen was bent over on to the parie¬
tal surface along one border and there were fibrous ad¬
hesions between the two surfaces of the spleen. Both
the hilar and non-hilar surfaces showed numerous 5-15 mm
sessile nodules. On cut surface, the spleen showed red
faintly lobulated tissue with indistinct 2 mm areas of
white pulp. The nodules were dark red/white mottled
and had a sharp border but no capsule. Some of the
larger nodules showed yellow dry central necrosis.
The surface of the duodenum was red and corrugated,
the mucosa being slightly thickened.
The small intestine was mostly empty. The wall
was flushed in some regions. In the ileum, the mucosa
was covered by an incomplete yellowish-brown fibrin cast.
It was corrugated and thickened up to 3 mm by white tissue
in the mucosa and submucosa, and in some places there were,
on cut surface, yellow ulcers penetrating down to the
muscle coat. The mesentery of the small intestine was
oedematous.
The caecum was full of rather fluid finely fibrous
material. The mucosa was greyish-brown in colour and
probably necrotic, but the wall was not markedly thick¬
ened. This reaction continued for the first coil of
the colon, but then the contents became more solid, the
mucosa was normal and pale in colour with occasional
brown plaque-like nodules, probably lymphoid masses.
There was marked submucosal oedema in the caecum, be¬
coming less in the colon, and there was marked oedema in
the serosal connective tissue between the coils of the
colon.
The lymph nodes showed a mottled pink and white or
fawn and white pattern, with no distinct cortex and medulla
on cut surface, and there was haemorrhage in some of them.
3785 - Castrated male
This was a very thin pig with sunken flanks, not
pot-bellied, and the bony prominences were very distinct.
There was marked yellow jaundice of the skin. There
were no subcutaneous petechiae when skinned.
There was only a small red translucent sheet in the
neck and anterior mediastinum at the site of the thymus.
The lungs were not quite fully expanded but there
were no focal lesions. The heart was rather small.
The right ventricle was very thin-walled (2 mm) dilated
with non-clotted blood. The left ventricle was rather
thin (10 mm). The valves and muscle colour were normal.
The major arteries were very jaundiced and the fat in the
coronary grooves was translucent, yellow and jelly-like.
The liver was very large. The borders were
slightly rounded, the lobulation distinct but the thick¬
ness of interlobular septae not excessive. The cut
surface showed congested lobules with prominent inter¬
lobular septae. The consistency of the surface and
cut surface was increased. The gall-bladder contained
only about 10 ml of clear pale yellow fluid but this ran
out into the small intestine lumen with gentle pressure,
indicating that the cause of jaundice was intrahepatic .
The dorsal end of the spleen showed a folding of
one edge on to the parietal surface where it was fixed
by fibrous tissue. The cut surface was deep red,
faintly nodular but with no clear cut white pulp. At
the dorsal end, there was a raised yellow 2-3 cm nodular
mass, which was roughly wedged-shaped on cut surface and
composed of dry yellow necrosis.
The stomach contained only a small amount of bile-
stained meal and fluid. The oesophageal region and
cardia were normal. The wall at the pylorus was thick¬
ened, on cut surface half muscle and half white, soft,
cellular submucosa.
The small intestine was normal. The large in¬
testine showed marked dilatation with the colon full of
normal faeces becoming very hard and dry covered with a
coat of mucus, suggesting some degree of gut stasis.
The fat round the viscera was atrophic, like trans¬
lucent jelly.
248
All the lymph nodes on cut surface showed a green
soft cellular tissue exuding fluid separated into lobules
by thin white trabeculae, no distinct cortex being visible,
except the mesenteric and colonic nodes which showed small
groups of white, soft,cellulart cortical nodules centrally.
The gastric lymph node showed red haemorrhagic tissue in
the centre.
The bone marrow of the femur was dark red and blood¬
like, and translucent i.e. congested serous atrophy.
Low-dose pigs - 1 mg/kg adriamycin
192 - female
This was a well-developed, well-nourished car¬
case .
Both ears showed scabs resulting from perivascular
injection of the drug.
The border of the right ear was curled over.
The nasal mucosa was congested but there was no
rhinitis. No ulceration was observed in the mouth.
The tonsils were slightly thickened and on cut surface
showed white lobulated tissue.
The thymus was of moderate size, both in the neck
and in the chest.
There was a moderate amount of serous fluid in all
three cavities but this may have been due to difficulty in
destroying the animal.
The diaphragmatic surface of the liver showed one
linear scratch 2 mm wide and 4 cm long not extending into
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the underlying tissue. The capsule was intact. There
were some ill-defined pale lobules scattered throughout
the surface and cut surface.
The kidneys showed a few 1-2 mm white nodules,
visible on the surface and cut surface of the cortex.
The capsules stripped easily.
The stomach showed an ill-defined shallow, dry,
yellow ulcer in a semi lunar shape, 3 cm long by 1 cm
wide, at the junction between the oesophageal region and
the fundus.
The duodenal mucosa was dull red with prominent folds.
The cut surface showed that the mucosa was thickened up
to 5 mm by creamy white firm cellular tissue.
The remainder of the small intestine was normal.
Peyer's patches were prominent due to a thickening of the
mucosa by white cellular tissue, often forming ridge¬
like patterns.
Lymphoid nodules in the large intestine were promin¬
ent. All lymph nodes showed a white/fawn, almost flat
field of firm tumour tissue with some lobulation but no
medulla, except in the iliac and prescapular lymph nodes
which had a 1 mm brown medulla. The gastric node showed
petechiation.
The spleen was grossly enlarged and its surface was
distorted by some degree of folding and by 2 cm sessile
nodules along the hilus. On cut surface the spleen was
red and cellular, exuding blood, showing lobulation but
no distinct white pulp. The nodular lesions were cellular
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with no white pulp. They had a distinct edge but no
capsule.
The ovaries showed multiple 2-4 mm clear cysts.
The bone marrow of the femur was reddish-pink and
floated heavily in formalin.
Low-dose pigs - 1 mg/kg adriamycin
194 - entire male
This was a well-developed but rather thin car¬
case .
The nose was bilaterally symmetrical, but with
Phloxine-Alcian Blue staining, however, there was a patchy
red colouration of the majority of the turbinate mucosal
surfaces indicating an abnormality in the mucosa (Done,
1976) .
The ears showed two 3 cm diameter scabs, one of
which on cut surface extended 5 mm down to the cartilage,
the result of the drug being injected outside the vein.
The thymus was composed of small white/fawn lobules
of cellular tissue.
Both ventricular walls of the heart were of equal
thickness, 2.5 cm, and were rather flabby. The lungs
showed no abnormality.
The liver was large and slightly friable, with dis¬
tinct lobulation. The periphery was pale.
The pole of one kidney showed a series of small
white scars depressing the surface, and extending towards
the medulla on cut surface. Otherwise the kidneys
showed no abnormality.
The spleen was large. The hilus showed some
1 - 2 cm sessile nodules. The cut surface was red
and cellular with ill-defined white pulp. The nodules
were white and cellular with discrete borders but no
capsule.
The stomach showed a broad crescent 3.5 cm x 6 cm
of green dry ulcerated slightly depressed lesion in the
oesophageal region. The wall under this was slightly
thickened by fibrous tissue. In the fundus there were
a few 1-2 mm x 5 mm long red ulcers.
The small intestine was normal but the mucous mem¬
brane of the duodenum and the Peyer1s patches of the
ileum were thicker than the rest. The large intestine
showed slight lymphoid follicular hyperplasia.
The bone marrow of the femur was red and cellular
throughout the whole of its length, with white cellular
foci - this tissue sank in formalin.
Only one testis was present, the other having been
removed. The testis was brown in colour on cut surface.
The head and body of the epididymis were larger than
normal and replaced by hard white cellular tissue.
All lymph nodes showed a flat field of fawn cel¬
lular tissue, except the prescapular, iliacs and pop¬
liteal which showed a 1 mm brown medulla and the splenic
which showed up to 4 mm of red medulla. The mesenteries
showed occasional cysts of 2 - 5 mm containing clear fluid.
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Relative weights of lymph nodes and organs
Table 35 shows the relative weights of lymph
nodes and organs of the treated animals compared with
those of three untreated normal pigs and 10 untreated
lymphosarcoma cases of similar ages.
In pig 3786, which died after two higher-dose
adriamycin treatments, the results show that the drug
did not reduce the relative weights of any node or organ
below the minimum value of the 10 untreated cases, with
the exception of the spleen.
In pig 3785, which had three treatments, the mesen¬
teric and colonic nodes were reduced to less than half
of the mean value for the 10 untreated cases. The
gastric and splenic nodes were reduced to well below
the minimum value of the untreated cases but were still
about 50 times larger than those of the normal pigs.
The bronchial nodes and spleen were also much reduced
in weight. The superficial nodes were not much af¬
fected. The liver was larger than in any of the un¬
treated cases and was more than four times larger than
the heaviest normal liver. The adrenals were also
large.
The relative weights of lymph nodes of 192 and 194
were similar to those of untreated cases, and, surpris¬
ingly those of 192 which was killed at the end of treat¬
ment, were larger than those of 194, which was allowed
to relapse. The thymus of 192 was more than twice as
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large as the mean value for untreated cases, and also

























































































































































































































































The higher dose level (2mg/kg) of adriamycin
appeared to be fairly effective in suppressing the tumour,
particularly in pig 3785. Shrinkage of lymph nodes,
as shown by the measurements of the superficial nodes and
the relative weights of nodes at autopsy, suggested that
a good remission might have been attained if it had been
possible to continue the experiment. However this dose
level was even more rapidly toxic in the lymphosarcoma tous
animals than it had been in the normal pigs, and the
sudden death of 3786 with necrotising enteritis was pro¬
bably a direct result of the therapy. The terminal
jaundice of 3785 raised the question of whether adria¬
mycin could be hepatotoxic in the pig. The predominance
of conjugated bilirubin on day 48 suggested an obstructive
cause of the jaundice. However at autopsy there was no
obstruction of the bile duct, therefore the obstruction
must have been within the liver. The rise in SGOT and
SGPT levels, though not dramatic, was likely to be due
to damage to liver cells. The gross appearance of
the liver indicated that the whole organ was involved„
Benjamin (1975) listed 11 side-effects of adriamycin
therapy in human patients, but hepatotoxicity was not
among them. Hepatopathy was reported after adriamycin
dosage in two patients by Kun and Camitta (1978), but
this occurred only after irradiation. The enhancing
effects of adriamycin on tissue damage after irradiation
has been documented by other authors. There was no
suggestion by Kun and Camitta (1978) that the hepato-
pathy was a direct effect of adriamycin.
It is recognised that liver dysfunction may in¬
crease markedly the other toxic effectsof adriamycin,
because it delays the metabolism and elimination of
the drug, resulting in prolonged and higher blood levels.
Elevation of serum bilirubin is the indication to de¬
crease the dose of adriamycin administered by 50% or
even 75% (Benjamin, 1975).
Pretreatment blood urea and SGOT levels were
slightly higher than the normal range in 3785, although
serum protein levels were normal, therefore it is pos¬
sible that liver function was already impaired e.g. due
to severe tumour infiltration, or previous toxic damage,
though the latter possibility was extremely unlikely.
If this were so, it is surprising that there were not
more marked adriamycin - induced effects on the red cell
picture, thrombocyte counts and gastro-intestinal tract
after the first two doses.
The results obtained from 192 and 194, which were
given 1 mg/kg adriamycin, suggest that this dose level
suppressed the tumour temporarily after each admini¬
stration but that the tumour recovered rapidly. How¬
ever, despite the fairly poor response both pigs re¬
mained very fit, and their growth rates were spectacular
for lymphosarcoma cases. As the normal pigs had shown
previously, this dose level was not associated with any
clinical signs of toxicity, until the unfortunate
intra-arterial injection of the fifth dose. The dis¬
astrous effects on the ear were similar to those occur¬
ring after perivenous extravasation. The effects of
this kind of accident in human patients were described
by Reilly, Neifeld and Rosenberg (1977) „ The tissue
damage caused by adriamycin may progress from painful
oedema and erythema to full-thickness skin necrosis,
often with involvement of underlying tissues such as
tendons and nerves, resulting in ulcers, which heal
slowly or not at all, and even joint contraction with
loss of function. They recommended immediate injection
of hydrocortisone and the application of ice packs to
the site, but it was felt that these measures would cause
the pig further distress as it very much resented hand¬
ling of the ear. Similar damage to pigs' ears was de¬
scribed by Van Vleet et al., (1979), caused by adriamycin
extravasation.
Both low-dose pigs had large ulcers in the oeso¬
phageal region of the stomach and 194 also had ulcers in
the fundus. These findings were not uncommon in older
lymphosarcoma cases and may not have been associated
with the treatment.
Adriamycin appeared to suppress the thymus in the
normal pigs. However, the large size of the thymus in
192 suggested that this effect was counteracted by the
effect on the tumour and the improvement in body condition.
The antitumour effect of the drug may not have been
dramatic, but it still suppressed the tumour at the end
of the treatment period of 150 days, therefore there was
no indication of resistance developing. Carter (1975)
quoted a short response duration in human lymphoma cases,
to whom adriamycin had been administered as a single
agent, but these were patients who had relapsed on con¬
ventional therapy. It would have been interesting to
use adriamycin in combination with other drugs in the
pigs, as it is now an accepted component of therapy pro¬
tocols for lymphoma in humans (See Introduction to this
Chapter). As a single agent, its toxicity made it im¬




Cyclophosphamide is the most commonly used example
of the group of antitumour drugs known as the alky¬
lating agents. Hill (1975) wroteadetailed review mono¬
graph about cyclophosphamide. In the introduction,
he stated that probably more individual doses of cyclo¬
phosphamide are given to cancer patients than any other
drug, due to the fact that this agent is effective
against more different types of human neoplastic disease
than any other chemotherapeutic compound. Since its
discovery, until 1975, it had been mentioned in 10,000
different publications, and at least 28 different names
have been applied to it in different parts of the world.
It was first synthesised by the German drug company
Asta-Werke (Arnold, Bourseaux and Brock, 1958).
The alkylating agents act by substituting alkyl
(R - CH2 - CH^} groups, usually for the hydrogen ions of
organic compounds. When one of these drugs enters a
cell, its side chains form covalent bonds with sites
on the DNA molecule causing cross-linking and breaks in
the molecule. The helix is either prevented from
dividing in mitosis, or if it does divide it may reunite
in an imperfect form. These effects result in cell
death. All rapidly dividing cells are affected and
the results resemble damage caused by ionising radiation
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It is a cell cycle non-specific agent, but tends to be more
active in S and G2 phases.
Cyclophosphamide is unusual in that it has little
or no activity by itself, and requires activation to an
alkylating metabolite by liver microsomes. It was in¬
tended to be a transport or "latent" form of the useful
but very toxic compound nitrogen mustard, which was the
first synthetic compound clearly shown to possess anti-
tumour activity in man (Hill, 1975). It was thought
that activation would occur selectively in tumours due
to the high levels of phosphoramidases present in some
tumour tissues, but in fact this does not occur, and
organs other than the liver appear to be incapable of
activating it.
The metabolic pathway of cyclophosphamide is thought
to be qualitatively identical in man and animals, and
the following was first proposed by Hill, Laster and
Struck (1972):
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Carboxyphosphamide and another fairly inactive
compound 4-ketocyclophosphamide are the major meta¬
bolites excreted in urine and to a small extent in bile,
along with unchanged parent drug. The metabolic
pathway described above is widely accepted as correct,
but there is still considerable controversy about the
intermediate metabolites and the exact mechanism of the
antitumour effect. Various authors, in a "Symposium
on the Metabolism and Mechanism of Action of Cyclophospha¬
mide", discussed this problem, e.g. Donelli, Bartosek,
Guaitani, Martini, Colombo, Pacciarini and Modica (1976).
The pharmacology of cyclophosphamide has been
studied in many species and was reviewed by Hill (1975).
Plasma levels and distribution studies, using radio-
labelled cyclophosphamide, have been carried out in the
rat, mouse, rabbit, dog, sheep, hamster and monkey, and
even in the nurse shark and various other kinds of fish,
lobster and protozoa.
In man, there is no binding of the parent drug
to plasma proteins, and the plasma disappearance curve
shows an initial rapid distribution phase and a second
slower phase representing metabolism and excretion
according to Bagley, Bostick and DeVita (1973) . The
half-life of intact plasma cyclophosphamide is 4 to
6.45 hours. These authors also stated that the rate
of metabolic activation may be affected by other drugs
(e.g. phenobarbital) given at the same time, depending
on their effects on liver microsomes, and even by
previous doses of cyclophosphamide. The antitumour
and toxic effects are not much affected, however, as they
appear to be independent of the rate of metabolic acti¬
vation, and are related to the dose administered.
Only minute concentrations of the drug are found
in the CSF.
Cyclophosphamide is known to have profound effects
on the lymphoid system of the body and it is mainly
because of this that it has been so successful as an
antilymphoma agent. The selective depletion of lym¬
phoid tissue in mice and guinea-pigs after dosing with
cyclophosphamide was well described in a histological
study by Turk and Poulter (1972). They stated that
depletion occurred from the lymph follicles, germinal
centres, the cortico-medullary junction in lymph nodes
and equivalent non thymus-dependent areas of the spleen.
After three massive dose injections on alternate days,
thymus-dependent areas still contained lymphocytes.
Total depletion of lymphocytes could only be produced
by neonatal thymectomy or anti-lymphocytic serum treat¬
ment along with cyclophosphamide. The animals were
killed 3 days after dosing, when the circulating small
lymphocyte count in the blood was at its lowest in both
species. Histologically the background of reticulum
cells was undisturbed, and mature plasma cells in the
medullary cords were unaffected. Whorl-like struct¬
ures of reticulum cells indicated where follicles or
germinal centres had been situated.
The mouse thymus showed depletion of lymphocytes
262.
from the cortex only, following a single dose. In the guinea
pig, three doses were required for this to occur. Three
doses in the mouse caused progressive depletion from the
medulla also.
Wagner, Chanana, Cottier, Cronkite, Gassmann, Joel
and Laissue (1976) described the effects of two dose
levels of cyclophosphamide on the thoracic duct lympho¬
cytes and blood white cells in calves. They decided that
there were four phases of effect on thoracic duct lympho¬
cytes : -
Phase I - initial damage with a decrease in output, es¬
pecially of large lymphocytes, lasting 8 to
10 hours.
Phase 2 - an intermediate post-damage recovery phase
lasting at least 10 hours.
Phase 3 - recovery, with overshoot of large thoracic
duct lymphocytes and a decrease in output of
small thoracic duct lymphocytes (larger
dose) and an obvious decrease in blood
neutrophil counts, lasting from the 2nd to
the 6th day.
Phase 4 - Stabilization of thoracic duct lymphocyte
and blood counts.
They concluded by deducing that "cyclophosphamide may
affect the mechanisms controlling the production of B -
lymphocytes".
This conclusion was also reached by Anderson, Binns,
Symons and Escajadillo (1974) after they injected
cyclophosphamide into 8-day-old piglets and studied
lymphoid tissues histologically, indicator cell adherence
to lymphoid tissue and surface markers of blood lympho¬
cytes.
However, Milton, Carpenter and Addison (1976)
presented evidence that cyclophosphamide also affects T-
lymphocyte activity in mice. They found that it de¬
pressed various T-cell activities in vitro, such as the
proliferative response to phytohaemagglutinin, which
fell to about 10% of normal. Skin-graft survival, an
in vivo test of T-cell activity, was only mildly affected,
and the prolongation of graft survival only occurred if
the test was carried out soon after cyclophosphamide
treatment.
In conclusion, the authors emphasised the possibility
that measurements of T-cell activity may be dependent on
the cell origin (e.g. spleen or lymph node) culture
conditions, species, and, in vivo, the effects of inter¬
actions between T cells, B cells and macrophages.
In man, cyclophosphamide has been widely used in
the therapy of neoplastic diseases of many kinds and
also in non-neoplastic diseases such as rheumatoid
arthritis and nephrotic syndrome in children. It is a
powerful immunosuppressant and has been used to prevent
rejection of transplanted organs. However, like most
anticancer drugs, it has severe toxic side-effects.
The most important side-effect in man is bone
marrow suppression, especially of the white cell series.
This was well described by Bergsagel, Robertson and
Hasselback (1968) and Buckner, Rudolph, Fefer, Clift,
Epstein, Funk, Neiman, Slichter, Storb and Thomas (1972).
White cell counts reach a nadir at 9 to 12 days after
dosing and then recover during the next 7 days. Platelet
counts may also be depressed, though usually only with
large doses. Bergsagel et al., (1968) did not find
significant changes in blood Hb value with any of the
dose levels they used. Other rapidly dividing cells,
such as those of the gastro-intestinal mucosa and hair
roots, may be affected, therefore vomiting and alopecia
are common in humans.
Severe damage to the bladder wall, oedema, necrosis,
haemorrhage, hyperplasia and fibrosis, is an important
side-effect of cyclophosphamide and its analogues. It
is thought to be associated with renal excretion of high
concentrations of active metabolites,particularly acro¬
lein, and was first investigated in rats and dogs by
Phillips, Sternberg, Cronin and Vidal (1961). This
side-effect has caused serious problems for patients and
may even be fatal (Spechter, Bauer, Muller and Traut 1965)
After methods of preventing cystitis were recognised, re¬
commendations were made that patients should receive a
high fluid intake before and during therapy (Leading
article British Medical Journal, 1971). Unless very
large doses are administered, bladder toxicity is usually
avoided if this is carried out. Renal damage has also
been reported (Spechter, et al., 1965) and is especially
likely if there is pre-existing abnormality of the kidneys
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Severe cardiac toxicity was also reported by
Buckner et al. (1972) in patients given high doses of
cyclophosphamide. This effect was studied in dogs by
O'Connell and Berenbaum (1974), who found that doses
equivalent to 250 mg/kg caused severe myocardial damage
and pulmonary oedema, and death occurred with a few hours
of dosing.
Liver damage appears to be mild, if it occurs at
all (Hill, 1975).
Cyclophosphamide is mutagenic, and carcinogenic.
It causes sterility, and is teratogenic. Ashby, Davis
Penn and Upshall
Dewhurst, Espina^(L976) investigated the latter effect in
rats. They stated that the teratogenic effect was a
function of the whole cyclophosphamide molecule as analogues
were not teratogenic even at four times the dose. It
was due to the alkylating effect, but, since the embryo
was thought to be incapable of converting the drug, they
suggested that the effect was mediated through the dam,
possibly as a result of altered materno-foetal exchange.
Greenberg and Tanaka (1964) reported human congenital
anomalies probably induced by cyclophosphamide.
The haematological and immunological effects of
the drug in many species were summarised by Hill (1975).
Biochemical effects of the drug have been recognised
in vitro, in animals and in humans (Hill, 1975). Serum
enzymes known to be affected in humans and other species
are lactate dehydrogenase, alkaline phosphatase and
glutamic-oxaloacetic, glutamic-pyruvic and other trans¬
aminases, which are elevated, and glucose-6-phosphate
dehydrogenase, malate dehydrogenase and cholinesterase,
which are lowered.
The earliest reports of studies using cyclophos¬
phamide were those of Brock and Wilmanns (1958) who in¬
vestigated the toxicity and therapeutic effect of the
drug in rats with Yoshida sarcoma, Jensen sarcoma and
Walker carcinoma, and Gross and Lambers (1958a and b)
who reported the first clinical trial of cyclophosphamide
in humans with various types of cancer. They treated
five cases of lymphosarcoma, of which four had a good
response and one a partial response, and found the only
toxic effects to be slight depression of granulocyte
counts, and nausea, loss of appetite and vomiting.
Coggins, Ravdin and Eisman (1959) reported on a clinical
trial in America in patients with twenty different types
of tumour, including nine cases of lymphoma. Eight
cases completed therapy and antitumour effect was de¬
monstrated in five of these cases. Side-effects were
bone marrow depression, nausea, vomiting, alopecia,
(which began about 20 days after the initiation of
therapy, with regrowth occurring within 6 to 8 weeks),
and sterile cystitis, symptoms of which appeared within
48 hours after a single large dose and lasted 4 to 5
days.
Since then,despite the problems associated with
its use, cyclophosphamide has won an undisputed place in
cancer chemotherapy. It is administered either orally
or, more commonly, intravenously. Several different
dosage schedules have been tried. In the early
1960 s, it was more often administered daily after a
loading dose, or as in the trial reported by Carbone,
Spurr, Schneiderman, Scotto, Holland and Schnider
(1968) in non-Hodgkin's lymphoma cases. The complete
remission rate in this study was 11% with a duration of
22 weeks, and a total response rate of 68%. Only
53% of their patients survived for 1 year. Bergsagel,
et al., (1968) showed that giving the drug in large
intermittent intravenous doses, with 3 or 4 weeks between
was a more successful approach in advanced lung cancer,
and Mendelson, Block and Serpick (1970) tried large in¬
termittent doses in lymphoma cases. They reported
5 out of 19 complete remissions (26%), and several
partial remissions. Jones, Rosenberg, Kaplan, Kadin
and Dorfman (1972) used cyclophosphamide as a single
agent in non-Hodgkin's lymphoma, making use of the
Rappaport classification, and found that in diffuse
poorly-differentiated lymphocytic lymphoma they had a
complete remission rate of 22% and a partial remission
rate of 45%. O'Connell, Wiernik and Sutherland (1976)
published a long-term follow-up of non-Hodgkin1s lym¬
phoma patients given high-dose intermittent intravenous
cyclophosphamide. There were complete remissions in
5 out of 17 patients, but according to the Rappaport
Classification, all of the complete responders had
nodular lymphomas. All the diffuse cases showed anti-







complete responders were "cured" of their lymphomas.
The therapy of the lymphomas was greatly improved
by the discovery that combinations of drugs could be
used to increase antitumour effect, and cyclophospha¬
mide has become an important component of combined
drug schedules for non-Hodgkin's lymphomas. Cyclo¬
phosphamide, vincristine and prednisolone have been the
most commonly used combination. Early reports of
this type of therapy were those by Hoogstraten, Owens,
Lenhard, Glidewell, Leone, Olson, Harley, Townsend,
Miller and Spurr (1969), Luce, Gamble, Wilson, Monto,
Isaacs, Palmer, Coltman, Hewlett, Gehan and Frei (1971)
and Bagley, DeVita, Berard and Canellos (1972). Since
then, many reports using this and other combinations
have been published. There are those who believe that
single agent therapy may still have a place in the
treatment of non-Hodgkin1s lymphomas if the patient has
a histological type which has a favourable prognosis
(Glatstein, Donaldson, Rosenberg and Kaplan, 1977).
However Kennedy, Bloomfield, Kiang, Vosika, Peterson
and Theologides (1978) disagreed.
Bearing in mind the information gained from the
literature, trials were designed to investigate the
effects of cyclophosphamide in normal and lymphosarcomatous
pigs.
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THE EFFECTS OF CYCLOPHOSPHAMIDE IN NORMAL PIGS
MATERIALS AND METHODS
This was a short-term experiment, extending to
only 2 doses per pig, as no cumulative toxicity was
expected.
Ten pigs (5 castrated males and 5 females) were
used. They were from two litters both sired by the
same boar and born on the same day. The sire and
both dams were all from non-carrier lines of the lympho¬
sarcoma strain.
As before, the pigs were allocated by lot to four
groups as follows but were housed in a single pen.
Pig No. 407 ) GROUP A LOW DOSE
Pig No. 415 ) First dose 20mg/kg, second dose 40mg/kg
Pig No. 404 ) GROUP B MEDIUM DOSE
Pig No. 416 ) First dose 30mg/kg, second dose 60mg/kg
Pig No. 402 ) GROUP C HIGH DOSE
Pig No. 412 ) First dose 40mg/kg, second dose 80mg/kg
Pig Nos. 405,)GROUP D CONTROLS
409, 411, 414)
The control animals were given saline, equal in
volume to the medium dose of cyclophosphamide.
At 9 weeks of age, all 10 piys were sensitised to
DNFB, and they were skin-tested a fortnight later
(14 days before the first dose). At this time weekly
weighing and blood sampling for WBC, RBC, PCV, Hb
differential and thrombocyte counts and blood urea
estimation were commenced. On days -7 and 0 serum
alkaline phosphatase, total protein and albumin
estimations were also carried out. The pigs were
observed daily in the pen for appetite, general fit¬
ness and state of urine and faeces. A detailed
clinical examination, including rectal temperature,
condition of visible mucous membranes, and auscult¬
ation of heart and lungs, were also carried out on each
animal once weekly, from 11 weeks of age.
The preparation used was "Endoxana" (Ward-
Blenkinsop, Bracknell). The drug was dissolved in
water at a concentration of 20 mg/ml as soon as poss¬
ible before dosing, as the solution has to be used
within 2 hours. The powder dissolved slowly and
required shaking.
The drug was administered intravenously on two
occasions, 18 days apart. As described in Chapter II
the pigs were tranquillised for dosing with 4% azaperone
intramuscularly, and the technique of intravenous dosing
was as described previously (see page 195). Although
the drug was not irritant, tranquillisation was still
required because of the large volume of liquid being
slowly injected.
During the treatment period, weekly weighing and
clinical examinations were continued. The pigs were
blood-sampled more frequently. The first dose was
on day 0 and the second on day 18. Complete blood
picture, blood serum alkaline phosphatase, and serum
total protein and albumin were measured on days 7, 14,
21, and after treatment was stopped, on days 28, 35
and 42. In addition, haematology samples, for WBC
counts, differential counts and PCV, were taken on
days 1, 2, 3, 4, 5 and 6 after the first dose, and on
days 21, 22, 23 and 24 after the second dose. Addit¬
ional alkaline phosphatase estimations were carried out
on serum samples on days 1 and 2.
By recording these results it was hoped to detect
evidence of bone marrow depression, urinary tract
damage or liver damage, if these toxic side-effects
occurred. Different, or more frequent, serum enzyme
estimations might have given more complete information
but the cost of performing them was prohibitive.
DNFB skin tests were repeated on day 22. Due
to unforeseen circumstances, it proved necessary to
destroy two of the control pigs before skin tests
could be carried out.
When it was considered that effects of the second
cyclophosphamide dose would be most marked, two of the
four control pigs and one pig from Group A, Group B
and Group C were killed by intravenous injection of 20%
pentobarbitone. The controls were killed on day 22,
the Groups B and C pigs on day 23 and the Group A pig




The remaining pigs were given no further treat¬
ment. Weekly clinical examinations were continued
and another skin test was carried out on day 43. By
this time, all effects of the drug had apparently
disappeared and these pigs were destroyed and autopsied
on days 44 and 45.
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RESULTS
Clinical Examinations (For clinical records, see
Appendix III) .
Thoughout the experiment, all the pigs remained
fit with excellent appetites. Rectal temperatures
stayed within the normal range, below 40°C. Faeces
and urine appeared normal, though urine was not
sampled for detailed examination. Fighting was a
problem in this group of animals, resulting in small
cuts, abrasions and contusions. Pigs 402 and 405
developed severe bursitis on the posterior aspect of
the tarsi, pig 416 had a bitten tail, pig 415 had a
bruised abdomen and a damaged hoof and pig 411 de¬
veloped cellulitis 6f the left hind leg and a swollen
lower lip which required an intramuscular injection
of benzathine penicillin. These injuries occurred
before the pigs were dosed with cyclophosphamide as
well as after, and there was no evidence that those
given cyclophosphamide suffered any more than the
control animals. Before the start of dosing, it was
observed that pig 407 had a loud heart murmur suggestive
of a patent ductus arteriosus. The animal was
clinically normal, and although it tended to become
dyspnoeic when forced to exercise, it was not incon¬
venienced by its condition, which did not worsen during
the course of the experiment. This animal was one of
the pair given the lowest dose level of cyclophosphamide.
274.
The only pig to show any clinical sign which may
have been related to cyclophosphamide dosage was one
of the high-dose pair, 412. Two weeks after the
second dose of the drug (80 mg/kg) the skin and
mucous membranes of this animal were noticeably paler
than those of the other groups which were left alive.
The other pig in this group had already been destroyed
by this time.
There was no indication in any of the treated
pigs of alopecia or foot lesions.
In a short term experiment such as this it was
unlikely that there would be any noticeable effect on
weight gains. However the results in Table 36












































































































































































It can be seen from Table 37 that the two control
pigs which were tested, and the low-dose pair, had end
of treatment reaction scores which were the same as, or
greater than, the pretreatment results. However,
all four medium and high-dose animals had lower response
scores after treatment than pretreatment.
In the test carried out 3h weeks after the last
dose, one control had a slightly reduced response, while
the other control's reaction was as severe as on the
previous occasion. The low-dose pig had a slightly
increased response, the medium-dose pig's reaction was
the same as that recorded at the end of treatment, and
the high-dose animal had a reaction score which was
higher than its end of treatment score, but the same as
its pretreatment score.
It would appear, therefore, that treatment with
cyclophosphamide temporarily depressed skin hyper¬
sensitivity reactions in the medium and high-dose
groups.
Haematology
Cyclophosphamide produced a pronounced effect on
total WBC counts (See Appendix hi ). Figure 19
shows the effect clearly, comparing mean counts of the
pigs in the high dose group with mean counts of the
saline treated controls. Mean total WBC counts and
mean absolute counts of total neutrophils, lymphocytes
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GROUPC 12.5+0.8 8.5+2.4 11.9+6.5
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deviations are shown on the graph where they do not
confuse the picture, otherwise see Table 38.
In all the cyclophosphamide-treated animals there
was a depression of WBC counts after each dose, the
lowest counts being obtained on the 4th or 5th day
after dosing. There was a rapid recovery, and by
14 days after dosing, the counts of the treated pigs
were similar to, or higher than, the mean counts of
the controls. Table 38 shows that the three types
of white cell were all affected, but neutrophils were
most severely depressed. At 5 days after dosing,
pigs which were given 40mg/kg, or more, had so few
neutrophils, that it became very difficult to find any
at all on the blood smear when performing a differential
count. Neutrophil counts in Group A and B pigs,
given 20 and 30 mg/kg, were not quite so severely de¬
pressed, but at 5 days the counts were too low to give
any clear indication of a dose-related effect.
When the mean lymphocyte counts are examined, the
effects are more complex. After the first dose,
lymphocyte counts in all pigs were depressed but not to
the same extent as the neutrophils. The nadir in the
low-dose pigs was at 4 days, in the medium-dose pigs
at 3 days and in the high-dose pigs at 5 days, although
the latter group had low lymphocyte counts on day 3
also. After the second dose, in the low-dose animals,
the nadir in the lymphocyte counts was 3 days later,
though the counts at 4 and 5 days were also low. In
the medium-dose pigs, the mean counts 3 and 5 days
after dosing were lower than at 4 days with the nadir
at 5 days, and in the pigs which received the highest
dose of all, the same pattern occurred with the nadir
at 3 days. The slight increase in the counts at 4
days after dosing is also apparent when the figures
for individual pigs are examined. (See Appendix III ).
The effect of cyclophosphamide on the lymphocytes was
clearly dose-related, the lowest counts being recorded
in the pigs receiving the highest dose (Table 38 ) .
Mean monocyte counts in the treated pigs also ap¬
peared to be depressed, particularly on the 3rd day afte
dosing, and from the 5th to the 7th day, counts higher
than those of the controls were obtained. However
because of the small numbers of monocytes counted nor¬
mally, it was difficult to assess the meaning of the
latter observation.
Mean values of RBC counts, Hb, PCV and MCV (See
Appendix III for individual results) in the high-dose
group compared with those of the controls are shown in
Figure 20A 3.nd 2.0B. Mean values - ISD of RBC counts
Hb, PCV, MCV, MCHC and MCH in all groups are shown in
Table 39. In all the treated groups, cyclophospha¬
mide, caused a depression in RBC counts, PCV and Hb,
though in the low-dose group it was very mild. Only
PCV was measured daily after dosing and these figures
indicate that the maximum depression occurred at 6 days
after both the first and second doses, apart from the
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0.27 0.28 0.35 0.35 34.3+0.6 34.8+0.5 35.0+0.1 35.6+0.4 33.3+0.6 33*9+0.5 34.6 33.0 34.0
12.9+0.4 12.7+0.4 11.9+0.5 12.0+0.6 12.7+0.4 12.5+0.6 MCH-EANS+ 16.5+0.7 16.4+0.8 16.5+0.7 16.2+0.8 15.7+0.6
15*8;+0.3 16.6+1.1 16.6+0.1 17.1+1.5
PCV at 10 days after the second dose. The only pig
to show clinical anaemia was the high-dose animal 412,
during the 2nd week after the 80 mg/kg dose. The
figures from this animal on day 28 (See Appendix III
Table 29 ) show that this observation was valid but the
anaemia was not severe and recovery was rapid.
Mean MCHC values in all groups were similar to
those of the controls and only the high-dose pig 412
showed a change in MCV and MCH. This was a marked
increase which was calculated from the figures obtained
on day 35, 17 days after the second dose.
Mean thrombocyte counts - 1 S.D. in the treated
animals and in the controls are shown in Table 40 .
Counts in the treated animals, especially those in the
high-dose pair, were slightly lower than counts in the
control group, at 7 days after the first dose and at
7 and 10 days after the second dose, but none of the
treated animals was ever dangerously thrombocytopenic.
TABLE40















































































































See Table 31 Appendix III for values in in¬
dividual animals.
There was considerable variation in the levels
of S.A.P. between animals, but all figures obtained
were within the normal range or slightly below normal.
One animal in each treated group, numbers 402,
404 and 407, showed a slight rise 1 day after the first
dose of cyclophosphamide. Pig 404, which received
a medium dose had another slight increase on day 2.
Low levels were recorded 3 days after the second dose,
but levels in the treated groups were similar to those
in the control group.
Blood Urea (See Appendix III Tables 21 to30)
Blood urea measurements in the treated pigs showed
no differences from those in the control pigs, which
could be attributed to the treatment. All urea re¬
sults, before, during and after treatment, were within
the normal range.
Serum Proteins (See Appendix III Table 32 )
Total protein and albumin were measured from
serum as previously described, and total serum globulin
levels were calculated. Means ^ 1 S.D. of albumin
and globulins are shown in Table 41.
Serum albumin rose in all the groups on day 7 and
fell again by day 14. There was a pronounced de¬
crease in the high-dose group (C), on day 14. There
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200.
dose on day 21. This also happened in the control
animals and so it may not have been related to the
treatment.
There was a rise in serum globulins in the high-
dose group on day 14, corresponding to the fall in
albumin, but otherwise there were no differences in
globulins between groups which could be attributed to
the treatment. There was an increase in globulins
in all groups on day 21.
Post-Mortem Findings
409 - Control
The carcase and viscera of this animal were normal.
The spleen was small and the cut surface exuded blood
1 mm white pulp nodules visible.
The thymus was large with pale fawn soft lobules.
The prescapular lymph nodes were fawn in colour.
The inguinal nodes showed half-and-half pale fawn
cortex and darker medulla, as did the popliteals.
The iliac lymph nodes had 25% cortex and 75%
medulla.
The mesenteric nodes showed 5 mm white nodular
cortex surrounded by 1 mm fawn or red medulla.
The gastrics had 5 mm white cortex surrounded by
1 mm pale fawn medulla.
Other lymph nodes showed pale fawn colouration
with an ill-defined slightly darker medulla.
411 - Control
This animal was normal in carcase and viscera.
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The spleen was of moderate size and on cut surface
showed 1 mm white pulp nodules in a red engorged back¬
ground .
The thymus was large and composed of pale soft
lobules.
The bronchial lymph nodes were large with 4 mm
white cortical nodules and 4 mm pink medulla.
The iliacs and inguinals showed a dark brown 1 mm
medulla around 3 mm white cortical nodules.
All other lymph nodes showed 3 mm white nodular
cortex surrounded by 1 mm fawn medulla.
405 - Control
This animal was normal in carcase and viscera.
The bone marrow at the ends of the fat in the shaft
of the femur showed slight red activity. It was similar
to 414 (See below).
414 - Control
The carcase and viscera of this animal were normal.
The femoral bone marrow showed slight red activity
at the ends of the fat in the shaft.
The popliteal, inguinal and iliac lymph nodes
showed dark brown medulla, and the prescapular showed
some haemorrhage and some white nodules, possibly as¬
sociated with blood-sampling shortly before death.
407 - Low Dose
This was an anatomically normal carcase
except for the heart. The ductus arteriosus
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was 4 mm in diameter, short in length with roughened
lining but there was no blood coagulum filling it.
The foramen ovale showed a 1 cm diameter patency and
the valve flaps did not completely cover it. The
lungs were normal. The liver showed a slight diffuse
pallor but lobulation and consistency were normal.
The spleen was small and on cut surface was red
with blood but no white pulp was visible.
The bladder mucous membrane was slightly nodular
and oedematous, with small petechiae scattered all over
it.
The thymus lobules were large, pale and soft.
All lymph nodes showed 3 to 4 mm white cortical
nodules surrounded by 1 to 2 mm pink/brown medulla, ex¬
cept for the popliteals which were mainly white with
only a trace of brown, the iliacs which showed half and
half white cortex and dark brown medulla, and the in-
guinals mesenteries, gastrics, prescapular and bronchia
which had 2 to 3 mm white cortical nodules with 1 mm
brown medulla.
The bone marrow of the femur was normal.
415 - Low Dose
The carcase and viscera of this animal were normal
The bladder showed no abnormality.
The spleen showed much blood on cut surface, which
was red with no white pulp visible.
The thymus was composed of fawn large lobules,
fairly firm in consistency.
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All lymph nodes showed 3 to 4 mm white cortex
surrounded by a hint of medulla, which was slightly
wider and darker in colour in the popliteal, iliac and
inguinal lymph nodes.
The bone marrow of the femur showed fat throughout
the shaft.
416 - Medium Dose
This was a well-developed, well-nourished anato¬
mically normal carcase.
The liver showed a slight diffuse pallor but the
consistency and lobulation were normal.
The bladder was full but normal.
The spleen was small and the cut surface was red,
showing no visible white pulp.
The thymus showed moderate-sized lobules which were
soft and pale fawn/white in colour.
All lymph nodes showed half-and-half fawn medulla
and white cortex, except for the bronchials which showed
1 mm white nodules surrounded by 3 mm red medulla, the
iliacs which had 1 mm white cortex surrounded by 2 mm
fawn/brown medulla, the inguinals and popliteals which
had 3 to 4 mm white cortex surrounded by 1 to 2 mm
dark brown medulla, the mesenteries and colonics which
showed 1 to 2 mm white cortex on a pink/buff background,
and the gastrics which showed 2 mm white nodules with
1 mm fawn medulla.
The bone marrow of the femur was normal.
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404 - Medium Dose
This was an anatomically normal carcase, similar
to 412.
The iliac, inguinal and popliteal lymph nodes
showed a 1 mm dark brown medulla.
The femoral marrow showed a little pink activity
at each end of the fat in the shaft.
402 - High Dose
This was a well-developed, well-nourished carcase
and was anatomically normal.
The liver showed a slight diffuse pallor but there
was no change in consistency or degree of lobulation.
The bladder was full but normal.
The spleen was small with no white pulp visible on
cut surface.
The thymus was white and soft in consistency and
the lobules were small.
All lymph nodes showed white trabeculae surrounded
by 1 to 3 mm pink or white cortical nodules surrounded
by a 1 to 2 mm pink, fawn or brown medulla.
The bone marrow of the femur was fatty.
412 - High Dose
This was an anatomically normal carcase.
The pancreas was slightly browner than normal.
The spleen was red and on cut surface showed no
visible white pulp. The lateral border was folded
backwards onto the non-hilar surface but was not adherent
to it.
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The bladder was normal.
The ovaries showed many small Graafian follicles
but the uterus was small and inactive.
The thymus was of moderate size, the lobules
pale but slightly firmer than normal.
All carcase lymph nodes showed white/fawn 3 to
4 mm cortical nodules with a hint of darker fawn medulla
round about.
The marrow of the femur was fatty throughout the
whole of its length.
Lymph Node and Organ Weights
See Appendix III for absolute weights in grams.
Table 42 shows the effects of cyclophosphamide on re¬
lative weights of lymph nodes and organs (cg/kg). At
the end of the treatment period, the most noticeable
effect was a moderate decrease in the weights of the
thymuses of the treated pigs (mean of 90.6 - 4.2
compared with 142 - 41 in the two control pigs).
Lymph node weights in the treated pigs were only mar¬
ginally less than in the controls.
At the end of the experiment, the thymus in the
low dose pig (415) was involuted, but the thymuses of
the other two treated pigs appeared to be much larger
than those of the controls. The mean thymus weight
in all three treated pigs was 153 - 76.6 compared with
119.5 - 24.7 in the controls, but the high and medium
dose pigs had relative thymus weights of 221 and 168.
Lymph node and other organ weights in the treated pigs
were similar to those of the controls.
TABLE42









































































































































































































The results of this experiment were surprising
because of the lack of severe toxicity compared with
the effects of the drug in man (See Introduction to
this chapter), and those described by Lee, Castles and
Kintner (1973). Their trial was one of the most re¬
levant to the use of the drug in man and investigated
the toxicity of various single doses of cyclophospha¬
mide in dogs and monkeys. Dogs were more severely
affected by the drug than monkeys. In the dog,
single intravenous doses of 2.5 mg/kg were non-toxic,
apart from mild haematological changes. A dose of
2 0 mg/kg caused serious changes and lesions, and 40 mg/
kg was lethal. Toxic signs were emesis, bloody
diarrhoea, haematuria, excessive salivation, poor ap¬
petite or anorexia and weight loss, with leucopenia
thrombocytopenia, reticulocytopenia, decreases in haem-
atocrit and haemoglobin values and changes in blood
chemistry. At autopsy, lesions included degenerative
and inflammatory changes in the intestinal tract, hae-
morrhagic cystitis, lymphoid tissue destruction and
bone marrow depression. In the monkey, 2.5 mg/kg
caused mild haematological changes only, but 80 mg/kg,
though it caused serious effects, was not lethal.
Similar changes to those observed in dogs occurred but
were less severe. In addition, the monkeys exhibited
alopecia. Cystitis occurred in two monkeys, one of
which was given only 10 mg/kg. Leucopenia occurred
in both species within 1 week of dosing. Relative
organ weights of treated and control animals were
given, but lymph node weights were not included.
In the treated pigs, the effects observed were
a decrease in weight gain at the highest dose level,
a temporary depression of skin hypersensitivity reactions
in the medium and high dose groups, a fall in white
cell counts at from 3 to 5 days after dosing, with a
particularly severe but temporary depression of neut¬
rophil counts, a fall in red cell parameters at 6 days
after dosing and a very slight reduction in thrombocyte
counts at 7 to 10 days.
The haematological effects were very similar to
those which have been recorded in other animals and in
man (Hill, 1975), though the nadir of WBC counts appears
to occur rather later in man at 9 to 12 days after
dosing (Bergsagel et crl. , 1968). Depression of
red cell parameters and thrombocyte counts do not
appear to be important features of the toxicity of
cyclophosphamide in man, however.The fact that cyclo¬
phosphamide causes alopecia may prove to be useful in
the sheep. The wool can be stripped off by hand
7 to 14 days after a carefully regulated dose (Homan,
Zendzian, Busey and Rail, 1969).
However, in the pigs there was no evidence of
alopecia or hoof changes. These might not have been
detected before the first half of the pigs were destroyed,
but would certainly have been visible in the remaining
pigs by the time they were destroyed. Such changes
were seen in pigs treated with the closely related
agent ifosfamide in more recent studies (unpublished
observations) by 3 weeks after dosing.
Serum alkaline phosphatase was only one of the
enzymes mentioned by Hill (1975) which is known to be
elevated by administration of cyclophosphamide. It was
shown to be elevated in rats, dogs and monkeys by Lee
et al., (1973) but although three out of the six treated
pigs showed a slight rise soon after dosing, the levels
of this enzyme stayed within the normal range.
Cyclophosphamide is known to be immunosuppressant,
and to cause depletion of B-lymphocytes in the pig
(Anderson et al., 1974) therefore it was expected that
levels of serum globulins would fall markedly. This
effect was not apparent at 3, 7 or 10 days after dosing,
though had it been possible to measure globulins daily,
a decrease might have been discovered. The increase
in globulins noted may have been a "rebound" effect,
though why there should have been a rise in all groups
on day 21 is difficult to explain. The albumin levels
on day 21 are very low, and any technical error in
measuring the levels of albumin would result in falsely
high calculated globulin levels.
Since urine samples were not taken, it was not
possible to detect mild temporary cystitis or, micro-
haematuria. However, only one pig (407) showed evidence
of abnormality in the bladder at post-mortem and this was
an animal which was given the lowest dose of cyclo-
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phosphamide. The absence of bladder abnormalities in the pigs
was disappointing, particularly as renal physiology in the pig
is considered to be very similar to man (Nielsen, Maaske and
Booth, 1966), but in the literature reports, summarised by Hill
(1975), the percentage of human patients developing cystitis
varied considerably, from 0.5% to 40%, and it has been recognised
that the occurrence of cystitis in man does not directly correlate
with dose level. One method of avoiding bladder toxicity in
human patients is to ensure a high fluid intake before and during
therapy. The pigs enjoyed playing with water, due to boredom,
and it was not possible to estimate how much water the experi¬
mental animals actually consumed. The effect of restricting
water intake was not investigated.
The metabolic pathway of cyclophosphamide is thought to be
qualitatively identical in man and animals (Hill, 1975). Never¬
theless, Hill's summary of the dose levels which are toxic in
different species suggests that there is much quantitative vari¬
ation. In mice, the single LD^q given intraperitoneally is
405mg/kg. In guinea-pigs, dosed intravenously, it is 40Qmg/kg,
but in rats, it is only 150 to 180mgAg and in rabbits 130mgAg¬
in dogs, the LD^ is 40mgAg/ but in monkeys 240mgAg is
described as a lethal dose. The maximum tolerated dose in man
is 27 to 41 mgAg (1 to 1.5 g/m ), therefore it appears that
the dog resembles man more closely than either the monkey or the
pig in this respect. It is interesting that the dog also ap¬
pears to be the species most prone to cyclophosphamide - induced
cystitis.
The effects on the thymus shown at post-mortem were
less pronounced than those noted with prednisolone (See
Chapter I) but were similar, with an "overshoot" after
treatment was stopped, in the medium and high dose animals
This finding, and the temporary depression of skin reac¬
tions to DNFB in these groups might suggest that T-cell
as well as B-cell activity may be affected by cyclopho¬
sphamide. However, as Milton et al., (1976) pointed
out, the complex interactions between T-cells and B-cells
make it difficult to assess what is a direct effect on
one cell population.
The very slight effect of the drug on relative lymph
node weights in the treated pigs probably did not re¬
flect the effects on the lymphocytes in these nodes, be¬
cause the framework of reticulum cells would be unaffected
Despite the lack of toxicity observed in this experi¬
ment, the relatively low dose level of 20mg/kg was chosen
for therapy of the lymphosarcoma cases, because of their




Animals and Pre-treatment Procedures
For the therapy trial, four pigs were used. All
were cases of lymphosarcoma which were diagnosed be¬
fore 8 weeks of age. Three were females from the
same litter, and the remaining pig was a younger en¬
tire male by the same sire. The dams of both
litters were closely related. By the age of 10
weeks, they had all been transferred from the breeding
unit to the experimental animal house. They were
then kept in isolation in individual pens and allowed
to become accustomed to their surroundings for several
weeks. Management was as described in "General
Methods". During this time, the pigs were sensitised
with DNFB.
After overnight starvation, they were anaesthe¬
tised and staging laparotomy was carried out as des¬
cribed on pages 81 to 83 in "Methods". The diagnosis
of lymphosarcoma was confirmed, and all four animals
had widespread abdominal tumour involvement, with
gross enlargement of mesenteric and gastric lymph
nodes, spleen and splenic lymph nodes. Invasion of
the liver was suspected, particularly in pig 420, be¬
cause of the large size of the organ and its pale mottled
appearance. A small piece of mesenteric lymph node
was removed for histopathology.and placed in 10%
formalin.
Weekly weighing and blood sampling for haematology
commenced in the three older animals from the date of
surgery 3 weeks before the start of treatment. The
operation was carried out only 10 days before the
start of treatment in the younger male, because of
dyspnoea under anaesthesia as a result of upper res¬
piratory tract infection, but weekly blood-sampling
was carried out on the same days as in the other three
animals. Clotted blood samples for estimation of
serum alkaline phosphatase, total protein and albumin,
were taken on days - 14, - 7 and 0 and blood urea was
measured from the haematology samples. Weekly de¬
tailed clinical examinations and recording of rectal
temperatures, abdominal and lymph node measurements
commenced at the same time. Fitness, appetite,
state of urine and faeces and any abnormal behaviour
were noted daily. If a pig was seen to be dull or
off food, the rectal temperature was recorded and a
detailed examination was carried out, so that sup¬
portive therapy could be administered promptly if re¬
quired .
Pretreatment skin tests were carried out 7 days
before the first dose of cyclophosphamide, except in
pig 420.
Treatment
As in the trial with normal pigs, the preparation
used was "Endoxana", and the drug was prepared for
injection as previously described. The dose level
used was 20 mg/kg in all four pigs.
The pigs were tranquillised and dosed as pre¬
viously described in the normal pig trial, on day
0, day 17 and day 37.
During the treatment period, weekly weighing
and clinical examinations were continued. The pigs
were blood sampled more frequently than during the
pretreatment period. Complete blood counts, urea,
serum alkaline phosphatase, total protein and albumin
were measured on days 7, 14, 21, 27, 34 and 41, and
weekly thereafter in pig 362, which remained alive.
In addition, haematology samples for WBC counts,
differential counts and PCV were taken on days 1, 2,
3, 4, 5 and 6 after the first dose, on day 22 after
the second dose and on days 42 and 43 after the third
dose. Additional alkaline phosphatase estimations
were carried out on serum samples on days 1 and 2.
DNFB skin tests were repeated on the day of the
first dose, as it was considered that effects on the
lymphoid system might develop rapidly, and again 19
days after the second dose.
When it was considered that the maximum effect
of the third dose of cyclophosphamide would be easily
demonstrated, two of the four pigs, 357 and 420, were
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destroyed, by pentobarbitone overdose, and autopsied.
Another laparotomy was carried out on pigs 359 and
362, so that effects of the drug on the tumour could
be assessed in all four pigs. It was intended that
these two animals should be left without treatment
until they relapsed. However pig 359 did not re¬
cover from the laparotomy, and so only one animal was
left alive.
It was finally destroyed nearly 8 weeks after the
last dose of cyclophosphamide. Weekly weighing,
clinical examinations and blood sampling were continued
during this time and another skin test was carried out
2 days before it was killed.
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RESULTS
Clinical Examinations (For clinical records, see
Appendix III)
Pig No. 357 This female had shown signs of
an attack of diarrhoea on the morning when staging
laparotomy was planned. The operation was uneventful,
but during the following day it vomited, and developed
severe diarrhoea with clots of blood and necrotic
debris being passed. It was treated with intramuscular
chloramphenicol and multivitamins with large doses of
kaolin by mouth. It became dehydrated and refused to
eat for a day, but gradually recovered, after being tempted
to eat with milk puddings and piglet creep. After 7
days it was eating normally and medication was changed
to neomycin by mouth for 5 days. It had become very
thin, but began to regain lost condition slowly as its
appetite improved, and during the treatment period it
remained well apart from a mild catarrhal conjunctivitis,
which was treated daily with topical application of
chloramphenicol ointment ( "Chloromycetin"- Parke Davis) .
Three days before the end of the treatment period,
it developed diarrhoea again, but this improved with
administration of neomycin in food.
Rectal temperatures stayed within the normal range
in this animal.
Pig No. 359 This female remained well, with a
good appetite, throughout the pretreatment and treatment
periods. Rectal temperatures were within the normal
range. Recovery from the first staging laparotomy
was uneventful, but after the second operation, it did
not recover its appetite as expected, and 5 days later
it started vomiting. It became very depressed and
dehydrated, though it drank a great deal. The rectal
temperature was 39.8°C initially but dropped to 37.5°C.
Normal abdominal sounds were audible posteriorly, but
only tinkling sounds of gas and fluid were audible in
the anterior of the abdomen. Intestinal obstruction
was suspected and the pig was reanaesthetised with
("Hypnodil", Janssen)
azaperone intramuscularly and metomidate/intravenously
to the required effect. The stomach was grossly
dilated almost filling the abdominal cavity and the
site of obstruction could not be identified, though
there were widespread peritoneal adhesions, and attempts
were made to break down some of these. The animal
recovered from the anaesthetic by the following morning
but there was no improvement in its condition, and so
it was destroyed on humane grounds in extremis.
Pig No. 362 - This female remained well with a
good appetite throughout the pretreatment and treatment
periods. Rectal temperatures were within the normal
range. Like 359, it underwent two staging laparoto¬
mies, and recovery from both operations was uneventful.
Three weeks after the second operation, the pig developed
severe diarrhoea and its rectal temperature rose to
41.0°C. It was given intramuscular injections of
oxytetracycline for 3 days, followed by neomycin in
food for 5 days. It improved rapidly and remained
well until it was destroyed at the end of the experiment.
By this time, however, it was beginning to lose con¬
dition and had developed the typical "pot-bellied"
appearance of an advanced lymphosarcoma case. See Plates 18 to 23.
Pig No. 420 - This male was already in poor
condition as a result of the tumour at the commencement
of the experiment. Staging laparotomy was delayed
because of dyspnoea under anaesthesia due to upper re¬
spiratory tract infection, and was carried out only 10
days before the start of treatment. Three days after
the operation, during which it ate little and passed no
faeces, it started vomiting repeatedly. No bowel
movements were heard on auscultation of the abdomen.
Intestinal tract obstruction was suspected and the pig
was reanaesthetised with azaperone intramuscularly and
metomidate intravenously, to effect. When the abdomen
was reopened at the same site, severe fibrinous adhesions
were discovered. Part of the small intestine was ad¬
herent to the laparotomy incision, and it appeared that
this was the site of obstruction. The adhesions were
broken down and the wound resutured. Intramuscular
ampicillin was administered for 3 days, and recovery
was rapid with a return of normal appetite.
The pig remained well during therapy until 5 days
after the second dose of cyclophosphamide when it de¬
veloped a severe attack of diarrhoea. It did not lose
its appetite and was treated orally with neomycin for 5
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days, and kaolin. The faeces became more normal with
this treatment, but from this time until it was destroyed
at the end of treatment, it did not seem as lively as
the others and its appetite was not as good as it had
been earlier in the experiment. Its rectal temper¬
ature stayed within the normal range throughout the
pre-treatment and treatment periods.
From Table 43, it can be seen that there was a
shrinkage of the inguinal and precrural lymph nodes
in the 1st week after the first dose in pigs 359 and
362, after the second dose in all four pigs, and after
the third dose in pig 359 but not 362. The greatest
response was after the first dose in pig 359, with a de¬
crease in inguinal lymph node size of 37%. By the 2nd
week after each dose however, the lymph nodes had in¬
creased in size again. The circumference of the




Weight gains in kg. over 3-weekly intervals.
Pig No. Pre- During After
treatment treatment treatment
357 4.5* 9.0 o•i—1 Dead
359 8.5 6.0 4.0 Dead
362 9.0 6.5 4.0 8.0
420 3.5 4.5 5.0 Dead
* _ ill during pre- treatment period.
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Weight gains
Effects of the treatment on weight gain were
difficult to assess because of complicating factors
(See Table 44 ). In two of the four pigs, 359
and 362, it appears that weight gain was definitely de¬
pressed during the treatment period. Pig 357 was ill
during the pre-treatment period and put on weight
rapidly after recovery despite the treatment. However
its weight gain was depressed again after the second
dose. The weight gain of pig 420 was apparently im¬
proved by the treatment, but like 357 its pre-treatment
condition was affected by illness, due to post-operative
complications.
DNFB Skin Test Results (See Table 45).
In two pigs, 357 and 362, there was an improvement
in response after the first dose and a greater improve¬
ment by 19 days after the second dose. In 362, which
was left alive 7 weeks after the last dose, this im¬
provement was maintained, despite clinical and haemato-
logical evidence of relapse.
It was unfortunate that a pretreatment test result
was not obtained from 420, as its first post-treatment
response was good (score 3) and its second post-treatment
response was even better (score 4).
Pig 359 had a negative response 2 days after the
first treatment, and this was even poorer than the

































However, after two doses, an improvement to a score of
2 was obtained.
It appears, therefore, that although the results
of post-treatment test 1 are not clear cut, by the time
of post-treatment test 2 all pigs showed a definite
improvement in skin hypersensitivity reaction.
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Haematology
(See Appendix III Tables 35 to 42).
As previously noted in the experiment with normal
pigs, WBC counts were depressed in all the pigs after
each dose of cyclophosphamide. Figures 21 and 22
show mean - S.D. of mononuclear and neutrophil counts
before and during treatment. From these it is clear
that the nadir occurred less than 5 days after each dose,
the lowest mononuclear counts occurring slightly earlier
than the lowest neutrophil counts. These results
were similar to those obtained in the normal pigs.
Neutrophil counts were again depressed much more than
the mononuclear cell counts, and at the nadir it was
difficult to find any neutrophils at all when performing
a differential count. For around 1 week after each
dose in all pigs, morphologically abnormal lymphocytes
were absent from blood smears. However, as the mono¬
nuclear cell counts increased again, tumour cells tended
to reappear, in small numbers, particularly in those
from pig 420.
Mean - 1 S.D. of RBC counts and Hb before and during
treatment are shown in Figure 23 and PCV in Figure 24.
From these, it can be seen that the pigs became more
anaemic during the 3 weeks of the pretreatment period.
Mean PCV increased slightly during the seven days after
dosing, though RBC counts in three of the four pigs were
lower on day 7 than on day 0. On the 14th day after
IlT
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dosing, in all four pigs, RBC counts, PCV and Hb were
much increased. After the second and third doses,
these parameters were depressed, increasing again during
the following 2 weeks, except in pig 420 which became
progressively more anaemic despite therapy until it was
destroyed. The high red cell values recorded in pig
359 on day 49 were undoubtedly due to dehydration, as
a result of repeated vomiting.
When the values from 362 are examined, the pig which
was left alive after treatment was stopped (See Table 42
Appendix III) it can be seen that 19 days after the third
dose, its red cell picture was not very different from
that of a normal pig. After this however it deterior¬
ated, and when it was destroyed, nearly 8 weeks after the
last dose it was once again moderately anaemic.
Means - 1 S.D. of MCV are shown in Figure 25 • There
was a progressive increase in this derived red cell index
during treatment. There was no decrease in MCHC or MCH.
There was a wide variation in thrombocyte counts
(See Appendix III) between pigs, and also in the same
animals from week to week. Counts during the treatment
period were within the normal range. The lowest count
9
obtained (91 x 10 /I) was in pig 362, 2 days before it
was destroyed, in relapse, after therapy was stopped.
Serum Proteins - Albumin and Total Globulins (See Appendix
III ) -
Total serum globulin values were obtained, as before,
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by subtraction of the measured values of serum albumin
from the total protein values. One serum sample,
from pig 420, was missing but it can be seen from
the results of the other three pigs that by 7 days
after the start of treatment, there was a fall in
serum globulins and a rise in serum albumin. Con¬
sidering only the three pigs for which results are
complete, the albumin/globulin ratio altered from a
mean of 0.54 ^ 0.02 on day 0 to 1.61 - 0.22 on day 7.
By day 14, globulins had increased again, but the rise
in albumin levels was maintained until day 14 and then
fell slightly on day 21.
Serum Alkaline Phosphatase (See Appendix III)
On days 1 and 2, after the first dose of cyclo¬
phosphamide, temporary increases in SAP levels were
noted in three out of the four pigs, but they were still
within the normal range, with the exception of pig 359,
which had a value of 201 iu/litre. By day 7 the
levels had fallen considerably. None of the pigs
showed increased levels after the second dose and only
pig 362 had a very slight increase in SAP after the
third dose. However, the pigs were not sampled until
4 days after the second and third doses, and increased
levels may have been missed. In general, the SAP
estimations tended to decrease progressively with age,
as noted previously.
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Blood Urea (See Appendix III, Tables 39 to 42).
Blood urea measurements were within the normal
range throughout the experiment, except for those ob¬
tained from pig 357 on day -14, and 359 on day 48, which
were slightly increased. On those particular days,
the animals concerned were suffering from severe intest¬
inal dysfunction (See Clinical Observations, page 295).
Post Mortem Findings:
Pig No. 357
This was a rather small but anatomically normal,
well developed, well nourished carcase.
The thymus was of moderate size with soft pale fawn
lobules.
There was a small amount of serous fluid in the peri¬
cardial sac.
The heart muscle was flabby but otherwise normal.
The lungs, liver, adrenals, and bladder showed no
abnormality, and the ovaries and uterus were small and
inactive.
The spleen v\as of moderate size, smooth and firm.
The cut surface showed engorgement with blood and no
visible white pulp.
There were marked fibrous adhesions between the
spleen and the right flank.
The kidney cortex was slightly pale, but the organ
was otherwise normal.
The stomach showed no abnormality, but there was
kinking of the small intestine by fibrous adhesions,
though there was no stenosis and dilatation.
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The caecum and colon were normal.
The bone marrow of the femur was pink and white
throughout its length.
Pig No. 359
This was a well-developed but thin and dehydrated
carcase with a very hairy coat.
The head and neck showed no abnormality but the
brain was congested.
There were two surgical wounds in the abdomen one
on the right lateral side, the other in the mid -line.
There was evidence of stomach contents staining the
snout and mouth.
There was no fluid in the chest or pericardial sac.
The lungs showed patchy partial collapse and con¬
gestion.
The heart was normal apart from the muscle being
flabby.
The thymus was not found.
There was a diffuse fibrous peritonitis, with a more
recent fibrinous peritonitis, involving the lateral right
abdominal wall where the fibrosis predominated and the
mid-line abdominal wall where the fibrin predominated.
The liver showed diffuse fibrinous adhesions between
the liver and the lesser curvature of the stomach, and
between the visceral surface of the liver and the entire
spleen. There was also a dense fibrous adhesion be¬
tween the distal segment of the spleen and the liver.
In this area the interlobular septae were thickened but
elsewhere the liver was normal on cut surface.
The spleen was enlarged. The cut surface was
red and cellular with indistinct 3 to 4mm white pulp
nodules. There was no folding of the borders, and no
nodules were noted along the hilus.
The kidney capsules and dorsal wall of the bladder
were involved in the peritonitis, but otherwise these
organs showed no abnormality.
There were many small Graafian follicles on the
ovaries but the uterus was small and inactive.
The stomach was very distended with watery green/
brown ingesta. The serosa showed a mild degree of
fibrinous peritonitis and the mucosa was slightly flushed.
At the site of the pancreas there were adhesions.
On cut surface, some small brown lobules, and other areas
of haemorrhage, fibrin and yellow necrosis were found,
but no normal pancreatic tissue.
The small intestine was distended with brown/green
ingesta of watery consistency as far as the middle.
After this point, the intestines were collapsed and empty
as far as the lower ileum. The serosal surface was in¬
volved in an acute fibrinous peritonitis causing adhesions
in the proximal coils. Fibrinous tags and adhesions
were also present in the large intestine. Peyer's
patches were slightly thickened.
The large intestine was distended with digested food.
There were adhesions between the caecum and the right
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abdominal wall.
All carcase lymph nodes showed slight bilateral
symmetrical enlargement and on cut surface 50 to 70
percent was formed by white cortex, the remainder by
light fawn medulla. The mesenteric, gastric and
bronchial nodes were much enlarged, and bulging and cel¬
lular on cut surface.
The bone marrow of the femur was red/pink with cel¬
lular and fatty mottling throughout the whole of its
length.
Pig No. 420
This was a small moderately developed, moderately
nourished carcase. The blood was very thin and watery.
The thymus was of moderate size with pale soft
lobules.
Heart, lungs, liver, adrenals, kidneys and bladder
showed no abnormality.
There were adhesions between the ventral end of
the spleen, which was folded over on itself, and the
abdominal wall. These could be broken down but were
fibrous. The spleen was of normal shape and the
cut surface showed red cellular tissue with blood but
no visible white pulp.
The only abnormality in the stomach was in the
cardiac region which showed three irregular areas of
black, slightly raised nodularity up to 3cm diameter
with several 5mm yellow raised necrotic plaques.
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The small intestine showed many adhesions to the
right flank, which were easily broken down, but were of
fibrous tissue. There was also firm white fibrous
thickening of the mesentery attachment which distorted
the coils, making it difficult to unravel the intestine.
The caecum and colon were normal.
The bone marrow of the femur was moderately red
and cellular.
Pig No. 362
The head and neck including the brain showed no
abnormality, though the tonsils were slightly thicker
and more nodular than usual.
The thymus was of moderate size with pale fawn
lobules.
There were extensive fibrous adhesions in the mid¬
line ventral abdomen between the abdominal wall and the
spleen and some of the loops of the small intestine.
Lungs, heart, liver, adrenals and bladder showed no
abnormality.
The kidney capsules stripped easily leaving a few
l-2mm white nodules visible on the surface, which ex¬
tended a little way into the cut surface.
The ovaries showed small corpora lutea and many
smaller Graafian follicles. The uterus was small and
inactive.
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The stomach was full of food. The oesophageal
region was normal. The mucosa of the fundus was slightly
congested but normal except for a 1cm stellate depressed
ulcer.
The bile-stained mucosa of the duodenum was slightly
thickened and corrugated by up to 3mm of white cellular
tissue.
The small intestine showed no abnormality but the
Peyer's patches of the ileum were moderately prominent.
The caecum and colon were normal.
The spleen was moderately large and engorged. The
edges were not curled and there were no nodules along
the hilar region. On cut surface there was a faint
nodularity but no obvious white pulp.
All lymph nodes were enlarged and on cut surface
showed a flat white field with some nodularity but no
obvious medulla. There was no evidence of haemorrhage.
The bone marrow of the femur was red/white mottled
and sank in formalin.
Lymph Node and Organ Weights
See Appendix III for absolute weights in grams.
Table 46 shows the relative weights of lymph nodes and
organs, compared with a range of weights from three
normal pigs killed at similar ages and 14 untreated cases
(mean and range).
From the results of the two pigs killed at the end
of treatment, and the one that died shortly after this,
it can be seen that cyclophosphamide therapy did reduce
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the relative lymph node weights, particularly of those
of the splanchnic group, compared with the mean value
for untreated cases and the nodes of the pig which was
allowed to relapse (362). However the weights were
still within the range for untreated cases and much
larger than the relative weights of the normal pig lymph
nodes. The haematology results suggested that pig 420
the only male, did not respond to the therapy nearly as
well as the females, and the relative lymph node weights
from 420 also showed a poor response compared with the
results from 357 and 359.
Apart from 359 which had been ill for several days
before its death, the relative thymus weights of the
treated pigs were greater than the mean value for un¬
treated cases, though not as great as in the normal pigs
The thymus was still large in the relapsed pig 362.
Splenic and liver relative weights were greatly re¬
duced in 357 and 359 but again there was a poor response
in pig 420. The spleen and liver of 362 were massive
a further indication of rapid tumour regrowth.
Kidney weights appeared to be unaffected by the
treatment, and those of 362 were no heavier than the
rest despite gross evidence of tumour involvement.
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DISCUSSION
Cyclophosphamide has been used to treat tumours
in animals, particularly lymphosarcoma in dogs (See
Page^SO in/Introduction) . McClelland (1963) noted
severe haemorrhagic cystitis in a treated dog but
apparently did not recognise that this was a side-
effect of the drug. More recently, the problem of
cyclophosphamide cystitis in the dog and cat was dis¬
cussed by Crow, Theilen, Madewell, Weller and Henness
(1977) .
As with the normal pigs, therapy with cyclophos¬
phamide at a dose level of 20mg/kg did not result in
any severe clinical toxicity, even in these advanced
cases which were in poor condition at the beginning of
the experiment. The tumour was undoubtedly affected
by the drug but the response, indicated by the shrinkage
of the superficial lymph nodes, was disappointing and
temporary. In retrospect, the results might well have
been improved by using a higher dose level, which would
probably have been well tolerated.
As already discovered in the prednisolone therapy
experiment, there was an improvement in the DNFB skin
test response during treatment. Pig 420 had a score
of 4 when tested for the second time, which would be
regarded as a good response in a normal pig. It is
interesting to note that this animal also had the
largest thymus at post-mortem, though the organ was not
as large as that of a normal pig. (See Table 46)
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Many problems were caused by the after effects of
laparotomy. Although excessive handling of the gut
was avoided as much as possible, and every precaution
was taken to keep the operations sterile, peritoneal ad¬
hesions occurred rapidly, particularly between the coils
of the small intestine. These were severe enough in
two of the pigs to cause complete intestinal obstruction.
As stated in the Methods section, the laparotomies were
undertaken to confirm the diagnosis and the stage of the
disease, to mimic the procedures used on human patients,
and to illustrate a similar response in those pigs which
were not killed at the end of treatment, but in fact
they yielded comparatively little information compared
with the problems that they caused. Weight gains in
particular were difficult to assess.
The haematology results were similar to those ob¬
tained in the normal pigs, i.e. after each dose, there
was a depression of WBC, mononuclear and neutrophil
counts. Tumour cells almost disappeared from the blood
smears at this time, and the mononuclear cells which
remained resembled small lymphocytes with a few typical
monocytes. However, their reappearance before the
next dose was administered indicated that the drug was
only suppressing the tumour temporarily. It was sur¬
prising that there were no problems with opportunist
infections during the first week after dosing when the
neutrophil counts were very low indeed. Undoubtedly,
the minimal disease status of the piggery helped, and if
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the pigs had been exposed to ordinary farm conditions,
they may well have succumbed to virulent infections.
As in the normal pigs, RBC, PCV and Hb were tem¬
porarily depressed after dosing, but by the 14th day
a marked improvement had occurred in three out of the
four animals, probably due to recovery of normal red
cell precursors following destruction of infiltrating





Cytarabine (also known as cytosine arabinoside,
arabinosyl cytosine, l-,B-D-arabinofuranosylcytos ine ,
Ara-C) is an example of the group of drugs known as
antimetabolites. Cytarabine is a pyrimidine nucleo¬
side analogue. Its structure is similar to that of
cytidine and deoxycytidine except that the sugar moiety
is arabinose rather than ribose or deoxyribose. Its
antitumour activity is due to competitive inhibition
by its active form, the triphosphate, of the enzyme
DNA polymerase, preventing it from completing the final
step in the assembly of DNA. The drug is converted
within the cell by a multistep phosphorylation pathway
(See Figure 25) involving three enzymes, the first of
which is called deoxycytidine kinase. It is also
subject to deactivation, however, by the enzyme cytidine
deaminase, to uracil arabinoside.
Cytarabine is therefore a cell-cycle specific
agent because it acts only in the S-phase of dividing
cells. In addition, it blocks the progression of cells
in G-^ into S-phase, resulting in a partial synchroni¬
sation of the cell population.
The literature about cytarabine was reviewed by
Kremer (1975).
Cytarabine was synthesised in 1959, and Evans,





















inhibiting growth of several mouse tumours. Clinical
trials began in 1964, and by 1969, several cancer
chemotherapy groups had shown that cytarabine was an
active agent in man, especially in the treatment of
acute myeloblastic leukaemia.
The enzymatic reactions in the metabolic pathway
of cytarabine may hold the key to the mechanisms of
resistance to the drug, since they determine the amount
of active product produced by the cells. In vitro
studies by Kessel, Hall and Rosenthal (1969) showed a
high ratio of deoxycytidine kinase to cytidine deami¬
nase in lymphocytes, suggesting that cytarabine might
be beneficial in lymphoproliferative disorders. It
has been shown that there is great variability among
human patients in the levels of kinase and deaminase
in tumour cells. (Frei, Ho, Bodey and Freireich, 1973).
Studies by Steuart, Burke and Owens (1971), and Ho
(1973) yielded evidence that kinase and deaminase levels
correlated well with clinical response in adult acute
leukaemia. However a more recent study found no re¬
lationship between pretreatment enzyme levels and re¬
sponse (Smyth, Robins and Leese, 1976).
Although cytarabine is not regularly used for re¬
mission induction in ALL and lymphomas, it has been
shown to be useful in patients who are resistant to
standard therapy (Lay, Ekert and Colebatch, 1975).
as one of a combination of agents used for maintenance
therapy (Wollner, Burchenal, Leiberman, Exelby, D'Angio
and Murphy 1976), and in lymphomas which have a poor
prognosis e.g. histiocytic (Levitt, Marsh, Deconti,
Mitchell, Skeel, Farber and Bertino, 1972).
The pharmacokinetics of cytarabine are determined
by cytidine deaminase, which is found in high con¬
centration in liver, kidney and gastro-intestinal
mucosa. It is ineffective when given orally. After
rapid intravenous injection in man, it has a very short
initial plasma half-life of 3 to 15 minutes, followed
by a slower phase with a half-life of 2 to 2.5 hours
(Ho and Frei, 1971, and Wan, Huffman, Azarnoff,
Hoogstraten and Larsen, 1974). The drug is rapidly
converted to uracil arabinoside and this metabolite be¬
comes the predominant compound in plasma within minutes
of drug administration. More than 90% of the
dose, as uracil arabinoside, is excreted in urine withi
24 hours.
Because of the S-phase specificity of cytarabine
and its very short plasma half-life, it has to be ad¬
ministered frequently. To maintain effective blood
levels, intravenous infusion is necessary (Ho and Frei,
1971, and Wan et al., 1974). It has been given in-
trathecally for meningeal leukaemia, as the drug per¬
sists in CBF for much longer periods.
The toxic action of cytarabine is directed at
rapidly dividing tissues such as bone marrow and gastro
intestinal tract. Depression of white cells and
thrombocytes may appear. Immunosuppression occurs,
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though large doses are required to suppress cell-
mediated immunity in laboratory animals (Griswald,
Heppner and Calabresi, 1972).
The bone marrow effects are reversible with dis¬
continuation of therapy. Long-term consequences of
cytarabine administration are unknown but the drug
produces striking cytogenetic abnormalities in bone-
marrow cells, (Bell, Whang, Car bone, Brecher and Block, 1966).
i.e. extensive fragmentation of chromatids, and there¬
fore must be considered potentially carcinogenic.
Other adverse effects recorded in man are vomiting
and diarrhoea, oral inflammation and ulceration, throm¬
bophlebitis, hepatic dysfunction, fever and skin rashes
(Upjohn Ltd., product information leaflet).
Using the information gained from the literature,
trials were planned using normal and lymphosarcomatous
pigs.
CYTARABINE IN NORMAL PIGS
MATERIALS AND METHODS
Ten pigs were used, four females and six castrated
males, five from each of two closely related litters
born within 2 days of each other. The sire and both
dams were of the lymphosarcoma strain but were non-
carriers by breeding. The piglets were weaned at 8
weeks and housing, management and feeding were as de¬
scribed in the General Methods section.
As before, the pigs were allocated by lot to four
groups, low-dose, medium-dose, high-dose and controls.
However, different dose-levels were not used until the
3rd week of the experiment. For the first 2 weeks,
all treated pigs were given the same dose of drug. The
reason for this was to determine whether cumulative
bone marrow toxicity would develop at the lower dose,
before proceeding to higher doses. Continuation
of the higher dose levels beyond one week was not pos¬
sible because of limited drug availability. The
control animals were given a similar volume of saline.
The pre-treatment procedures were as follows (see
General Methods).
At 8 weeks of age, all the pigs were sensitised to
DNFB, and they were skin-tested 10 days later. At 9
weeks of age, 4 weeks before treatment started, weekly
weighing, and blood-sampling for WBC, RBC, PCV, Hb
differential and thrombocyte counts, blood urea, and
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serum protein estimations were commenced. SGOT and
alkaline phosphatase were measured from the sample taken
immediately before the start of treatment. The pigs
were observed daily in the pen for appetite and general
fitness, and state of urine and faeces.
A detailed clinical examination, including rectal
temperature, condition of visible mucous membranes and
auscultation of heart and lungs, was carried out weekly
from 2 weeks before the start of treatment.
One week before treatment, the right inguinal lymph
node was removed from each animal. Local anaesthetic
solution, 2% lignocaine ("Xylocaine", Astra) was
infiltrated subcutaneously around the lymph node.
The skin was incised, and the node separated from sub¬
cutaneous fat by blunt dissection. Blood vessels were
clamped with artery forceps and tied off with catgut
(Ethicon Ltd.). The skin incision was closed with
single interrupted sutures of 2.5 nylon, and an intra¬
muscular injection of 2ml benzathine penicillin was
administered. For the first 2 or 3 days after the
node was removed, there was marked swelling caused by
lymph accumulation, and leakage of fluid from the wound,
which resulted in the wound becoming infected in six
animals. This was treated with further penicillin
injections in the most severely affected, removal of
some of the stitches to allow drainage and dusting with
320.
chlortetracycline powder ("Aureomycin", 2% Cyanamid).
The excised lymph nodes were wrapped in aluminium
foil and frozen at -40°C for estimation of deoxycyti-
dine kinase (DCK) at a later date.
Drug administration commenced when the pigs were
13 weeks old.
The preparation used was "Cytosar" (Upjohn Ltd.,
Crawley). Each vial contained lOOmg freeze-dried
cytarabine powder, which was dissolved immediately
before use in 5ml water for injection. The powder
dissolved easily, giving a solution of 20mg/ml.
Upjohn Ltd. recommend in their instruction
leaflet a starting dose of 2rng/kg/day for continuous
treatment and 3 to 5mg/kg/day for intermittent treat¬
ment in man, this to be continued for 10 days or until
signs of toxicity appear. If no toxicity appears,
the dose is increased.
The animals were first allocated to a treatment







Pigs 304, 305, 308, 309 - 2.5 ml saline/day.
As all the treatment group pigs weighed between
20 and 25 kg at the start of dosing, 50 mg was chosen
-50 mg (2.5ml) Cytarabine/day
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as being a suitable and convenient dose for initial
study.
The drug was administered by subcutaneous injection
in the side of the neck, after swabbing the skin with
methylated spirit. Half of the daily dose was ad¬
ministered in the morning and half in the late after¬
noon. This was continued for 5 days and not admini¬
stered at the weekend, then given for a further 5 days.
Blood-sampling was carried out daily, before the
morning injection, on weekdays only. WBC, differential,
RBC and thrombocyte counts, PCV and Hb were recorded,
and once weekly a larger sample was taken for serum
total protein and albumin, SGOT and alkaline phosph¬
atase measurements. Blood urea estimations were
carried out weekly on the haematology samples. Weekly
estimations and weighing were continued.
At the start of the 3rd week, the treated pigs
were allocated to low -medium-and high-dose groups as
follows:-
Pigs 307 )
) Group A - 50mg/day as before
312 )
Pigs 300 )
) Group B - 70mg/day
310 )
Pigs 298 )
) Group C - 90mg/day
306 )
As before,the increased doses were administered
subcutaneously, half in the morning and half in the late
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afternoon. Daily blood-sampling for haematology
was continued.
During the 1st and 3rd weeks of treatment, DNFB
skin tests were carried out, and at the end of the 3rd
week, the left inguinal lymph nodes were removed from two
control animals and one animal from each of the treated
groups. These pigs were given no further treatment
and were left to recover from the effects of the drug.
The remaining five pigs were destroyed by pentobarbi¬
tone overdose and autopsies were performed. The con¬
trols were killed on day 17 and the treated animals on
day 18.
The surviving pigs were blood-sampled three times
during the following week on days 21, 23 and 35, and
twice during weeks 5, 6 and 7. At the end of the 7th
week from the start of dosing i.e. after 4 weeks of
recovery, these pigs were skin-tested once more, then
destroyed and autopsied.
Enzyme Estimations
Estimation of DCK levels in lymphoid tissue from
the normal pigs, and also from lymphosarcoma pigs, was
carried out by Dr. A. Baxter at the Department of
Clinical Oncology, University of Glasgow, 1 Horselet-
hill Road, Glasgow.
The enzyme was assayed by the disc method of Durham
and Ives (1969).
Briefly, the method was as follows. Homogenised
tissue was incubated with a reaction mixture containing
3 . 3
H-deoxycytidme or H-cytarabme, and after the reaction
was stopped by heating, the mixture was centrifuged.
The phosphorylated reaction products were quantitated
by placing aliquots of the supernatant on to paper
discs, washing, adding scintillation solvent and counting
in a liquid scintillation counter. In further experi¬
ments, the enzyme was partially purified, by the method
of Durham and Ives (1970), as far as fraction V. Kine¬
tic studies were carried out and Km values (dissociation
constants) were determined for the enzyme in tumour
tissue compared with normal tissue, i.e. this was a
measure of the affinity of the enzymes for the substrates.
324.
RESULTS
Clinical Examinations (For clinical records, see
Appendix IV)
Throughout the experiment, all the pigs remained
fit with excellent appetites. Rectal temperatures
stayed within the normal range, below 40°C. Faeces
and urine appeared normal. Pig 298 had bursitis on
the posterior aspect of the right tarsus, which was in¬
flamed throughout the experiment but this caused little
inconvenience to the animal. The only problems were
associated with poor healing of the wounds made to re¬
move the inguinal lymph nodes, as already described and
this occurred in two out of the four control animals,
as well as in the treated group.
DNFB Skin Test Results
It can be seen from Table 48 that the reaction
scores in the control animals were rather variable
particularly in 304 and 309, which showed decreases in
response during the treatment period. This may have
been due to the pigs becoming wet in the pen immediately
after the DNFB was applied. The two low-dose pigs
also showed a decrease in reaction score during treatment,
compared with their pretreatment scores, but the remaining
treated pigs showed similar or increased responses. It
appears therefore that cytarabine did not affect cell-
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Body weight gains
From Table 47 it can be seen that during treatment
the controls and low-dose pigs gained weight and the
medium- and high-dose pigs lost weight. In three
out of the four controls, body weight gain was greater
than in either of the low-dose animals. This effect
of cytarabine on weight was marked considering the
short period of treatment but it was only temporary.
Three weeks after the end of treatment the remaining
animals' weight gains had improved dramatically.
Haematology
Cytarabine administration produced a progressive
decrease in total WBC counts and in absolute neutrophil,
lymphocyte and monocyte counts, which became apparent
from the 4th day of treatment onwards. See Appendix iv
for results from individual pigs. Figure 27 com¬
pares mean WBC counts of all the treated animals with
mean counts of the saline-treated controls. Mean total
WBC counts and mean absolute counts of neutrophils,
lymphocytes and monocytes - 1 S.D. are shown in Table 49,
from the controls and all treated pigs in weeks 1 and 2
and from low--medium-and high-dose groups in week 3.
Figure 27 does not show the mean counts of the separate
groups in week 3, or standard deviations where they would
have confused the picture. From Table 49, it can be
seen that, although the mean counts of all the treated
groups were lowest in week 3, the effect did not appear
to be dose-related, being most marked in the medium-
dose group.
After dosing was stopped, the counts remained low
for a further week, in the surviving animals from the
treated groups, and then began to recover rapidly. By
the end of the experiment the counts of all types of WBC
in the treated pigs were indistinguishable from those of
the remaining controls.
Table 50 shows mean RBC counts PCV, Hb and MCV, MCHC
and MCH values - 1 S.D. of the control pigs and all
MeanWBCccuntsofsixnormalpigtreatedw thcyt rabinec mparedmeou tsff rsalin -treated controls.Arrowindicatebeginninga de ftr atment.Opsymbolsfterh fhigsw rek ll d.
EFFECTSOFCYTARABINENHAEM TOLOGYNORMALPIGS
TABLE49
DAYS FROM START OF DOSING
-28 -21 -14 -7
0
Startof Dosing
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treated pigs in weeks 1 and 2, and of the controls and
low, medium and high-dose groups in week 3. As with the
white cells, RBC counts, PCV and Hb were decreased in
the treated animals, but the effect was not seen until
the beginning of the second week of treatment.
Figures 28 and 29 compare mean Hb, RBC counts and
PCV respectively of all the treated animals compared
with the controls. As before the maximum effect was
observed in week 3 and it was not dose-related, all
treated groups being similarly affected (See Table 50 )•
In the remaining animals after dosing was stopped, RBC
counts, PCV and Hb remained lower than the mean values
of the controls for a further 10 days, and then rapidly
recovered. There was no treatment-related effect on
MCV, MCHC or MCH, but MCV was slightly increased in the
treated group during the recovery period, especially on
day 28 (52.0 il.6fl compared with 46.3 il.9fl in the con¬
trol group).
Figure 29 shows mean thrombocyte counts of the
treated animals compared with the controls. As with
the white and red cell pictures, thrombocyte counts were
depressed in the treated animals, but this effect did
not become obvious until the 3rd week. Table 51 shows
mean counts for low -medium-and high-dose groups in week
3, compared with the controls and once again, the effect
was not dose-related, being similar in all treated groups.
When treatment was stopped there was rapid recovery in
the remaining animals, but before the improvement occurred
Hb 9/dL
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TABLE 51
CYTARABINE IN NORMAL PIGS
9
Mean Thrombocyte Counts +1 S.D< x 10 /L
Days from Group D Treated Groups
Start of
Dosing Controls A +B + C
- 28 472 + 50 361 + 144
- 21 309 + 56 311 + 49
- 14 350 + 86 299 + 49
- 7 286 + 41 306 + 57
0 327 + 14 372 + 44
Start of
Dosing
1 316 + 35 321 + 49
2 317 + 31 345 + 51
3 369 + 29 378 + 88
4 377 + 26 403 + 122
7 354 + 16 343 + 94
8 374 + 58 287 + 69
9 357 + 91 258 + 64
10 322 + 22 248 + 51
11 362 + 49 275 + 60
Dose
Increased D A- B-
Low Dose Medium Dose High Dose
14 368 + 32 157 + 86 178 + 69 240 + 64
15 291 + 45 103 + 33 136 + 73 123 + 21
16 325 + 36 105 + 13 131 + 83 167 + 2
17 299 + 58 154 + 62 187 + 30 139 + 26




21 178 + 168 29 81 54
23 300 + 52 194 248 167
25 340 + 76 396 359 247
28 350 + 103 237 269 220
31 288 + 37 249 191 236
35 342 + 163 164 329 229
38 295 + 34 198 245 263
42 332 + 82 316 465 321
45 265 + 57 394 346 352
Two controls and one pig from each treated group
destroyed.
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very low counts were recorded on day 21 (mean of 55 -
g
26x10 /L. However, there were no signs of thrombocyto¬
penic purpura.
Serum Enzymes
SGOT and serum alkaline phosphatase levels in
individual animals are shown in Tables 33 and, 34 in
Appendix IV. All values recorded were on the low
side of the normal range. There were no differences
between groups which were likely to be caused by the
treatment, though serum alkaline phosphatase levels
tended to be lower in the treated pigs than in the con¬
trols .
Blood Urea (See Appendix IV, Tables 21 to 30)
All blood urea measurements before, during and
after treatment were within the normal range.
Serum Proteins (See Appendix IV, Tables 31 and 32).
Total protein and albumin were measured from serum
as described in the "Methods" section and total serum
globulin levels were obtained by difference.
Table 52 shows means - 1 S.D. of the albumin and
globulin values recorded just before, during, and just
after the treatment period.
It can be seen that there was a slight progressive
rise in serum albumin during treatment, though only in
Group B on day 18 are the standard deviations narrow
enough to suggest a real effect. The albumin levels
fell again in all groups by day 25.


















































in the control group at the beginning of the treatment
period, but the decrease was slightly greater in the
treated group. On day 18, globulins in group B were
particularly depressed compared with the control group.





309 and 305 - killed at the end of treatment.
These were normal carcases and the viscera showed
no abnormalities.
The thymuses were composed of moderately large
firm fawn lobules.
The bone marrow of the femurs was red and active
in the proximal half of the shaft but floated in form¬
alin.
At the site of removal of the right inguinal
lymph nodes there was in each a small red ulcerated
nodule which on cut surface extended into the underly¬
ing tissue like a healed sinus. The subcutaneous
fat showed ill-defined areas of fibrosis with yellowish
firm nodules from which no pus could be expressed.
All carcase and visceral lymph nodes were of
normal size and showed a nodular 5mm white cortex sur¬
rounded by a variable 1mm brownish medulla.
304 - killed at the end of the experiment.
No abnormalities were detected in carcase or vis¬
cera, except in the inguinal region where the lymph
nodes had been removed. On the right side under the
skin there was an irregular mass of fibrous tissue
about 10mm thick, and on the left side a mass about
25mm thick with a soft yellowish granuloma.
308 -
Similar to 304, except that the areas of fibrosis
331.
were smaller and less marked.
Low-dose pigs
312 - killed at the end of treatment.
This normal carcase resembled those of 309 and
305.
307 - killed at the end of treatment.
The carcase and viscera were normal, except for a
2mm raised red nodule on the mucosa in the mid-length
of the caecum, and fibrous masses in the inguinal region.
The stomach contents were very fluid.
Medium-dose pigs
310 - killed at the end of treatment.
This normal carcase resembled those of 309 and
305.
300 - killed at the end of the experiment.
No abnormalities were detected except for very
slight fibrosis at the sites of the removed inguinal
lymph nodes.
High-dose pigs
306 - killed at the end of treatment
This normal carcase resembled those of 309 and
305.
298 - killed at the end of the experiment.
No abnormalities were detected except for a fibrous
reaction at the site of the left inguinal lymph node
which had a central yellow core of pus.
The stomach contents were very fluid.
332.
Relative weights of lymph nodes and organs
It can be seen from Table 53 that the relative
weights of the mesenteric and colonic nodes of medium
dose pigs 310 and 300 were considerably less than those
of the control pigs, even though 300 was killed 4 weeks
after treatment was stopped. The same group of nodes
in the high-dose pig, 306, however, were heavier than
in the controls.
The thymuses of the treated pigs 312, 310 and 306
were very much smaller than those of the controls,
particularly pronounced once again in medium-dose pig
310. The thymuses of the treated pigs killed 4 weeks
later were also slightly smaller than those of the
controls.
TABLE53










































































































































































































The results of this experiment indicate that sub¬
cutaneous, twice daily administration of cytarabine
produced no clinical signs of toxicity, other than
slight weight loss. The haematology results indicated
a progressive, but apparently not dose-related, bone
marrow depression with all types of WBC, RBC and throm¬
bocyte counts affected. There was a slight fall in
serum globulins and a rise in serum albumin. These
effects were temporary and were reversed in the surviving
animals when cytarabine administration was stopped.
The haematological effects are similar to those
which have been recorded in man (Kremer, 1975). These
effects, and the serum protein effects were most pro¬
nounced in treated Group B. According to Kremer, the
leucopenia produced in man is due primarily to granulo¬
cyte depression as lymphocyte counts are barely affected.
Although absolute lymphocyte counts in the pigs were de¬
pressed, this experiment showed that the neutrophils
were more severely affected. Kremer (1975) also stated
that when thrombocyte counts recover in man, there is
often a significant "overshoot" with counts reaching
Q
]OOO x 10 /I. This was not observed in the pigs.
The post-mortem evidence of thymus suppression was
not associated with an effect on skin delayed hypersen¬
sitivity reactions. However, this agreed with Kremer
(1975), when he stated that cytarabine prevents the
334.
induction of delayed hypersensitivity to dinitrochloro-
benzene but it has no effect on already established
hypersensitivity.
SGOT and alkaline phosphatase levels in the pigs
were unaffected. They were measured because there have
been occasional reports in man of the occurrence of ab¬
normal liver function tests with cytarabine. However
according to Kremer (1975) these have been rare, and not




Animals and pretreatment procedures
Four pigs were used for the therapy trial.
All were cases of lymphosarcoma which were diagnosed
before 8 weeks of age. Three were entire males and
one was a female. The female and one male were litter-
mates, and the other two males were also littermates.
The first pair were almost 4 weeks older than the second
pair. Both pairs were moved to the experimental
animal house at 8 weeks of age. They were then kept
in isolation in individual pens and allowed to become
accustomed to their surroundings for several weeks.
Management was as described in "General Methods".
During this period, all four animals became ill and
required treatment. Female 4243 and male 4248 became
febrile and dyspnoeic with harsh dry lung sounds. Pig
4243 had impetigo. Intramuscular injections of chlo¬
ramphenicol were administered for 5 days. Rapid im¬
provement occurred, but lung sounds in 4248 remained
abnormal for some weeks after this episode. Males 317
and 318 developed severe diarrhoea soon after being
moved to the animal house. Treatment with neomycin
sulphate and "Streptaquaine" mixture brought about tem¬
porary improvement but treatment had to be repeated on
three occasions before the faeces returned to normal
consistency.
Staging laparotomy was carried out 3h weeks before
cytarabine treatment was started, as described in the
"Methods" section, pages 81 to 84. The diagnosis of
lymphosarcoma was confirmed and all four animals had
widespread abdominal involvement with gross enlargement
of the spleen and gastric and mesenteric lymph nodes.
The livers were pale and mottled. There was at least 1
litre of fluid in the abdomen of 318. This was clear
and reddish-brown and formed a soft clot on standing.
There was no evidence of peritonitis. Abdominal fluid
was present in all lymphosarcoma pigs which were subjected
to laparotomy, especially the untreated cases, but was
rarely seen in large amounts at post-mortem. Two pieces
of mesenteric lymph node were removed, one for histo-
pathological examination and one for DCK estimation.
The former was placed in 10% formalin and the latter was
wrapped in aluminium foil and deep frozen. No tissue
was removed from pig 317 because the splenic capsule
developed a small rupture while being handled. Haemor¬
rhage was not severe but it was thought to be unwise
to continue the operation.
Recovery from laparotomy was uneventful except for
a breakdown of some of the internal sutures in pig 4243,
resulting in a large hernia. Since this did not appear
to inconvenience the animal, and healing of the skin in¬
cision was rapid, repair was not attempted.
One week after surgery, all the pigs were sensitised
with DNFB, and skin tests were carried out 2 weeks after
sensitisation.
Weekly weighing and blood-sampling commenced 4 weeks
before the start of treatment and detailed clinical ex¬
aminations with rectal temperature recording and lymph
node measurements 2 weeks before, after the laparotomy in¬
cisions were healed. Haematology samples were taken
and also clotted samples for estimation of serum total
protein, albumin, SGOT and alkaline phosphatase. Fit¬
ness, appetite and any abnormal behaviour were noted
daily, also the state of urine and faeces.
Treatment
At the start of treatment, 4243 and 4248 were 6
months old, and 317 and 318 were 5 months old.
As in the experiment using normal pigs the preparation
was "Cytosar" and the drug was prepared for injection as
previously described.
The pigs were heavier than the normal animals used
in the trial but as all were in very poor condition
with large amounts of tumour, it was decided to start
with exactly the same cytarabine dosage schedule as had been
used in the previous experiment and to use the same in all four pigs,
i.e. 25mg subcutaneously twice daily for 5 days/week.
After 2 weeks on this dose level, it was doubled to 50mg
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twice daily for 5 days. As in the trial using normal pigs,
the drug was administered first thing in the morning
and in the late afternoon.
During the treatment period, weekly weighing and
clinical examinations were continued. Blood samples
for haematology were taken daily, 5 days/week. A larger
sample was taken once weekly for serum proteins and SGOT,
and blood urea estimations were carried out twice weekly
on Mondays and Fridays.
Skin tests were repeated during the last week of
treatment.
At the end of the 3 weeks of treatment two of
the four pigs, 4243 and 318 were destroyed by pentobar¬
bitone overdose and autopsied. Another laparotomy
was carried out on pigs 4248 and 317, so that the effects
of the drug could be assessed in all four pigs. Weekly
weighing and clinical examinations were continued for
4 weeks after the end of treatment. Blood sampling
for haematology was carried out three times weekly on
Mondays, Wednesdays and Fridays during this time. At
the end of the 4 weeks, these pigs showed no remaining
effects of cytarabine treatment. As the number of new
lymphosarcoma cases available for drug trials was very
small at that time, they were not destroyed and were
given a different drug, therefore autopsy results are not
available for these two animals.
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RESULTS
Clinical Examinations (See Appendix IV)
Pig 4243 - This female was rather depressed during
the 1st week of treatment. It had a cough and its
mucous membranes and skin were extremely pale. The im¬
petigo noted during the pretreatment period had returned
and its appetite was poor. The rectal temperature was
within the normal range and auscultation of the chest did
not reveal any abnormality. Benzathine penicillin was
administered intramuscularly. During the 2nd and 3rd
weeks of treatment, there was a marked improvement in
the pig's condition and it became quite difficult to
handle. The circumference of its abdomen decreased by
4cm from the beginning to the end of treatment even though
its appetite had improved. This decrease occurred during
the 3rd week of treatment.
It had sufficient subcutaneous fat, despite the ad¬
vanced stage of the disease, to make accurate measurement
of the precrural lymph nodes impossible. The size of
the inguinal lymph nodes (see Table 54) decreased by 21%,
again mainly during the 3rd week of treatment.
This pig was destroyed at the end of the 3rd week.
Pig 4248 - This male was also quiet and rather
depressed at the beginning of treatment and its appetite
was poor. Its rectal temperature stayed within the
normal range. There was no change in its general con¬
dition during the first 2 weeks of therapy, but during the
3rd week, it improved considerably. The circumference
of its abdomen decreased by 5cm during therapy, from
97cm to 92cm, again despite an improvement in appetite.
The size of the inguinal lymph nodes decreased by
34% and the precrurals by 31% when the measurements of
week 3 are compared with those of week 0. (See Table
54) .
After the second laparotomy, the pig was very de¬
pressed, and it only regained its appetite 10 days
later. It lost 6.5kg during this time, which inter¬
fered with the results shown in Table 55. Although
rectal temperatures were still within the normal range,
antibiotic cover was thought to be advisable and intra¬
muscular injections of ampicillin were given for 7 days
after surgery. After this time, it developed severe
diarrhoea, but its appetite had improved slightly and
so it was given neomycin sulphate orally with kaolin.
Healing of the incision was uneventful, and the diarrhoea
stopped.
By 4 weeks after the end of cytarabine therapy,
the circumference of its abdomen had increased to 99.5cm.
The inguinal and precrural lymph nodes increased in size
rapidly by 66%, when the measurements of week 7 are com¬
pared with those taken at the end of week 3. (See Table
54) .
After this, 4248 was given a different drug.
Pig 317 - This male was well and active through¬
out the treatment period, apart from a mild attack of
diarrhoea at the end of the 1st week which responded to
oral neomycin sulphate, administered for 5 days. Its
appetite was moderately good, and was unaffected during
the time it had diarrhoea. Its rectal temperature
stayed within the normal range.
The circumference of the abdomen increased from
87.5cm to 89.5cm during treatment. The size of the
inguinal lymph nodes decreased only 6% during the 3 weeks
of treatment, but decreased a further 29% during the 1st
week after treatment was stopped. The precrural nodes
decreased by 32% during therapy and did not decrease any
more after it was stopped (See Table 54).
Five days after the second laparotomy, 317 again
developed diarrhoea. The rectal temperature was still
within the normal range, but it would not eat and was
very depressed. Ampicillin was injected intramus¬
cularly for 3 days and there was a rapid improvement.
This treatment was repeated 2 weeks later when the pig
was noticed to be off its food once again. On this
occasion, the faeces were not so fluid, but its rectal
temperature was 40.8°C. Healing of the laparotomy
incision was rapid.
By 4 weeks after the end of treatment, its abdominal
measurement had increased slightly to 90.5cm. Its in¬
guinal and precrural lymph nodes lhad increased in size
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again, having similar measurements to those obtained
just before the start of cytarabine treatment.
Like 4248, this animal was then given a different
drug.
Pig 318 - This male was in poor body condition
and very pale and anaemic-looking at the start of treat¬
ment. Its appetite was fairly good. Its condition
did not improve during treatment, and it suffered from
diarrhoea almost constantly. A 5 day course of neo¬
mycin sulphate in its food brought about a slight im¬
provement but at the end of the 2nd week it was very
sick. It had no appetite and its rectal temperature
had risen to 42.2°C. Chloramphenicol was administered
intramuscularly for 4 days. The faeces became more
normal but its appetite remained very poor and it would
only eat green vegetables. There was a slight improve¬
ment during the 3rd week but when it was destroyed at
the end of the week it had severe diarrhoea once again.
The abdominal measurements fluctuated, probably
due to variation in intestinal contents, but there was
an overall increase of 1.5cm during the 3 weeks of cy¬
tarabine treatment.
The inguinal lymph nodes decreased in size by 33%
from the beginning to the end of treatment, and the
precrurals by 39% (See Table 54).
Weight gains
The results of body weight gains over 3-weekly
periods, pretreatment, during treatment and after treatment,
TABLE54
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are shown in Table 55.
During the pretreatment period, the weight gains
achieved by pigs 4243, 317 and 318 were fairly good,
and in all three weight gains during treatment were de¬
pressed. The only pig to show an improvement was
4248, which lost weight during the pretreatment period
because of a respiratory infection.
Both 4248 and 317 which were left alive lost weight




At Pre¬ Last week *
Pig No. sensitisation treatment of treatment
4243 2 3 2
4248 3 2 3
317 3 3 1 1'
318 2 3 1
DNFB Skin-Test Results
The pretreatment reaction scores, shown in Table 56
were quite high for lymphosarcomatous pigs, three out of the
four pigs showing marked erythema and skin thickening
with vesicle formation (3) . During the last week of
treatment, one pig, 4248, had an increased reaction
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score, but those of the other three pigs were reduced.
It appears, therefore, that the cytarabine treatment
may have caused a slight suppression of cell-mediated
response in three out of the four pigs.
Unfortunately, the two pigs left alive at the end
of the experiment were not retested.
Haematology
See Tables 36 to 43, Appendix IV for results
from the individual pigs.
Table 57 shows the means - 1 S.D. of WBC and absolute
neutrophil and mononuclear cell counts of the four pigs,
and after day 18, the two pigs which had not been de¬
stroyed .
During each of the three 5 day periods of treatment,
the lowest WBC counts were recorded on days 3, 10 and 17.
There was a slight overall reduction in mean WBC counts
during treatment but the standard deviations were wide.
If the absolute figures for each pig are considered in¬
dividually, there was an overall increase in WBC counts
in pigs 4243 and 4248 from day 0 to day 18, and a decrease
in pigs 317 and 318 during the same time. See Table 58
The mononuclear cell counts show very similar changes,
+ +9
with a mean decrease, from 19.3 - 8.2 to 14.7 - 3.9 x 10 /
litre. The effect on morphologically abnormal cells
varied. There were still many in blood smears from
pig 4248 at the end of treatment but very few were present
in those from pig 318.
TABLE 57
CYTARABINE THERAPY
MEANS + ISD OF WBC, ABSOLUTE NEUTROPHIL AND MONONUCLEAR
CELL COUNTS, X 109/LITRE :
DAYS FROM
START OF
DOSING WBC NEUTROPHILS MONONUCLEAR CELLS
- 20 20.7 + 5.2 7.6 + 6.3 13.0 + 3.0
- 14 27.4 + 4.5 7.8 + 1.7 19.3 + 4.0
- 7 30.9 + 4.2 5.1 + 2.7 25.3 + 4.0
0 26.0 + 10.7 6.6 + 2.8 19.3 + 8.2
Start of Dosing
I 23.0 + 10.4 6.5 + 3.5 16.3 + 7.2
2 22.9 + 9.5 5.2 + 2.1 17.6 + 7.9
3 20.5 + 6.5 6.4 + 2.2 14.1 + 6.0
4 22.3 + 7.1 5.6 + 4.6 16.6 + 7.6
7 25.3 + 3.1 4.7 + 0.9 20.5 + 3.8
8 20.4 + 2.5 4.5 + 1.7 15.8 + 4.0
9 21.4 + 4.1 3.2 + 1.3 18.2 + 5.2
10 16.7 + 6.3 4.1 + 1.8 12.6 + 7.6
11 18.6 + 4.6 4.6 + 1.0 13.7 + 5.4
Dose Increased
14 21.7 + 5.4 4.2 + 1.4 17.2 + 5.2
15 16.8 + 2.8 3.0 + 1.8 13.6 + 4.6
16 16.9 + 2.1 3.3 + 1.5 13.4 + 3.8
17 15.1 + 2.0 2.3 + 1.7 12.3 + 2.4
18
+
17.6 + 5.1 2.6 + 2.0 14.7 + 3.9
End of Dosing
21 21.3 + 10.1 4.6 + 3.5 16.6 + 6.7
23 24.9 + 11.9 9.8 + 4.3 15.1 + 7.6
25 24.0 + 0.8 10.0 + 1.0 13.8 + 1.6
28 27.5 + 7.6 12.7 + 7.4 14.6 + 0
30 27.6 + 2.2 9.6 + 3.3 17.7 + 1.4
32 22.3 + 0.4 7.5 + 0.9 14.7 + 0.7
35 23.9 + 3.3 5.6 + 0.9 17.9 + 2.1
37 24.3 + 4.0 8.5 + 1.0 15.7 + 2.7
39 30.0 + 0.1 6.6 + 1.7 23.2 + 2.0
+
Two out of the four pigs destroyed.
Absolute neutrophil counts at the end of treatment
were decreased in three out of the four pigs (See Table 58)
As with the mononuclear cells, the effect on
pigs 317 and 318 was more pronounced. After therapy was
discontinued, there was a rapid increase in neutrophil
counts from day 21 to day 28, followed by a gradual re¬
turn to pretreatment levels.
The effects of cytarabine on the red cell picture
also varied between pigs (See Appendix IV) .
Female 4243 showed a sudden deterioration before
the start of treatment. During the first 5 days of
cytarabine administration, the deterioration continued,
but during the following 2 weeks of therapy, the RBC
count rose from 3.18 to 5.02 x 10^/1., the PCV rose
from 0.185 to 0.32 1/1 and Hb rose from 7.4 to 10.2g/dl.
There was an overall increase in MCV in this animal from
53.8 fl on day 0 to 63.7 fl on day 18 andaslight fall in
MCHC from 35.2 to 31.9 g/dl.
Pig 4248 showed an initial improvement in red cell
picture during treatment, but there was a deterioration
during each of the following 2 weeks resulting in a fall
in RBC count from 4.93 x 10"^/1 on day 0 to 4.68 x 10^/1
on day 18. There was, however, a rise in PCV from
0.2551/1 to 0.30 1/1, therefore the calculated MCV rose
markedly from 51.7fl to 64.1fl. There was little over¬
all change in Hb and a slight fall in MCHC. After the




Changes in WBC picture of individual pigs during the







4243 + 5.6 + 6.4 - 1.7
4248 + 1.2 + 1.3 No change
317 - 12.2 - 5.2 - 7.2
318 - 28.3 - 21.1 - 7.3
on day 25 were almost as high as those of a normal pig.
However, the animal was ill with diarrhoea at this time,
therefore it seemed likely that this indicated dehydration,
particularly as the calculated MCV value was still high
at 62.2fl and the blood urea level was 10.35mmol/l, slightly
higher than normal.
Two and a half weeks after the end of treatment, RBC,
PCV and Hb had genuinely improved to 5.95 x lO^^/l, 0.301/1
and 10.5 g/dl respectively, and the MCV value indicated
that the red cells were smaller at 50.4fl. After this
time the pig again became gradually more anaemic.
Pig 317 showed a progressive deterioration in its red
cell picture throughout the period of cytarabine admini¬
stration. The RBC count decreased from 5.48 to 3.96 x
347.
10^/1, PCV from 0.27 to 0.22 1/1 and Hb from 9.5 to
7.2 g/dl. MCV increased only slightly from 49.3 to
55.6fl. Following the end of treatment there was
a slight improvement, but after day 28 the pig once
again became gradually more anaemic.
Pig 318 was the most anaemic of the four at the
start of treatment, and apart from a slight improvement
on day 14, its red cell picture continued to deteriorate.
The RBC count fell from 3.50 to 2.62 x lO^^/l, PCV from
0.23 to 0.17 1/1 and Hb from 7.7 to 5.6 g/dl during
therapy. There was little overall change in the cal¬
culated indices in this animal but the MCV showed that
the red cells were large (64.9fl).
Thrombocyte counts fluctuated widely throughout the
treatment period, but were mostly between 100 and 200 x
9
10 /l. Low counts were frequently obtained from pig
4243 but these were always associated with severe clumping
of thrombocytes. On occasions, this was due to delay
in obtaining the samples, as this animal was rather dif¬
ficult to handle, but it also occurred when there were
Q
no sampling problems. High counts (up to 300 x 10 /l)
were recorded in pig 4248 after the end of therapy. See
Appendix IV) .
Serum Enzymes
Serum alkaline phosphatase and SG0T levels in the
individual pigs are shown in Table 44 , Appendix IV.
Serum alkaline phosphatase levels were within or
lower than the normal range for pigs of this age
throughout the experiment.
SGOT levels fluctuated, but in general these were
also within the normal range. Pig 4243 had a slightly
increased level on day 0, but it decreased by day 4.
Blood Urea
See Appendix IV, Tables 40 to 43).
Slightly increased blood urea levels were recorded
in pig 317 on day 18, the last day of treatment, (11.29
mmol/1) and in pig 4248 after the end of treatment on
day 25 (10.35). There was no clinical indication of
a reason for the increase in 317, but on day 25, 4248
was dehydrated with severe diarrhoea. Otherwise blood
urea levels were within the normal range.
Serum Proteins
See Appendix TV, Tables 45 and 46).
All four pigs had fairly low serum albumin levels
before treatment started. By subtraction of albumin
from total protein levels, high total globulin levels
were calculated, particularly in pigs 4248 and 317.
During treatment, there were slight fluctuations
but the overall change in serum albumin was a decrease,
particularly in pig 318. This animal had a marked in¬
crease in serum globulins at the end of treatment, but
the other pigs showed no changes in globulins which could
be attributed to the treatment. From day 0 to day 18,
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the albumin/globulin ratios fell in all four animals,
particularly in pig 318 (0.53 to 0.24).
During the post treatment period, there was little
change in the albumin or globulin levels in pig 317,
but 4248 showed a rise in serum albumin and a fall in
globulins, despite apparent progression of the tumour.
Post-Mortem Results
Pig 4243 - killed at the end of treatment.
This was a well-developed, well-nourished carcase.
The head and neck including the brain, showed no ab¬
normality.
The thymus consisted of small, fawn lobules lying
in fat and connective tissue. No thymus was found in
the chest.
There was a little clear fluid in the pericardial
sac but the heart was normal.
The tip of the left cardiac and the whole of the
right cardiac lobes of the lungs showed depressed
nodular consolidation. The cut surface was collapsed
and cellular with a little pus in the bronchi.
The liver showed adhesions to the left anterior
flank and to the spleen where laparotomy had been
carried out. The adhesion was relatively easily
broken down. Liver lobulation was not distinct and
the organ was of normal colour.
There was a 15cm pendulous umbilical hernia. On
cut surface it had a 5cm thick fibrous and oedematous
wall. Some coils of the colon were attached by firm
fibrosis between the serosa and the inner lining of the
hernia but there was no obvious obstruction of the colon
The stomach contained a little bedding. The
oesophageal region showed slight nodular yellow crust¬
iness but no ulceration.
The duodenum was bile-stained and was not thickened
The mucosa of small intestine, caecum and colon was
normal. Peyer's patches were just visible as thickened
areas in the mucosa.
The spleen was large but there were no nodules
along the hilus. The cut surface showed engorgement
and ill-defined 2-3mm white pulp foci throughout.
The kidneys showed a few ill-defined 1mm white
foci in the cortex.
The adrenals, uterus and bladder were normal. The
ovaries showed numerous clear, red 3-4mm cysts.
The bone marrow of the femur was red and white
mottled. It was cellular and sank in formalin.
All lymph nodes were nodular, fawn and soft, with
no medulla except at one pole of the prescapular and in
the mesenteries, iliacs and inguinals. The bronchials,
mesenteries, gastrics, iliacs and inguinals showed a
few small cysts.
Pig 318 - killed at the end of treatment.
This was a rather small pig but there was plenty of
fat present. The blood was very thin and watery.
The head and neck, including brain and tonsils,
showed no abnormality.
There was a little clear fluid in the chest cavity
and pericardial sac. All major lymphatic vessels were
full of lymph and the lymph nodes were oedematous.
The thymus in the neck consisted of small, fawn,
rather wet nodules. No thymus was found in the chest.
Lungs, heart, adrenals, kidneys and bladder were
normal.
The liver was large but the edges were sharp and
it was of normal colour. The lobulation was not di¬
stinct and there were no focal lesions.
The spleen was large and there were adhesions to
the flank at the site of the laparotomy incision in the
left anterior mid flank region. There were 2-3cm
diameter sessile nodules along the hilus and occasional
smaller ones along the edges. The cut surface was con¬
gested, with ill-defined l-2mm white pulp foci. The
nodules were soft and cellular, red and white.
The testes and epididymis were small but normal.
On cut surface, the testis showed 5mm red foci of hae¬
morrhage.
The oesophageal region of the stomach showed yellow
crustiness but no ulceration. The duodenum was slightly
thickened and bile-stained.
The small intestine contained a little fluid and the
mucosa was normal. The Peyer's patches were slightly
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thickened. Many of the loops of the small intestine
were caught up in the fibrinous reaction noted around
the spleen and there may have been some restriction
of movement in those loops, though they were not more
congested than elsewhere.
The mucosa of caecum and colon was normal but
the contents of the colon were rather fluid.
The bone marrow of the whole length of the femur
was red and white mottled, cellular and sank in formalin.
All lymph nodes showed a firm, fawn flat field of
tissue, with no medulla except in the iliacs, inguinals
and splenic. In the splenic, the medulla was haem-
orrhagic. The bronchial and mesenteric nodes contained
small clear cysts.
Relative Lymph Node and Organ Weights
Table 59 shows the relative weights from pigs 4243
and 318 killed at the end of treatment, compared with
those from three normal and 14 untreated lymphosarcoma
pigs of similar age. It can be seen that although the
relative lymph node weights from the treated pigs are
reduced compared with the mean values from untreated
cases, they are still within the range of weights from
untreated cases, and much larger than the range of re¬
lative weights from normal pigs. Although the total
weights of superficial nodes are comparable in the two
treated pigs, the relative weight of mesenteric and col¬
onic nodes in female 4243 was about half that in male
318.
TABLE59









































































































































Thymuses in both animals were involuted, spleens
were large and livers fairly small, compared with mean
weights from untreated cases.
Results of studies on deoxycytidine kinase (DCK) (Baxter,
personal communication).
Initially, relative amounts of DCK in control and
tumour lymph nodes were measured. The specific acti¬
vity of DCK in nodes from tumour-bearing animals was up
to four times greater than that in lymph nodes from the
normal pigs.
However, kinetic studies performed on partially
purified DCK indicated a Km (dissociation constant) of
14.4 ,uM for the normal enzyme and 55.8 /jM for the tumour
enzyme. As the Kim is inversely related to the affinity
of the enzyme for the substrate, it was concluded that
the tumour enzyme would be less effective than the con¬
trol enzyme in activating cytarabine. This obviously
lessened any therapeutic advantage of having higher
levels of the enzyme in the tumour.
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DISCUSSION
The effects of subcutaneous twice daily cytarabine
on these four lymphosarcoma cases were not dramatic. Two
pigs improved in clinical condition, one neither improved
nor deteriorated but had a mild attack of diarrhoea, and
the fourth deteriorated and suffered from almost constant
diarrhoea. Diarrhoea is recognised as a side-effect
of cytarabine therapy in man (Upjohn Limited, Product
Information Leaflet), but both these pigs had suffered
from diarrhoea before cytarabine therapy, and therefore
the drug may not have been responsible.
Shrinkage of superficial lymph nodes occurred in all
four pigs, ranging from 20 to 40%, indicating
an effect on the tumour. However, it is doubtful if
this could be described as a partial remission, even tem¬
porarily. Abnormal cells never completely disappeared
from blood smears, even in pig 318 in which the effect
on WBC counts was most pronounced. The effects on the
red cell pictures suggested that the pig which showed
most improvement with therapy may have been the female
4243, and this was also suggested by the relative weight
of the mesenteric and colonic lymph nodes at post-mortem.
Although relative weights are not available for 4248 and
317, the post-treatment laparotomies showed that any
effects on the mesenteric nodes of these two pigs were
marginal.
Cytarabine has been used, in combination with other
drugs (usually vincristine, cyclophosphamide and pre¬
dnisolone) , to treat lymphosarcoma in dogs (Theilen
et al., 1977, MacEwen et al., 1977, Crow et al., 1977,
and Owen and Bostock, 1978). It has never been reported
as a single agent for the treatment of lymphosarcoma in
dogs, but pharmacokinetic studies have been carried out
in normal dogs (Ho, Carter, Loo, Abbot and McBride,
1975) . These authors showed that tissue levels of
cytidine deaminase, which converts cytarabine to uracil
arabinoside, were very low and that the initial plasma
half-life was 40 minutes, which is longer than in man.
This information is not available in pigs, and Dr.
Baxter and his co-workers have not yet investigated
cytidine deaminase levels, therefore several theories
may be put forward to explain the disappointing results
of this experiment.
(1) Cytarabine is a cell-cycle specific agent, which
acts best in rapidly-growing cells. It has been shown
in many advanced tumours that the growth fraction is
fairly small, many of the cells being in a resting phase.
The growth fraction may be increased by reducing the
tumour burden, using cell-cycle non-specific agents
first, or in combination (Schabel, 1975). This may ex¬
plain why cytarabine tends to be more effective in com¬
bination than as a single agent.
(2) Cytarabine is likely to have a short plasma half-
life, and would probably have been more effective if it
could have been given more frequently, or by infusion,
but this latter method was not practicable in our experi¬
ments .
(3) Tumours commonly become resistant to cytarabine.
The mechanisms by which this occurs are not fully under¬
stood, but two possibilities have to be considered.
Firstly, the tumour may increase manufacture of cytidine
deaminase (though Smyth et al., 1976, did not find this
to be the case in human acute myeloid leukaemia). Cy¬
tidine deaminase may be inhibited in vivo by an agent
called tetrahydrouridine (THU). It would have been
interesting to treat an animal with cytarabine plus THU.
Secondly, the normal substrate with which cytarabine tri¬
phosphate competes is deoxycytidine triphosphate. Some
tumours can respond to cytarabine triphosphate by ex¬
panding pools of deoxycytidine triphosphate, and so
overcoming the DNA polymerase inhibition (Baxter, per¬
sonal communication).
(4) The dose level may not have been adequate.
This is not a likely possibility because the experiment
using normal pigs showed that bone marrow depression
occurred during the first 14 days of treatment before
the dose was increased, and at least two of the lympho¬
sarcoma pigs (317 and 318) showed depression of neutro¬
phil and RBC counts, PCV and Hb during therapy. How¬
ever, it has been suggested (Kremer, 1975) that in human
acute myeloblastic leukaemia, severe bone marrow hypo-
plasia may be a requirement for a complete remission,
and if this was also true in hereditary porcine lympho¬
sarcoma, this could have been achieved by prolonging
the treatment. According to Capizzi, Keiser and
Sartorelli (1977), once an initial threshold of marrow
toxicity has been reached with a phase-specific agent,
further toxicity is usually not dose-dependent but is
related to the duration of exposure. The reason
for this is thought to be as follows. It has been de¬
monstrated in experimental systems that a significant
fraction of haematopoietic stem cells are normally out
of cell cycle in the Go state. However as continued
therapy destroys the descendents of these cells, there
is an increasing demand on the stem cells to enter cycle
and replace the increasingly depleted functional cells.
Entry of more stem cells into the cycle makes them sen¬
sitive to phase-specific agents. The early descendents
of the stem cells are highly proliferative and these too




Leucocyte Chemotaxis in Hereditary Porcine Lymphosarcoma
In 1962, Boyden described a technique for the
measurement of the capability of neutrophils to move
towards a chemical attractant. This is known as
chemotaxis. Since then many authors have used the
technique or adapted it in attempts to discover why
neutrophils and mononuclear phagocytes migrate towards
areas of inflammation and what factors are involved
in inhibiting this important function. The litera¬
ture was reviewed by Wilkinson (1974).
In recent years there has been considerable in¬
terest in defects of the immune system in cancer patients
as many appear to be more prone to infections than
normal. Chemotaxis is only one aspect of the response
of the body's defense mechanisms and to be able to fully
assess neutrophil and monocyte or macrophage function,
one must also investigate phagocytic and bactercidal abil¬
ity. However these functions are dependent for their
success on the ability of the cells to migrate.
Snyderman, Dickson, Meadows and Pike (1974) described
deficient monocyte chemotaxis in patients with various
types of cancer and suggested that this might be one
reason why tumour cells are allowed to multiply rather
than being killed by cellular immune responses. Later
Snyderman and Pike (1976) reported isolation of a
"chemotaxis inhibitor" from cancer patients. McVie
(1978) described depressed monocyte chemotaxis in
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lymphoma patients. In 16 out of 22 patients, there
was a reduction of more than 20% compared with controls.
Mean depression in the patient group was 35% but was
greater in patients with advanced disease. There was
no relationship between chemotactic ability and age,
histological type of lymphoma, presence or absence of
systemic symptoms and absolute blood monocyte counts.
Results tended to become nearer to control results
after therapy. Chemotherapy tended to depress mono¬
cyte chemotaxis but there was a wide scatter in the
results.
There has been little investigation of the effects
of individual anticancer drugs on chemotaxis. It is
frequently stated that corticosteroids depress cellular
defense mechanisms. Rinehart and LoBuglio (1973) in¬
vestigated the effect of incorporating hydrocortisone
with the medium in which the cells were suspended.
They found that monocyte chemotaxis and bactericidal
ability were markedly reduced, though there was no
effect on neutrophil chemotaxis. However, when
Rinehart, Sagone, Balcerzak, Ackerman and LoBuglio
(1975) investigated chemotaxis of blood leucocytes from
patients treated with oral prednisone, given every 12
hours for 3 days, the results were quite different.
Monocyte chemotaxis was increased.
The principle of the method of Boyden (1962) was
well explained by Wilkinson (1974). Chambers are
used similar to those designed by Boyden (See Plate 24.) .
There are two compartments in each chamber, the
lower one containing the chemotactic substance and the
upper one the cell suspension, separated by a piece of
filter which has micropores of an appropriate size
small enough to prevent the cells from simply falling
through but large enough to enable them to squeeze
through by active movement.
Distance migrated by the cells has been shown to be
dependent on time allowed for migration, the absolute
concentration of the chemotactic substance, the concen¬
tration gradient of the chemotactic substance across
the filter and the strength of the particular attractant
used. Casein is an example of a strong attractant
but other substances such as bacterial filtrates, lymphoid
culture supernatants or cobra venom may be used. There
are optimum conditions of temperature and pH and an opti¬
mum concentration of chemotactic substance. The dose
response curve reaches a maximum and then begins to de¬
cline perhaps because receptors on the cells become sat¬
urated or because the metabolic processes required for
migration become exhausted. Chemotactic substances
may be simply metabolic stimulators but this does not ex¬
plain the directional migration. Gravity has no effect
- the cells move uphill as readily as downhill - and if
the gradient is reversed, the cells have been shown to
change direction (Wilkinson, 1974).
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It was decided that it would be interesting to in¬
vestigate monocyte and neutrophil chemotaxis in lympho-
sarcomatous pigs compared with normal pigs, and the




Reagents required were as follows:-
(1) Phosphate buffered saline (PBS)
2.72g of K H2P04 and 7.095g of Na2 HP04. 2H20 were
weighed out. The KH2P04 was dissolved in distilled
water and made up to 100ml. The Na2 HP04 2H20 was
dissolved similarly and made up to 250ml.
These solutions were mixed in the ratio of 3:7, and
10ml of the mixture was added to 990ml of normal saline.
(2) Hepes buffer 1 molar pH 7.3 (Gibco, Bio-Cult,
Glasgow).
(3) Medium 199, 10 times concentrated, (stock medium)
with Hank's salts and L-Glutamine without NaHCO^ (Gibco
BioCult, Glasgow).
(4) 4N NaOH. This was made by dissolving 4g of NaOH
and making up to 25ml with distilled water.
The working medium 199 was made up as follows
Medium 199 (conc.) - 10ml.
Distilled water - 86ml.
* Hepes/NaOH - 4ml.
* This was made by adding 5.5ml 4N NaOH to 100ml Hepes
buffer.
The working solution ph was checked and brought
to 7.0, if too alkaline, with concentrated hydrochloric
acid.
These solutions were sterilised, by autoclavation
at 15 lb for 10 minutes and stored at 4°C.
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(5) Casein (BDH)
This was prepared as a concentration of lOmg/ml,
200mg was dissolved in 20ml of distilled water by
raising the pH to 11.0 with N NaOH in a water bath at
56°C. Once the casein was dissolved, the pH was grad¬
ually reduced to 7.0 using phosphoric acid. The solu¬
tion was frozen at -40°C in 1ml aliquots, and was re¬
placed after one month's storage.
The working solutions were lmg/ml and 0.5mg/ml
casein, and occasionally 2mg/M., in Medium 199. Twd aliquots
were added to 8ml Medium 199 and Hepes, prepared as described
above, to make 2mg/ml casein. An aliquot of this was
diluted with equal parts of the medium to make lmg/ml
casein, and repeated to make 0.5mg/ml.
(6) Ficoll (Ficoll 40a- Pharmacia Fine Chemicals,
Uppsala, Sweden).
(7) Hypaque (Hypaque Sodium, Winthrop Laboratories,
Surrey).
Preparation of Ficoll/Hypaque was carried out as
follows:-
To make a 9% solution of Ficoll - a convenient
volume was 250ml.—
22.5g of Ficoll was weighed out and dissolved in
distilled water. Placing in a water bath at 56°C aided
solution. Distilled water was added to make up to 250ml.
To make a 34% solution, 34g of Hypaque was weighed out,
dissolved in distilled water and made up to 100ml. The
two solutions were mixed in the proportions of 24 parts
Ficoll to lO parts of Hypaque. The specific gravity of the
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resulting mixture should be 1.076 - 1.078, and if it
was too high, distilled water was added to bring the
specific gravity to the correct reading. This was
dispensed in universal containers in volumes just greater
than 20ml, and sterilised by autoclavation at 15 lb pres¬
sure for 10 minutes.
(8) Gelatin
This was prepared by dissolving 2.5g gelatin powder
in PBS in a 56°C water bath. The solution was made up
to lOOml with PBS and dispensed in sterile plastic
universal containers in volumes just greater than 20ml.
These were stored in the refrigerator and liquified when
required by placing them in a 37°C incubator half an
hour before use.
Apparatus Used
(1) Chemotaxis filter chambers. The number required
was 12 but 16 were used on some occasions for monocytes.
sarcoma
Half of the chambers were used for a lympho/ pig's cells
and half for those of a control pig. See Plate 24.
The cells were tested as follows
(a) Two chambers with no chemotactic attractant.
(b) Two chambers with 0.5 mg/ml casein.
(c) Two chambers with lmg/ml casein.
(d) For monocytes, two chambers with 2mg/ml casein.
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(2) Filters, pore size 8 x 10 m (ytm) for monocytes,
3pm for neutrophils (Millipore, Molsheim, France).
Pieces of filter of suitable size to fit the chambers
were cut out and placed in position using Millipore
forceps. The membranes were then kept in position
by screwing in the screw insert using a metal key.
The filter area exposed to the test cells was therefore
similar to the area of the lumen of the screw insert.
Methods
Monocytes
For each run, a sample of 20ml of venous blood was
collected from one normal pig and one lymphosarcoma pig
of the same sex and approximately the same age. The
blood was taken from the anterior vena cava as described
in the General Methods section, and 2ml was put into
EDTA for WBC and differential counts. The remainder
was defibrinated, by gentle shaking, in glass universal
containers with 10 to 15 glass beads in each. Probably
some monocytes were lost using this method because of their
tendency to adhere to glass. However heparin and acid
citrate dextrose had been tried previously as anticoagul¬
ants and found to be unsuitable. This was because large
numbers of thrombocytes were mixed with the separated
mononuclear cells, obscuring the filters and occasionally
causing the cells to aggregate forming large cell and throm¬
bocyte masses which prevented migration of the monocytes.
Defibrination effectively removed most of the thrombocytes.
In the laboratory, the blood was removed from the
universals by Pasteur pipette, leaving behind the beads
with the fibrin clot adhering to them. Unless the lym¬
phosarcoma pig was very anaemic, the blood was diluted
with an approximately equal volume of PBS. The diluted
blood was carefully layered on to Ficoll-Hypaque in plastic
conical centrifuge tubes, about 5ml of each. The tubes
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were spun at 2D00G for 15 minutes in a bench centrifuge.
The layer of mononuclear cells just above the interface
was removed from each tube along with some plasma using
a Pasteur pipette and the cell suspension put into
Taylor tubes. They were spun down at 400G for 10 min¬
utes, the supernatant was removed, the cell button was
gently resuspended and PBS was added. This procedure
was repeated for two PBS washes and finally the cells
were resuspended in the Medium 199/Hepes working solution.
The number of cells/ml present was calculated after
counting the number in a white cell dilution using the
Coulter counter and diluter (as previously described in
the General Methods section for whole blood). The cell
suspensions were diluted until there were approximately
2.5 x 10^ cells/ml.
Neutrophils
Blood samples of 20ml were taken as for monocytes,
but into "Vacutainers" containing acid citrate dextrose.
The samples were mixed well.
In the laboratory, the samples were centrifuged at
500G for 20 minutes in a bench centrifuge. The thrombocyte-
rich plasma and buffy coat layer of mainly mononuclear
cells were removed using a fine pasteur pipette. The re¬
mainder was mixed with liquified 2.5% gelatin in PBS and
the erythrocytes were allowed to sediment at an angle in
an incubator at 37°C for 45 minutes to one hour. The
supernatant was removed and centrifuged at 400G for 10
minutes at room temperature. The neutrophils were then
washed, suspended in Medium 199 and counted as described
above. It was found that the optimum cell concentra¬
tion was 2 x 10^ cells/ml.
The cell types present in the cell suspensions ob¬
tained by these methods were investigated using a "Cyto-
spin" centrifuge. Using this apparatus, one or two
drops of fairly concentrated cell suspension could be
spun on to microscope slides. These preparations were
stained with Leishmann's stain, as previously described
for blood smears but mixing the stain well every few
minutes, so that the cells would take up stain evenly.
The mononuclear cell suspensions contained lympho¬
cytes, tumour cells in those from the lymphosarcoma cases,
and monocytes, with relatively few neutrophils and eosi¬
nophils. The neutrophil suspensions contained eosino¬
phils and a few mononuclear cells. Contamination with
red cells was variable depending on the success of
the gelatin sedimentation but, unless very numerous, they
did not affect the reading of the filters. Absolutely
pure cell suspensions were not necessary because the
different types were quite easy to identify under the
microscope.
The cells suspensions were used to fill the chemo-
taxis chambers as follows:-
Medium or medium containing casein was introduced
into the horizontal part of the chamber and up to the
level of the underside of the filter. Then, using two
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Pasteur pipettes, the test cells were added to the
lumen of the screw insert above the filter, and medium
(or medium plus casein) to the other side of the chambers.
Simultaneous filling of both sides was important so that
the pressure was equal on the top and underside of the
filter. Both sides were taken as filled when menisci
developed above the level of the top of the chamber.
This allowed for evaporation of moisture during the in¬
cubation period.
After 2 hours incubation at 37°C for monocytes,
1 hour for neutrophils, in a sandwich box containing
moist tissues, both sides of the chambers were emptied
simultaneously with Pasteur pipettes. Each chamber
was then tilted so that an air bubble displaced the fluid
in the horizontal part and this was sucked off. The
insert was unscrewed and finally the filter was removed
gently using Millipore forceps and placed in 98% ethanol.
The filters were either left in this overnight, or for
10 minutes before proceeding with the staining of the
filters. Ice cube trays were used for the staining
process which was as follows
90% ethanol - 2 to 5 minutes
75% ethanol - 2 to 5 minutes
50% ethanol - 2 to 5 minutes
Distilled water - 2 to 5 minutes
Mayer's Haematoxylin - 4.5 minutes
Tap water - 10 to 30 minutes
50% ethanol - 2 to 5 minutes
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75% ethanol 2 to 5 minutes
90 ethanol 2 to 5 minutes
98% ethanol 2 to 5 minutes
Xylol overnight
98% ethanol was used instead of absolute ethanol as
the latter tended to dissolve the filters.
The filters became almost transparent in the xylol
and were mounted next morning on microscope slides in
D.P.X.
Examination of the Membranes
This had to be carried out within 48 hours as the
membranes tended to become opaque after this time.
Readings were carried out on a Leitz microscope using
the x 40 dry objective.
The filters were scanned initially using a low power
objective to locate the main cell population.
Using the fine adjustment, the top of the filter
was located by focussing on cells which had not migrated
into the filter. The number of the Vernier scale on the
fine adjustment was noted. The focus was adjusted down
through the filter until the plane containing the last
two or three cells was found. The fine adjustment
Vernier travel between the first and second readings was
noted. The reading was carried out five times on each
filter and then another five times by a second observer.
Means and standard deviations on the readings were cal¬
culated for no casein, 0.5mg/ml, lmg/ml and 2
mg/ml casein for each pig and the results plotted on linear
graph paper.
The method was similar to that used by McVie
(1978) with the following modifications.
(a) The Ficoll/Hypaque mixture used for monocytes
was one which had been found to be suitable for pig
cells. McVie (1978) used a Ficoll/Triosil mixture.
(b) Almost all the anticoagulants tried, including
heparin, allowed thrombocyte aggregation. Acid cit¬
rate dextrose caused fewest problems and was suitable
for the neutrophil separation but, despite the risk of
losing many of the monocytes by adherence, it was nec¬
essary to defibrinate blood for mononuclear separation.
Gelatin was used for sedimentation of RBCs instead of
dextran (Henson, Johnson and Spiegelberg, 1972).
(c) Absolute alcohol tended to dissolve the filters
and so 98% was used.
(d) The cell concentration for monocytes was in¬
creased to offset the smaller numbers of monocytes
present.
McVie (1978) counted monocytes in the cell sus¬
pensions in a haemocytometer but it proved very difficult
to identify pig monocytes, particularly in suspensions
from the lymphosarcoma cases in which there were many
large mononuclear tumour cells. These were not a
problem in the test because neither the lymphocytes
nor the tumour cells migrated, therefore attempts to
isolate monocytes were abandoned and the cells were
counted using the Coulter counter to speed up this
rather slow technique.
372.
(e) In the monocyte tests, the maximum casein
concentration was increased to 2mg/ml.
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RESULTS
The results of the 20 test runs are shown in Figures
Ml to nio.
Untreated pigs - It can be seen from all the Figures
that monocytes and neutrophils migrated a short distance
into the filters even in the absence of casein. In tests
Ml, M2 and M3 the normal pigs' monocytes did not migrate
very much further at 0.5 and l.Omg/ml casein and so
another casein concentration, 2mg/ml, was introduced.
The distance migrated by the normal pigs' monocytes in¬
creased greatly at this concentration. In Test M3 both
filters with the lymphosarcomatous pig's cells were spoiled
at 2mg/ml. In all monocyte Test runs (Ml to 5) it can be
seen that at 0.5 and lmg/ml the lymphosarcomatous pig's
cells migrated further than those of the normal pig, part¬
icularly in Tests M2 and M5. At 2mg/ml, this was rever¬
sed (See Tests M4 and M5).
Neutrophil chemotaxis in all five tests (N1 to N5)
showed a fairly good dose-related reponse and 2mg/ml casein
was considered to be unnecessary. In Tests N1 and 2, the
lymphosarcoma case's cells showed a slightly poorer mig¬
ration than those of the normal but the standard devia¬
tions of the readings overlap. In test N3 the distance
migrated by the lymphosarcoma pig's neutrophils was
slightly greater than the normal and in Test N5 this was
also the case at 0.5mg/ml casein. In Test N4, the chemo¬
taxis of the lymphosarcoma neutrophils appeared to be
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depressed at both 0.5 and lmg/ml.
Prednisolone - treated pigs - Monocyte chemotaxis of
the lymphosarcoma case in Test M7 was poorer than that
of the normal at lmg/ml casein and in Tests M9 and 10
there was virtually no difference. However in every
test (M6 to 10) there was still a tendency for the migra¬
tion of the lymphosarcoma pig's monocytes to exceed that
of the normal pig, though the standard deviations of the
readings overlap.
In the neutrophil tests (N6 to N10) the results were
very variable. In tests N6 and N7, and at 0.5mg/ml
casein in test N8, chemotaxis in the lymphosarcoma cases
was apparently depressed. In Test N9 there was no dif¬
ference and in Test N10 at 0.5mg/ml the distance migrated
by the normal pig's cells appeared to be abnormally low.





















FIGURES MI and M2
Distance migrated through filters by monocytes from
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FIGURES M3, M4 and M5
Distance migrated through filters by monocytes from three
lymphosarcoma cases and three normal pigs.
M6
FIGURES M6 and M7
Distance migrated through filters by monocytes from two
prednisolone - treated lymphosarcoma cases and two normal
controls.
M8
Figures M8, M9 and M10
Distance migrated through filters by monocytes from



















FIGURES N1 and N2
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Distance migrated through filters by neutrophils from two
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Figures N3, N4 and N5
Distance migrated through filters by neutrophils from








FIGURES N6 and N7
Distance migrated through filters by neutrophils from two
prednisolone-treated lymphosarcoma cases and two normal pigs.
FIGURES N8, N9 and N10
Distance migrated through filters by neutrophils from three pred-
nisolone-treated lymphosarcoma cases and three normal pigs.
375.
DISCUSSION
The results of 10 tests of monocyte chemotaxis
suggest that it is not depressed in lymphosarcomatous
pigs and at lower concentrations of casein these mono¬
cytes may be much more active than normal monocytes,
especially in untreated cases. In the prednisolone
treated cases monocyte chemotaxis was much closer to that
of the normal pigs.
The observation that the monocytes of lymphosarcoma-
tous pigs may be more active than those of normal pigs
may be supported by a single test of phagocytic ability
which was investigated by the hexose monophosphate shunt
method by Dr. Anne Naysmith, Department of Therapeutics,
Edinburgh Royal Infirmary. The activity of this enzyme
in monocytes is related to phagocytic ability and is
14
measured by determining the amount of CC>2 generated
from l~14c glucose in the resting state and when phago-
cytosing latex particles. The lymphosarcoma monocytes
were shown to be more active than normal both in the
resting state (350 counts/minute compared with 82 counts/
minute) and at 1 in lOO dilution of latex particles
(408 counts/minute compared with 160 counts/minute).
These results do not agree with the observations of
Snyderman et. al. , (1974) and McVie (1978) in human patients.
The tendency for chemotaxis to return to normal when
patients were in remission was noted by McVie (1978).
It would have been interesting to compare the effects of
prednisolone with other agents both in normal and lympho-
sarcomatous pigs.
The results of the 10 tests of neutrophil chemotaxis
are very variable but it appears that in certain lympho-
sarcomatous animals this function may be depressed and
this was also true in two out of the five prednisolone
treated animals (N6 and N7). These were .the same cases
used for the monocyte chemotaxis (M6 and M7) and it is in¬
teresting to note that although neutrophil chemotaxis was
depressed, monocyte chemotaxis was not. McVie (1978)
suggested that there may be some mechanism whereby mono¬
cytes compensate for defects in neutrophil numbers or
functions.
All of the results are very dependent on the technical
accuracy of the technique. It was complicated and very
time-consuming, with many stages where errors could occur
and a considerable amount of practice was required before
the manual dexterity necessary for filling the chambers
was acquired. Nevertheless, the Boyden chamber technique
is undoubtedly much easier to perform than other methods,
such as that using sawn-off syringe barrels with filters
stuck to them (Wilkinson, 1974).
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CONCLUSIONS
The effects of one of each of the four major classes
of anticancer chemotherapeutic agents have been investi¬
gated in normal pigs and pigs with hereditary lymphosar¬
coma .
The first agent, a glucocorticosteroid, was pred¬
nisolone. Administered daily intramuscularly in normal
pigs, it produced mild clinical effects at a dose level
of 6mg/kg, which included polydipsia, polyuria, abdominal
muscle weakness, depression of weight gain and suppression
of skin delayed hypersensitivity reactions. Other effects
noted were a fall in lymphocyte counts and a reduction in
relative weights of thymus and lymph nodes at autopsy.
These effects are similar to those which occur during
corticosteroid therapy in man and place the pig in the
group of corticosteroid resistant species which includes
man, the ferret and the guinea-pig. In cases of heredi¬
tary lymphosarcoma, prednisolone therapy, whether adminis¬
tered intramuscularly or orally, rapidly produced a good
partial remission, though there were signs that this may
only have been temporary. Appetite and fitness improved,
though growth rate did not, there was rapid shrinkage of
superficial lymph nodes and skin delayed hypersensitivity
tests showed increased responses. Absolute mononuclear
few
cell counts were dramatically reduced and/abnormal cells
were seen in blood smears by the end of treatment.
The anaemia and thrombocytopenia, typical of the advanced
lymphosarcoma case, improved greatly and these improve¬
ments were maintained for a short time after therapy was
stopped. Marked reductions in relative weights of
lymph nodes, spleen and adrenal glands were shown at
autopsy. These findings correspond well with the reported
effects of prednisolone therapy of lymphoid tumours in
human patients. However there were certain differences
between the results described here and reports of some
effects of corticosteroids in man and other animals, in¬
cluding pigs. Neutrophilia was observed in two animals
only, the lymphosarcoma cases which were dosed orally,
and these had suffered from severe diarrhoea. Eosino-
penia, a classic feature in man, was not detected, though
no special counting technique was employed. Anticipated
changes in serum levels of sodium, potassium, chloride,
calcium and inorganic phosphate did not occur. The only
animal to show gastric lesions at autopsy was one of the
orally treated cases. Nevertheless, several interesting
features came to light. These were the marked increases
in serum albumin and decreases in serum globulins, the
fluctuations in magnesium levels, the correction of
anergy to DNFB in the lymphosarcoma cases which contrasted
with the suppression of response in the normal pigs>and
the histological evidence of different degrees of tumour
suppression in different organs and even within the same
organ and infiltration of the ovaries which never occurs
in untreated cases.
The second agent used was the antitumour antibiotic
adriamycin which was administered intravenously every 3
weeks. It appears from the results described in this
thesis that there are many similarities between the ef¬
fects of adriamycin in man and its effects in the pigs,
which were cumulative. Bone marrow depression, gastro¬
intestinal damage, alopecia, stomatitis with ulceration,
sclerosis of blood vessels and tissue damage and the pos¬
sibility of cardiotoxicity are features in both species.
A dose-level of 4mg/kg caused death within 8 weeks and
2mg/kg within 16 weeks in normal pigs, but few clinical
effects were noted in pigs given lmg/kg. In cases of
hereditary porcine lymphosarcoma, a dose level of 2mg/kg
was associated with severe liver dysfunction which has
not been reported in man as an effect of adriamycin alone,
and death occurred rapidly in both the cases treated,
though tumour suppression did occur. In the lower dose
animals, a shrinkage of tumourous lymph nodes, a tempo¬
rary reduction in numbers of abnormal cells in the blood
and an improvement in body condition and weight gain
provided objective evidence of a response to adriamycin
therapy, though the response was not good enough to be
described as a partial remission. In man remissions in¬
duced by adriamycin alone have been reported to be short
but these animals showed no signs of development of tumour
resistance after 5 months of therapy.
The third agent used was the alkylating agent cyclo¬
phosphamide which was also administered intravenously
every 3 weeks. In the experiment using normal pigs the
only clinical effect noted was temporary pallor of skin
and mucous membranes which corresponded with slight
anaemia, in one animal given the highest dose of 80mg/kg.
WBC counts, and neutrophil counts in particular, were sev
erely depressed during the first 5 days after dosing but
rapid recovery took place. This also occurs in man but
several days later. Alopecia is common with this agent
in man but was not seen in the pigs, though it did occur
with the closely related agent ifosfamide. Haemorrhagic
cystitis, also common in man, was not seen, though one
low-dose animal showed mild bladder changes at autopsy.
The experiment was disappointing in that it did not de¬
monstrate many similarities between the responses of
humans and pigs to cyclophosphamide. From the literature
it appears that dogs resemble man more closely in this
respect. One interesting feature was the depression of
skin delayed hypersensitivity response and reduction in
size of the thymuses of the treated pigs - apparently an
effect on T cells by a drug which is reputed to act pri¬
ncipally on B cells. Cyclophosphamide therapy of lympho¬
sarcoma cases, at a dose level of 20mg/kg, which may
have been too low, was not associated with any clinical
signs of toxicity. WBC counts were depressed as in the
normal pigs and abnormal cells disappeared from blood
smears but this was only temporary. As with prednisolone
there appeared to be an improvement in skin delayed hyper
sensitivity responses. The females in the experiment
responded moderately well, though not well enough for the
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response to be called a partial remission, but the only
treated male hardly responded at all as shown by relative
lymph node weights at autopsy. It has been shown (un¬
published observations) that untreated entire male cases
do not live as long as female cases and, though the
mechanism is not known, it is possible that sex also af¬
fects response to treatment in some way. Cyclophosphamide
was much more useful as a component of a combination chem¬
otherapy regime, but the results are not included here.
The fourth major group of anticancer agents are the
antimetabolites and cytarabine was chosen from this group
because initial studies had shown that in tumour tissue
from the lymphosarcoma cases the specific activity of DCK,
the enzyme which activates cytarabine, was much greater
than in lymphoid tissue from the normal pigs. This
activity was shown to be up to four times greater in lym¬
phosarcoma tissue. In normal pigs a dose level of about
2mg/kg/day given subcutaneously twice daily resulted in
progressive bone marrow depression and although the dose
level was increased later the results were not dose-related.
Recovery was rapid when dosing was stopped. All types of
WBC, RBC and thrombocyte counts were affected. This also
occurs in man, though lymphocyte counts are said to be
barely affected. The only clinical effect noted was
slight weight loss and the vomiting and diarrhoea, oral in¬
flammation and ulceration, hepatic dysfunction, fevers and
skin rashes reported as side-effects in man were not seen
in the normal pigs. Two out of the four lymphosarcoma cases
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treated with cytarabine suffered from diarrhoea but this
may not have been caused by the drug. The results of
therapy were disappointing. One male actually deteriorated
and only one pig, the only female, showed any real
evidence of improvement in body condition, haematological
parameters and at autopsy. Though superficial lymph
nodes decreased in size by between 20 and 40% the response,
even in the female, was not good enough to be called a
partial remission. Enzyme kinetic studies suggested that
the advantages of high levels of DCK in the tumour tissue
would be lessened because the tumour enzyme was less ef¬
fective than the control enzyme in activating cytarabine.
Nevertheless, further studies could be carried out to de¬
termine whether the response could be improved by alter¬
ation of dose-level and scheduling or whether the poor
response was due to deactivation by cytidine deaminase
which could be inhibited by administration of tetrahy-
drouridine. In man, cytarabine is most frequently used
in cases of acute myeloid leukaemia, although it is
often effective in lymphoid tumours which do not respond
to standard therapy.
From the results of these trials, it appears that
the pig may be relatively resistant to some of the toxic
side-effects of anticancer agents. However, it must be
remembered that many of the side-effects reported in
humans only occur in a small proportion of patients treated
with a given drug and it would be unwise to draw conclusions
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based on experiments using such a small number of animals.
The normal pig trials were carried out to establish a
suitable dose-level for the lymphosarcoma cases and this
objective was achieved. The most important conclusions
concern the responses of the lymphosarcoma cases to
therapy. It has been shown clearly that hereditary por¬
cine lymphosarcoma is a valuable model for the chemo¬
therapy of lymphoma in man and companion animals because
of the vast amount of information which has been obtained
from serial detailed studies on a few animals. This
information is not only about different degrees of tumour
suppression with different agents and schedules but also
about aspects which are so important in clinical human
or veterinary medicine but cannot be investigated easily
using any other type of model i.e. the effects of the
drugs on animals which are in a poor nutritional state,
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